
<html lang="en"     class="pb-page"  data-request-id="a015efd0-61fb-480e-81fe-e4775d56510a"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2014.57.issue-19;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/jm500873e;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Thioaryl Naphthylmethanone Oxime Ether Analogs as Novel Anticancer Agents" /></meta><meta name="dc.Creator" content="Bandana  Chakravarti" /></meta><meta name="dc.Creator" content="Tahseen  Akhtar" /></meta><meta name="dc.Creator" content="Byanju  Rai" /></meta><meta name="dc.Creator" content="Manisha  Yadav" /></meta><meta name="dc.Creator" content="Jawed  Akhtar Siddiqui" /></meta><meta name="dc.Creator" content="Shailendra Kumar  Dhar Dwivedi" /></meta><meta name="dc.Creator" content="Ravi  Thakur" /></meta><meta name="dc.Creator" content="Anup Kumar  Singh" /></meta><meta name="dc.Creator" content="Abhishek Kumar  Singh" /></meta><meta name="dc.Creator" content="Harish  Kumar" /></meta><meta name="dc.Creator" content="Kainat  Khan" /></meta><meta name="dc.Creator" content="Subhashis  Pal" /></meta><meta name="dc.Creator" content="Srikanta Kumar  Rath" /></meta><meta name="dc.Creator" content="Jawahar  Lal" /></meta><meta name="dc.Creator" content="Rituraj  Konwar" /></meta><meta name="dc.Creator" content="Arun Kumar  Trivedi" /></meta><meta name="dc.Creator" content="Dipak  Datta" /></meta><meta name="dc.Creator" content="Durga Prasad  Mishra" /></meta><meta name="dc.Creator" content="Madan Madhav  Godbole" /></meta><meta name="dc.Creator" content="Sabyasachi  Sanyal" /></meta><meta name="dc.Creator" content="Naibedya  Chattopadhyay" /></meta><meta name="dc.Creator" content="Atul  Kumar" /></meta><meta name="dc.Description" content="Employing a rational design of thioaryl naphthylmethanone oxime ether analogs containing functional properties of various anticancer drugs, a series of compounds were identified that displayed pote..." /></meta><meta name="Description" content="Employing a rational design of thioaryl naphthylmethanone oxime ether analogs containing functional properties of various anticancer drugs, a series of compounds were identified that displayed pote..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 22, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm500873e" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm500873e" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm500873e" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm500873e" /></link>
        
    
    

<title>Thioaryl Naphthylmethanone Oxime Ether Analogs as Novel Anticancer Agents | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm500873e" /></meta><meta property="og:title" content="Thioaryl Naphthylmethanone Oxime Ether Analogs as Novel Anticancer Agents" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/large/jm-2014-00873e_0010.jpeg" /></meta><meta property="og:description" content="Employing a rational design of thioaryl naphthylmethanone oxime ether analogs containing functional properties of various anticancer drugs, a series of compounds were identified that displayed potent cytotoxicity toward various cancer cells, out of which 4-(methylthio)phenyl)(naphthalen-1-yl)methanone O-2-(diethylamino)ethyl oxime (MND) exhibited the best safety profile. MND induced apoptosis, inhibited migration and invasion, strongly inhibited cancer stem cell population on a par with salinomycin, and demonstrated orally potent tumor regression in mouse MCF-7 xenografts. Mechanistic studies revealed that MND strongly abrogated EGF-induced proliferation, migration, and tyrosine kinase (TK) signaling in breast cancer cells. However, MND failed to directly inhibit EGFR or other related receptor TKs in a cell-free system. Systematic investigation of a putative target upstream of EGFR revealed that the biological effects of MND could be abrogated by pertussis toxin. Together, MND represents a new nonquinazoline potential drug candidate having promising antiproliferative activity with good safety index." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm500873e"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm500873e">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm500873e&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm500873e&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm500873e&amp;href=/doi/10.1021/jm500873e" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 19</span><span class="cit-fg-pageRange">, 8010-8025</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/19" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm500872p" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm5008962" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Thioaryl Naphthylmethanone Oxime Ether Analogs as Novel Anticancer Agents</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bandana++Chakravarti">Bandana Chakravarti</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tahseen++Akhtar">Tahseen Akhtar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Byanju++Rai">Byanju Rai</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Manisha++Yadav">Manisha Yadav</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jawed++Akhtar+Siddiqui">Jawed Akhtar Siddiqui</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shailendra+Kumar++Dhar+Dwivedi">Shailendra Kumar Dhar Dwivedi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ravi++Thakur">Ravi Thakur</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anup+Kumar++Singh">Anup Kumar Singh</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Abhishek+Kumar++Singh">Abhishek Kumar Singh</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Harish++Kumar">Harish Kumar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kainat++Khan">Kainat Khan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Subhashis++Pal">Subhashis Pal</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Srikanta+Kumar++Rath">Srikanta Kumar Rath</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jawahar++Lal">Jawahar Lal</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rituraj++Konwar">Rituraj Konwar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Arun+Kumar++Trivedi">Arun Kumar Trivedi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dipak++Datta">Dipak Datta</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Durga+Prasad++Mishra">Durga Prasad Mishra</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Madan+Madhav++Godbole">Madan Madhav Godbole</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sabyasachi++Sanyal">Sabyasachi Sanyal</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Naibedya++Chattopadhyay">Naibedya Chattopadhyay</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Atul++Kumar">Atul Kumar</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Medicinal and Process Chemistry Division; <sup>‡</sup>Endocrinology Division, <sup>§</sup>Biochemistry Division, <sup>∥</sup>Toxicology Division, and <sup>⊥</sup>Pharmacokinetics and Metabolism Division, CSIR-Central Drug Research Institute, Lucknow 226031, India</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">#</span> <span class="aff-text">Department of Molecular Medicine and Biotechnology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, 226014, India</span></div><div class="corresp-info"><strong>*</strong>Tel.: +91-522-26 4967 1. Fax: +91-522-2623 4050. E-mail: <a href="/cdn-cgi/l/email-protection#640a3b070c0510100b1405000c1d051d240700160d4a1601174a0d0a"><span class="__cf_email__" data-cfemail="8be5d4e8e3eaffffe4fbeaefe3f2eaf2cbe8eff9e2a5f9eef8a5e2e5">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>Tel.: +91-522-26 1241 1. Fax: +91-522-2623 4050. E-mail: <a href="/cdn-cgi/l/email-protection#e286908396978e91839aa2858f838b8ecc818d8f"><span class="__cf_email__" data-cfemail="f094829184859c839188b0979d91999cde939f9d">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm500873e&amp;href=/doi/10.1021%2Fjm500873e" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 19</span><span class="cit-pageRange">, 8010–8025</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 8, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>10 June 2014</li><li><span class="item_label"><b>Published</b> online</span>22 September 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 October 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm500873e" title="DOI URL">https://doi.org/10.1021/jm500873e</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8010%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DBandana%2BChakravarti%252C%2BTahseen%2BAkhtar%252C%2BByanju%2BRai%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D19%26contentID%3Djm500873e%26title%3DThioaryl%2BNaphthylmethanone%2BOxime%2BEther%2BAnalogs%2Bas%2BNovel%2BAnticancer%2BAgents%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8025%26publicationDate%3DOctober%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm500873e"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1823</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">28</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm500873e" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Thioaryl Naphthylmethanone Oxime Ether Analogs as Novel Anticancer Agents&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Bandana&quot;,&quot;last_name&quot;:&quot;Chakravarti&quot;},{&quot;first_name&quot;:&quot;Tahseen&quot;,&quot;last_name&quot;:&quot;Akhtar&quot;},{&quot;first_name&quot;:&quot;Byanju&quot;,&quot;last_name&quot;:&quot;Rai&quot;},{&quot;first_name&quot;:&quot;Manisha&quot;,&quot;last_name&quot;:&quot;Yadav&quot;},{&quot;first_name&quot;:&quot;Jawed&quot;,&quot;last_name&quot;:&quot;Akhtar Siddiqui&quot;},{&quot;first_name&quot;:&quot;Shailendra&quot;,&quot;last_name&quot;:&quot;Kumar Dhar Dwivedi&quot;},{&quot;first_name&quot;:&quot;Ravi&quot;,&quot;last_name&quot;:&quot;Thakur&quot;},{&quot;first_name&quot;:&quot;Anup&quot;,&quot;last_name&quot;:&quot;Kumar Singh&quot;},{&quot;first_name&quot;:&quot;Abhishek&quot;,&quot;last_name&quot;:&quot;Kumar Singh&quot;},{&quot;first_name&quot;:&quot;Harish&quot;,&quot;last_name&quot;:&quot;Kumar&quot;},{&quot;first_name&quot;:&quot;Kainat&quot;,&quot;last_name&quot;:&quot;Khan&quot;},{&quot;first_name&quot;:&quot;Subhashis&quot;,&quot;last_name&quot;:&quot;Pal&quot;},{&quot;first_name&quot;:&quot;Srikanta&quot;,&quot;last_name&quot;:&quot;Kumar Rath&quot;},{&quot;first_name&quot;:&quot;Jawahar&quot;,&quot;last_name&quot;:&quot;Lal&quot;},{&quot;first_name&quot;:&quot;Rituraj&quot;,&quot;last_name&quot;:&quot;Konwar&quot;},{&quot;first_name&quot;:&quot;Arun&quot;,&quot;last_name&quot;:&quot;Kumar Trivedi&quot;},{&quot;first_name&quot;:&quot;Dipak&quot;,&quot;last_name&quot;:&quot;Datta&quot;},{&quot;first_name&quot;:&quot;Durga&quot;,&quot;last_name&quot;:&quot;Prasad Mishra&quot;},{&quot;first_name&quot;:&quot;Madan&quot;,&quot;last_name&quot;:&quot;Madhav Godbole&quot;},{&quot;first_name&quot;:&quot;Sabyasachi&quot;,&quot;last_name&quot;:&quot;Sanyal&quot;},{&quot;first_name&quot;:&quot;Naibedya&quot;,&quot;last_name&quot;:&quot;Chattopadhyay&quot;},{&quot;first_name&quot;:&quot;Atul&quot;,&quot;last_name&quot;:&quot;Kumar&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;22&quot;,&quot;issue&quot;:&quot;19&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;8010-8025&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm500873e&quot;},&quot;abstract&quot;:&quot;Employing a rational design of thioaryl naphthylmethanone oxime ether analogs containing functional properties of various anticancer drugs, a series of compounds were identified that displayed potent cytotoxicity toward various cancer cells, out of which 4-(methylthio)phenyl)(naphthalen-1-yl)methanone O-2-(diethylamino)ethyl oxime (MND) exhibited the best safety profile. MND induced apoptosis, inhibited migration and invasion, strongly inhibited cancer stem cell population on a par with salinomycin, and demonstrated orally potent tumor regression in mouse MCF-7 xenografts. Mechanistic studies revealed that MND strongly abrogated EGF-induced proliferation, migration, and tyrosine kinase (TK) signaling in breast cancer cells. However, MND failed to directly inhibit EGFR or other related receptor TKs in a cell-free system. Systematic investigation of a putative target upstream of EGFR revealed that the biological effects of MND could be abrogated by pertussis toxin. Together, MND represents a new nonquinazoline &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500873e&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500873e" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500873e&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500873e" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500873e&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500873e" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm500873e&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500873e&amp;href=/doi/10.1021/jm500873e" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm500873e" /></input><a href="/doi/pdf/10.1021/jm500873e" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (9 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm500873e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm500873e%26sid%3Dliteratum%253Aachs%26pmid%3D25198997%26genre%3Darticle%26aulast%3DChakravarti%26date%3D2014%26atitle%3DThioaryl%2BNaphthylmethanone%2BOxime%2BEther%2BAnalogs%2Bas%2BNovel%2BAnticancer%2BAgents%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D19%26spage%3D8010%26epage%3D8025%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/19" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jmcmar.2014.57.issue-19/20141009/jmcmar.2014.57.issue-19.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/medium/jm-2014-00873e_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/large/jm-2014-00873e_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500873e&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Employing a rational design of thioaryl naphthylmethanone oxime ether analogs containing functional properties of various anticancer drugs, a series of compounds were identified that displayed potent cytotoxicity toward various cancer cells, out of which 4-(methylthio)phenyl)(naphthalen-1-yl)methanone <i>O</i>-2-(diethylamino)ethyl oxime (<b>MND</b>) exhibited the best safety profile. <b>MND</b> induced apoptosis, inhibited migration and invasion, strongly inhibited cancer stem cell population on a par with salinomycin, and demonstrated orally potent tumor regression in mouse MCF-7 xenografts. Mechanistic studies revealed that <b>MND</b> strongly abrogated EGF-induced proliferation, migration, and tyrosine kinase (TK) signaling in breast cancer cells. However, <b>MND</b> failed to directly inhibit EGFR or other related receptor TKs in a cell-free system. Systematic investigation of a putative target upstream of EGFR revealed that the biological effects of <b>MND</b> could be abrogated by pertussis toxin. Together, <b>MND</b> represents a new nonquinazoline potential drug candidate having promising antiproliferative activity with good safety index.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81674" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81674" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Tyrosine kinases (TK) are important mediators of signal transduction and cellular communication and has been well studied pertaining to their roles in cancer.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> TK inhibitors targeting both receptor and nonreceptor tyrosine kinases (RTK and NRTK, respectively) have been widely investigated and a number of such inhibitors have been approved for treatment against various cancers, expressing their target receptors.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a></div><div class="NLM_p last">A detailed analysis of the published information regarding the efficacies and mechanisms of action of these kinase inhibitors, however, raised some interesting points that remain unexplained. First, some of these inhibitors have been reported to inhibit cell proliferation and induce apoptosis in cells lacking their cognate targets, for example, inhibitors of epidermal growth factor receptor (EGFR) and human EGF receptor 2 (Her2) including gefitinib (Iressa), lapatinib, and erlotinib, induce apoptosis and differentiation in acute and chronic myelogenous leukemia (AML and CML respectively) cell lines and patient samples that are devoid of EGFR or Her2 expression.<a onclick="showRef(event, 'ref2 ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5">(2-5)</a> Here, it is important to note that kinase interaction profile for lapatinib exhibits extreme specificity, where this compound inhibits only 4 out of 133 kinases tested.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> These findings, together with available kinase profiling data for gefitinib and erlotinib<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and the ATP binding cassette (ABC) transporter inhibitory activities of these drugs,<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> indicate that at least the antileukemic activities of these drugs could be kinase-independent. Second, despite exhibiting distinct kinase inhibitory profile, most of the kinase inhibitor drugs including EGFR inhibitors that have been named previously, BCR-ABL inhibitors (Imatinib, Dasatinib and Nilotinib), FLT3 inhibitors (Sorafenib/BAY43-9006, Sunitinib/SU11248), and CDK inhibitors (Roscovitine and Flavopiridol) induce mitochondria-mediated apoptosis;<a onclick="showRef(event, 'ref2 ref9 ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref2 ref9 ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref17">(2, 9-17)</a> however, the mechanism behind the mitochondrial damage and consequent rapid induction of apoptosis by these drugs that are expected to arrest cell growth remains elusive. Based on above observations we first asked if there exists a commonality in the structure of kinase inhibitors, which could be responsible for their apoptosis-inducing functions. Here we report the chemical synthesis of a new variety of nonquinazoline/nonpyrimidine compounds that were based on the commonality across some of the major chemotherapeutic pharmacophores in the area of TK inhibitors and detailed characterization of one of these compounds, referred to here as MND, that displayed robust cancer cell-specific cytotoxicity.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Rationale for Design</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31637" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31637" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Structurally numerous TK inhibitors can be divided into having three major regions—“Base” (A), “Crown” (B), and a “Hinge” (C), with an aminoalkyl side chain as an additional arm. The base region that is mostly used in TKIs is aminoquinazoline (gefitinib, vandetanib, erlotinib, lapatinib, and afatinib),<a onclick="showRef(event, 'ref18 ref19 ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20 ref21 ref22">(18-22)</a> aminopyrimidine (nilotinib, imatinib, bafetinib, dasatinib, taundutinib, and saracatinib),<a onclick="showRef(event, 'ref23 ref24 ref25 ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25 ref26 ref27 ref28">(23-28)</a> or aminoquinoline (bosutinib)<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and aminopurines (roscovitine).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> We replaced the base moiety with naphthalene because a number of scaffolds with a naphthalene base such as resveratrol analog,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> adamantyl phenyl naphthalenes,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> furyl naphthalene derivatives,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> and doramapimod<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> exhibit promising anticancer activity. The crowns in all the TKIs are aryl moieties, and in our design we kept the same aryl system intact. Structural analyses of all the TKIs revealed that the hinge region is highly conserved and all the active TKIs have amino functionality.<a onclick="showRef(event, 'ref35 ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37">(35-37)</a> To explore if alterations of this conserved hinge region amino functionality could improve cytotoxic potency, we modified this region with oxime. It is important to note that a number of anticancer agents such as (hydroxyimino) naphthofuranones, methoxyphenyl oximes, and piperazinyl indenoquinolinone have oxime functionality as pharmacophores (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref38 ref39 ref40">(38-40)</a> Together, the newly designed scaffold consists of three main components, i.e., naphthalene as nucleus, oxime, and its alkyl amino derivatives as functional group in the hinge region and an aryl moiety constituting the crown. The attachment of substituted phenyl ring over naphthalene has been done at the C-1 position of the naphthalene ring, keeping in mind the attachments in gefitinib and vandetanib. The synthesized compounds together with intermediate oxime yielded a novel phenyl naphthalen-1-yl methanone oxime series that were then evaluated for their antiproliferative and cytotoxic activities in various human cancer cells (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). One such derivative, <b>MND</b> (4-(methylthio)phenyl)(naphthalen-1-yl)methanone <i>O</i>-2-(diethylamino)ethyl oxime stood out in these screens (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) and was selected as lead molecules for detailed mechanism of action.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/medium/jm-2014-00873e_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/large/jm-2014-00873e_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Designing strategy of thioaryl naphthylmethanone oxime ether analogs. Base (A) of the designed pharmacophore is taken from natural product resveratrol, whereas the crown (B) part is kept as aryl system as in most TKIs. The major portion is contributed by the hinge (C) which is based on novel oxime and their corresponding ether alkyl amine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/large/jm-2014-00873e_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500873e&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Synthesis of Thioaryl Naphthylmethanone Oxime Ether Analogs<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> and EC<sub>50</sub> Values in Different Cancer Cell Lines (in μM) after 24 h Treatment</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/medium/jm-2014-00873e_0008.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/medium/jm-2014-00873e_0009.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Reactions were conducted under anhydrous conditions.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Isolated yields.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">Microwave assisted reaction 120 °C. The EC<sub>50</sub> values of compounds were determined from dose response curve (doses 100 nM to 50 μM) using GraphPad Prism 3.02 software. Compounds which were not tested listed as N.D. Abbreviations; N.D. (Not done), and Int. (Intermediate products).</p></div></div><div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48420" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48420" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Chemistry</h3><div class="NLM_p">Ketones <b>3a</b>–<b>3b</b> were synthesized via Friedel-Craft acylation of 1-napthoic acid <b>1</b> with thioanisole/anisole <b>2</b> according to the published procedure.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Ketone <b>3</b> on reaction with hydroxylamine hydrochloride yielded oxime <b>4</b>. Intermediate <b>4</b> on Williamson <i>O</i>-alkylation with haloalkyl amines or dihaloalkanes afforded compound <b>5a</b>–<b>k</b> and <b>6a</b>–<b>i</b>. Compounds <b>7a</b>–<b>e</b> and <b>8a</b>–<b>d</b> were synthesized from <b>5j</b> and <b>5k</b>, respectively, on reaction with excess of corresponding amines. Oxime <b>4</b> on reaction with ethylbromoacetate gave <b>5l</b> which on amidation in microwaves yielded <b>5m</b>. Subsequent treatment of compounds <b>5</b>, <b>6</b>, and <b>7</b> with organic acids in methanol leads to the formation of corresponding salts (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). These compounds were tested against several cancer cell lines including MCF-7, MDA-MB231, DU-145, Ishikawa, and HeLa.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/medium/jm-2014-00873e_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/large/jm-2014-00873e_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Chemical Synthesis of Thioarylnaphthylmethanone Oxime Ether Analogs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/large/jm-2014-00873e_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500873e&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagent and conditions: (a) NH<sub>2</sub>OH·HCl, pyridine, ethanol, anhyd., reflux; (b) haloalkylamines, K<sub>2</sub>CO<sub>3</sub>, acetone/DMF, anhyd., reflux; (c) dihaloalkanes, K<sub>2</sub>CO<sub>3</sub>, Acetone/DMF, anhyd., reflux; (d) primary or secondary amines, MeOH/DMF, anhyd., reflux; (e) organic acid, dry methanol, dry ether; (f) ethylbromoacetate, K<sub>2</sub>CO<sub>3</sub>, acetone, anhyd., reflux; (g) <i>t</i>-BuOK, diethylamine, microwave assisted reaction, 120 °C.</p></p></figure></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Biological Evaluation</h3><div id="sec3_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i8" class="anchor-spacer"></div><h4 class="article-section__title" id="_i8"> Antiproliferative Effect of Novel Thioaryl Naphthylmethanone Oxime Ether Analogs in Cancer and Noncancer Cells</h4><div class="NLM_p">The synthesized compounds were first screened for their antiproliferative activity in various human endocrine cancer cell lines including MCF-7 (breast, ER positive), MDA-MB-231(breast, ER negative), DU-145 (prostate, androgen receptor positive), Ishikawa (endometrial adenocarcinoma, ER positive), and HeLa (cervical cancer) using MTT assay. The EC<sub>50</sub> values (effective concentration or drug concentration at which 50% inhibition of cell proliferation occurs) in various cell lines are presented in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. Out of these, five compounds (<b>5b</b>, <b>5d</b>,<b> 5i</b>, <b>7a</b>, and <b>8a</b>) caused loss of viability of breast cancer cells at concentrations that were comparable to either Raloxifene or Hydroxy-tamoxifen (OH-TAM) and Gefitinib (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><div class="NLM_p">Because specific cytotoxicity toward the cancer cells without affecting normal cell growth is a key safety feature of cancer chemotherapy, assessments of growth inhibition by <b>5b</b>, <b>5d</b>, <b>5i</b>, <b>7a</b>, and <b>8a</b> were made in mammary epithelial cell line (MCF-10A). We next determined the safety indices [the ratio between the concentration of an agent causing cytotoxicity of normal breast cells and the concentration causing cytotoxicity of cancer cell lines; IC<sub>50</sub>/EC<sub>50</sub>] of <b>5b</b>, <b>5d</b>, <b>5i</b>, <b>7a</b>, <b>8a</b>, OH-TAM, and gefitinib at 72 h. Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> show much greater safety index of <b>5d</b> and <b>5i</b> over OH-TAM and gefitinib in MCF-7 and MDA-MDA-231 cells. Out of the compounds tested, <b>5d</b> exhibited much higher IC<sub>50</sub> values in the normal cells compared to breast cancer cells (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), and thus was selected as the lead compound (further abbreviated and addressed as <b>MND</b> henceforth). <b>MND</b> also displayed cytotoxicity in colon cancer cells with a much higher efficacy and greater safety index as compared to a human noncancerous epithelial cell line (HEK-293) than the chemotherapeutic drug 5-fluorouracil (5-FU) except in the DLD1 cell line (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Safety Indexes of Compounds at 72 h<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">safety index IC<sub>50</sub>/EC<sub>50</sub></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">activity/treatments</th><th class="colsep0 rowsep0" align="center">MCF-7 (EC<sub>50</sub>)</th><th class="colsep0 rowsep0" align="center">MDA-MB231 (EC<sub>50</sub>)</th><th class="colsep0 rowsep0" align="center">MCF-10A (IC<sub>50</sub>)</th><th class="colsep0 rowsep0" align="center" char=".">MCF-7</th><th class="colsep0 rowsep0" align="center" char=".">MDA-MB231</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5b</b></td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">3.8</td><td class="colsep0 rowsep0" align="left">5.5</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5d</b></td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="char" char=".">16.6</td><td class="colsep0 rowsep0" align="char" char=".">50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5i</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">5.6</td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="char" char=".">30</td><td class="colsep0 rowsep0" align="char" char=".">5.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7a</b></td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8a</b></td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">18</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">OH-TAM</td><td class="colsep0 rowsep0" align="left">7.4</td><td class="colsep0 rowsep0" align="left">7.8</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="char" char=".">13.5</td><td class="colsep0 rowsep0" align="char" char=".">1.28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Gefitinib</td><td class="colsep0 rowsep0" align="left">35</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="char" char=".">0.857</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">EC<sub>50</sub> and IC<sub>50</sub> values are in μM.</p></div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Safety Indexes of Compounds in Colon Cancer Cell Line<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" colspan="8" align="center">compound</th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">safety index (IC<sub>50</sub>/EC<sub>50</sub>)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">SW620 (EC<sub>50</sub>)</th><th class="colsep0 rowsep0" align="center" char=".">DLD1 (EC<sub>50</sub>)</th><th class="colsep0 rowsep0" align="center">HCT116 (EC<sub>50</sub>)</th><th class="colsep0 rowsep0" align="center" char=".">Colo205 (EC<sub>50</sub>)</th><th class="colsep0 rowsep0" align="center">Vero (IC<sub>50</sub>)</th><th class="colsep0 rowsep0" align="center">NIH3T3 (IC<sub>50</sub>)</th><th class="colsep0 rowsep0" align="center">HEK-293(IC<sub>50</sub>)</th><th class="colsep0 rowsep0" align="center" char=".">SW620</th><th class="colsep0 rowsep0" align="center" char=".">DLD1</th><th class="colsep0 rowsep0" align="center" char=".">HCT116</th><th class="colsep0 rowsep0" align="center" char=".">Colo205</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MND</td><td class="colsep0 rowsep0" align="left">8.78</td><td class="colsep0 rowsep0" align="char" char=".">15.6</td><td class="colsep0 rowsep0" align="left">7.7</td><td class="colsep0 rowsep0" align="char" char=".">4.2</td><td class="colsep0 rowsep0" align="left">>25</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="char" char=".">4.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-FU</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="char" char=".">16.3</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="char" char=".">38.06</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">48.7</td><td class="colsep0 rowsep0" align="char" char=".">0.97</td><td class="colsep0 rowsep0" align="char" char=".">2.98</td><td class="colsep0 rowsep0" align="char" char=".">0.97</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">EC<sub>50</sub> and IC<sub>50</sub> values are in μM.</p></div></div></div></div><div id="sec3_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11"> Effects of MND on Reversibility of Cell Growth, Apoptosis, and Cell Cycle of Breast Cancer Cells</h4><div class="NLM_p">First, we determined if the antiproliferative effect of <b>MND</b> in MCF-7 and MDA-MB-231 was reversible. To this end, cells were first treated with different concentrations of <b>MND</b> for 24 h and then were maintained in drug free medium for a further 72 h, and as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>a, at <b>MND</b> concentrations up to 5 μM, the growth recovery was ∼50% in MCF-7 and ∼20% in MDA-MB-231. However, beyond 5 μM, no growth recovery in either cell type was noted (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>a). This antiproliferative effect of <b>MND</b> was associated with apoptosis as determined by Annexin V/PI staining followed by flow cytometric analysis (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>b). Consistent with the lower IC<sub>50</sub> of <b>MND</b> for MDA-MB-231 in MTT assay, the apoptosis-inducing effect of <b>MND</b> was stronger in MDA-MB-231 than in MCF-7 cells (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>b).</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/medium/jm-2014-00873e_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/large/jm-2014-00873e_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. MND irreversibly inhibits cell growth, and induces apoptosis and cell cycle arrest of MCF-7 and MDA-MB-231 cells. (a) Cells were exposed to <b>MND</b> for 24 h (MCF-7–24 h, MDA-MB-231-24h) after which they were allowed to recover for 72 h in drug free medium (MCF-7-W, MDA-MB-231-W), and cell viability was determined by MTT assay. (b) Apoptosis was assessed at indicated concentration by flow cytometry using the FL1-H channel (Annexin-V) and FL2-H channel (PI) of a Becton Dickinson FACS Calibur. Shown are representative dot plots. (c) Caspase-8, caspase-9, and caspase-3 activity was determined by Caspase-Glo 8, 9, and 3 Assay kit. (d) Cell viability was determined by MTT assay in the presence of <b>MND</b> with or without caspase-inhibitors. (e) Membrane potential (<b>Δ</b><i><b>Ψ</b></i><b>m</b>) were assessed by JC-1 staining using flow cytometry analysis. (f) Immunoblotting of Bax and Bcl-2 protein. Protein loading was controlled with an anti-actin. (g) Cell cycle distribution was assessed by flow cytometry. Quantification of flow cytometry data has been shown as the percent of cells in different phases. (h) MCF-7 and (i) MDA-MB-231. Cells were treated with <b>MND</b> (1 μM). (j) MCF-7 and (k) MDA-MB-231 for the indicated length of time. Cell lysates were used for Western blot to detect the protein levels of cyclin D1 and p27. Protein loading was controlled with an anti-actin. Data presented as mean ± SEM from three independent experiments; *<i>P</i> < 0.05, **<i>P</i> < 0.01, and ***<i>P</i> < 0.001 compared to vehicle (<i>N</i> = 3). As indicated *<i>a</i> < 0.05, **<i>b</i> < 0.01, and ***<i>c</i> < 0.001 compared with <b>MND</b> alone.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/large/jm-2014-00873e_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500873e&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p"><b>MND</b> induced both caspase-8 and caspase-9 activities in MCF-7 and MDA-MB-231 cells (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>c), indicating that both extrinsic and intrinsic pathways of apoptosis are activated by <b>MND</b>. In addition, <b>MND</b> activated caspase-3 in MDA-MB-231 but not in MCF-7 cells (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>c). Consistent with the increase in caspases, pan caspase inhibitor (z-VAD-FMK), caspase-8 inhibitor (z-IETD-FMK), and caspase 9 inhibitor (z-LEHD-FMK) protected against <b>MND</b>-induced loss of viable cells (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>d). <b>MND</b> activation of the mitochondrial death pathway was illustrated by <b>MND</b>-induced loss of mitochondrial membrane potential (indicating mitochondrial damage) (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>e) and increased in Bax-to-Bcl2 ratio in both MCF-7 and MDA-MB-231 cells (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>f). From these findings, it appears that treatment with <b>MND</b> leads to initiation of the both Type I and Type II apoptotic programs via the disruption of mitochondrial function.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></div><div class="NLM_p last">Analysis of cell cycle phase distribution by flow cytometry revealed that <b>MND</b> caused greater cell accumulation in the G1 phase and decrease in the S phase (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>g–i). Consistent with G1 arrest, <b>MND</b> decreased cyclin D1 and increased p27 protein levels (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>j, k).</div></div><div id="sec3_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> Effects of MND on Migration and Invasion</h4><div class="NLM_p">We next investigated the effect of <b>MND</b> on migration and invasion of MDA-MB-231 cells. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>a, <b>MND</b> caused a significant decrease (<i>p</i> < 0.01) in the number of cells that have migrated toward free space in a wound healing assay. <b>MND</b> also inhibited number of invaded cells in the Matrigel coated invasion chamber (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>b). Phosphatase and tensin homologue (PTEN) is frequently disrupted in cancer and has been reported to govern multiple processes of tumor biology including survival, proliferation, energy metabolism, and motility.<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43, 44)</a> Consistent with the inhibition of cellular proliferation, migration, and invasion, <b>MND</b> significantly increased PTEN expression (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>c). <b>MND</b> also inhibited the mRNA expressions of multiple markers of breast cancer migration and invasion, including vascular endothelial growth factor-A (VEGF-A), transforming growth factor b1 (TGF-β1), metastasis-associated protein 1 (MTA1), and matrix metaloprotease-9 (MMP-9); however, it did not affect VEGF-C and TGF-βR1 (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>c). CDC42 and PAI-1 are also known to play key roles in cancer invasion and metastasis,<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45, 46)</a> and <b>MND</b> significantly inhibited CDC42 protein level and secreted PAI-1 in MDA-MB-231 cells (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>d, e).</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/medium/jm-2014-00873e_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/large/jm-2014-00873e_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. MND inhibits migration and invasion of breast cancer cells. (a) MDA-MB-231 cells were treated with <b>MND</b> (1 μM) for 24 h. Afterwards, the photograph was taken and cell migration was determined using image analysis software (Image-Pro Plus 6.1.0). (b) MCF-7 and MDA-MB-231 cells were placed in the upper Matrigel invasion chamber or <b>MND</b> (1 μM) in the bottom chamber for 24 h. Invaded cells were stained with crystal violet and quantified by measuring the absorbance of dissolved crystals in 0.1% SDS at 540 nm. (c) MDA-MB-231 cells were treated with <b>MND</b> (1 μM) for 24 h and qPCR was performed to measure PTEN, VEGF-A, VEGF-C, TGF-β1, TGF-β1R, MTA-1, and MMP-9. (d) CDC42 was analyzed in <b>MND</b> (1 μM) treated MDA-MB-231 cells for 24 h by ELISA. CDC42 control protein was used as a positive control (provided in kit). (e) MDA-MB-231 cells were treated with <b>MND</b> (1 μM) for 24 h and conditioned medium was collected and subjected for detection of secreted PAI-1 using ELISA. Data represent mean ± SEM *<i>P</i> < 0.05, **<i>P</i> < 0.01, and ***<i>P</i> < 0.001 compared to vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/large/jm-2014-00873e_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500873e&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> Effect of MND on Xenograft Tumor</h4><div class="NLM_p">The effect of <b>MND</b> on the growth of MCF-7 xenograft tumor was studied. Injection of MCF-7 cells in the peritoneal cavity of NIH-III strain of nude mice resulted in the appearance of palpable tumors that rapidly grew from 9 to 29 d. Beyond 29 d, vehicle treated mice bearing tumors (control) show significant mortality (data not shown). Administration of <b>MND</b> (8 and 16 mg/kg p.o.doses) to mice for 29 d resulted in no significant differences in the initial and final body weights when compared with controls (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>a). Mean tumor volume was nearly 50% less in mice receiving <b>MND</b> at 16 mg/kg dose compared to vehicle treated mice on days 25 and 29 following the inoculation of MCF-7 cells (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>b). Mean tumor volume was not different between the vehicle and <b>MND</b> at 8 mg/kg treated mice (<a class="ref internalNav" href="#notes-2" aria-label="Supporting Information Figure S2">Supporting Information Figure S2</a>).</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/medium/jm-2014-00873e_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/large/jm-2014-00873e_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Regression of xenograft tumor by MND in athymic nude mice. (a) Effect of MND on body weight over time in various treatment groups indicated. <i>N</i> = 10 mice/group. (b) Increase in relative tumor volume over time in various treatment groups indicated. <i>N</i> = 10 mice/group; data represent mean ± SEM. *<i>P</i> < 0.05 and **<i>P</i> < 0.01 compared to control. (c) Effect of <b>MND</b> treatment on tumor morphology. Representative tumor sections from mice treated with vehicle or <b>MND</b> (16 mg.kg<sup>–1</sup>.day<sup>–1</sup>) for 25 days. (d) Effect of <b>MND</b> treatment on DNA fragmentation of tumors. Representative tumor sections from mice treated with vehicle or <b>MND</b> for 29 days were stained for TUNEL and quantified using image analysis software; *<i>P</i> < 0.05. (e) Effect of <b>MND</b> treatment on PCNA levels were analyzed by Western blotting in tumors of vehicle or <b>MND</b> treated mice, *<i>P</i> < 0.05. (f) mRNA levels of Bcl-2, Bax, and cyclin D1 were measured by qPCR from the tumors of vehicle or <b>MND</b> treated mice; *<i>P</i> < 0.05 compared to control. Error bars represent SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/large/jm-2014-00873e_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500873e&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Histological assessment showed that tumors from vehicle-treated mice were primarily composed of tumor epithelial cells with small amounts of mouse-derived stroma and frequent blood vessels. Tumors from mice treated with <b>MND</b> presented with large areas of stroma where deletion of epithelial cells had occurred as evident from few mitotic figures (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>c). Representative sections with TUNEL staining (indicative of DNA fragmentation) are presented in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>d. Nuclei of epithelial cells in MCF-7 tumors from control mice were generally negative for DNA fragmentation. In contrast, sections of tumors from <b>MND</b> treated mice exhibited a high prevalence of TUNEL positive cells. Quantitative analysis shows >50% increase in the percentage of TUNEL-positive cells in tumors from <b>MND</b> treated mice compared with that in tumors from control mice (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>d). In addition, a significant reduction in the levels of PCNA (marker of proliferation) was observed in tumors from <b>MND</b> treated mice compared to control (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>e). Consistent with increased apoptosis, we observed significantly elevated Bax-to-Bcl-2 ratio and down-regulation of cyclin D1 (corroborating our <i>in vitro</i> data indicating G1 arrest by <b>MND</b>) in the tumors of <b>MND</b> treated mice compared to control (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>f).</div></div><div id="sec3_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> Effect of MND on Cancer Stem Cells</h4><div class="NLM_p">Cancer stem cells (CSCs) are implicated in disease relapse and drug resistance,<a onclick="showRef(event, 'ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref47 ref48">(47, 48)</a> and thus the ability to target this subpopulation could represent an extremely attractive property in an anticancer therapeutic. Since one of the properties of CSCs is anchorage-independent growth, leading to colony formation,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> the effect of <b>MND</b> was first evaluated in a mammosphere formation assay, and as demonstrated in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>a <b>MND</b> strongly inhibited mammosphere formation in MDA-MB-231 cells.</div><div class="NLM_p">Since aldehyde dehydrogenase 1 (ALDH1) is an established CSC marker in breast cancer cells,<a onclick="showRef(event, 'ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref49 ref50">(49, 50)</a> we also evaluated the effect of <b>MND</b> on ALDH1 +ve cells by flow cytometry and consistent with its mammosphere inhibiting property <b>MND</b> remarkably reduced ALDH1 +ve MDA-MB-231 cells (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>b).</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/medium/jm-2014-00873e_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/large/jm-2014-00873e_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. MND inhibits mammosphere formation and cancer stem cell load. (a) MDA-MB-231 cells seeded at a density of 1000 cells per well in 12-well low-attachment plates were treated with various concentration (5 μM, 10 μM, and 20 μM) of <b>MND</b> and Salinomycin. After 8 days, mammospheres were counted and photographed. Shown are representative mammosphere pictures (magnification 40×) and quantitation of mammosphere-forming efficiency of MDA-MB-231 cells in presence or absence of <b>MND</b> and Salinomycin. (b) MDA-MB-231 cells derived mammospheres were treated with the indicated concentrations of <b>MND</b> and salinomycin for 24 h. Cells at 1 × 10<sup>6</sup> cells per mL were then incubated with activated ALDEFLUOR substrate. DEAB (ALDH1 inhibitor) was used to establish the baseline fluorescence of each sample and to define the ALDEFLUOR-positive region. FACS analysis using the SSC and FL1-H channel (ALDEFLOUR) was performed to examine ALDEFLOUR high-ALDH1 positive population in MDA-MB-231 cells. Shown are the representative dot plots. (c) Colon cancer stem cells were treated with the indicated concentrations of <b>MND</b>, 5-FU, and salinomycin for 24 h. Cells (1 × 10<sup>6</sup>) were then incubated with CD133 antibody and analyzed by flow cytometry using FL-1 and FL-2 channels.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/large/jm-2014-00873e_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500873e&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Cluster of differentiation 133 (also known as Prominin 1) is an established marker for colon cancer stem cells.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Since, <b>MND</b> exhibited cytotoxicity toward colon cancer cells (<a class="ref internalNav" href="#notes-2" aria-label="Supporting Information Table 4">Supporting Information Table 4</a>), we tested if it reduced CSC subpopulation in colon cancer cells as well, and as evident in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>c, <b>MND</b> remarkably reduced CD133 +ve colon CSCs in DLD-1 cells. The efficacy of <b>MND</b> in these assays was comparable to an established CSC inhibitor, salinomycin.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></div></div><div id="sec3_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> Effect of MND on EGFR Signaling</h4><div class="NLM_p">Given that <b>MND</b> was designed based on TKIs, to define its mechanism of action, first its ability to prevent enhancement of viability by a panel of tumorigenic growth factors/cytokines such as epidermal growth factor (EGF), VEGF, insulin like growth factor-1 (IGF-1), insulin (INS), and TGF-β were tested. In the absence of <b>MND</b>, EGF, VEGF, and IGF-1, increased viability of MCF-7 cells, whereas TGFβ inhibited it, and INS had no significant effect (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>a). In MDA-MB-231 cells, EGF, VEGF, and TGFβ increased cell viability but IGF-1 and INS had no effect (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>a). Treatment with <b>MND</b> completely abolished the effect of EGF in both MCF-7 and MDA-MB-231 cells, but it failed to affect cell viability induced by other growth factors/cytokines (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>a).</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/medium/jm-2014-00873e_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/large/jm-2014-00873e_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. <b>MND</b> inhibits EGFR signaling in breast cancer cells. (a) Cell viability (MTT assay) of MCF-7 and MDA-MB-231 cells, treated with a panel of growth factors alone (Vehicle-V) or in the presence of <b>MND</b> (5 μM) as indicated. (b) p-EGFR at different tyrosine residues pTyr1068, pTyr845, and pTyr1173 were analyzed by ELISA. (c) p-EGFR was determined by immunoblotting of whole cell lysates with antibodies to the indicated proteins. (d) p-HER2 was measured using ELISA. (e) Total and phosphorylated levels of ERK, AKT, STAT1, and STAT3 were determined by Western blot. (f) Invasion of MDA-MB-231 cells was analyzed by Matrigel-coated invasion chamber assay. (g) Protein level of p-ELK-1, ELK-1, Mcl-1, and β-actin (loading control) were determined by Western blot method. (h) Secreted PAI-1 was determined using ELISA. (i) % migration was determined by scratch wound healing assay. (j) Protein levels of p-FAK-Tyr397, and total FAK were determined by Western blotting. (k) Tyrosine kinase profiling in cell free assay system with <b>MND</b> (10 μM). (l) cAMP level was measured using an HTRF-based kit and normalized with protein content. (m) Intracellular Ca<sup>2+</sup> was analyzed using flow cytometry. (n) Phosphodiesterase activity was determined in MDA-MB-231 cells. (o) Cell viability (MTT assay) of MDA-MB-231 cells, treated with <b>MND</b> (5 μM) in the presence of Pertussis toxin (PTX) 100 ng/mL and Cholera toxin (CTX) 100 ng/mL for 16 h. Data represent mean ± SEM. *<i>P</i> < 0.05, **<i>P</i> < 0.01, and ***<i>P</i> < 0.001 compared to control. As indicated, *<i>a</i> < 0.05, **<i>b</i> < 0.01, ***<i>c</i> < 0.001 compared with EGF.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/large/jm-2014-00873e_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500873e&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We thus investigated if <b>MND</b> could inhibit TK activity of the EGF receptor (EGFR), since its overexpression and activation do correlate with neoplastic progression.<a onclick="showRef(event, 'ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref53 ref54">(53, 54)</a> Treatment with increasing concentration of <b>MND</b> (0.1–1 μM) inhibited EGF-induced phosphorylation of EGFR at different tyrosine residues: Tyr<sup>1068</sup> at 0.5 μM, Tyr<sup>1173</sup> at 0.1 μM, and Tyr<sup>845</sup> at 1 μM (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>b). <b>MND</b> also inhibited EGF-induced EGFR phosphorylation at Tyr<sup>1148</sup>, Tyr<sup>1045</sup>, and Tyr<sup>992</sup> at 1 μM, without affecting the level of total EGFR (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>c). Further, <b>MND</b> also inhibited EGF-stimulated phosphorylation of human EGFR receptor 2 (HER2) at 1 μM in MDA-MB-231 cells (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>d), and its efficacy against p-EGFR and p-HER2 appeared to be higher than that against AG1478 and gefitinib (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>b, d). We also attempted to evaluate the effect of <b>MND</b> on phosphorylations of ErbB3 and ErbB4; however, we failed to detect these proteins inMDA-MB-231 cells by ELISA (data not shown).</div><div class="NLM_p last">Consistent with its inhibition of EGFR phosphorylation, <b>MND</b> inhibited EGF-induced phosphorylation of ERK1/2, AKT, STAT-3, but had no effect on STAT-1 (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>e). <b>MND</b> also inhibited the basal level of p-ERK1/2; however, it failed to affect basal levels of p-AKT, p-STAT-1, and p-STAT-3 (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>e).</div></div><div id="sec3_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> Effect of MND on EGF-Induced Migration and Invasion</h4><div class="NLM_p">Since EGF induction of breast cancer cell invasion and migration is well-known,<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> we evaluated the effect of <b>MND</b> on EGF-induced invasion and migration ofMDA-MB-231 cells using various assays. <b>MND</b> significantly inhibited EGF-induced invasion of MDA-MB-231 cells through matrigel (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>f). EGF is known to activate transcription factor ELK-1 and through it induces the expression of plasminogen activator inhibitor-1 (PAI-1) (a chemo attractant involved in breast cancer invasion and migration<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a>) and myeloid cell leukemia-1 (MCL-1).<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> The latter is an anti-apoptotic member of the BCL2 family, that has been linked to high tumor grade and poor patient survival<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> and along with enhancing tumor survival is also known to influence cell migration, invasion, and colony forming ability.<a onclick="showRef(event, 'ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref58 ref59">(58, 59)</a> We therefore evaluated the ability of <b>MND</b> to influence these factors and <b>MND</b> at 1 μM inhibited both basal and EGF- induced levels of pELK-1, Mcl-1, and PAI-1 in MDA-MB-231 cells (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>g, h).</div><div class="NLM_p">Consistent with Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, <b>MND</b> inhibited both basal and EGF-induced migration of MDA-MB-231 cells (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>i). Focal adhesion kinase (FAK) activation has been found to be a key component of cellular migration, especially in the context of growth factor-induced migration,<a onclick="showRef(event, 'ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref60 ref61">(60, 61)</a> and <b>MND</b> inhibited both basal and EGF-induced FAK phosphorylation at Tyr<sup>397</sup> (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>j).</div><div class="NLM_p last">Since <b>MND</b> inhibited EGFR phosphorylation and relevant downstream signaling, we next assessed if <b>MND</b> is a direct inhibitor of EGFR or other related RTKs. However, cell free RTK assays revealed that <b>MND</b> had no significant effect on any of these kinases tested, indicating that the effect of <b>MND</b> on EGFR phosphorylation might result from modulation of factors acting upstream of EGFR (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>k).</div></div><div id="sec3_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> Effect of MND on GPCR-Mediated Cell Death</h4><div class="NLM_p last">GPCRs have been reported to influence EGFR signaling (reviewed in refs <a onclick="showRef(event, 'ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref62 ref63">62,63</a>), we therefore evaluated if <b>MND</b> could regulate primary GPCR signaling events. While <b>MND</b> enhanced cellular accumulation of cAMP in absence or presence of adenylyl cyclase activator forskolin (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>l), it failed to influence cellular Ca<sup>2+</sup> level (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>m). This enhancement in cAMP was not associated with inhibition of cellular phosphodiesterase activity (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>n). Finally, to conclude that the effect of <b>MND</b> was indeed GPCR-dependent, we analyzed <b>MND</b>-induced cell death in the presence of Gα<sub>i/o</sub> inhibitor, Pertussis toxin (PTX), and Gα<sub>s</sub> activator, Cholera toxin (CTX). As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>o, PTX significantly blocked <b>MND</b> induced cell death but CTX failed to do so. Taken together, <b>MND</b>-induced cell death appears to result from modulation of a PTX-sensitive GPCR, which in turn regulates the activity of EGFR and its downstream signaling events.</div></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Discussion and Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61104" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61104" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We synthesized a series of phenyl naphthalen-1-yl methanone oxime analogs based on a rational design taking inputs from various scaffolds with anticancer effects. The series contains naphthalene as nucleus, oxime, and its alkyl amino derivatives as a functional group and a substituted phenyl moiety. The aim was to create a novel pharmacophore against breast cancer and define its mechanism of action. The SAR of the series revealed a very distinct feature that appeared essential for the cytotoxic activity of compounds was S-alkyl substitutions in the aryl ring but no other substitutions, viz., <i>O</i>-alkyl or OH in this ring. In addition, whereas both alkyl amine (<b>5a</b>) and alicyclic amines (<b>5b</b>) having two carbon alkyl chain had exhibited activities; however, the best activity was observed in aminoalkyl basic chain having <i>N,N</i>-diethylamino substitutions, i.e., <b>MND</b>. The better safety profile of <b>MND</b> over those of <b>5b</b>, <b>5i</b>, <b>7a</b>, and <b>8a</b> in normal cell line could also be attributed to the structural differences noted before, i.e., the amino alkyl linker at C1 position of naphthalene ring via a ketoxime hinge tie in <b>MND</b> as opposed to cyclic amine as amino alkyl linker in other compounds.</div><div class="NLM_p">The 4-anilinoquinazoline class of compounds that includes gefitinib, erlotinib, and lapatinib targets the ATP binding site of EGFR to suppress TK activity of the receptor.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> This class of compounds is clinically used in various cancers as reversible blockers of EGFR signaling. However, the contended specificity of their action could be disputed by the reports which showed induction of apoptosis and differentiation by a number of these compounds in AML and CML cells that do not express EGFR or Her2. Moreover, a variety of clinically used RTK and NRTK inhibitors exhibit mitochondrial damage and consequent induction of apoptosis, while it is still unclear how the inhibition of TKs and mitochondrial death programs are connected. Based on these observations highlighting a limited degree of specificity of RTK and NRTK compounds and yet exhibiting effective cancer chemotherapeutic activity, we embarked on synthesizing phenyl naphthyl methanone oxime, a novel scaffold taking cues from the major chemotherapeutic agents. <b>MND</b>, the compound with the best combination of strong cytotoxicity to a variety of cancer (breast, prostate, and endometrial) cells, but least so in the case of normal cells, induced cancer cell apoptosis via mitochondrial damage in concordance with reports from other groups showing that gefitinib or erlotinib induce cell cycle arrest and apoptosis in cancer cells.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Proof-of-concept of anticancer activity of <b>MND</b> in vivo has been obtained by daily oral administration of this compound which resulted in substantial regression in the xenograft tumor volumes in mice. <b>MND</b> dose (16 mg/kg) is less than the reported effective dose of gefitinib (50–200 mg/kg/day) in similar preclinical chemotherapeutic model,<a onclick="showRef(event, 'ref66 ref67'); return false;" href="javascript:void(0);" class="ref ref66 ref67">(66, 67)</a> thus suggesting that <b>MND</b> possesses substantial antitumor efficacy in vivo.</div><div class="NLM_p">CSCs represent a subset of cancer cells that possess normal stem cell-like properties, that is, self-renewal and generation of diverse cells comprising a tumor through differentiation. CSCs are refractory to conventional cancer chemotherapeutic agents and are often responsible for drug-resistance and disease relapse in a number of cancers, including breast and colon cancers. Salinomycin, initially used as a veterinary antiprotozoal agent, was identified as an anti-breast cancer CSC agent by Gupta et al., in a large screen of 16 000 compounds for their anti-CSC activities.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> However, salinomycin displays neural and reproductive toxicity in mice,<a onclick="showRef(event, 'ref68 ref69'); return false;" href="javascript:void(0);" class="ref ref68 ref69">(68, 69)</a> and therefore, it is difficult to envisage its future as an anti-CSC agent against human malignancies. Intense search thus for new compounds with robust anti-CSC activities is currently the focus of cancer research. Given that <b>MND</b> inhibited growth and expansion of CSC subpopulation not only in breast but also in colon cancer cells as compared with salinomycin therefore is exciting indeed.</div><div class="NLM_p">Given that <b>MND</b> was synthesized based on the commonality of TKI structures, our first attempt to identify its mechanism of action was to evaluate its potential to abrogate the downstream signaling of TKIs. Since <b>MND</b> action was blocked by administration of EGF, first the EGFR phosphorylation status was determined in the presence of <b>MND</b>. <b>MND</b> indeed inhibited p-EGFR at all seven Tyr residues phosphorylated by EGF more potently than AG1478 and also inhibited EGF-induced p-HER2 more potently than gefitinib. Consistent with the abrogation of EGFR signaling by <b>MND</b>, postreceptor signaling elicited by EGF that are associated with proliferation, survival, and migration of cancer cells such as phosphorylation of ERK, AKT, STAT-1, STAT-3, and Elk were suppressed by <b>MND</b>. Furthermore, EGF-induced invasion and migration of cancer cells were both suppressed by <b>MND</b> as well as inhibition of p-FAK and PAI-1 secretion, suggesting that <b>MND</b> could mitigate EGF-induced cancer metastasis.</div><div class="NLM_p">Interestingly, however, although <b>MND</b> activated EFGR signaling in breast cancer cells, it failed to affect the kinase activities of EGFR or any of the RTKs tested in a cell free RTK profiling which suggested that the effect of <b>MND</b> on EGFR phosphorylation might result from modulation of factors acting upstream of EGFR. GPCRs have been shown to modulate activities of EGFR or other TKs, and we thus evaluated whether <b>MND</b> could modulate GPCR-related signaling pathways. <b>MND</b> robustly induced accumulation of cellular cAMP, but had little effect on cellular Ca<sup>2+</sup> levels. <b>MND</b>-induced cellular cAMP level was not associated with inhibition of phosphodiesterases as <b>MND</b> failed to inhibit any of the 11 phosphodiesterases tested, thus indicating that its action might be routed through a GPCR. We thus evaluated <b>MND</b>-mediated loss of cell survival in the presence of CTX and PTX, that are modulators for Gα<sub>s</sub> and Gα<sub>i/0</sub>, respectively, and <b>MND</b> action was significantly blocked by PTX but not CTX, indicating that <b>MND</b> action could indeed by mediated through modulation of a PTX-sensitive GPCR.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a></div><div class="NLM_p last">In summary, the present study provides the proof-of-concept in preclinical cellular, molecular, and animal settings toward <b>MND</b> being a low-molecular mass and orally potent anticancer agent. <b>MND</b> also has a great potential for further preclinical evaluation of its therapeutic efficacy in drug-resistant forms of breast cancers as well as other types of cancers. Finally, <b>MND</b> could contribute to an enhanced understanding of structure-based drug design to facilitate drug discovery and development of thioaryl naphthylmethanone oxime as GPCR inhibitors and nontoxic cancer chemotherapeutic agents. However, detailed mechanistic studies including identification of its GPCR target is necessary before it can be taken to the clinic.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02330" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02330" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Methods: Chemistry</h3><div class="NLM_p last">All the chemical reagents were purchased from Sigma–Aldrich Chemical Co. and were used directly without further any purification. NMR spectra were recorded on a Bruker DRX 200, 300, or 400 MHz spectrometer. Chemical shifts (δ) are given in ppm relative to tetramethylsilane (TMS, δ = 0.0 ppm) as internal reference. Coupling constants (<i>J</i>) are given in hertz (Hz). Mass spectrometry was performed by fast atom bombardment (FAB) or electrospray ionization (ESI) using JEOL SX-102 instrument. IR spectra were taken on a VARIAN FT-IR spectrometer as KBr pellets or neat. Elemental analysis was performed at a PerkinElmer Autosystem XL Analyzer. Melting points were measured on a COMPLAB melting point apparatus and all the melting points were uncorrected. Unless otherwise mentioned, all the analytical and spectral data (<sup>1</sup>H NMR, <sup>13</sup>C NMR, Mass, IR elemental analysis, and melting points) are given for the free base of the compounds. All the reactions were monitored by thin-layer chromatography (TLC) carried out on 0.25 mm silica gel plates visualized with UV light. The purification of compounds was carried out by column chromatography using silica gel (100–200 mesh) or basic alumina and ethyl acetate/hexane or methanol/chloroform as eluent as per requirement. Microwave irradiation was carried out with Initiator 2.5 Microwave Synthesizers from Biotage. All the reactions were performed in special 5 mL glass vessels under an atmosphere of nitrogen. The temperature was fixed and maintained to 120 °C. The purity of all the compounds was determined by using reversed phase HPLC method on a Discovery HS C-18 (Supelco, Bellefonte, USA) column (5 μm, 100 × 4.6 mm i.d.) preceded with a C-18 guard column (5 μm, 20 × 4.0 mm, i.d.) packed with the same material under isocratic condition at ambient temperature using mobile phase [acetonitrile:methanol:phosphate buffer (10 mM, pH 3.5), 30:35:35, v/v] at a flow rate of 0.6 mL/min. The HPLC system consisted of a pump (LC-10AT VP with FCV-10AL VP), degasser (DGU-14A), and autoinjector (SIL-HTc, fixed with a 100 μL loop) (Shimadzu, Japan). Eluents were monitored at 294 nm with UV–vis multiple wavelength detector and chromatograms were integrated using Class-VP (version 6.12 SP5) software (Shimadzu, Japan). The purity of the tested compounds was reported as ≥95% on the basis of HPLC analysis.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Compound Synthesis and Characterization</h3><div class="NLM_p last">The complete synthetic procedures and compound characterization details for all the synthesized compounds are given in <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Chemicals and Reagents: Biology</h3><div class="NLM_p last">Cell culture media and supplements were purchased from Invitrogen (Carlsbad, CA). Unless otherwise mentioned, all the chemicals used in the present study were from Sigma–Aldrich, USA. All inhibitors/antagonists used in this study were from Tocris Biosciences (Ellisville, MO) unless otherwise indicated. HTRF cAMP femto kit was from Cisbio bioassays (Parc Marcel Boiteux, France).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Antibodies and ELISA Kits</h3><div class="NLM_p last">Bcl-2 (sc-492), Bax (sc-493), PCNA (sc-56), and mouse β-Actin (sc-47778) antibodies were from Santa Cruz Biotechnology Inc. (Santa Cruz, CA). p27 (ab7961) and cyclin D1 (ab16663) were from Abcam. p-ERK (4370), ERK (9102), p-AKT (4060), AKT (9272), p-STAT1 (9171), STAT1 (9172), p-STAT3 (9131), STAT3 (9132), p-ELK1 (9181), ELK1 (9182), p-FAK (3283), FAK (3285), Mcl-1 (5453), p-EGFR<sup>Tyr1086</sup> (2220), p-EGFR<sup>Tyr1148</sup> (4404), p-EGFR<sup>Tyr1045</sup> (2237), p-EGFR<sup>Tyr992</sup> (2235), Phospho-HER4/ErbB4<sup>Tyr984</sup> (3790), HER4/EbbB4 (4795), and rabbit β-Actin (4970) antibodies were from Cell Signaling Technology (Boston, MA). Phospho-EGF Receptor<sup>Tyr1068</sup> (7240), Phospho-EGF Receptor<sup>Tyr1173</sup> (7187), Phospho-EGF Receptor<sup>Tyr845</sup> (7189), Total EGF Receptor (7250), phospho-HER2/ErbB2<sup>panTyr</sup> (7968), total HER2/ErbB2 (7310), Phospho-HER3/ErbB3<sup>panTyr</sup> (7890), and total HER3/ErbB3 (7888) Sandwich ELISA kits were from Cell Signaling Technology (Boston, MA). Human Plasminogen activator inhibitor-1 (PAI-1) ELISA kit (KHC3071) was from Invitrogen. CDC42 G-LISA kit (BK127) was from Cytoskeleton, Denver, CO, USA.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Cells and Cell Culture Condition</h3><div class="NLM_p last">MCF-7, MDA-MB-231(breast cancer cell lines), DU-145 (prostate cancer cell line), Ishikawa (endometrial cancer cell line), MCF-10A (nontumorigenic mammary epithelial cell line), and colon cancer cells (SW620, DLD1, HCT116, and Colo205) were obtained from ATCC, USA, and grown according to the manufacturer’s recommendations.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> MTT Cytotoxicity Assay</h3><div class="NLM_p">Cells (1 × 10<sup>4</sup> cells/well) were seeded in 96-well plates in DMEM medium containing 10% FBS and allowed to adhere overnight and synchronized by serum starvation for 4 h. Cells were then treated with different doses of compounds (<b>4a</b>, <b>5a</b>–<b>m</b>, <b>6a</b>–<b>i</b>, <b>7a</b>–<b>e</b>, and <b>8a</b>–<b>d</b>), various growth factors (EGF - 100 ng/mL, VEGF- 10 ng/mL, IGF - 1–10 ng/mL, insulin - 10 ng/mL, TGF-β - 5 ng/mL) and caspase inhibitors (pan-capase inhibitor Z-VAD-FMK-10 μM, caspase-8 inhibitor Z-IETD-FMK-10 μM, and caspase-9 inhibitor Z-LEHD-FMK-10 μM) or vehicle (0.1% DMSO) as control for different time period, as indicated in <a class="ref internalNav" href="#sec3" aria-label="Results">Results</a> section. For caspase inhibition assay, cells were preincubated with zVAD-FMK (pan caspase inhibitor), zIETD-FMK (caspase-8 inhibitor), and z-LEHD-FMK (caspase-9 inhibitor) for 2 h. After 2 h cells were treated with 5 μM <b>MND</b> for additional 24 h and cell viability was determined.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a></div><div class="NLM_p last">To study the reversibility of the antiproliferative effect of <b>MND</b>, cells were preincubated in 96-well plates to approximately 70% of confluence and exposed to <b>MND</b> for 24 h, after which they were allowed to recover for 72 h in drug free medium and cell viability was determined by MTT assay.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Apoptosis Detection by Flow Cytometry</h3><div class="NLM_p last">MCF-7 and MDA-MB231 cells (1 × 10<sup>6</sup>) were seeded in 6 well plates and allowed to grow overnight. The medium was then replaced with fresh complete medium containing 2.5 μM, 5 μM, and 7.5 μM final concentration of compound <b>MND</b> for 24 h or with vehicle (0.001% DMSO) for control. Annexin V-FITC apoptosis detection kit was used to detect early and late apoptosis by flow cytometry.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a></div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Cell Cycle Analysis</h3><div class="NLM_p last">MCF-7 and MDA-MB-231 cells were treated with compound <b>MND</b>, at the end of the incubation adherent cells were trypsinized and combined with any floating cells present and then washed with cold PBS. Cells were fixed in 70% ethanol and incubated with RNase A and stained with 50 μg/mL propidium iodide (PI) for 30 min before acquiring the flow cytometry reading (FACScan, BD Biosciences, USA).<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a></div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Measurement of Mitochondrial Membrane Potential (MMP)</h3><div class="NLM_p last">In brief, MCF-7 and MDA-MB-231 cells were treated with <b>MND</b> (5 μM) for 24 h and harvested by trypsinization. Cells were incubated with 2 mL of medium containing JC-1 (1 μg/mL) for 15 min at 37 °C. Stained cells were washed with PBS and subjected to flow cytometry analyses as per standard protocol using FL1, and FL2 channel.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a></div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> qPCR</h3><div class="NLM_p last">qPCR was performed for assessing the expression of metastatic gene in <b>MND</b> (1 μM) treated MDA-MB-231 breast cancer cells, following our optimized protocol. The housekeeping gene GAPDH was used as the internal control. Primers were designed using the Universal Probe Library (Roche Applied sciences) for different genes (<a class="ref internalNav" href="#notes-2" aria-label="Supporting Information Table S1">Supporting Information Table S1</a>). cDNA was synthesized with a RevertAid cDNA synthesis kit (Fermentas, Austin, USA) using 2.0 μg of total RNA. SYBR green chemistry was used to perform quantitative determination of relative expression of transcripts for all genes. All genes were analyzed using the Light Cycler 480 (Roche Molecular Biochemicals, Indianapolis, Indiana, USA) real time PCR machine.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a></div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Receptor Enzyme-Linked Immunosorbant Assay (ELISA)</h3><div class="NLM_p last">MDA-MB-231 cells were seeded in 6 well plates and treated with <b>MND</b> at indicated concentration in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>c,d for 1 h in serum free medium prior to stimulation with EGF for 15 min. After drug treatment, cells were washed with ice-cold PBS and lysed in ice-cold cell lysis buffer (20 mM Tris pH 7.5, 150 mM NaCl, 10 mM EDTA, 1% w/v NP-40, 20 mM sodium fluoride, 5 mM sodium pyrophosphate, 1 mM sodium vanadate, 10% v/v glycerol, 1× protease inhibitor cocktail). Protein concentration was determined using the Bradford method. Equal amount of cell lysates were used for determination of p-EGFR (EGFR phosphorylation at different tyrosine residues including pTyr1068, pTyr845, and pTyr1173), total EGFR, p-Her2, and total Her2 using ELISA kits according to manufacturer’s instructions. Values for receptor phosphorylation were determined by measuring absorbance at 450 nm using ELISA plate reader (μQuant, BioTek) and normalized with total EGFR and HER2 protein.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a></div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Plasminogen Activator Inhibitor-1 (PAI-1) and CDC42 ELISA</h3><div class="NLM_p last">MDA-MB-231 cells were seeded in 6 well plates and treated with <b>MND</b> (1 μM) for 24 h with or without EGF. After that, conditioned medium was collected and PAI-1 protein concentration was determined using a PAI-1 ELISA kit according to the manufacturer’s instructions. CDC42 protein level was determined in <b>MND</b> (1 μM) treated MDA-MB-231 cells for 24 h using an ELISA kit according to the manufacturer’s protocols.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a></div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Migration Assay</h3><div class="NLM_p last">MDA-MB-231 cells were seeded in a six-well plate and grown overnight to confluence. The monolayers were scratched with a 200 μL pipet tip to create a wound, and then washed twice with serum-free DMEM to remove floating cells. Cells were treated with <b>MND</b> at 1 μM in serum-free medium for 24 h with or without EGF (100 ng/mL) and the wound was photographed 24 h later using light microscope in six random fields at 10× magnification. The rate of wound closure was assessed by measuring distances from six randomly selected fields using image analysis software (Image-Pro Plus 6.1.0).<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a></div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Invasion Assay</h3><div class="NLM_p last">Transwell invasion assays were performed using BD BioCoat matrigel invasion chambers in 24-well tissue culture plates according to the manufacturer’s protocol (BD Biosciences). In brief, MCF-7 and MDA-MB-231 cells (1 × 10<sup>5</sup>cells/mL) were plated in medium containing 2% FBS to the upper chamber of an 8 μM pore Matrigel coated invasion chamber (BD Bioscience). In the lower chamber, medium was supplemented with <b>MND</b> (1 μM) and EGF (100 ng/mL). After 24 h, cells that had migrated through the Matrigel to the underside of the transwell filters of an 8 μm pore size membrane were fixed, stained (crystal violet stain), and counted under a light microscope in six random fields at 20× magnification. Stained cells were quantified by measuring the absorbance of dissolved crystals in 0.1% SDS at 540 nm. All assays were done in triplicate chambers.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a></div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Mammosphere Formation Assay</h3><div class="NLM_p last">Human breast epithelial single cells were plated in ultralow attachment plates (Corning Inc., Corning NY) at a density of 100 000 viable cells/mL in primary culture and 5000 cells/mL in passages. Primary mammospheres were allowed to form for 7–10 days in serum-free mammary epithelial basal medium (MEBM) with <b>MND</b> and salinomycin. Primary mammospheres were centrifuged (1000 rpm), dissociated with trypsin, and used for serial passage. Sphere number was counted manually and verified by two independent observers blinded to treatment. Breast stem cells were identified using Aldefluor (Stem Cell Technologies, Newark, NJ) and antibodies against stem cell surface marker according to the method of Dontu et al.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a></div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Cyclic AMP Measurement</h3><div class="NLM_p last">Cellular cAMP was estimated using a homogeneous time-resolved fluorescence (HTRF)-based assay kit from Cisbio International using manufacturer’s protocol. Briefly, MDA-MB-231 cells seeded onto 96 well plates were serum starved for 4 h followed by treatment with 500 μM 3-isobutyl-1-methylxanthine (IBMX) (Sigma-Aldrich) for 30 min, and the cells were then treated with the indicated compounds for an additional 30 min. After completion of incubation with compounds, cells were lysed and the lysates were used for estimation of cAMP using a fluorimeter (Fluostar Omega, BMG Labtech; Ortenberg, Germany).<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a></div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Intracellular Calcium Measurement</h3><div class="NLM_p last">Fluo-4 AM (Invitrogen) was used to determine changes in intracellular calcium upon stimulation with the test compounds. MDAMB-231 cells were trypsinized and washed with phosphate buffer saline (pH 7.4), followed by labeling with Fluo-4AM for 45 min in HBSS buffer. Cells were then washed and suspended in calcium free HBSS. A baseline flourescence was measured in a BD FACS Calibur instrument for 2 min followed by stimulation with <b>MND</b> for another 7 min and analysis using Cell Quest Pro software.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a></div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Western Blot</h3><div class="NLM_p last">Western blot was performed following previously described protocol and reprobed with actin.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a></div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> PDE Profiling</h3><div class="NLM_p"><b>MND</b>’s ability to modulate phosphodiesterase isoforms were determined at SB Drug discovery (Glasgow, UK; <a href="http://www.sbdrugdiscovery.com/" class="extLink">http://www.sbdrugdiscovery.com/</a>), using IMAP technology (except for PDE6AB), which is based on the high affinity binding of phosphate by immobilized metal coordination complexes on nanoparticles. The binding reagent complexes with phosphate groups on nucleotide monophosphate generated from cyclic nucleotides (cAMP/cGMP) through phosphodiesterases. With fluorescence polarization detection, binding causes a change in the rate of the molecular motion of the phosphate bearing molecule, and results in an increase in the fluorescence polarization value observed for the fluorescent label attached to the substrate.</div><div class="NLM_p">For PDE6AB, radiometric assay was used, which is a modification of the two-step method of Thompson and Appleman.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a></div><div class="NLM_p last">Standards used for each isoform are PDE1A3; 10 μM IBMX, PDE2A3; 1 nM BAY 60–7550, PDE3CAT; 1 μM Cilostazol, PDE4CAT; 10 μm Rolipram, PDE5CAT and PDE6AB; 0.1 μM and 1 μM Sildenafil, respectively, PDE7A; 10 mM BRL-50481, PDE8A1; 10 μM BRL-50481, PDE9A1; 1 μM SB 36216, PDE10A1; 1 μM Papaverine, PDE11A1; 1 μm Dipyridamole.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Cell-Free Kinase Assays</h3><div class="NLM_p last"><b>MND</b>’s ability to modulate EGFR or related kinases was assessed at Millipore (Kinase Profiling Services; Dundee, UK) using standard γ-33P-ATP-based in vitro kinase assay, where ATP concentration was kept within 15 μM of the apparent <i>K</i><sub>m</sub> for ATP where determined.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a></div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Development of MCF-7 Xenograft Tumor, Morphological Analyses, and TUNEL Staining</h3><div class="NLM_p">MCF-7 cells (5 × 10<sup>6</sup> cells in 100 μL PBS) were injected into the peritoneal cavity of NIH-III strain of nude mice. After induction of tumor, two groups were recruited for each compound out of which there was one group (<i>n</i> = 10) for control (only vehicle) and another group (<i>n</i> = 10, each) for <b>MND</b> (8 and 16 mg.kg<sup>–1</sup>.day<sup>1</sup>). Animals were treated p.o. for 29 days with the previously mentioned doses in 1% carboxymethyl cellulose as the vehicle. Tumor volumes were measured using vernier calipers every third day. Assuming that tumors formed in the animals were spherical, their volume was calculated using the formula [π/6 × <i>d</i><sup>3</sup>], where <i>d</i> is the mean diameter. Tumor samples from each animal were removed and fixed in 4% buffered formalin phosphate, sectioned to 5 μm thickness, and stained with hematoxylin and eosin (H/E).<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> Animal studies were approved by Institutional Animal Ethics Committee (IAEC) of Advanced Center for Treatment, Research & Education in Cancer (ACTREC), Navi Mumbai, India. This facility is accredited to AALAC and the registration number of ACTREC is 65/1999 granted by Committee for the Purpose of Control and Supervision of Experiments on Animals, Ministry of Environment and Forest, Government of India.</div><div class="NLM_p last">Apoptotic DNA degradation in tumor tissue was assessed using the terminal deoxynucleotidyl transferase (TdT)-mediated dUDP-biotin nick end labeling (TUNEL) method. In this study, In Situ Cell Death Detection Kit, Fluorescein (Roche) was used for this purpose. Tumor sections were observed under fluorescence microscope (Nikon 80i, Japan) at 40×, and images were captured digitally with NIS Elements F 3.0 camera (Nikon, Japan). Quantification of TUNEL positive cells was done using image analysis software (Image-Pro Plus 6.1.0).<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a></div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Statistical Analysis</h3><div class="NLM_p last">Data are expressed as mean ± SEM with at least three independent experiments. The data were analyzed using one-way ANOVA followed by post hoc Newman-Keuls multiple comparison test of significance or unpaired, two-tailed Student’s <i>t</i> test, as appropriate. Qualitative observations have been represented following assessments made by three individuals blinded to the experimental designs.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i42"><a href="/doi/suppl/10.1021/jm500873e">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15572" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15572" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Synthetic scheme, spectral data (<sup>1</sup>H NMR and <sup>13</sup>C NMR) for characterization of compounds, and biological results.This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm500873e/suppl_file/jm500873e_si_001.pdf">jm500873e_si_001.pdf (538.14 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm500873e" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68677" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68677" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Naibedya Chattopadhyay</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
and Process Chemistry Division; ‡Endocrinology Division, §Biochemistry Division, ∥Toxicology Division, and ⊥Pharmacokinetics
and Metabolism Division, CSIR-Central Drug
Research Institute, Lucknow 226031, India</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Molecular Medicine and Biotechnology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, 226014, India</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#b9d7e6dad1d8cdcdd6c9d8ddd1c0d8c0f9daddcbd097cbdcca97d0d7"><span class="__cf_email__" data-cfemail="c3ad9ca0aba2b7b7acb3a2a7abbaa2ba83a0a7b1aaedb1a6b0edaaad">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Atul Kumar</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
and Process Chemistry Division; ‡Endocrinology Division, §Biochemistry Division, ∥Toxicology Division, and ⊥Pharmacokinetics
and Metabolism Division, CSIR-Central Drug
Research Institute, Lucknow 226031, India</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Molecular Medicine and Biotechnology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, 226014, India</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#91f5e3f0e5e4fde2f0e9d1f6fcf0f8fdbff2fefc"><span class="__cf_email__" data-cfemail="b3d7c1d2c7c6dfc0d2cbf3d4ded2dadf9dd0dcde">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bandana Chakravarti</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
and Process Chemistry Division; ‡Endocrinology Division, §Biochemistry Division, ∥Toxicology Division, and ⊥Pharmacokinetics
and Metabolism Division, CSIR-Central Drug
Research Institute, Lucknow 226031, India</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Molecular Medicine and Biotechnology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, 226014, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tahseen Akhtar</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
and Process Chemistry Division; ‡Endocrinology Division, §Biochemistry Division, ∥Toxicology Division, and ⊥Pharmacokinetics
and Metabolism Division, CSIR-Central Drug
Research Institute, Lucknow 226031, India</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Molecular Medicine and Biotechnology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, 226014, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Byanju Rai</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
and Process Chemistry Division; ‡Endocrinology Division, §Biochemistry Division, ∥Toxicology Division, and ⊥Pharmacokinetics
and Metabolism Division, CSIR-Central Drug
Research Institute, Lucknow 226031, India</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Molecular Medicine and Biotechnology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, 226014, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Manisha Yadav</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
and Process Chemistry Division; ‡Endocrinology Division, §Biochemistry Division, ∥Toxicology Division, and ⊥Pharmacokinetics
and Metabolism Division, CSIR-Central Drug
Research Institute, Lucknow 226031, India</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Molecular Medicine and Biotechnology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, 226014, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jawed Akhtar Siddiqui</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
and Process Chemistry Division; ‡Endocrinology Division, §Biochemistry Division, ∥Toxicology Division, and ⊥Pharmacokinetics
and Metabolism Division, CSIR-Central Drug
Research Institute, Lucknow 226031, India</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Molecular Medicine and Biotechnology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, 226014, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shailendra Kumar Dhar Dwivedi</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
and Process Chemistry Division; ‡Endocrinology Division, §Biochemistry Division, ∥Toxicology Division, and ⊥Pharmacokinetics
and Metabolism Division, CSIR-Central Drug
Research Institute, Lucknow 226031, India</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Molecular Medicine and Biotechnology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, 226014, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ravi Thakur</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
and Process Chemistry Division; ‡Endocrinology Division, §Biochemistry Division, ∥Toxicology Division, and ⊥Pharmacokinetics
and Metabolism Division, CSIR-Central Drug
Research Institute, Lucknow 226031, India</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Molecular Medicine and Biotechnology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, 226014, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anup Kumar Singh</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
and Process Chemistry Division; ‡Endocrinology Division, §Biochemistry Division, ∥Toxicology Division, and ⊥Pharmacokinetics
and Metabolism Division, CSIR-Central Drug
Research Institute, Lucknow 226031, India</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Molecular Medicine and Biotechnology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, 226014, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Abhishek Kumar Singh</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
and Process Chemistry Division; ‡Endocrinology Division, §Biochemistry Division, ∥Toxicology Division, and ⊥Pharmacokinetics
and Metabolism Division, CSIR-Central Drug
Research Institute, Lucknow 226031, India</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Molecular Medicine and Biotechnology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, 226014, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Harish Kumar</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
and Process Chemistry Division; ‡Endocrinology Division, §Biochemistry Division, ∥Toxicology Division, and ⊥Pharmacokinetics
and Metabolism Division, CSIR-Central Drug
Research Institute, Lucknow 226031, India</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Molecular Medicine and Biotechnology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, 226014, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kainat Khan</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
and Process Chemistry Division; ‡Endocrinology Division, §Biochemistry Division, ∥Toxicology Division, and ⊥Pharmacokinetics
and Metabolism Division, CSIR-Central Drug
Research Institute, Lucknow 226031, India</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Molecular Medicine and Biotechnology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, 226014, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Subhashis Pal</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
and Process Chemistry Division; ‡Endocrinology Division, §Biochemistry Division, ∥Toxicology Division, and ⊥Pharmacokinetics
and Metabolism Division, CSIR-Central Drug
Research Institute, Lucknow 226031, India</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Molecular Medicine and Biotechnology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, 226014, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Srikanta Kumar Rath</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
and Process Chemistry Division; ‡Endocrinology Division, §Biochemistry Division, ∥Toxicology Division, and ⊥Pharmacokinetics
and Metabolism Division, CSIR-Central Drug
Research Institute, Lucknow 226031, India</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Molecular Medicine and Biotechnology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, 226014, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jawahar Lal</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
and Process Chemistry Division; ‡Endocrinology Division, §Biochemistry Division, ∥Toxicology Division, and ⊥Pharmacokinetics
and Metabolism Division, CSIR-Central Drug
Research Institute, Lucknow 226031, India</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Molecular Medicine and Biotechnology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, 226014, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rituraj Konwar</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
and Process Chemistry Division; ‡Endocrinology Division, §Biochemistry Division, ∥Toxicology Division, and ⊥Pharmacokinetics
and Metabolism Division, CSIR-Central Drug
Research Institute, Lucknow 226031, India</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Molecular Medicine and Biotechnology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, 226014, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Arun Kumar Trivedi</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
and Process Chemistry Division; ‡Endocrinology Division, §Biochemistry Division, ∥Toxicology Division, and ⊥Pharmacokinetics
and Metabolism Division, CSIR-Central Drug
Research Institute, Lucknow 226031, India</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Molecular Medicine and Biotechnology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, 226014, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dipak Datta</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
and Process Chemistry Division; ‡Endocrinology Division, §Biochemistry Division, ∥Toxicology Division, and ⊥Pharmacokinetics
and Metabolism Division, CSIR-Central Drug
Research Institute, Lucknow 226031, India</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Molecular Medicine and Biotechnology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, 226014, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Durga Prasad Mishra</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
and Process Chemistry Division; ‡Endocrinology Division, §Biochemistry Division, ∥Toxicology Division, and ⊥Pharmacokinetics
and Metabolism Division, CSIR-Central Drug
Research Institute, Lucknow 226031, India</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Molecular Medicine and Biotechnology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, 226014, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Madan Madhav Godbole</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Medicine and Biotechnology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, 226014, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sabyasachi Sanyal</span> - <span class="hlFld-Affiliation affiliation">†Medicinal
and Process Chemistry Division; ‡Endocrinology Division, §Biochemistry Division, ∥Toxicology Division, and ⊥Pharmacokinetics
and Metabolism Division, CSIR-Central Drug
Research Institute, Lucknow 226031, India</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Molecular Medicine and Biotechnology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, 226014, India</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>B.C. and T.A. have equal contributions.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d957e2290-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i44">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11105" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11105" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Authors acknowledge funding received from CSIR network projects and DST (BSC0201 to N.C.; BSC0103 to S.R.K., A.K.T., D.P.M., and S.S., BSC0101 to R.K., SB/FT/LS-368/2012 to B.C., and BSC0108 to A.K.).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i45" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i45"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i46" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i46"> Abbreviations</h2><tr><td class="NLM_term">MND</td><td class="NLM_def"><p class="first last">4-(methylthio)phenyl)(naphthalen-1-yl)methanone-<i>O</i>-2-(diethylamino) ethyl oxime</p></td></tr><tr><td class="NLM_term">TK</td><td class="NLM_def"><p class="first last">tyrosine kinase</p></td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G-protein coupled receptor</p></td></tr><tr><td class="NLM_term">RTK</td><td class="NLM_def"><p class="first last">receptor tyrosine kinase</p></td></tr><tr><td class="NLM_term">NRTK</td><td class="NLM_def"><p class="first last">nonreceptor tyrosine kinase</p></td></tr><tr><td class="NLM_term">EGFR</td><td class="NLM_def"><p class="first last">epidermal growth factor receptor</p></td></tr><tr><td class="NLM_term">Her2</td><td class="NLM_def"><p class="first last">human EGF receptor 2</p></td></tr><tr><td class="NLM_term">AML</td><td class="NLM_def"><p class="first last">acute myelogenous leukemia</p></td></tr><tr><td class="NLM_term">CML</td><td class="NLM_def"><p class="first last">chronic myelogenous leukemia</p></td></tr><tr><td class="NLM_term">ABC</td><td class="NLM_def"><p class="first last">ATP binding cassette</p></td></tr><tr><td class="NLM_term">OH-TAM</td><td class="NLM_def"><p class="first last">hydroxy-tamoxifen</p></td></tr><tr><td class="NLM_term">PTEN</td><td class="NLM_def"><p class="first last">phosphatase and tensin homologue</p></td></tr><tr><td class="NLM_term">VEGF-A</td><td class="NLM_def"><p class="first last">vascular endothelial growth factor-A</p></td></tr><tr><td class="NLM_term">TGF-β1</td><td class="NLM_def"><p class="first last">transforming growth factor b1</p></td></tr><tr><td class="NLM_term">MTA1</td><td class="NLM_def"><p class="first last">metastasis-associated protein 1</p></td></tr><tr><td class="NLM_term">MMP-9</td><td class="NLM_def"><p class="first last">matrix metaloprotease-9</p></td></tr><tr><td class="NLM_term">ALDH1</td><td class="NLM_def"><p class="first last">aldehyde dehydrogenase 1</p></td></tr><tr><td class="NLM_term">EGF</td><td class="NLM_def"><p class="first last">epidermal growth factor</p></td></tr><tr><td class="NLM_term">IGF-1</td><td class="NLM_def"><p class="first last">insulin-like growth factor-1</p></td></tr><tr><td class="NLM_term">INS</td><td class="NLM_def"><p class="first last">insulin</p></td></tr><tr><td class="NLM_term">PAI-1</td><td class="NLM_def"><p class="first last">plasminogen activator inhibitor-1</p></td></tr><tr><td class="NLM_term">MCL-1</td><td class="NLM_def"><p class="first last">myeloid cell leukemia-1</p></td></tr><tr><td class="NLM_term">FAK</td><td class="NLM_def"><p class="first last">focal adhesion kinase</p></td></tr><tr><td class="NLM_term">BCSC</td><td class="NLM_def"><p class="first last">breast cancer stem cells</p></td></tr><tr><td class="NLM_term">PTX</td><td class="NLM_def"><p class="first last">pertussis toxin</p></td></tr><tr><td class="NLM_term">CTX</td><td class="NLM_def"><p class="first last">cholera toxin</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i47">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12418" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12418" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 80 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Levitzki, A.</span><span> </span><span class="NLM_article-title">Tyrosine kinase inhibitors: views of selectivity, sensitivity, and clinical performance</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2013&pages=161-185&author=A.+Levitzki&title=Tyrosine+kinase+inhibitors%3A+views+of+selectivity%2C+sensitivity%2C+and+clinical+performance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLevitzki%26aufirst%3DA.%26atitle%3DTyrosine%2520kinase%2520inhibitors%253A%2520views%2520of%2520selectivity%252C%2520sensitivity%252C%2520and%2520clinical%2520performance%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2013%26volume%3D53%26spage%3D161%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Huang, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. J.</span><span> </span><span class="NLM_article-title">Lapatinib induces autophagy, apoptosis and megakaryocytic differentiation in chronic myelogenous leukemia K562 cells</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e29014</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e29014&author=H.+L.+Huangauthor=Y.+C.+Chenauthor=Y.+C.+Huangauthor=K.+C.+Yangauthor=H.+Panauthor=S.+P.+Shihauthor=Y.+J.+Chen&title=Lapatinib+induces+autophagy%2C+apoptosis+and+megakaryocytic+differentiation+in+chronic+myelogenous+leukemia+K562+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%2BL.%26aulast%3DChen%26aufirst%3DY.%2BC.%26aulast%3DHuang%26aufirst%3DY.%2BC.%26aulast%3DYang%26aufirst%3DK.%2BC.%26aulast%3DPan%26aufirst%3DH.%26aulast%3DShih%26aufirst%3DS.%2BP.%26aulast%3DChen%26aufirst%3DY.%2BJ.%26atitle%3DLapatinib%2520induces%2520autophagy%252C%2520apoptosis%2520and%2520megakaryocytic%2520differentiation%2520in%2520chronic%2520myelogenous%2520leukemia%2520K562%2520cells%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De29014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Lainey, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfromm, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marie, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enot, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scoazec, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouteloup, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Micol, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Botton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galluzzi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenaux, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroemer, G.</span><span> </span><span class="NLM_article-title">Azacytidine and erlotinib exert synergistic effects against acute myeloid leukemia</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">4331</span><span class="NLM_x">–</span> <span class="NLM_lpage">4342</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=4331-4342&author=E.+Laineyauthor=A.+Wolfrommauthor=N.+Marieauthor=D.+Enotauthor=M.+Scoazecauthor=C.+Bouteloupauthor=C.+Leroyauthor=J.+B.+Micolauthor=S.+De+Bottonauthor=L.+Galluzziauthor=P.+Fenauxauthor=G.+Kroemer&title=Azacytidine+and+erlotinib+exert+synergistic+effects+against+acute+myeloid+leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLainey%26aufirst%3DE.%26aulast%3DWolfromm%26aufirst%3DA.%26aulast%3DMarie%26aufirst%3DN.%26aulast%3DEnot%26aufirst%3DD.%26aulast%3DScoazec%26aufirst%3DM.%26aulast%3DBouteloup%26aufirst%3DC.%26aulast%3DLeroy%26aufirst%3DC.%26aulast%3DMicol%26aufirst%3DJ.%2BB.%26aulast%3DDe%2BBotton%26aufirst%3DS.%26aulast%3DGalluzzi%26aufirst%3DL.%26aulast%3DFenaux%26aufirst%3DP.%26aulast%3DKroemer%26aufirst%3DG.%26atitle%3DAzacytidine%2520and%2520erlotinib%2520exert%2520synergistic%2520effects%2520against%2520acute%2520myeloid%2520leukemia%26jtitle%3DOncogene%26date%3D2013%26volume%3D32%26spage%3D4331%26epage%3D4342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Lainey, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfromm, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukkurwala, A. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Micol, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenaux, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galluzzi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kepp, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroemer, G.</span><span> </span><span class="NLM_article-title">EGFR inhibitors exacerbate differentiation and cell cycle arrest induced by retinoic acid and vitamin D3 in acute myeloid leukemia cells</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2978</span><span class="NLM_x">–</span> <span class="NLM_lpage">2991</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=2978-2991&author=E.+Laineyauthor=A.+Wolfrommauthor=A.+Q.+Sukkurwalaauthor=J.+B.+Micolauthor=P.+Fenauxauthor=L.+Galluzziauthor=O.+Keppauthor=G.+Kroemer&title=EGFR+inhibitors+exacerbate+differentiation+and+cell+cycle+arrest+induced+by+retinoic+acid+and+vitamin+D3+in+acute+myeloid+leukemia+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLainey%26aufirst%3DE.%26aulast%3DWolfromm%26aufirst%3DA.%26aulast%3DSukkurwala%26aufirst%3DA.%2BQ.%26aulast%3DMicol%26aufirst%3DJ.%2BB.%26aulast%3DFenaux%26aufirst%3DP.%26aulast%3DGalluzzi%26aufirst%3DL.%26aulast%3DKepp%26aufirst%3DO.%26aulast%3DKroemer%26aufirst%3DG.%26atitle%3DEGFR%2520inhibitors%2520exacerbate%2520differentiation%2520and%2520cell%2520cycle%2520arrest%2520induced%2520by%2520retinoic%2520acid%2520and%2520vitamin%2520D3%2520in%2520acute%2520myeloid%2520leukemia%2520cells%26jtitle%3DCell%2520Cycle%26date%3D2013%26volume%3D12%26spage%3D2978%26epage%3D2991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Stegmaier, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corsello, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deangelo, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golub, T. R.</span><span> </span><span class="NLM_article-title">Gefitinib induces myeloid differentiation of acute myeloid leukemia</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">2841</span><span class="NLM_x">–</span> <span class="NLM_lpage">2848</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2005&pages=2841-2848&author=K.+Stegmaierauthor=S.+M.+Corselloauthor=K.+N.+Rossauthor=J.+S.+Wongauthor=D.+J.+Deangeloauthor=T.+R.+Golub&title=Gefitinib+induces+myeloid+differentiation+of+acute+myeloid+leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStegmaier%26aufirst%3DK.%26aulast%3DCorsello%26aufirst%3DS.%2BM.%26aulast%3DRoss%26aufirst%3DK.%2BN.%26aulast%3DWong%26aufirst%3DJ.%2BS.%26aulast%3DDeangelo%26aufirst%3DD.%2BJ.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26atitle%3DGefitinib%2520induces%2520myeloid%2520differentiation%2520of%2520acute%2520myeloid%2520leukemia%26jtitle%3DBlood%26date%3D2005%26volume%3D106%26spage%3D2841%26epage%3D2848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Fabian, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biggs, W. H.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azimioara, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benedetti, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grotzfeld, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lelias, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velasco, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span> </span><span class="NLM_article-title">A small molecule-kinase interaction map for clinical kinase inhibitors</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1038%2Fnbt1068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=15711537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=329-336&author=M.+A.+Fabianauthor=W.+H.+Biggsauthor=D.+K.+Treiberauthor=C.+E.+Atteridgeauthor=M.+D.+Azimioaraauthor=M.+G.+Benedettiauthor=T.+A.+Carterauthor=P.+Ciceriauthor=P.+T.+Edeenauthor=M.+Floydauthor=J.+M.+Fordauthor=M.+Galvinauthor=J.+L.+Gerlachauthor=R.+M.+Grotzfeldauthor=S.+Herrgardauthor=D.+E.+Inskoauthor=M.+A.+Inskoauthor=A.+G.+Laiauthor=J.+M.+Leliasauthor=S.+A.+Mehtaauthor=Z.+V.+Milanovauthor=A.+M.+Velascoauthor=L.+M.+Wodickaauthor=H.+K.+Patelauthor=P.+P.+Zarrinkarauthor=D.+J.+Lockhart&title=A+small+molecule-kinase+interaction+map+for+clinical+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule-kinase interaction map for clinical kinase inhibitors</span></div><div class="casAuthors">Fabian, Miles A.; Biggs, William H.; Treiber, Daniel K.; Atteridge, Corey E.; Azimioara, Mihai D.; Benedetti, Michael G.; Carter, Todd A.; Ciceri, Pietro; Edeen, Philip T.; Floyd, Mark; Ford, Julia M.; Galvin, Margaret; Gerlach, Jay L.; Grotzfeld, Robert M.; Herrgard, Sanna; Insko, Darren E.; Insko, Michael A.; Lai, Andiliy G.; Lelias, Jean-Michel; Mehta, Shamal A.; Milanov, Zdravko V.; Velasco, Anne Marie; Wodicka, Lisa M.; Patel, Hitesh K.; Zarrinkar, Patrick P.; Lockhart, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">329-336</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors show great promise as a new class of therapeutics.  Here the authors describe an efficient way to det. kinase inhibitor specificity by measuring binding of small mols. to the ATP site of kinases.  The authors have profiled 20 kinase inhibitors, including 16 that are approved drugs or in clin. development, against a panel of 119 protein kinases.  The authors find that specificity varies widely and is not strongly correlated with chem. structure or the identity of the intended target.  Many novel interactions were identified, including tight binding of the p38 inhibitor BIRB-796 to an imatinib-resistant variant of the ABL kinase, and binding of imatinib to the SRC-family kinase LCK.  The authors also show that mutations in the epidermal growth factor receptor (EGFR) found in gefitinib-responsive patients do not affect the binding affinity of gefitinib or erlotinib.  Our results represent a systematic small mol.-protein interaction map for clin. compds. across a large no. of related proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA0vNmMOXrnrVg90H21EOLACvtfcHk0liVVkST3JUUSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D&md5=6aedd5ceb8f77cd26ee50425dcec7bdf</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnbt1068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1068%26sid%3Dliteratum%253Aachs%26aulast%3DFabian%26aufirst%3DM.%2BA.%26aulast%3DBiggs%26aufirst%3DW.%2BH.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DAzimioara%26aufirst%3DM.%2BD.%26aulast%3DBenedetti%26aufirst%3DM.%2BG.%26aulast%3DCarter%26aufirst%3DT.%2BA.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DFord%26aufirst%3DJ.%2BM.%26aulast%3DGalvin%26aufirst%3DM.%26aulast%3DGerlach%26aufirst%3DJ.%2BL.%26aulast%3DGrotzfeld%26aufirst%3DR.%2BM.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DInsko%26aufirst%3DD.%2BE.%26aulast%3DInsko%26aufirst%3DM.%2BA.%26aulast%3DLai%26aufirst%3DA.%2BG.%26aulast%3DLelias%26aufirst%3DJ.%2BM.%26aulast%3DMehta%26aufirst%3DS.%2BA.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DVelasco%26aufirst%3DA.%2BM.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26atitle%3DA%2520small%2520molecule-kinase%2520interaction%2520map%2520for%2520clinical%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Biotechnol.%26date%3D2005%26volume%3D23%26spage%3D329%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Leggas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panetta, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuetz, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorrentino, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghton, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, C. F.</span><span> </span><span class="NLM_article-title">Gefitinib modulates the function of multiple ATP-binding cassette transporters in vivo</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">4802</span><span class="NLM_x">–</span> <span class="NLM_lpage">4807</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=4802-4807&author=M.+Leggasauthor=J.+C.+Panettaauthor=Y.+Zhuangauthor=J.+D.+Schuetzauthor=B.+Johnstonauthor=F.+Baiauthor=B.+Sorrentinoauthor=S.+Zhouauthor=P.+J.+Houghtonauthor=C.+F.+Stewart&title=Gefitinib+modulates+the+function+of+multiple+ATP-binding+cassette+transporters+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeggas%26aufirst%3DM.%26aulast%3DPanetta%26aufirst%3DJ.%2BC.%26aulast%3DZhuang%26aufirst%3DY.%26aulast%3DSchuetz%26aufirst%3DJ.%2BD.%26aulast%3DJohnston%26aufirst%3DB.%26aulast%3DBai%26aufirst%3DF.%26aulast%3DSorrentino%26aufirst%3DB.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DHoughton%26aufirst%3DP.%2BJ.%26aulast%3DStewart%26aufirst%3DC.%2BF.%26atitle%3DGefitinib%2520modulates%2520the%2520function%2520of%2520multiple%2520ATP-binding%2520cassette%2520transporters%2520in%2520vivo%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D4802%26epage%3D4807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Shi, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, X. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shukla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Si, Q. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robey, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashby, C. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambudkar, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z. S.</span><span> </span><span class="NLM_article-title">Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">11012</span><span class="NLM_x">–</span> <span class="NLM_lpage">11020</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=11012-11020&author=Z.+Shiauthor=X.+X.+Pengauthor=I.+W.+Kimauthor=S.+Shuklaauthor=Q.+S.+Siauthor=R.+W.+Robeyauthor=S.+E.+Batesauthor=T.+Shenauthor=C.+R.+Ashbyauthor=L.+W.+Fuauthor=S.+V.+Ambudkarauthor=Z.+S.+Chen&title=Erlotinib+%28Tarceva%2C+OSI-774%29+antagonizes+ATP-binding+cassette+subfamily+B+member+1+and+ATP-binding+cassette+subfamily+G+member+2-mediated+drug+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DZ.%26aulast%3DPeng%26aufirst%3DX.%2BX.%26aulast%3DKim%26aufirst%3DI.%2BW.%26aulast%3DShukla%26aufirst%3DS.%26aulast%3DSi%26aufirst%3DQ.%2BS.%26aulast%3DRobey%26aufirst%3DR.%2BW.%26aulast%3DBates%26aufirst%3DS.%2BE.%26aulast%3DShen%26aufirst%3DT.%26aulast%3DAshby%26aufirst%3DC.%2BR.%26aulast%3DFu%26aufirst%3DL.%2BW.%26aulast%3DAmbudkar%26aufirst%3DS.%2BV.%26aulast%3DChen%26aufirst%3DZ.%2BS.%26atitle%3DErlotinib%2520%2528Tarceva%252C%2520OSI-774%2529%2520antagonizes%2520ATP-binding%2520cassette%2520subfamily%2520B%2520member%25201%2520and%2520ATP-binding%2520cassette%2520subfamily%2520G%2520member%25202-mediated%2520drug%2520resistance%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D11012%26epage%3D11020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Aparicio-Gallego, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figueroa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Campelo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valladares-Ayerbes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grande-Pulido, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anton-Aparicio, L.</span><span> </span><span class="NLM_article-title">New insights into molecular mechanisms of sunitinib-associated side effects</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2215</span><span class="NLM_x">–</span> <span class="NLM_lpage">2223</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1158%2F1535-7163.MCT-10-1124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=22161785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFylurjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=2215-2223&author=G.+Aparicio-Gallegoauthor=M.+Blancoauthor=A.+Figueroaauthor=R.+Garcia-Campeloauthor=M.+Valladares-Ayerbesauthor=E.+Grande-Pulidoauthor=L.+Anton-Aparicio&title=New+insights+into+molecular+mechanisms+of+sunitinib-associated+side+effects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">New Insights into Molecular Mechanisms of Sunitinib-Associated Side Effects</span></div><div class="casAuthors">Aparicio-Gallego, Guadalupe; Blanco, Moises; Figueroa, Angelica; Garcia-Campelo, Rosario; Valladares-Ayerbes, Manuel; Grande-Pulido, Enrique; Anton-Aparicio, Luis</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2215-2223</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  The introduction of targeted therapy represents a major advance in the treatment of tumor progression.  Targeted agents are a novel therapeutic approach developed to disrupt different cellular signaling pathways.  The tyrosine kinase inhibitor sunitinib specifically blocks multiple tyrosine kinase receptors that are involved in the progression of many tumors.  Sunitinib is the current std. of care in first-line treatment of advanced renal cell carcinoma, and it is approved in imatinib-intolerant and imatinib-refractory gastrointestinal stromal tumors.  However, it is increasingly evident that sunitinib may display collateral effects on other proteins beyond its main target receptors, eliciting undesirable and unexpected adverse events.  A better understanding of the mol. mechanisms underlying these undesirable sunitinib-assocd. side effects will help physicians to maximize efficacy of sunitinib and minimize adverse events.  Here, we focus on new insights into mol. mechanisms that may mediate sunitinib-assocd. adverse events.  Mol Cancer Ther; 10(12); 2215-23.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpru_DT0hrZGbVg90H21EOLACvtfcHk0lhTxd4TbWr50w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFylurjN&md5=41d9f9d97b4c5910555bedef358c77f9</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-10-1124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-10-1124%26sid%3Dliteratum%253Aachs%26aulast%3DAparicio-Gallego%26aufirst%3DG.%26aulast%3DBlanco%26aufirst%3DM.%26aulast%3DFigueroa%26aufirst%3DA.%26aulast%3DGarcia-Campelo%26aufirst%3DR.%26aulast%3DValladares-Ayerbes%26aufirst%3DM.%26aulast%3DGrande-Pulido%26aufirst%3DE.%26aulast%3DAnton-Aparicio%26aufirst%3DL.%26atitle%3DNew%2520insights%2520into%2520molecular%2520mechanisms%2520of%2520sunitinib-associated%2520side%2520effects%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2011%26volume%3D10%26spage%3D2215%26epage%3D2223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Jacquel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrant, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Legros, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belhacene, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luciano, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pages, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auberger, P.</span><span> </span><span class="NLM_article-title">Imatinib induces mitochondria-dependent apoptosis of the Bcr-Abl-positive K562 cell line and its differentiation toward the erythroid lineage</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2160</span><span class="NLM_x">–</span> <span class="NLM_lpage">2162</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=2160-2162&author=A.+Jacquelauthor=M.+Herrantauthor=L.+Legrosauthor=N.+Belhaceneauthor=F.+Lucianoauthor=G.+Pagesauthor=P.+Hofmanauthor=P.+Auberger&title=Imatinib+induces+mitochondria-dependent+apoptosis+of+the+Bcr-Abl-positive+K562+cell+line+and+its+differentiation+toward+the+erythroid+lineage"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJacquel%26aufirst%3DA.%26aulast%3DHerrant%26aufirst%3DM.%26aulast%3DLegros%26aufirst%3DL.%26aulast%3DBelhacene%26aufirst%3DN.%26aulast%3DLuciano%26aufirst%3DF.%26aulast%3DPages%26aufirst%3DG.%26aulast%3DHofman%26aufirst%3DP.%26aulast%3DAuberger%26aufirst%3DP.%26atitle%3DImatinib%2520induces%2520mitochondria-dependent%2520apoptosis%2520of%2520the%2520Bcr-Abl-positive%2520K562%2520cell%2520line%2520and%2520its%2520differentiation%2520toward%2520the%2520erythroid%2520lineage%26jtitle%3DFASEB%2520J.%26date%3D2003%26volume%3D17%26spage%3D2160%26epage%3D2162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Ling, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Soler, R.</span><span> </span><span class="NLM_article-title">Erlotinib induces mitochondrial-mediated apoptosis in human H3255 non-small-cell lung cancer cells with epidermal growth factor receptorL858R mutation through mitochondrial oxidative phosphorylation-dependent activation of BAX and BAK</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">793</span><span class="NLM_x">–</span> <span class="NLM_lpage">806</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2008&pages=793-806&author=Y.+H.+Lingauthor=R.+Linauthor=R.+Perez-Soler&title=Erlotinib+induces+mitochondrial-mediated+apoptosis+in+human+H3255+non-small-cell+lung+cancer+cells+with+epidermal+growth+factor+receptorL858R+mutation+through+mitochondrial+oxidative+phosphorylation-dependent+activation+of+BAX+and+BAK"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLing%26aufirst%3DY.%2BH.%26aulast%3DLin%26aufirst%3DR.%26aulast%3DPerez-Soler%26aufirst%3DR.%26atitle%3DErlotinib%2520induces%2520mitochondrial-mediated%2520apoptosis%2520in%2520human%2520H3255%2520non-small-cell%2520lung%2520cancer%2520cells%2520with%2520epidermal%2520growth%2520factor%2520receptorL858R%2520mutation%2520through%2520mitochondrial%2520oxidative%2520phosphorylation-dependent%2520activation%2520of%2520BAX%2520and%2520BAK%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D74%26spage%3D793%26epage%3D806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Newcomb, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamasdan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Entzminger, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedlander, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crisan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zagzag, D.</span><span> </span><span class="NLM_article-title">Flavopiridol induces mitochondrial-mediated apoptosis in murine glioma GL261 cells via release of cytochrome c and apoptosis inducing factor</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">250</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=243-250&author=E.+W.+Newcombauthor=C.+Tamasdanauthor=Y.+Entzmingerauthor=J.+Alonsoauthor=D.+Friedlanderauthor=D.+Crisanauthor=D.+C.+Millerauthor=D.+Zagzag&title=Flavopiridol+induces+mitochondrial-mediated+apoptosis+in+murine+glioma+GL261+cells+via+release+of+cytochrome+c+and+apoptosis+inducing+factor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNewcomb%26aufirst%3DE.%2BW.%26aulast%3DTamasdan%26aufirst%3DC.%26aulast%3DEntzminger%26aufirst%3DY.%26aulast%3DAlonso%26aufirst%3DJ.%26aulast%3DFriedlander%26aufirst%3DD.%26aulast%3DCrisan%26aufirst%3DD.%26aulast%3DMiller%26aufirst%3DD.%2BC.%26aulast%3DZagzag%26aufirst%3DD.%26atitle%3DFlavopiridol%2520induces%2520mitochondrial-mediated%2520apoptosis%2520in%2520murine%2520glioma%2520GL261%2520cells%2520via%2520release%2520of%2520cytochrome%2520c%2520and%2520apoptosis%2520inducing%2520factor%26jtitle%3DCell%2520Cycle%26date%3D2003%26volume%3D2%26spage%3D243%26epage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Premkumar, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jane, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollack, I. F.</span><span> </span><span class="NLM_article-title">Co-administration of NVP-AEW541 and dasatinib induces mitochondrial-mediated apoptosis through Bax activation in malignant human glioma cell lines</span> <span class="citation_source-journal">Int. J. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">633</span><span class="NLM_x">–</span> <span class="NLM_lpage">643</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=20664932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFSkt73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2010&pages=633-643&author=D.+R.+Premkumarauthor=E.+P.+Janeauthor=I.+F.+Pollack&title=Co-administration+of+NVP-AEW541+and+dasatinib+induces+mitochondrial-mediated+apoptosis+through+Bax+activation+in+malignant+human+glioma+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Co-administration of NVP-AEW541 and dasatinib induces mitochondrial-mediated apoptosis through Bax activation in malignant human glioma cell lines</span></div><div class="casAuthors">Premkumar, Daniel R.; Jane, Esther P.; Pollack, Ian F.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">633-643</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">Glioblastoma multiforme represents a largely incurable tumor for which novel therapeutic strategies are required.  We report the effect of NVP-AEW541, an inhibitor of insulin-like growth factor-I receptor (IGF-IR) kinase activity on growth and signaling in a panel of glioma cell lines.  NVP-AEW541 blocked phosphorylation of IGF-IR in a dose- and time-dependent manner and inhibited proliferation and clonogenicity with median effective concns. of 2.5-10 μM.  NVP-AEW541 also induced loss of mitochondrial membrane potential and release of cytochrome c and apoptosis-inducing factor (AIF) from mitochondria.  Because concns. of NVP-AEW541 required to significantly inhibit glioma cell viability and downstream signaling also inhibited non-neoplastic astrocytes, we questioned whether differential efficacy could be enhanced by combination with inhibition of other tyrosine kinases dysregulated in gliomas.  Dasatinib was selected as a combination agent based on its distinct inhibitory profile for other relevant signaling targets.  Combined treatment with NVP-AEW541 and dasatinib induced significantly more apoptosis than either agent alone in glioma cells, but not non-neoplastic astrocytes, and synergistically inhibited clonogenic survival.  Mechanistic studies indicated that combination of NVP-AEW541 and dasatinib significantly reduced pERK and pAkt and markedly increased AIF release, Bax oligomerization and loss of mitochondrial potential compared to each agent alone.  Overexpression of Bcl-2 and Akt significantly attenuated NVP-AEW541 and dasatinib-induced Bax activation and cell death.  Our data indicate that activation of Bax plays a crit. role in mediating NVP-AEW541 and dasatinib-induced apoptosis, and suggest the potential value of combining IGFR inhibition with other classes of tyrosine kinase inhibitors to potentiate therapeutic efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFVHjUeZD8m7Vg90H21EOLACvtfcHk0lhTxd4TbWr50w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFSkt73I&md5=7cf31004535ed63dddb02afc9c8afbf9</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPremkumar%26aufirst%3DD.%2BR.%26aulast%3DJane%26aufirst%3DE.%2BP.%26aulast%3DPollack%26aufirst%3DI.%2BF.%26atitle%3DCo-administration%2520of%2520NVP-AEW541%2520and%2520dasatinib%2520induces%2520mitochondrial-mediated%2520apoptosis%2520through%2520Bax%2520activation%2520in%2520malignant%2520human%2520glioma%2520cell%2520lines%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2010%26volume%3D37%26spage%3D633%26epage%3D643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Shaker, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiha, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibrahim, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehal, W. Z.</span><span> </span><span class="NLM_article-title">Nilotinib induces apoptosis and autophagic cell death of activated hepatic stellate cells via inhibition of histone deacetylases</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">1833</span><span class="NLM_x">, </span> <span class="NLM_fpage">1992</span><span class="NLM_x">–</span> <span class="NLM_lpage">2003</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1833&publication_year=2013&pages=1992-2003&author=M.+E.+Shakerauthor=A.+Ghaniauthor=G.+E.+Shihaauthor=T.+M.+Ibrahimauthor=W.+Z.+Mehal&title=Nilotinib+induces+apoptosis+and+autophagic+cell+death+of+activated+hepatic+stellate+cells+via+inhibition+of+histone+deacetylases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShaker%26aufirst%3DM.%2BE.%26aulast%3DGhani%26aufirst%3DA.%26aulast%3DShiha%26aufirst%3DG.%2BE.%26aulast%3DIbrahim%26aufirst%3DT.%2BM.%26aulast%3DMehal%26aufirst%3DW.%2BZ.%26atitle%3DNilotinib%2520induces%2520apoptosis%2520and%2520autophagic%2520cell%2520death%2520of%2520activated%2520hepatic%2520stellate%2520cells%2520via%2520inhibition%2520of%2520histone%2520deacetylases%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2013%26volume%3D1833%26spage%3D1992%26epage%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Wesierska-Gadek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gueorguieva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horky, M.</span><span> </span><span class="NLM_article-title">Roscovitine-induced up-regulation of p53AIP1 protein precedes the onset of apoptosis in human MCF-7 breast cancer cells</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">113</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.4161%2Fcbt.4.1.1446" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=15657359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXksFyqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=113-124&author=J.+Wesierska-Gadekauthor=M.+Gueorguievaauthor=M.+Horky&title=Roscovitine-induced+up-regulation+of+p53AIP1+protein+precedes+the+onset+of+apoptosis+in+human+MCF-7+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Roscovitine-induced up-regulation of p53AIP1 protein precedes the onset of apoptosis in human MCF-7 breast cancer cells</span></div><div class="casAuthors">Wesierska-Gadek, Jozefa; Gueorguieva, Marieta; Horky, Marcel</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">113-124</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">We reported recently that roscovitine arrested human MCF-7 cancer cells at G2-M phase of the cell cycle and concomitantly induced apoptosis.  After roscovitine treatment, the level of wild-type p53 protein strongly increased and p53 was accumulated in the nucleus.  Here, we raised the question of which pathway would be involved in roscovitine-induced apoptosis in MCF-7 cells, which are known to be caspase-3-deficient, and whether roscovitine-mediated activation of p53 protein might pos. affect the execution of cell death.  Roscovitine induced a depolarization of mitochondrial potential beginning at 6 h posttreatment as evidenced by changes in J-aggregate formation and release of the mitochondrial proteins cytochrome c and apoptosis-inducing factor.  Interestingly, roscovitine stimulated a site-specific phosphorylation of wild-type p53 protein in a time-dependent manner. p53 protein was specifically phosphorylated at Ser46.  P-Ser46-activated wild-type p53 tumor suppressor up-regulated p53AIP1 protein, its downstream target known to mediate the depolarization of mitochondria.  The onset of phosphorylation of p53 at Ser46 preceded the up-regulation of p53AIP1 protein and the depolarization of mitochondrial potential.  We compared the kinetics of roscovitine-mediated p53 activation between caspase-3-deficient parental MCF-7 cells and cells reconstituted with caspase-3.  The kinetics and the extent of p53 protein activation in caspase-3-proficient cells differed from those obsd. in caspase-3-deficient parental cells.  Remarkably, roscovitine failed to induce phosphorylation at Ser46 in caspase-3-reconstituted MCF-7 cells.  Our results indicate that, depending on the status of caspase-3 in MCF-7 cells, different apoptotic pathways were initialized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9w1R5p512sbVg90H21EOLACvtfcHk0lglfXBc6hJSIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXksFyqtg%253D%253D&md5=ecdb5babc47f5308ac2bdea69f47a52d</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.4161%2Fcbt.4.1.1446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.4.1.1446%26sid%3Dliteratum%253Aachs%26aulast%3DWesierska-Gadek%26aufirst%3DJ.%26aulast%3DGueorguieva%26aufirst%3DM.%26aulast%3DHorky%26aufirst%3DM.%26atitle%3DRoscovitine-induced%2520up-regulation%2520of%2520p53AIP1%2520protein%2520precedes%2520the%2520onset%2520of%2520apoptosis%2520in%2520human%2520MCF-7%2520breast%2520cancer%2520cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2005%26volume%3D4%26spage%3D113%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Min, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span> </span><span class="NLM_article-title">Gefitinib induces mitochondrial-dependent apoptosis in Saccharomyces cerevisiae</span> <span class="citation_source-journal">Mol. Med. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">362</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.3892%2Fmmr.2011.427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVOju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2011&pages=357-362&author=J.+Wuauthor=R.+Minauthor=M.+Wuauthor=W.+Chen&title=Gefitinib+induces+mitochondrial-dependent+apoptosis+in+Saccharomyces+cerevisiae"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Gefitinib induces mitochondrial-dependent apoptosis in Saccharomyces cerevisiae</span></div><div class="casAuthors">Wu, Jing; Min, Rou; Wu, Minchen; Chen, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine Reports</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">357-362</span>CODEN:
                <span class="NLM_cas:coden">MMROA5</span>;
        ISSN:<span class="NLM_cas:issn">1791-2997</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Gefitinib, a selective inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase, has been clin. demonstrated to be effective in certain cancer cell types.  In the present study, using the yeast Saccharomyces cerevisiae as a model, gefitinib-induced apoptotic cell death was demonstrated.  Gefitinib inhibited yeast cell proliferation and ultimately led to cell death in a time- and dose-dependent manner.  Furthermore, when cells were exposed to 15 μM gefitinib, typical apoptotic markers, including phosphatidylserine exposure, DNA fragmentation, reactive oxygen species prodn. and decrease in mitochondrial membrane potential, were obsd.  The Δcyc3 strain deleted in cyt c heme lyase and the rho0 mutant strain lacking mtDNA-delayed cell death, provided further evidence that the yeast cell death process involved the mitochondria.  Thus, these findings suggest that gefitinib induces apoptosis in yeast cells through a mitochondrial-dependent pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0VvQy-w4fVrVg90H21EOLACvtfcHk0lglfXBc6hJSIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVOju7s%253D&md5=254c63e9526e6084f114fdc5285a991a</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.3892%2Fmmr.2011.427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fmmr.2011.427%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DMin%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DW.%26atitle%3DGefitinib%2520induces%2520mitochondrial-dependent%2520apoptosis%2520in%2520Saccharomyces%2520cerevisiae%26jtitle%3DMol.%2520Med.%2520Rep.%26date%3D2011%26volume%3D4%26spage%3D357%26epage%3D362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konopleva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruvolo, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McQueen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bornmann, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCubrey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreeff, M.</span><span> </span><span class="NLM_article-title">Sorafenib induces apoptosis of AML cells via Bim-mediated activation of the intrinsic apoptotic pathway</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">808</span><span class="NLM_x">–</span> <span class="NLM_lpage">818</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=808-818&author=W.+Zhangauthor=M.+Konoplevaauthor=V.+R.+Ruvoloauthor=T.+McQueenauthor=R.+L.+Evansauthor=W.+G.+Bornmannauthor=J.+McCubreyauthor=J.+Cortesauthor=M.+Andreeff&title=Sorafenib+induces+apoptosis+of+AML+cells+via+Bim-mediated+activation+of+the+intrinsic+apoptotic+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DKonopleva%26aufirst%3DM.%26aulast%3DRuvolo%26aufirst%3DV.%2BR.%26aulast%3DMcQueen%26aufirst%3DT.%26aulast%3DEvans%26aufirst%3DR.%2BL.%26aulast%3DBornmann%26aufirst%3DW.%2BG.%26aulast%3DMcCubrey%26aufirst%3DJ.%26aulast%3DCortes%26aufirst%3DJ.%26aulast%3DAndreeff%26aufirst%3DM.%26atitle%3DSorafenib%2520induces%2520apoptosis%2520of%2520AML%2520cells%2520via%2520Bim-mediated%2520activation%2520of%2520the%2520intrinsic%2520apoptotic%2520pathway%26jtitle%3DLeukemia%26date%3D2008%26volume%3D22%26spage%3D808%26epage%3D818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Sordella, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haber, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Settleman, J.</span><span> </span><span class="NLM_article-title">Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">305</span><span class="NLM_x">, </span> <span class="NLM_fpage">1163</span><span class="NLM_x">–</span> <span class="NLM_lpage">1167</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2004&pages=1163-1167&author=R.+Sordellaauthor=D.+W.+Bellauthor=D.+A.+Haberauthor=J.+Settleman&title=Gefitinib-sensitizing+EGFR+mutations+in+lung+cancer+activate+anti-apoptotic+pathways"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSordella%26aufirst%3DR.%26aulast%3DBell%26aufirst%3DD.%2BW.%26aulast%3DHaber%26aufirst%3DD.%2BA.%26aulast%3DSettleman%26aufirst%3DJ.%26atitle%3DGefitinib-sensitizing%2520EGFR%2520mutations%2520in%2520lung%2520cancer%2520activate%2520anti-apoptotic%2520pathways%26jtitle%3DScience%26date%3D2004%26volume%3D305%26spage%3D1163%26epage%3D1167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Martin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliver, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partridge, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchison, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giles, P.</span><span> </span><span class="NLM_article-title">Pharmacokinetics of vandetanib: three phase I studies in healthy subjects</span> <span class="citation_source-journal">Clin. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span><span class="NLM_x">–</span> <span class="NLM_lpage">237</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1016%2Fj.clinthera.2011.11.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=22206795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVektb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2012&pages=221-237&author=P.+Martinauthor=S.+Oliverauthor=S.+J.+Kennedyauthor=E.+Partridgeauthor=M.+Hutchisonauthor=D.+Clarkeauthor=P.+Giles&title=Pharmacokinetics+of+vandetanib%3A+three+phase+I+studies+in+healthy+subjects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics of Vandetanib: Three Phase I Studies in Healthy Subjects</span></div><div class="casAuthors">Martin, Paul; Oliver, Stuart; Kennedy, Sarah-Jane; Partridge, Elizabeth; Hutchison, Michael; Clarke, David; Giles, Petrina</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">221-237</span>CODEN:
                <span class="NLM_cas:coden">CLTHDG</span>;
        ISSN:<span class="NLM_cas:issn">0149-2918</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Background: Vandetanib is an orally available inhibitor of vascular endothelial growth factor receptor 2 and epidermal growth factor receptor and is rearranged during transfection tyrosine kinase activity.  Development has included studies in non-small cell lung cancer and other tumor types.  Accurate elimination kinetics were not detd. in patient studies, and so the current human volunteer studies were performed to derive detailed kinetic data.  Objective: The aim of this study was to investigate pharmacokinetics, metab., excretion, and elimination kinetics after single oral doses of vandetanib in healthy subjects.  Methods: Three studies were conducted.  In Study A (n = 23), cohorts of 8 subjects were randomized to receive double-blind, ascending doses of vandetanib (300-1200 mg) or placebo (6:2).  Study B had a crossover design; subjects (n = 16) received vandetanib 300 mg under fed and fasted conditions.  In Study C, subjects (n = 4) received [14C] vandetanib 800 mg.  Blood samples were collected for pharmacokinetic anal. for up to 28 days after the dose (Studies A and B) and 42 days after the dose (Study C).  Plasma (all studies) and urine (Study A only) samples were collected for detn. of vandetanib concns.  In Study C radioactivity was measured in plasma, blood, urine, and feces, and metabolites were identified chromatog.  Tolerability was evaluated by recording of adverse events, clin. chem., hematol. and urinalysis parameters, vital signs, and ECGs (all studies).  Results: Study A: mean (SD) age 34.4 (6.9) years; 23/23 male; mean (SD; range) wt. 80.6 (8.1; 62-97) kg.  Study B: mean (SD) age 35.3 (8.4) years; 15/16 male; mean (SD; range) wt. 80.7 (11.2; 57-100) kg.  Study C: mean (SD) age 60.3 (7.4) years; 4/4 male; mean (SD; range) wt. 78.0 (7.7l; 72-87) kg.  Pharmacokinetic parameters were consistent across all studies (Studies A and C, vandetanib 800 mg: geometric mean CL/F, 13.1-13.3 L/h; geometric mean apparent vol. of distribution at steady state [VSS/F], 3592-4103 L; mean t1/2, 215.8-246.6 h).  Vandetanib was absorbed and eliminated slowly after single oral doses.  AUC0-∞ and Cmax were not significantly affected by ingestion of food.  Median (range) Tmax was 8 (3-18) hours after food and 6 (5-18) hours after fasting.  In plasma, concns. of total radioactivity were higher than vandetanib concns. at all time points, indicating the presence of circulating metabolites.  Unchanged vandetanib and 2 anticipated metabolites (N-desmethylvandetanib and vandetanib N-oxide) were detected in plasma, urine, and feces.  A further trace minor metabolite (glucuronide conjugate) was found in urine and feces.  Approx. two thirds of the dose was recovered in feces (44%) and urine (25%) over 21 days, underlining the importance of both routes of elimination.  Adverse events were reported by all subjects in Study A apart from 2 at a vandetanib dose of 300 mg; 12/15 (80%) and 14/16 (88%) subjects who took vandetanib under fed and fasted conditions, resp., in Study B; and 2/4 (50%) subjects in Study C. No serious adverse events were reported.  Increasing doses of vandetanib, in Study A, were assocd. with variable increases in systolic and diastolic blood pressures and variable increases from baseline in QTc interval.  Hematuria was reported by 3 subjects (vandetanib 300 mg) in Study A. Small but consistent increases from baseline in serum creatinine were noted in subjects who received vandetanib in these studies.  No other clin. important changes were obsd. in clin. chem., hematol. and urinalysis parameters, vital signs, and ECGs in any of the studies.  Conclusions: The pharmacokinetics of vandetanib after single oral doses to healthy subjects were defined and the metabolic pathway was proposed.  Vandetanib was absorbed and eliminated slowly with a t1/2 of ∼10 days after single oral doses.  The extent of absorption was not significantly affected by the presence of food.  Approx. two thirds of the dose was recovered in feces (44%) and urine (25%) over 21 days.  Unchanged vandetanib and N-desmethyl and N-oxide metabolites were detected in plasma, urine, and feces.  Vandetanib appeared to be was well tolerated in the populations studied.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJUcGqrKlcbLVg90H21EOLACvtfcHk0ljP2ku4yFHOOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVektb4%253D&md5=cb3159f6708d6d95e4439e3e5c8242f5</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.clinthera.2011.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clinthera.2011.11.011%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DP.%26aulast%3DOliver%26aufirst%3DS.%26aulast%3DKennedy%26aufirst%3DS.%2BJ.%26aulast%3DPartridge%26aufirst%3DE.%26aulast%3DHutchison%26aufirst%3DM.%26aulast%3DClarke%26aufirst%3DD.%26aulast%3DGiles%26aufirst%3DP.%26atitle%3DPharmacokinetics%2520of%2520vandetanib%253A%2520three%2520phase%2520I%2520studies%2520in%2520healthy%2520subjects%26jtitle%3DClin.%2520Ther.%26date%3D2012%26volume%3D34%26spage%3D221%26epage%3D237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z. J.</span><span> </span><span class="NLM_article-title">Erlotinib effectively inhibits JAK2V617F activity and polycythemia vera cell growth</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">3428</span><span class="NLM_x">–</span> <span class="NLM_lpage">3432</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=3428-3432&author=Z.+Liauthor=M.+Xuauthor=S.+Xingauthor=W.+T.+Hoauthor=T.+Ishiiauthor=Q.+Liauthor=X.+Fuauthor=Z.+J.+Zhao&title=Erlotinib+effectively+inhibits+JAK2V617F+activity+and+polycythemia+vera+cell+growth"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DXing%26aufirst%3DS.%26aulast%3DHo%26aufirst%3DW.%2BT.%26aulast%3DIshii%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DFu%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DZ.%2BJ.%26atitle%3DErlotinib%2520effectively%2520inhibits%2520JAK2V617F%2520activity%2520and%2520polycythemia%2520vera%2520cell%2520growth%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D3428%26epage%3D3432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Higa, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, J.</span><span> </span><span class="NLM_article-title">Lapatinib in the treatment of breast cancer</span> <span class="citation_source-journal">Expert Rev. Anticancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1183</span><span class="NLM_x">–</span> <span class="NLM_lpage">1192</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1586%2F14737140.7.9.1183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=17892419" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVOgtLnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=1183-1192&author=G.+M.+Higaauthor=J.+Abraham&title=Lapatinib+in+the+treatment+of+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Lapatinib in the treatment of breast cancer</span></div><div class="casAuthors">Higa, Gerald M.; Abraham, Jame</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anticancer Therapy</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1183-1192</span>CODEN:
                <span class="NLM_cas:coden">ERATBJ</span>;
        ISSN:<span class="NLM_cas:issn">1473-7140</span>.
    
            (<span class="NLM_cas:orgname">Future Drugs Ltd.</span>)
        </div><div class="casAbstract">A review.  Within the past 2 years, four sep. groups have reported marked improvement in relapse-free survival when trastuzumab was added to adjuvant chemotherapy in patients with HER2-overexpressing breast cancer.  These results add further credence to the relevance of this receptor as a tumor target.  Despite the significant benefits obsd. in early and advanced HER2-pos. breast cancer, overexpression of the receptor is still assocd. with a poorer prognosis and an increased risk of disease relapse, even in patients with primary operable disease.  Besides cytotoxic chemotherapy, and possibly hormonal therapy, patients whose tumors exhibit resistance to trastuzumab have few mol.-targeted options available.  Recently, lapatinib, a small mol. dual inhibitor of both HER2 and EGF receptors, has been developed to expand the options for treating HER-pos. breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUgtgQa41YwbVg90H21EOLACvtfcHk0ljP2ku4yFHOOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVOgtLnK&md5=7d0a454789b2734587cfb9660ea94e97</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1586%2F14737140.7.9.1183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737140.7.9.1183%26sid%3Dliteratum%253Aachs%26aulast%3DHiga%26aufirst%3DG.%2BM.%26aulast%3DAbraham%26aufirst%3DJ.%26atitle%3DLapatinib%2520in%2520the%2520treatment%2520of%2520breast%2520cancer%26jtitle%3DExpert%2520Rev.%2520Anticancer%2520Ther.%26date%3D2007%26volume%3D7%26spage%3D1183%26epage%3D1192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Lin, N. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winer, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheatley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carey, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houston, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendelson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munster, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frakes, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleator, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uttenreuther-Fischer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wind, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinisko, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickish, T.</span><span> </span><span class="NLM_article-title">A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x">, </span> <span class="NLM_fpage">1057</span><span class="NLM_x">–</span> <span class="NLM_lpage">1065</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1007%2Fs10549-012-2003-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=22418700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvFeqsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2012&pages=1057-1065&author=N.+U.+Linauthor=E.+P.+Winerauthor=D.+Wheatleyauthor=L.+A.+Careyauthor=S.+Houstonauthor=D.+Mendelsonauthor=P.+Munsterauthor=L.+Frakesauthor=S.+Kellyauthor=A.+A.+Garciaauthor=S.+Cleatorauthor=M.+Uttenreuther-Fischerauthor=H.+Jonesauthor=S.+Windauthor=R.+Viniskoauthor=T.+Hickish&title=A+phase+II+study+of+afatinib+%28BIBW+2992%29%2C+an+irreversible+ErbB+family+blocker%2C+in+patients+with+HER2-positive+metastatic+breast+cancer+progressing+after+trastuzumab"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab</span></div><div class="casAuthors">Lin, Nancy U.; Winer, Eric P.; Wheatley, Duncan; Carey, Lisa A.; Houston, Stephen; Mendelson, David; Munster, Pamela; Frakes, Laurie; Kelly, Steve; Garcia, Agustin A.; Cleator, Susan; Uttenreuther-Fischer, Martina; Jones, Hilary; Wind, Sven; Vinisko, Richard; Hickish, Tamas</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1057-1065</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Afatinib is an oral, ErbB family blocker, which covalently binds and irreversibly blocks all kinase-competent ErbB family members.  This phase II, open-label, single-arm study explored afatinib activity in human epidermal growth factor receptor 2 (HER2)-pos. breast cancer patients progressing after trastuzumab treatment.  Patients had stage IIIB/IV HER2-pos. metastatic breast cancer, with progression following trastuzumab or trastuzumab intolerance and an Eastern Cooperative Oncol. Group (ECOG) performance status of 0-2.  Patients received 50 mg afatinib once-daily until disease progression.  Primary endpoint was objective response rate (Response Evaluation Criteria in Solid Tumors 1.0), with tumor assessments every 8 wk.  Forty-one patients were treated.  Patients had received a median of three prior chemotherapy lines (range, 0-15) and 68.3% had received trastuzumab for >1 yr.  Four patients (10% of 41 treated; 11% of evaluable patients) had partial response.  Fifteen patients (37% of 41) had stable disease as best response and 19 (46% of 41) achieved clin. benefit.  Median progression-free survival was 15.1 wk (95% confidence interval [CI]: 8.1-16.7); median overall survival was 61.0 wk (95% CI: 56.7-not evaluable).  Most frequent common terminol. criteria for adverse events grade 3 treatment-related adverse events were diarrhea (24.4%) and rash (9.8%).  Afatinib monotherapy was assocd. with promising clin. activity in extensively pretreated HER2-pos. breast cancer patients who had progressed following trastuzumab treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVxOybv2RnJrVg90H21EOLACvtfcHk0liZXtTLeufOAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvFeqsLg%253D&md5=4922019e7aa039292a5b4df98786ac3b</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2Fs10549-012-2003-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-012-2003-y%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DN.%2BU.%26aulast%3DWiner%26aufirst%3DE.%2BP.%26aulast%3DWheatley%26aufirst%3DD.%26aulast%3DCarey%26aufirst%3DL.%2BA.%26aulast%3DHouston%26aufirst%3DS.%26aulast%3DMendelson%26aufirst%3DD.%26aulast%3DMunster%26aufirst%3DP.%26aulast%3DFrakes%26aufirst%3DL.%26aulast%3DKelly%26aufirst%3DS.%26aulast%3DGarcia%26aufirst%3DA.%2BA.%26aulast%3DCleator%26aufirst%3DS.%26aulast%3DUttenreuther-Fischer%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DH.%26aulast%3DWind%26aufirst%3DS.%26aulast%3DVinisko%26aufirst%3DR.%26aulast%3DHickish%26aufirst%3DT.%26atitle%3DA%2520phase%2520II%2520study%2520of%2520afatinib%2520%2528BIBW%25202992%2529%252C%2520an%2520irreversible%2520ErbB%2520family%2520blocker%252C%2520in%2520patients%2520with%2520HER2-positive%2520metastatic%2520breast%2520cancer%2520progressing%2520after%2520trastuzumab%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2012%26volume%3D133%26spage%3D1057%26epage%3D1065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Kantarjian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giles, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wunderle, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhalla, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wassmann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rae, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mietlowski, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bochinski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochhaus, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelzer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albitar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dugan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alland, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottmann, O. G.</span><span> </span><span class="NLM_article-title">Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">354</span><span class="NLM_x">, </span> <span class="NLM_fpage">2542</span><span class="NLM_x">–</span> <span class="NLM_lpage">2551</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1056%2FNEJMoa055104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=16775235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A280%3ADC%252BD28zmtFaitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=354&publication_year=2006&pages=2542-2551&author=H.+Kantarjianauthor=F.+Gilesauthor=L.+Wunderleauthor=K.+Bhallaauthor=S.+O%E2%80%99Brienauthor=B.+Wassmannauthor=C.+Tanakaauthor=P.+Manleyauthor=P.+Raeauthor=W.+Mietlowskiauthor=K.+Bochinskiauthor=A.+Hochhausauthor=J.+D.+Griffinauthor=D.+Hoelzerauthor=M.+Albitarauthor=M.+Duganauthor=J.+Cortesauthor=L.+Allandauthor=O.+G.+Ottmann&title=Nilotinib+in+imatinib-resistant+CML+and+Philadelphia+chromosome-positive+ALL"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL</span></div><div class="casAuthors">Kantarjian Hagop; Giles Francis; Wunderle Lydia; Bhalla Kapil; O'Brien Susan; Wassmann Barbara; Tanaka Chiaki; Manley Paul; Rae Patricia; Mietlowski William; Bochinski Kathy; Hochhaus Andreas; Griffin James D; Hoelzer Dieter; Albitar Maher; Dugan Margaret; Cortes Jorge; Alland Leila; Ottmann Oliver G</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">354</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2542-51</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Resistance to imatinib mesylate can occur in chronic myelogenous leukemia (CML).  Preclinical in vitro studies have shown that nilotinib (AMN107), a new BCR-ABL tyrosine kinase inhibitor, is more potent than imatinib against CML cells by a factor of 20 to 50.  METHODS:  In a phase 1 dose-escalation study, we assigned 119 patients with imatinib-resistant CML or acute lymphoblastic leukemia (ALL) to receive nilotinib orally at doses of 50 mg, 100 mg, 200 mg, 400 mg, 600 mg, 800 mg, and 1200 mg once daily and at 400 mg and 600 mg twice daily.  RESULTS:  Common adverse events were myelosuppression, transient indirect hyperbilirubinemia, and rashes.  Of 33 patients with the blastic phase of disease, 13 had a hematologic response and 9 had a cytogenetic response; of 46 patients with the accelerated phase, 33 had a hematologic response and 22 had a cytogenetic response; 11 of 12 patients with the chronic phase had a complete hematologic remission.  CONCLUSIONS:  Nilotinib has a relatively favorable safety profile and is active in imatinib-resistant CML. (ClinicalTrials.gov number, NCT00109707 [ClinicalTrials.gov].).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTSMguWnBLtEAaK-_ZudimnfW6udTcc2eYm4KexD1_GFbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28zmtFaitQ%253D%253D&md5=929692a4d24d87a38ded7900953453f8</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa055104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa055104%26sid%3Dliteratum%253Aachs%26aulast%3DKantarjian%26aufirst%3DH.%26aulast%3DGiles%26aufirst%3DF.%26aulast%3DWunderle%26aufirst%3DL.%26aulast%3DBhalla%26aufirst%3DK.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DS.%26aulast%3DWassmann%26aufirst%3DB.%26aulast%3DTanaka%26aufirst%3DC.%26aulast%3DManley%26aufirst%3DP.%26aulast%3DRae%26aufirst%3DP.%26aulast%3DMietlowski%26aufirst%3DW.%26aulast%3DBochinski%26aufirst%3DK.%26aulast%3DHochhaus%26aufirst%3DA.%26aulast%3DGriffin%26aufirst%3DJ.%2BD.%26aulast%3DHoelzer%26aufirst%3DD.%26aulast%3DAlbitar%26aufirst%3DM.%26aulast%3DDugan%26aufirst%3DM.%26aulast%3DCortes%26aufirst%3DJ.%26aulast%3DAlland%26aufirst%3DL.%26aulast%3DOttmann%26aufirst%3DO.%2BG.%26atitle%3DNilotinib%2520in%2520imatinib-resistant%2520CML%2520and%2520Philadelphia%2520chromosome-positive%2520ALL%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2006%26volume%3D354%26spage%3D2542%26epage%3D2551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Goldman, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melo, J. V.</span><span> </span><span class="NLM_article-title">Chronic myeloid leukemia--advances in biology and new approaches to treatment</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">349</span><span class="NLM_x">, </span> <span class="NLM_fpage">1451</span><span class="NLM_x">–</span> <span class="NLM_lpage">1464</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1056%2FNEJMra020777" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=14534339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotVGgsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=2003&pages=1451-1464&author=J.+M.+Goldmanauthor=J.+V.+Melo&title=Chronic+myeloid+leukemia%2D%2Dadvances+in+biology+and+new+approaches+to+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic myeloid leukemia - Advances in biology and new approaches to treatment</span></div><div class="casAuthors">Goldman, John M.; Melo, Junia V.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">349</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1451-1464</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review presents recent advances in knowledge related to the pathogenesis of chronic myeloid leukemia (CML) and indicates where these may have important therapeutic implications.  It discusses the cytokinetics, cytogenetics, mol. events, graft-vs.-leukemia effect and treatment options of CML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXmKTzKKnN9bVg90H21EOLACvtfcHk0ljgBoHpGTa2HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotVGgsLc%253D&md5=88ae3d2434d003dca02f0e4af5bfff8d</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1056%2FNEJMra020777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra020777%26sid%3Dliteratum%253Aachs%26aulast%3DGoldman%26aufirst%3DJ.%2BM.%26aulast%3DMelo%26aufirst%3DJ.%2BV.%26atitle%3DChronic%2520myeloid%2520leukemia--advances%2520in%2520biology%2520and%2520new%2520approaches%2520to%2520treatment%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2003%26volume%3D349%26spage%3D1451%26epage%3D1464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Yokota, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashihara, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuroda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamitsuji, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawata, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urasaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruthardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatake, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inui, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maekawa, T.</span><span> </span><span class="NLM_article-title">INNO-406, a novel BCR-ABL/Lyn dual tyrosine kinase inhibitor, suppresses the growth of Ph+ leukemia cells in the central nervous system, and cyclosporine A augments its in vivo activity</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">306</span><span class="NLM_x">–</span> <span class="NLM_lpage">314</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2007&pages=306-314&author=A.+Yokotaauthor=S.+Kimuraauthor=S.+Masudaauthor=E.+Ashiharaauthor=J.+Kurodaauthor=K.+Satoauthor=Y.+Kamitsujiauthor=E.+Kawataauthor=Y.+Deguchiauthor=Y.+Urasakiauthor=Y.+Teruiauthor=M.+Ruthardtauthor=T.+Uedaauthor=K.+Hatakeauthor=K.+Inuiauthor=T.+Maekawa&title=INNO-406%2C+a+novel+BCR-ABL%2FLyn+dual+tyrosine+kinase+inhibitor%2C+suppresses+the+growth+of+Ph%2B+leukemia+cells+in+the+central+nervous+system%2C+and+cyclosporine+A+augments+its+in+vivo+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYokota%26aufirst%3DA.%26aulast%3DKimura%26aufirst%3DS.%26aulast%3DMasuda%26aufirst%3DS.%26aulast%3DAshihara%26aufirst%3DE.%26aulast%3DKuroda%26aufirst%3DJ.%26aulast%3DSato%26aufirst%3DK.%26aulast%3DKamitsuji%26aufirst%3DY.%26aulast%3DKawata%26aufirst%3DE.%26aulast%3DDeguchi%26aufirst%3DY.%26aulast%3DUrasaki%26aufirst%3DY.%26aulast%3DTerui%26aufirst%3DY.%26aulast%3DRuthardt%26aufirst%3DM.%26aulast%3DUeda%26aufirst%3DT.%26aulast%3DHatake%26aufirst%3DK.%26aulast%3DInui%26aufirst%3DK.%26aulast%3DMaekawa%26aufirst%3DT.%26atitle%3DINNO-406%252C%2520a%2520novel%2520BCR-ABL%252FLyn%2520dual%2520tyrosine%2520kinase%2520inhibitor%252C%2520suppresses%2520the%2520growth%2520of%2520Ph%252B%2520leukemia%2520cells%2520in%2520the%2520central%2520nervous%2520system%252C%2520and%2520cyclosporine%2520A%2520augments%2520its%2520in%2520vivo%2520activity%26jtitle%3DBlood%26date%3D2007%26volume%3D109%26spage%3D306%26epage%3D314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Gambacorti-Passerini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Assouline, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scapozza, L.</span><span> </span><span class="NLM_article-title">Abl inhibitor BMS354825 binding mode in Abelson kinase revealed by molecular docking studies</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1267</span><span class="NLM_x">–</span> <span class="NLM_lpage">1269</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2005&pages=1267-1269&author=C.+Gambacorti-Passeriniauthor=M.+Gasserauthor=S.+Ahmedauthor=S.+Assoulineauthor=L.+Scapozza&title=Abl+inhibitor+BMS354825+binding+mode+in+Abelson+kinase+revealed+by+molecular+docking+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGambacorti-Passerini%26aufirst%3DC.%26aulast%3DGasser%26aufirst%3DM.%26aulast%3DAhmed%26aufirst%3DS.%26aulast%3DAssouline%26aufirst%3DS.%26aulast%3DScapozza%26aufirst%3DL.%26atitle%3DAbl%2520inhibitor%2520BMS354825%2520binding%2520mode%2520in%2520Abelson%2520kinase%2520revealed%2520by%2520molecular%2520docking%2520studies%26jtitle%3DLeukemia%26date%3D2005%26volume%3D19%26spage%3D1267%26epage%3D1269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Clark, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cools, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curley, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lokker, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giese, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, D. G.</span><span> </span><span class="NLM_article-title">Variable sensitivity of FLT3 activation loop mutations to the small molecule tyrosine kinase inhibitor MLN518</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">2867</span><span class="NLM_x">–</span> <span class="NLM_lpage">2872</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2004&pages=2867-2872&author=J.+J.+Clarkauthor=J.+Coolsauthor=D.+P.+Curleyauthor=J.+C.+Yuauthor=N.+A.+Lokkerauthor=N.+A.+Gieseauthor=D.+G.+Gilliland&title=Variable+sensitivity+of+FLT3+activation+loop+mutations+to+the+small+molecule+tyrosine+kinase+inhibitor+MLN518"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DJ.%2BJ.%26aulast%3DCools%26aufirst%3DJ.%26aulast%3DCurley%26aufirst%3DD.%2BP.%26aulast%3DYu%26aufirst%3DJ.%2BC.%26aulast%3DLokker%26aufirst%3DN.%2BA.%26aulast%3DGiese%26aufirst%3DN.%2BA.%26aulast%3DGilliland%26aufirst%3DD.%2BG.%26atitle%3DVariable%2520sensitivity%2520of%2520FLT3%2520activation%2520loop%2520mutations%2520to%2520the%2520small%2520molecule%2520tyrosine%2520kinase%2520inhibitor%2520MLN518%26jtitle%3DBlood%26date%3D2004%26volume%3D104%26spage%3D2867%26epage%3D2872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Nam, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Im, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elvin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Min, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bang, Y. J.</span><span> </span><span class="NLM_article-title">Antitumor activity of saracatinib (AZD0530), a c-Src/Abl kinase inhibitor, alone or in combination with chemotherapeutic agents in gastric cancer</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1158%2F1535-7163.MCT-12-0109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=23144237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntValtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=16-26&author=H.+J.+Namauthor=S.+A.+Imauthor=D.+Y.+Ohauthor=P.+Elvinauthor=H.+P.+Kimauthor=Y.+K.+Yoonauthor=A.+Minauthor=S.+H.+Songauthor=S.+W.+Hanauthor=T.+Y.+Kimauthor=Y.+J.+Bang&title=Antitumor+activity+of+saracatinib+%28AZD0530%29%2C+a+c-Src%2FAbl+kinase+inhibitor%2C+alone+or+in+combination+with+chemotherapeutic+agents+in+gastric+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor Activity of Saracatinib (AZD0530), a c-Src/Abl Kinase Inhibitor, Alone or in Combination with Chemotherapeutic Agents in Gastric Cancer</span></div><div class="casAuthors">Nam, Hyun-Jin; Im, Seock-Ah; Oh, Do-Youn; Elvin, Paul; Kim, Hwang-Phill; Yoon, Young-Kwang; Min, Ahrum; Song, Sang-Hyun; Han, Sae-Won; Kim, Tae-You; Bang, Yung-Jue</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">16-26</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Src is a nonreceptor tyrosine kinase involved in the cross-talk and mediation of many signaling pathways that promote cell proliferation, adhesion, invasion, migration, and tumorigenesis.  Increased Src activity has been reported in many types of human cancer, including gastric cancer.  Therefore, this factor has been identified as a promising therapeutic target for cancer treatments, and targeting Src in gastric cancer is predicted to have potent effects.  We evaluated the antitumor effect of a c-Src/Abl kinase inhibitor, saracatinib (AZD0530), alone or combined with chemotherapeutic agents in gastric cancer cell lines and a NCI-N87 xenograft model.  Among 10 gastric cancer cell lines, saracatinib specifically inhibited the growth and migration/invasion of SNU216 and NCI-N87 cells.  Saracatinib blocked the Src/FAK, HER family, and oncogenic signaling pathways, and it induced G1 arrest and apoptosis in SNU216 and NCI-N87 cells.  Apoptosis required induction of the proapoptotic BCL2 family member Bim.  Knockdown of Bim using siRNA decreased apoptosis induced by treatment with saracatinib, suggesting that Bim has an important role in saracatinib-induced apoptosis.  Saracatinib enhanced the effects of lapatinib, an EGFR/HER2 dual inhibitor, in SNU216 and NCI-N87 cells.  Furthermore, combined treatment with saracatinib and 5-fluorouracil (5-FU) or cisplatin exerted synergistic effects in both saracatinib-sensitive and saracatinib-resistant cells.  Consistent with our in vitro findings, cotreatment with saracatinib and 5-FU resulted in enhanced antitumor activity in the NCI-N87 xenografts.  These data indicate that the inhibition of Src kinase activity by saracatinib alone or in combination with other agents can be a strategy to target gastric cancer.  Mol Cancer Ther; 12(1); 16-26. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpFSWq6HNftrVg90H21EOLACvtfcHk0lj8gdtlr2WcrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntValtw%253D%253D&md5=de92a9e602764f294ae9d231758ab283</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-12-0109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-12-0109%26sid%3Dliteratum%253Aachs%26aulast%3DNam%26aufirst%3DH.%2BJ.%26aulast%3DIm%26aufirst%3DS.%2BA.%26aulast%3DOh%26aufirst%3DD.%2BY.%26aulast%3DElvin%26aufirst%3DP.%26aulast%3DKim%26aufirst%3DH.%2BP.%26aulast%3DYoon%26aufirst%3DY.%2BK.%26aulast%3DMin%26aufirst%3DA.%26aulast%3DSong%26aufirst%3DS.%2BH.%26aulast%3DHan%26aufirst%3DS.%2BW.%26aulast%3DKim%26aufirst%3DT.%2BY.%26aulast%3DBang%26aufirst%3DY.%2BJ.%26atitle%3DAntitumor%2520activity%2520of%2520saracatinib%2520%2528AZD0530%2529%252C%2520a%2520c-Src%252FAbl%2520kinase%2520inhibitor%252C%2520alone%2520or%2520in%2520combination%2520with%2520chemotherapeutic%2520agents%2520in%2520gastric%2520cancer%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2013%26volume%3D12%26spage%3D16%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Boschelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arndt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gambacorti-Passerini, C.</span><span> </span><span class="NLM_article-title">Bosutinib: a review of preclinical studies in chronic myelogenous leukaemia</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1781</span><span class="NLM_x">–</span> <span class="NLM_lpage">1789</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2010&pages=1781-1789&author=F.+Boschelliauthor=K.+Arndtauthor=C.+Gambacorti-Passerini&title=Bosutinib%3A+a+review+of+preclinical+studies+in+chronic+myelogenous+leukaemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoschelli%26aufirst%3DF.%26aulast%3DArndt%26aufirst%3DK.%26aulast%3DGambacorti-Passerini%26aufirst%3DC.%26atitle%3DBosutinib%253A%2520a%2520review%2520of%2520preclinical%2520studies%2520in%2520chronic%2520myelogenous%2520leukaemia%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2010%26volume%3D46%26spage%3D1781%26epage%3D1789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Raje, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hideshima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roccaro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishitsuka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiraishi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauhan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. C.</span><span> </span><span class="NLM_article-title">Seliciclib (CYC202 or R-roscovitine), a small-molecule cyclin-dependent kinase inhibitor, mediates activity via down-regulation of Mcl-1 in multiple myeloma</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">1042</span><span class="NLM_x">–</span> <span class="NLM_lpage">1047</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2005&pages=1042-1047&author=N.+Rajeauthor=S.+Kumarauthor=T.+Hideshimaauthor=A.+Roccaroauthor=K.+Ishitsukaauthor=H.+Yasuiauthor=N.+Shiraishiauthor=D.+Chauhanauthor=N.+C.+Munshiauthor=S.+R.+Greenauthor=K.+C.+Anderson&title=Seliciclib+%28CYC202+or+R-roscovitine%29%2C+a+small-molecule+cyclin-dependent+kinase+inhibitor%2C+mediates+activity+via+down-regulation+of+Mcl-1+in+multiple+myeloma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRaje%26aufirst%3DN.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DHideshima%26aufirst%3DT.%26aulast%3DRoccaro%26aufirst%3DA.%26aulast%3DIshitsuka%26aufirst%3DK.%26aulast%3DYasui%26aufirst%3DH.%26aulast%3DShiraishi%26aufirst%3DN.%26aulast%3DChauhan%26aufirst%3DD.%26aulast%3DMunshi%26aufirst%3DN.%2BC.%26aulast%3DGreen%26aufirst%3DS.%2BR.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26atitle%3DSeliciclib%2520%2528CYC202%2520or%2520R-roscovitine%2529%252C%2520a%2520small-molecule%2520cyclin-dependent%2520kinase%2520inhibitor%252C%2520mediates%2520activity%2520via%2520down-regulation%2520of%2520Mcl-1%2520in%2520multiple%2520myeloma%26jtitle%3DBlood%26date%3D2005%26volume%3D106%26spage%3D1042%26epage%3D1047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Minutolo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sala, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagnacani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carboni, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Placanica, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prota, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rapposelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sacchi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macchia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghidoni, R.</span><span> </span><span class="NLM_article-title">Synthesis of a resveratrol analogue with high ceramide-mediated proapoptotic activity on human breast cancer cells</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6783</span><span class="NLM_x">–</span> <span class="NLM_lpage">6786</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050528k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6783-6786&author=F.+Minutoloauthor=G.+Salaauthor=A.+Bagnacaniauthor=S.+Bertiniauthor=I.+Carboniauthor=G.+Placanicaauthor=G.+Protaauthor=S.+Rapposelliauthor=N.+Sacchiauthor=M.+Macchiaauthor=R.+Ghidoni&title=Synthesis+of+a+resveratrol+analogue+with+high+ceramide-mediated+proapoptotic+activity+on+human+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm050528k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050528k%26sid%3Dliteratum%253Aachs%26aulast%3DMinutolo%26aufirst%3DF.%26aulast%3DSala%26aufirst%3DG.%26aulast%3DBagnacani%26aufirst%3DA.%26aulast%3DBertini%26aufirst%3DS.%26aulast%3DCarboni%26aufirst%3DI.%26aulast%3DPlacanica%26aufirst%3DG.%26aulast%3DProta%26aufirst%3DG.%26aulast%3DRapposelli%26aufirst%3DS.%26aulast%3DSacchi%26aufirst%3DN.%26aulast%3DMacchia%26aufirst%3DM.%26aulast%3DGhidoni%26aufirst%3DR.%26atitle%3DSynthesis%2520of%2520a%2520resveratrol%2520analogue%2520with%2520high%2520ceramide-mediated%2520proapoptotic%2520activity%2520on%2520human%2520breast%2520cancer%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6783%26epage%3D6786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Dawson, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobbs, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leid, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lange, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolluri, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontana, J. A.</span><span> </span><span class="NLM_article-title">Apoptosis induction in cancer cells by a novel analogue of 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalenecarboxylic acid lacking retinoid receptor transcriptional activation activity</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">4723</span><span class="NLM_x">–</span> <span class="NLM_lpage">4730</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=4723-4730&author=M.+I.+Dawsonauthor=P.+D.+Hobbsauthor=V.+J.+Petersonauthor=M.+Leidauthor=C.+W.+Langeauthor=K.+C.+Fengauthor=G.+Chenauthor=J.+Guauthor=H.+Liauthor=S.+K.+Kolluriauthor=X.+Zhangauthor=Y.+Zhangauthor=J.+A.+Fontana&title=Apoptosis+induction+in+cancer+cells+by+a+novel+analogue+of+6-%5B3-%281-adamantyl%29-4-hydroxyphenyl%5D-2-naphthalenecarboxylic+acid+lacking+retinoid+receptor+transcriptional+activation+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDawson%26aufirst%3DM.%2BI.%26aulast%3DHobbs%26aufirst%3DP.%2BD.%26aulast%3DPeterson%26aufirst%3DV.%2BJ.%26aulast%3DLeid%26aufirst%3DM.%26aulast%3DLange%26aufirst%3DC.%2BW.%26aulast%3DFeng%26aufirst%3DK.%2BC.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DGu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DKolluri%26aufirst%3DS.%2BK.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DFontana%26aufirst%3DJ.%2BA.%26atitle%3DApoptosis%2520induction%2520in%2520cancer%2520cells%2520by%2520a%2520novel%2520analogue%2520of%25206-%255B3-%25281-adamantyl%2529-4-hydroxyphenyl%255D-2-naphthalenecarboxylic%2520acid%2520lacking%2520retinoid%2520receptor%2520transcriptional%2520activation%2520activity%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D4723%26epage%3D4730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastow, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span> </span><span class="NLM_article-title">Antitumor agents. 266. Design, synthesis, and biological evaluation of novel 2-(furan-2-yl)naphthalen-1-ol derivatives as potent and selective antibreast cancer agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3586</span><span class="NLM_x">–</span> <span class="NLM_lpage">3590</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9001567" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3586-3590&author=Y.+Dongauthor=Q.+Shiauthor=Y.+N.+Liuauthor=X.+Wangauthor=K.+F.+Bastowauthor=K.+H.+Lee&title=Antitumor+agents.+266.+Design%2C+synthesis%2C+and+biological+evaluation+of+novel+2-%28furan-2-yl%29naphthalen-1-ol+derivatives+as+potent+and+selective+antibreast+cancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm9001567&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9001567%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DY.%26aulast%3DShi%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DY.%2BN.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DBastow%26aufirst%3DK.%2BF.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DAntitumor%2520agents.%2520266.%2520Design%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520novel%25202-%2528furan-2-yl%2529naphthalen-1-ol%2520derivatives%2520as%2520potent%2520and%2520selective%2520antibreast%2520cancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3586%26epage%3D3590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Yasui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hideshima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ocio, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiziltepe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vallet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishitsuka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pargellis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raje, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. C.</span><span> </span><span class="NLM_article-title">BIRB 796 enhances cytotoxicity triggered by bortezomib, heat shock protein (Hsp) 90 inhibitor, and dexamethasone via inhibition of p38 mitogen-activated protein kinase/Hsp27 pathway in multiple myeloma cell lines and inhibits paracrine tumour growth</span> <span class="citation_source-journal">Br. J. Hamaetol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">414</span><span class="NLM_x">–</span> <span class="NLM_lpage">423</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1111%2Fj.1365-2141.2006.06443.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=17173546" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2007&pages=414-423&author=H.+Yasuiauthor=T.+Hideshimaauthor=H.+Ikedaauthor=J.+Jinauthor=E.+M.+Ocioauthor=T.+Kiziltepeauthor=Y.+Okawaauthor=S.+Valletauthor=K.+Podarauthor=K.+Ishitsukaauthor=P.+G.+Richardsonauthor=C.+Pargellisauthor=N.+Mossauthor=N.+Rajeauthor=K.+C.+Anderson&title=BIRB+796+enhances+cytotoxicity+triggered+by+bortezomib%2C+heat+shock+protein+%28Hsp%29+90+inhibitor%2C+and+dexamethasone+via+inhibition+of+p38+mitogen-activated+protein+kinase%2FHsp27+pathway+in+multiple+myeloma+cell+lines+and+inhibits+paracrine+tumour+growth"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2141.2006.06443.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2141.2006.06443.x%26sid%3Dliteratum%253Aachs%26aulast%3DYasui%26aufirst%3DH.%26aulast%3DHideshima%26aufirst%3DT.%26aulast%3DIkeda%26aufirst%3DH.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DOcio%26aufirst%3DE.%2BM.%26aulast%3DKiziltepe%26aufirst%3DT.%26aulast%3DOkawa%26aufirst%3DY.%26aulast%3DVallet%26aufirst%3DS.%26aulast%3DPodar%26aufirst%3DK.%26aulast%3DIshitsuka%26aufirst%3DK.%26aulast%3DRichardson%26aufirst%3DP.%2BG.%26aulast%3DPargellis%26aufirst%3DC.%26aulast%3DMoss%26aufirst%3DN.%26aulast%3DRaje%26aufirst%3DN.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26atitle%3DBIRB%2520796%2520enhances%2520cytotoxicity%2520triggered%2520by%2520bortezomib%252C%2520heat%2520shock%2520protein%2520%2528Hsp%2529%252090%2520inhibitor%252C%2520and%2520dexamethasone%2520via%2520inhibition%2520of%2520p38%2520mitogen-activated%2520protein%2520kinase%252FHsp27%2520pathway%2520in%2520multiple%2520myeloma%2520cell%2520lines%2520and%2520inhibits%2520paracrine%2520tumour%2520growth%26jtitle%3DBr.%2520J.%2520Hamaetol.%26date%3D2007%26volume%3D136%26spage%3D414%26epage%3D423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Targeting cancer with small molecule kinase inhibitors</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1038%2Fnrc2559" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=19104514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1yg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=28-39&author=J.+Zhangauthor=P.+L.+Yangauthor=N.+S.+Gray&title=Targeting+cancer+with+small+molecule+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cancer with small molecule kinase inhibitors</span></div><div class="casAuthors">Zhang, Jianming; Yang, Priscilla L.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-39</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Deregulation of kinase activity has emerged as a major mechanism by which cancer cells evade normal physiol. constraints on growth and survival.  To date, 11 kinase inhibitors have received US Food and Drug Administration approval as cancer treatments, and there are considerable efforts to develop selective small mol. inhibitors for a host of other kinases that are implicated in cancer and other diseases.  Herein we discuss the current challenges in the field, such as designing selective inhibitors and developing strategies to overcome resistance mutations.  This Review provides a broad overview of some of the approaches currently used to discover and characterize new kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriSM3BN_uEz7Vg90H21EOLACvtfcHk0ljWNpTa0K2GBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1yg&md5=35bc38f414cd21eef5e61ce181b580fb</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fnrc2559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2559%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DP.%2BL.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DTargeting%2520cancer%2520with%2520small%2520molecule%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2009%26volume%3D9%26spage%3D28%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Xing, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rai, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunney, E. A.</span><span> </span><span class="NLM_article-title">Scaffold mining of kinase hinge binders in crystal structure database</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">23</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1007%2Fs10822-013-9700-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=24375079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitVWhsLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2014&pages=13-23&author=L.+Xingauthor=B.+Raiauthor=E.+A.+Lunney&title=Scaffold+mining+of+kinase+hinge+binders+in+crystal+structure+database"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Scaffold mining of kinase hinge binders in crystal structure database</span></div><div class="casAuthors">Xing, Li; Rai, Brajesh; Lunney, Elizabeth A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-23</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Protein kinases are the second most prominent group of drug targets, after G-protein-coupled receptors.  Despite their distinct inhibition mechanisms, the majority of kinase inhibitors engage the conserved hydrogen bond interactions with the backbone of hinge residues.  The authors mined Pfizer internal crystal structure database (CSDb) comprising of several thousand of public as well as internal x-ray binary complexes to compile an inclusive list of hinge binding scaffolds.  The min. ring scaffolds with directly attached hetero-atoms and functional groups were extd. from the full compds. by applying a rule-based filtering procedure employing a comprehensive annotation of ATP-binding site of the human kinase complements.  The results indicated large no. of kinase inhibitors of diverse chem. structures are derived from a relatively small no. of common scaffolds, which serve as the crit. recognition elements for protein kinase interaction.  Out of the nearly 4,000 kinase-inhibitor complexes in the CSDb the authors identified approx. 600 unique scaffolds.  Hinge scaffolds are overwhelmingly flat with very little sp3 characteristics, and are less lipophilic than their corresponding parent compds.  Examples of the most common as well as the uncommon hinge scaffolds are presented.  Although the most common scaffolds are found in complex with multiple kinase targets, a large no. of them are uniquely bound to a specific kinase, suggesting certain scaffolds could be more promiscuous than the others.  The compiled collection of hinge scaffolds along with their three-dimensional binding coordinates could serve as basis set for hinge hopping, a practice frequently employed to generate novel invention as well as to optimize existing leads in medicinal chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_KvTBKTNyBbVg90H21EOLACvtfcHk0ljWNpTa0K2GBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitVWhsLfO&md5=0dfcd290ca89041e699b610020e7109b</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1007%2Fs10822-013-9700-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-013-9700-4%26sid%3Dliteratum%253Aachs%26aulast%3DXing%26aufirst%3DL.%26aulast%3DRai%26aufirst%3DB.%26aulast%3DLunney%26aufirst%3DE.%2BA.%26atitle%3DScaffold%2520mining%2520of%2520kinase%2520hinge%2520binders%2520in%2520crystal%2520structure%2520database%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2014%26volume%3D28%26spage%3D13%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caflisch, A.</span><span> </span><span class="NLM_article-title">Discovery of tyrosine kinase inhibitors by docking into an inactive kinase conformation generated by molecular dynamics</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1983</span><span class="NLM_x">–</span> <span class="NLM_lpage">90</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1983-90&author=H.+Zhaoauthor=D.+Huangauthor=A.+Caflisch&title=Discovery+of+tyrosine+kinase+inhibitors+by+docking+into+an+inactive+kinase+conformation+generated+by+molecular+dynamics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DD.%26aulast%3DCaflisch%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520tyrosine%2520kinase%2520inhibitors%2520by%2520docking%2520into%2520an%2520inactive%2520kinase%2520conformation%2520generated%2520by%2520molecular%2520dynamics%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D1983%26epage%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Tseng, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tzeng, C. C.</span><span> </span><span class="NLM_article-title">Synthesis and antiproliferative evaluation of certain iminonaphtho[2,3-b]furan derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5172</span><span class="NLM_x">–</span> <span class="NLM_lpage">5182</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=5172-5182&author=C.+H.+Tsengauthor=Y.+L.+Chenauthor=S.+H.+Yangauthor=S.+I.+Pengauthor=C.+M.+Chengauthor=C.+H.+Hanauthor=S.+R.+Linauthor=C.+C.+Tzeng&title=Synthesis+and+antiproliferative+evaluation+of+certain+iminonaphtho%5B2%2C3-b%5Dfuran+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTseng%26aufirst%3DC.%2BH.%26aulast%3DChen%26aufirst%3DY.%2BL.%26aulast%3DYang%26aufirst%3DS.%2BH.%26aulast%3DPeng%26aufirst%3DS.%2BI.%26aulast%3DCheng%26aufirst%3DC.%2BM.%26aulast%3DHan%26aufirst%3DC.%2BH.%26aulast%3DLin%26aufirst%3DS.%2BR.%26aulast%3DTzeng%26aufirst%3DC.%2BC.%26atitle%3DSynthesis%2520and%2520antiproliferative%2520evaluation%2520of%2520certain%2520iminonaphtho%255B2%252C3-b%255Dfuran%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D5172%26epage%3D5182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Wang, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, I. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsiao, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tzeng, C. C.</span><span> </span><span class="NLM_article-title">Synthesis, antiproliferative, and antiplatelet activities of oxime- and methyloxime-containing flavone and isoflavone derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">6045</span><span class="NLM_x">–</span> <span class="NLM_lpage">6053</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=6045-6053&author=T.+C.+Wangauthor=I.+L.+Chenauthor=P.+J.+Luauthor=C.+H.+Wongauthor=C.+H.+Liaoauthor=K.+C.+Tsiaoauthor=K.+M.+Changauthor=Y.+L.+Chenauthor=C.+C.+Tzeng&title=Synthesis%2C+antiproliferative%2C+and+antiplatelet+activities+of+oxime-+and+methyloxime-containing+flavone+and+isoflavone+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%2BC.%26aulast%3DChen%26aufirst%3DI.%2BL.%26aulast%3DLu%26aufirst%3DP.%2BJ.%26aulast%3DWong%26aufirst%3DC.%2BH.%26aulast%3DLiao%26aufirst%3DC.%2BH.%26aulast%3DTsiao%26aufirst%3DK.%2BC.%26aulast%3DChang%26aufirst%3DK.%2BM.%26aulast%3DChen%26aufirst%3DY.%2BL.%26aulast%3DTzeng%26aufirst%3DC.%2BC.%26atitle%3DSynthesis%252C%2520antiproliferative%252C%2520and%2520antiplatelet%2520activities%2520of%2520oxime-%2520and%2520methyloxime-containing%2520flavone%2520and%2520isoflavone%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D6045%26epage%3D6053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Tseng, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tzeng, C. C.</span><span> </span><span class="NLM_article-title">Synthesis and antiproliferative evaluation of certain indeno[1,2-c]quinoline derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3153</span><span class="NLM_x">–</span> <span class="NLM_lpage">3162</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=3153-3162&author=C.+H.+Tsengauthor=Y.+L.+Chenauthor=P.+J.+Luauthor=C.+N.+Yangauthor=C.+C.+Tzeng&title=Synthesis+and+antiproliferative+evaluation+of+certain+indeno%5B1%2C2-c%5Dquinoline+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTseng%26aufirst%3DC.%2BH.%26aulast%3DChen%26aufirst%3DY.%2BL.%26aulast%3DLu%26aufirst%3DP.%2BJ.%26aulast%3DYang%26aufirst%3DC.%2BN.%26aulast%3DTzeng%26aufirst%3DC.%2BC.%26atitle%3DSynthesis%2520and%2520antiproliferative%2520evaluation%2520of%2520certain%2520indeno%255B1%252C2-c%255Dquinoline%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D3153%26epage%3D3162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Srivastava, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sangita, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dwivedi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, A.</span><span> </span><span class="NLM_article-title">Diaryl naphthyl methanes a novel class of anti-implantation agents</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1011</span><span class="NLM_x">–</span> <span class="NLM_lpage">1021</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=1011-1021&author=N.+Srivastavaauthor=R.+S.+Sangitaauthor=M.+M.+Singhauthor=A.+Dwivediauthor=A.+Kumar&title=Diaryl+naphthyl+methanes+a+novel+class+of+anti-implantation+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSrivastava%26aufirst%3DN.%26aulast%3DSangita%26aufirst%3DR.%2BS.%26aulast%3DSingh%26aufirst%3DM.%2BM.%26aulast%3DDwivedi%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DA.%26atitle%3DDiaryl%2520naphthyl%2520methanes%2520a%2520novel%2520class%2520of%2520anti-implantation%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D1011%26epage%3D1021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Chang, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capacio, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peter, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span> </span><span class="NLM_article-title">Interdimer processing mechanism of procaspase-8 activation</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">4132</span><span class="NLM_x">–</span> <span class="NLM_lpage">4142</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=4132-4142&author=D.+W.+Changauthor=Z.+Xingauthor=V.+L.+Capacioauthor=M.+E.+Peterauthor=X.+Yang&title=Interdimer+processing+mechanism+of+procaspase-8+activation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DD.%2BW.%26aulast%3DXing%26aufirst%3DZ.%26aulast%3DCapacio%26aufirst%3DV.%2BL.%26aulast%3DPeter%26aufirst%3DM.%2BE.%26aulast%3DYang%26aufirst%3DX.%26atitle%3DInterdimer%2520processing%2520mechanism%2520of%2520procaspase-8%2520activation%26jtitle%3DEMBO%2520J.%26date%3D2003%26volume%3D22%26spage%3D4132%26epage%3D4142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Song, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmena, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandolfi, P. P.</span><span> </span><span class="NLM_article-title">The functions and regulation of the PTEN tumour suppressor</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">296</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1038%2Fnrm3330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=22473468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvFSrurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=283-296&author=M.+S.+Songauthor=L.+Salmenaauthor=P.+P.+Pandolfi&title=The+functions+and+regulation+of+the+PTEN+tumour+suppressor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">The functions and regulation of the PTEN tumour suppressor</span></div><div class="casAuthors">Song, Min Sup; Salmena, Leonardo; Pandolfi, Pier Paolo</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">283-296</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The importance of the physiol. function of phosphatase and tensin homolog (PTEN) is illustrated by its frequent disruption in cancer.  By suppressing the phosphoinositide 3-kinase (PI3K)-AKT-mammalian target of rapamycin (mTOR) pathway through its lipid phosphatase activity, PTEN governs a plethora of cellular processes including survival, proliferation, energy metab. and cellular architecture.  Consequently, mechanisms regulating PTEN expression and function, including transcriptional regulation, post-transcriptional regulation by non-coding RNAs, post-translational modifications and protein-protein interactions, are all altered in cancer.  The repertoire of PTEN functions has recently been expanded to include phosphatase-independent activities and crucial functions within the nucleus.  Our increasing knowledge of PTEN and pathologies in which its function is altered will undoubtedly inform the rational design of novel therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_3dPgW7uhabVg90H21EOLACvtfcHk0liz8RWz4wt-HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvFSrurg%253D&md5=c0d6524414a050876046c647caacb9fa</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fnrm3330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3330%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DM.%2BS.%26aulast%3DSalmena%26aufirst%3DL.%26aulast%3DPandolfi%26aufirst%3DP.%2BP.%26atitle%3DThe%2520functions%2520and%2520regulation%2520of%2520the%2520PTEN%2520tumour%2520suppressor%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2012%26volume%3D13%26spage%3D283%26epage%3D296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Tamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aota, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, K. M.</span><span> </span><span class="NLM_article-title">Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">1614</span><span class="NLM_x">–</span> <span class="NLM_lpage">1617</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=1998&pages=1614-1617&author=M.+Tamuraauthor=J.+Guauthor=K.+Matsumotoauthor=S.+Aotaauthor=R.+Parsonsauthor=K.+M.+Yamada&title=Inhibition+of+cell+migration%2C+spreading%2C+and+focal+adhesions+by+tumor+suppressor+PTEN"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTamura%26aufirst%3DM.%26aulast%3DGu%26aufirst%3DJ.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DAota%26aufirst%3DS.%26aulast%3DParsons%26aufirst%3DR.%26aulast%3DYamada%26aufirst%3DK.%2BM.%26atitle%3DInhibition%2520of%2520cell%2520migration%252C%2520spreading%252C%2520and%2520focal%2520adhesions%2520by%2520tumor%2520suppressor%2520PTEN%26jtitle%3DScience%26date%3D1998%26volume%3D280%26spage%3D1614%26epage%3D1617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Bray, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillette, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loughran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sears, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargo-Gogola, T.</span><span> </span><span class="NLM_article-title">Cdc42 overexpression induces hyperbranching in the developing mammary gland by enhancing cell migration</span> <span class="citation_source-journal">Breast Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">R91</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=R91&author=K.+Brayauthor=M.+Gilletteauthor=J.+Youngauthor=E.+Loughranauthor=M.+Hwangauthor=J.+C.+Searsauthor=T.+Vargo-Gogola&title=Cdc42+overexpression+induces+hyperbranching+in+the+developing+mammary+gland+by+enhancing+cell+migration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBray%26aufirst%3DK.%26aulast%3DGillette%26aufirst%3DM.%26aulast%3DYoung%26aufirst%3DJ.%26aulast%3DLoughran%26aufirst%3DE.%26aulast%3DHwang%26aufirst%3DM.%26aulast%3DSears%26aufirst%3DJ.%2BC.%26aulast%3DVargo-Gogola%26aufirst%3DT.%26atitle%3DCdc42%2520overexpression%2520induces%2520hyperbranching%2520in%2520the%2520developing%2520mammary%2520gland%2520by%2520enhancing%2520cell%2520migration%26jtitle%3DBreast%2520Cancer%2520Res.%26date%3D2013%26volume%3D15%26spage%3DR91" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Fabre-Guillevin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cartier-Michaud, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peinado, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno-Bueno, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vallee, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palacios, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barlovatz-Meimon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charriere-Bertrand, C.</span><span> </span><span class="NLM_article-title">PAI-1 and functional blockade of SNAI1 in breast cancer cell migration</span> <span class="citation_source-journal">Breast Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">R100</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=R100&author=E.+Fabre-Guillevinauthor=M.+Maloauthor=A.+Cartier-Michaudauthor=H.+Peinadoauthor=G.+Moreno-Buenoauthor=B.+Valleeauthor=D.+A.+Lawrenceauthor=J.+Palaciosauthor=A.+Canoauthor=G.+Barlovatz-Meimonauthor=C.+Charriere-Bertrand&title=PAI-1+and+functional+blockade+of+SNAI1+in+breast+cancer+cell+migration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFabre-Guillevin%26aufirst%3DE.%26aulast%3DMalo%26aufirst%3DM.%26aulast%3DCartier-Michaud%26aufirst%3DA.%26aulast%3DPeinado%26aufirst%3DH.%26aulast%3DMoreno-Bueno%26aufirst%3DG.%26aulast%3DVallee%26aufirst%3DB.%26aulast%3DLawrence%26aufirst%3DD.%2BA.%26aulast%3DPalacios%26aufirst%3DJ.%26aulast%3DCano%26aufirst%3DA.%26aulast%3DBarlovatz-Meimon%26aufirst%3DG.%26aulast%3DCharriere-Bertrand%26aufirst%3DC.%26atitle%3DPAI-1%2520and%2520functional%2520blockade%2520of%2520SNAI1%2520in%2520breast%2520cancer%2520cell%2520migration%26jtitle%3DBreast%2520Cancer%2520Res.%26date%3D2008%26volume%3D10%26spage%3DR100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Beck, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanpain, C.</span><span> </span><span class="NLM_article-title">Unravelling cancer stem cell potential</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">727</span><span class="NLM_x">–</span> <span class="NLM_lpage">738</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1038%2Fnrc3597" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=24060864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsV2jsLvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=727-738&author=B.+Beckauthor=C.+Blanpain&title=Unravelling+cancer+stem+cell+potential"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Unravelling cancer stem cell potential</span></div><div class="casAuthors">Beck, Benjamin; Blanpain, Cedric</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">727-738</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The maintenance and repair of many adult tissues are ensured by stem cells (SCs), which reside at the top of the cellular hierarchy of these tissues.  Functional assays, such as in vitro clonogenic assays, transplantation and in vivo lineage tracing, have been used to assess the renewing and differentiation potential of normal SCs.  Similar strategies have suggested that solid tumors may also be hierarchically organized and contain cancer SCs (CSCs) that sustain tumor growth and relapse after therapy.  In this Opinion article, we discuss the different parallels that can be drawn between adult SCs and CSCs in solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJkbBvFMsWQrVg90H21EOLACvtfcHk0liz8RWz4wt-HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsV2jsLvI&md5=b48e1852cdee58e0106cb5592f1c4243</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1038%2Fnrc3597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3597%26sid%3Dliteratum%253Aachs%26aulast%3DBeck%26aufirst%3DB.%26aulast%3DBlanpain%26aufirst%3DC.%26atitle%3DUnravelling%2520cancer%2520stem%2520cell%2520potential%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2013%26volume%3D13%26spage%3D727%26epage%3D738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Welte, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adjaye, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehrach, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regenbrecht, C. R.</span><span> </span><span class="NLM_article-title">Cancer stem cells in solid tumors: elusive or illusive?</span> <span class="citation_source-journal">Cell Commun. Signal.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">6</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1186%2F1478-811X-8-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=20459772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A280%3ADC%252BC3cvhsVOnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=6&author=Y.+Welteauthor=J.+Adjayeauthor=H.+R.+Lehrachauthor=C.+R.+Regenbrecht&title=Cancer+stem+cells+in+solid+tumors%3A+elusive+or+illusive%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer stem cells in solid tumors: elusive or illusive?</span></div><div class="casAuthors">Welte Yvonne; Adjaye James; Lehrach Hans R; Regenbrecht Christian Ra</div><div class="citationInfo"><span class="NLM_cas:title">Cell communication and signaling : CCS</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">During the past years in vivo transplantation experiments and in vitro colony-forming assays indicated that tumors arise only from rare cells.  These cells were shown to bear self-renewal capacities and the ability to recapitulate all cell types within an individual tumor.  Due to their phenotypic resemblance to normal stem cells, the term "cancer stem cells" is used.  However, some pieces of the puzzle are missing: (a) a stringent definition of cancer stem cells in solid tumors (b) specific markers that only target cells that meet the criteria for a cancer stem cell in a certain type of tumor.  These missing parts started an ongoing debate about which is the best method to identify and characterize cancer stem cells, or even if their mere existence is just an artifact caused by the experimental procedures.  Recent findings query the cancer stem cell hypothesis for solid tumors itself since it was shown in xenograft transplantation experiments that under appropriate conditions tumor-initiating cells are not rare.In this review we critically discuss the challenges and prospects of the currently used major methods to identify cancer stem cells.  Further on, we reflect the present discussion about the existence of cancer stem cells in solid tumors as well as the amount and characteristics of tumor-initiating cells and finally provide new perspectives like the correlation of cancer stem cells and induced pluripotent cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRrWRy0-Q1KhRFwe7cAcrfPfW6udTcc2eZHV68LDbZdMbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cvhsVOnsw%253D%253D&md5=c47d8d1793536e3e5ea4c420c026f7ed</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1186%2F1478-811X-8-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1478-811X-8-6%26sid%3Dliteratum%253Aachs%26aulast%3DWelte%26aufirst%3DY.%26aulast%3DAdjaye%26aufirst%3DJ.%26aulast%3DLehrach%26aufirst%3DH.%2BR.%26aulast%3DRegenbrecht%26aufirst%3DC.%2BR.%26atitle%3DCancer%2520stem%2520cells%2520in%2520solid%2520tumors%253A%2520elusive%2520or%2520illusive%253F%26jtitle%3DCell%2520Commun.%2520Signal.%26date%3D2010%26volume%3D8%26spage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Ginestier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hur, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charafe-Jauffret, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monville, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutcher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacquemier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viens, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleer, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schott, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birnbaum, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wicha, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dontu, G.</span><span> </span><span class="NLM_article-title">ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome</span> <span class="citation_source-journal">Cell Stem Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">555</span><span class="NLM_x">–</span> <span class="NLM_lpage">567</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1016%2Fj.stem.2007.08.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=18371393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVahtrvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2007&pages=555-567&author=C.+Ginestierauthor=M.+H.+Hurauthor=E.+Charafe-Jauffretauthor=F.+Monvilleauthor=J.+Dutcherauthor=M.+Brownauthor=J.+Jacquemierauthor=P.+Viensauthor=C.+G.+Kleerauthor=S.+Liuauthor=A.+Schottauthor=D.+Hayesauthor=D.+Birnbaumauthor=M.+S.+Wichaauthor=G.+Dontu&title=ALDH1+is+a+marker+of+normal+and+malignant+human+mammary+stem+cells+and+a+predictor+of+poor+clinical+outcome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome</span></div><div class="casAuthors">Ginestier, Christophe; Hur, Min Hee; Charafe-Jauffret, Emmanuelle; Monville, Florence; Dutcher, Julie; Brown, Marty; Jacquemier, Jocelyne; Viens, Patrice; Kleer, Celina G.; Liu, Suling; Schott, Anne; Hayes, Dan; Birnbaum, Daniel; Wicha, Max S.; Dontu, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Cell Stem Cell</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">555-567</span>CODEN:
                <span class="NLM_cas:coden">CSCEC4</span>;
        ISSN:<span class="NLM_cas:issn">1934-5909</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Application of stem cell biol. to breast cancer research has been limited by the lack of simple methods for identification and isolation of normal and malignant stem cells.  Utilizing in vitro and in vivo exptl. systems, we show that normal and cancer human mammary epithelial cells with increased aldehyde dehydrogenase activity (ALDH) have stem/progenitor properties.  These cells contain the subpopulation of normal breast epithelium with the broadest lineage differentiation potential and greatest growth capacity in a xenotransplant model.  In breast carcinomas, high ALDH activity identifies the tumorigenic cell fraction, capable of self-renewal and of generating tumors that recapitulate the heterogeneity of the parental tumor.  In a series of 577 breast carcinomas, expression of ALDH1 detected by immunostaining correlated with poor prognosis.  These findings offer an important new tool for the study of normal and malignant breast stem cells and facilitate the clin. application of stem cell concepts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9M3nlUhhfGLVg90H21EOLACvtfcHk0lgCKDknTmpM-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVahtrvF&md5=a2f281c7f984404848e7195390a15012</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.stem.2007.08.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.stem.2007.08.014%26sid%3Dliteratum%253Aachs%26aulast%3DGinestier%26aufirst%3DC.%26aulast%3DHur%26aufirst%3DM.%2BH.%26aulast%3DCharafe-Jauffret%26aufirst%3DE.%26aulast%3DMonville%26aufirst%3DF.%26aulast%3DDutcher%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DM.%26aulast%3DJacquemier%26aufirst%3DJ.%26aulast%3DViens%26aufirst%3DP.%26aulast%3DKleer%26aufirst%3DC.%2BG.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DSchott%26aufirst%3DA.%26aulast%3DHayes%26aufirst%3DD.%26aulast%3DBirnbaum%26aufirst%3DD.%26aulast%3DWicha%26aufirst%3DM.%2BS.%26aulast%3DDontu%26aufirst%3DG.%26atitle%3DALDH1%2520is%2520a%2520marker%2520of%2520normal%2520and%2520malignant%2520human%2520mammary%2520stem%2520cells%2520and%2520a%2520predictor%2520of%2520poor%2520clinical%2520outcome%26jtitle%3DCell%2520Stem%2520Cell%26date%3D2007%26volume%3D1%26spage%3D555%26epage%3D567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Douville, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balicki, D.</span><span> </span><span class="NLM_article-title">ALDH1 as a functional marker of cancer stem and progenitor cells</span> <span class="citation_source-journal">Stem Cells Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2009&pages=17-25&author=J.+Douvilleauthor=R.+Beaulieuauthor=D.+Balicki&title=ALDH1+as+a+functional+marker+of+cancer+stem+and+progenitor+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDouville%26aufirst%3DJ.%26aulast%3DBeaulieu%26aufirst%3DR.%26aulast%3DBalicki%26aufirst%3DD.%26atitle%3DALDH1%2520as%2520a%2520functional%2520marker%2520of%2520cancer%2520stem%2520and%2520progenitor%2520cells%26jtitle%3DStem%2520Cells%2520Dev.%26date%3D2009%26volume%3D18%26spage%3D17%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Ren, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, W. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, X.</span><span> </span><span class="NLM_article-title">CD133: a cancer stem cells marker, is used in colorectal cancers</span> <span class="citation_source-journal">World J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2603</span><span class="NLM_x">–</span> <span class="NLM_lpage">2611</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.3748%2Fwjg.v19.i17.2603" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=23674867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptVGlu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=2603-2611&author=F.+Renauthor=W.+Q.+Shengauthor=X.+Du&title=CD133%3A+a+cancer+stem+cells+marker%2C+is+used+in+colorectal+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">CD133: a cancer stem cells marker, is used in colorectal cancers</span></div><div class="casAuthors">Ren, Fei; Sheng, Wei-Qi; Du, Xiang</div><div class="citationInfo"><span class="NLM_cas:title">World Journal of Gastroenterology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2603-2611</span>CODEN:
                <span class="NLM_cas:coden">WJGAF2</span>;
        ISSN:<span class="NLM_cas:issn">1007-9327</span>.
    
            (<span class="NLM_cas:orgname">Baishideng Publishing Group Co., Ltd.</span>)
        </div><div class="casAbstract">A review.  Colorectal cancer is one of the most common malignant tumors worldwide.  A model of cancer development involving cancer stem cells has been put forward because it provides a possible explanation of tumor hierarchy.  Cancer stem cells are characterized by their proliferation, tumorigenesis, differentiation and self-renewal capacities and chemoradiotherapy resistance.  Due to the role of cancer stem cells in tumor initiation and treatment failure, studies of cancer stem cell markers, such as CD133, have been of great interest.  CD133, a five-transmembrane glycoprotein, is widely used as a marker to identify and isolate colorectal cancer stem cells.  This marker has been investigated to better understand the characteristics and functions of cancer stem cells.  Moreover, it can also be used to predict tumor progression, patient survival, chemoradiotherapy resistance and other clin. parameters.  In this review, we discuss the use of CD133 in the identification of colorectal cancer stem cell, which is currently controversial.  Although the function of CD133 is as yet unclear, we have discussed several possible functions and assocd. mechanisms that may partially explain the role of CD133 in colorectal cancers.  In addn., we focus on the prognostic value of CD133 in colorectal cancers.  Finally, we predict that CD133 may be used as a possible target for colorectal cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzw7ya2O2nJrVg90H21EOLACvtfcHk0lir_GF-lemGpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptVGlu78%253D&md5=6d534acbf5123eb513f7c5bdecca3c59</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.3748%2Fwjg.v19.i17.2603&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3748%252Fwjg.v19.i17.2603%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DF.%26aulast%3DSheng%26aufirst%3DW.%2BQ.%26aulast%3DDu%26aufirst%3DX.%26atitle%3DCD133%253A%2520a%2520cancer%2520stem%2520cells%2520marker%252C%2520is%2520used%2520in%2520colorectal%2520cancers%26jtitle%3DWorld%2520J.%2520Gastroenterol.%26date%3D2013%26volume%3D19%26spage%3D2603%26epage%3D2611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Gupta, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onder, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuperwasser, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lander, E. S.</span><span> </span><span class="NLM_article-title">Identification of selective inhibitors of cancer stem cells by high-throughput screening</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">138</span><span class="NLM_x">, </span> <span class="NLM_fpage">645</span><span class="NLM_x">–</span> <span class="NLM_lpage">659</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1016%2Fj.cell.2009.06.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=19682730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVCjs73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2009&pages=645-659&author=P.+B.+Guptaauthor=T.+T.+Onderauthor=G.+Jiangauthor=K.+Taoauthor=C.+Kuperwasserauthor=R.+A.+Weinbergauthor=E.+S.+Lander&title=Identification+of+selective+inhibitors+of+cancer+stem+cells+by+high-throughput+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of selective inhibitors of cancer stem cells by high-throughput screening</span></div><div class="casAuthors">Gupta, Piyush B.; Onder, Tamer T.; Jiang, Guozhi; Tao, Kai; Kuperwasser, Charlotte; Weinberg, Robert A.; Lander, Eric S.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">645-659</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Screens for agents that specifically kill epithelial cancer stem cells (CSCs) have not been possible due to the rarity of these cells within tumor cell populations and their relative instability in culture.  We describe here an approach to screening for agents with epithelial CSC-specific toxicity.  We implemented this method in a chem. screen and discovered compds. showing selective toxicity for breast CSCs.  One compd., salinomycin, reduces the proportion of CSCs by >100-fold relative to paclitaxel, a commonly used breast cancer chemotherapeutic drug.  Treatment of mice with salinomycin inhibits mammary tumor growth in vivo and induces increased epithelial differentiation of tumor cells.  In addn., global gene expression analyses show that salinomycin treatment results in the loss of expression of breast CSC genes previously identified by analyses of breast tissues isolated directly from patients.  This study demonstrates the ability to identify agents with specific toxicity for epithelial CSCs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2-8wgLz3XkbVg90H21EOLACvtfcHk0lir_GF-lemGpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVCjs73E&md5=d848e78a13fa2b5d78ce87bec07d1ed1</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2009.06.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2009.06.034%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DP.%2BB.%26aulast%3DOnder%26aufirst%3DT.%2BT.%26aulast%3DJiang%26aufirst%3DG.%26aulast%3DTao%26aufirst%3DK.%26aulast%3DKuperwasser%26aufirst%3DC.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26aulast%3DLander%26aufirst%3DE.%2BS.%26atitle%3DIdentification%2520of%2520selective%2520inhibitors%2520of%2520cancer%2520stem%2520cells%2520by%2520high-throughput%2520screening%26jtitle%3DCell%26date%3D2009%26volume%3D138%26spage%3D645%26epage%3D659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Wheeler, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harari, P. M.</span><span> </span><span class="NLM_article-title">Understanding resistance to EGFR inhibitors-impact on future treatment strategies</span> <span class="citation_source-journal">Nat. Rev. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">493</span><span class="NLM_x">–</span> <span class="NLM_lpage">507</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1038%2Fnrclinonc.2010.97" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=20551942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVyjsr7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2010&pages=493-507&author=D.+L.+Wheelerauthor=E.+F.+Dunnauthor=P.+M.+Harari&title=Understanding+resistance+to+EGFR+inhibitors-impact+on+future+treatment+strategies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding resistance to EGFR inhibitors-impact on future treatment strategies</span></div><div class="casAuthors">Wheeler, Deric L.; Dunn, Emily F.; Harari, Paul M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Clinical Oncology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">493-507</span>CODEN:
                <span class="NLM_cas:coden">NRCOAA</span>;
        ISSN:<span class="NLM_cas:issn">1759-4774</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  EGFR is one of the most studied targets in oncol., and several inhibitors have shown promising results in selected patient populations.  However, intrinsic and acquired resistance to these targeted therapies is increasingly recognized.  The authors of this Review describe the successful translation of EGFR inhibitors to the clinic, and highlight the mechanisms of resistance to these agents that limit their long-term efficacy.  Understanding these processes will allow researchers to develop therapies that overcome resistance and ultimately lead to more successful outcomes.  EGFR is a tyrosine kinase that participates in the regulation of cellular homeostasis.  Following ligand binding, EGFR stimulates downstream cell signaling cascades that influence cell proliferation, apoptosis, migration, survival and complex processes, including angiogenesis and tumorigenesis.  EGFR has been strongly implicated in the biol. of human epithelial malignancies, with therapeutic applications in cancers of the colon, head and neck, lung, and pancreas.  Accordingly, targeting EGFR has been intensely pursued, with the development of a series of promising mol. inhibitors for use in clin. oncol.  As is common in cancer therapy, challenges with respect to treatment resistance emerge over time.  This situation is certainly true of EGFR inhibitor therapies, where intrinsic and acquired resistance is now well recognized.  In this Review, we provide a brief overview regarding the biol. of EGFR, preclin. and clin. development of EGFR inhibitors, and mol. mechanisms that underlie the development of treatment resistance.  A greater understanding of the mechanisms that lead to EGFR resistance may provide valuable insights to help design new strategies that will enhance the impact of this promising class of inhibitors for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrw7LepfpXQa7Vg90H21EOLACvtfcHk0li8Ag4QOxNcvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVyjsr7L&md5=2f043ede90d7206e45ec80642302a766</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1038%2Fnrclinonc.2010.97&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrclinonc.2010.97%26sid%3Dliteratum%253Aachs%26aulast%3DWheeler%26aufirst%3DD.%2BL.%26aulast%3DDunn%26aufirst%3DE.%2BF.%26aulast%3DHarari%26aufirst%3DP.%2BM.%26atitle%3DUnderstanding%2520resistance%2520to%2520EGFR%2520inhibitors-impact%2520on%2520future%2520treatment%2520strategies%26jtitle%3DNat.%2520Rev.%2520Clin.%2520Oncol.%26date%3D2010%26volume%3D7%26spage%3D493%26epage%3D507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Habib, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neel, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vartanian, T.</span><span> </span><span class="NLM_article-title">Increased expression of epidermal growth factor receptor induces sequestration of extracellular signal-related kinases and selective attenuation of specific epidermal growth factor-mediated signal transduction pathways</span> <span class="citation_source-journal">Mol. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">233</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=12556561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnt1yltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2003&pages=219-233&author=A.+A.+Habibauthor=S.+J.+Chunauthor=B.+G.+Neelauthor=T.+Vartanian&title=Increased+expression+of+epidermal+growth+factor+receptor+induces+sequestration+of+extracellular+signal-related+kinases+and+selective+attenuation+of+specific+epidermal+growth+factor-mediated+signal+transduction+pathways"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Increased Expression of Epidermal Growth Factor Receptor Induces Sequestration of Extracellular Signal-Related Kinases and Selective Attenuation of Specific Epidermal Growth Factor-Mediated Signal Transduction Pathways</span></div><div class="casAuthors">Habib, Amyn A.; Chun, Soo Jin; Neel, Benjamin G.; Vartanian, Timothy</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">219-233</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Increased expression of the epidermal growth factor receptor (EGFR) is common in cancer and correlates with neoplastic progression.  Although the biol. of this receptor has been the subject of intense investigation, surprisingly little is known about how increased expression of the wild-type EGFR affects downstream signal transduction in cells.  We show that increasing the expression of the receptor results in dramatic shifts in signaling with attenuation of EGF-induced Ras, extracellular signal-related kinases (ERKs), and Akt activation, as well as amplification of STAT1 and STAT3 signaling.  In this study, we focus on the mechanism of attenuated ERK signaling and present evidence suggesting that the mechanism of attenuated ERK signaling in EGFR-overexpressing cells is a sequestration of ERKs at the cell membrane in EGFR-contg. complexes.  Increased expression of the EGFR results in an aberrant localization of ERKs to the cell membrane.  Furthermore, ERKs become assocd. with the EGFR in a phys. complex in EGFR-overexpressing cells but not in control cells.  The EGFR-ERK assocn. is detected in unstimulated cells or on exposure to a low concn. of EGF; under these conditions, ERK activation is minimal.  Exposure of these cells to satg. concns. of EGF results in a decreased membrane localization of ERKs, a concomitant dissocn. of ERKs from the EGFR, and restores ERK activation.  A similar assocn. can be detected between the EGFR and MEK1 in receptor-overexpressing cells, suggesting that multiple components of the ERK signaling pathway may become trapped in complexes with the EGFR.  These findings can be demonstrated in cells transfected to express high levels of the EGFR as well as in cancer cells which naturally overexpress the EGFR and, thus, may be representative of altered EGFR signaling in human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroMu6youqq3rVg90H21EOLACvtfcHk0li8Ag4QOxNcvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnt1yltQ%253D%253D&md5=8f8fbbc1c2a2269fbc51db62ca5da9cc</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHabib%26aufirst%3DA.%2BA.%26aulast%3DChun%26aufirst%3DS.%2BJ.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26aulast%3DVartanian%26aufirst%3DT.%26atitle%3DIncreased%2520expression%2520of%2520epidermal%2520growth%2520factor%2520receptor%2520induces%2520sequestration%2520of%2520extracellular%2520signal-related%2520kinases%2520and%2520selective%2520attenuation%2520of%2520specific%2520epidermal%2520growth%2520factor-mediated%2520signal%2520transduction%2520pathways%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2003%26volume%3D1%26spage%3D219%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Price, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiganis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agarwal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Djakiew, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, E. W.</span><span> </span><span class="NLM_article-title">Epidermal growth factor promotes MDA-MB-231 breast cancer cell migration through a phosphatidylinositol 3′-kinase and phospholipase C-dependent mechanism</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">5475</span><span class="NLM_x">–</span> <span class="NLM_lpage">5478</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=5475-5478&author=J.+T.+Priceauthor=T.+Tiganisauthor=A.+Agarwalauthor=D.+Djakiewauthor=E.+W.+Thompson&title=Epidermal+growth+factor+promotes+MDA-MB-231+breast+cancer+cell+migration+through+a+phosphatidylinositol+3%E2%80%B2-kinase+and+phospholipase+C-dependent+mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrice%26aufirst%3DJ.%2BT.%26aulast%3DTiganis%26aufirst%3DT.%26aulast%3DAgarwal%26aufirst%3DA.%26aulast%3DDjakiew%26aufirst%3DD.%26aulast%3DThompson%26aufirst%3DE.%2BW.%26atitle%3DEpidermal%2520growth%2520factor%2520promotes%2520MDA-MB-231%2520breast%2520cancer%2520cell%2520migration%2520through%2520a%2520phosphatidylinositol%25203%25E2%2580%25B2-kinase%2520and%2520phospholipase%2520C-dependent%2520mechanism%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D5475%26epage%3D5478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Chazaud, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricoux, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christov, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plonquet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gherardi, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barlovatz-Meimon, G.</span><span> </span><span class="NLM_article-title">Promigratory effect of plasminogen activator inhibitor-1 on invasive breast cancer cell populations</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">160</span><span class="NLM_x">, </span> <span class="NLM_fpage">237</span><span class="NLM_x">–</span> <span class="NLM_lpage">246</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1016%2FS0002-9440%2810%2964367-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=11786417" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BD38XnvFegsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2002&pages=237-246&author=B.+Chazaudauthor=R.+Ricouxauthor=C.+Christovauthor=A.+Plonquetauthor=R.+K.+Gherardiauthor=G.+Barlovatz-Meimon&title=Promigratory+effect+of+plasminogen+activator+inhibitor-1+on+invasive+breast+cancer+cell+populations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Promigratory effect of plasminogen activator inhibitor-1 on invasive breast cancer cell populations</span></div><div class="casAuthors">Chazaud, Benedicte; Ricoux, Remy; Christov, Christo; Plonquet, Anne; Gherardi, Romain K.; Barlovatz-Meimon, Georgia</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">237-246</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">The urokinase-type plasminogen activator (uPA) system is a dynamic complex in which the membrane receptor uPAR binds uPA that binds the plasminogen activator inhibitor (PAI)-1 localized in the extracellular matrix, resulting in endocytosis of the whole complex by the low-d. lipoprotein receptor-related protein (LRP).  High expression of PAI-1 is paradoxically assocd. with marked tumor spreading and poor prognosis.  We previously reported a nonproteolytic role of the [uPAR:uPA:PAI-1:LRP] complex operative in cell migration.  Here the authors explored whether matrix PAI-1 could be used as a migration support by human breast cancer cells.  We showed that the uPA system and LRP are localized at filopodia of invasive cells, and that formation/internalization of the [uPAR:uPA:PAI-LRP] complex is required for attachment and migration of cancer cells on plastic and on a PAI-1 coat.  PAI-1 increased both filopodia formation and migration of cancer cells suggesting a chemokine-like activity.  Migration velocity, expression of the uPA system, use of the [uPAR:uPA:PAI-1:LRP] complex to migrate, and promigratory effects of PAI-1 paralleled cancer cell invasiveness.  Phenotyping and functional anal. of invasive cancer cel subclones indicated that different cell subpopulations may use different strategies to migrate depending on both the environment and their expression of the uPA system, some of them taking advantage of abundant available PAI-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofmUpT5GvSQLVg90H21EOLACvtfcHk0lj_SL672StO0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnvFegsQ%253D%253D&md5=77e495407e0ab2db6a6202f38d3863ff</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2FS0002-9440%2810%2964367-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-9440%252810%252964367-2%26sid%3Dliteratum%253Aachs%26aulast%3DChazaud%26aufirst%3DB.%26aulast%3DRicoux%26aufirst%3DR.%26aulast%3DChristov%26aufirst%3DC.%26aulast%3DPlonquet%26aufirst%3DA.%26aulast%3DGherardi%26aufirst%3DR.%2BK.%26aulast%3DBarlovatz-Meimon%26aufirst%3DG.%26atitle%3DPromigratory%2520effect%2520of%2520plasminogen%2520activator%2520inhibitor-1%2520on%2520invasive%2520breast%2520cancer%2520cell%2520populations%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2002%26volume%3D160%26spage%3D237%26epage%3D246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Booy, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henson, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, S. B.</span><span> </span><span class="NLM_article-title">Epidermal growth factor regulates Mcl-1 expression through the MAPK-Elk-1 signalling pathway contributing to cell survival in breast cancer</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">2367</span><span class="NLM_x">–</span> <span class="NLM_lpage">2378</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=2367-2378&author=E.+P.+Booyauthor=E.+S.+Hensonauthor=S.+B.+Gibson&title=Epidermal+growth+factor+regulates+Mcl-1+expression+through+the+MAPK-Elk-1+signalling+pathway+contributing+to+cell+survival+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBooy%26aufirst%3DE.%2BP.%26aulast%3DHenson%26aufirst%3DE.%2BS.%26aulast%3DGibson%26aufirst%3DS.%2BB.%26atitle%3DEpidermal%2520growth%2520factor%2520regulates%2520Mcl-1%2520expression%2520through%2520the%2520MAPK-Elk-1%2520signalling%2520pathway%2520contributing%2520to%2520cell%2520survival%2520in%2520breast%2520cancer%26jtitle%3DOncogene%26date%3D2011%26volume%3D30%26spage%3D2367%26epage%3D2378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Gao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, X.</span><span> </span><span class="NLM_article-title">MiR-26a inhibits proliferation and migration of breast cancer through repression of MCL-1</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e65138</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e65138&author=J.+Gaoauthor=L.+Liauthor=M.+Wuauthor=M.+Liuauthor=X.+Xieauthor=J.+Guoauthor=H.+Tangauthor=X.+Xie&title=MiR-26a+inhibits+proliferation+and+migration+of+breast+cancer+through+repression+of+MCL-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DH.%26aulast%3DXie%26aufirst%3DX.%26atitle%3DMiR-26a%2520inhibits%2520proliferation%2520and%2520migration%2520of%2520breast%2520cancer%2520through%2520repression%2520of%2520MCL-1%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De65138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Koehler, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherr, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorenz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urbanik, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kautz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elssner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welte, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bermejo, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jager, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulze-Bergkamen, H.</span><span> </span><span class="NLM_article-title">Beyond cell death - antiapoptotic Bcl-2 proteins regulate migration and invasion of colorectal cancer cells in vitro</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e76446</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e76446&author=B.+C.+Koehlerauthor=A.+L.+Scherrauthor=S.+Lorenzauthor=T.+Urbanikauthor=N.+Kautzauthor=C.+Elssnerauthor=S.+Welteauthor=J.+L.+Bermejoauthor=D.+Jagerauthor=H.+Schulze-Bergkamen&title=Beyond+cell+death+-+antiapoptotic+Bcl-2+proteins+regulate+migration+and+invasion+of+colorectal+cancer+cells+in+vitro"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoehler%26aufirst%3DB.%2BC.%26aulast%3DScherr%26aufirst%3DA.%2BL.%26aulast%3DLorenz%26aufirst%3DS.%26aulast%3DUrbanik%26aufirst%3DT.%26aulast%3DKautz%26aufirst%3DN.%26aulast%3DElssner%26aufirst%3DC.%26aulast%3DWelte%26aufirst%3DS.%26aulast%3DBermejo%26aufirst%3DJ.%2BL.%26aulast%3DJager%26aufirst%3DD.%26aulast%3DSchulze-Bergkamen%26aufirst%3DH.%26atitle%3DBeyond%2520cell%2520death%2520-%2520antiapoptotic%2520Bcl-2%2520proteins%2520regulate%2520migration%2520and%2520invasion%2520of%2520colorectal%2520cancer%2520cells%2520in%2520vitro%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De76446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Han, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGonigal, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giranda, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span> </span><span class="NLM_article-title">Functional analysis of focal adhesion kinase (FAK) reduction by small inhibitory RNAs</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">3899</span><span class="NLM_x">–</span> <span class="NLM_lpage">3905</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=15736429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitFylsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=3899-3905&author=E.+K.+Hanauthor=T.+McGonigalauthor=J.+Wangauthor=V.+L.+Girandaauthor=Y.+Luo&title=Functional+analysis+of+focal+adhesion+kinase+%28FAK%29+reduction+by+small+inhibitory+RNAs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Functional analysis of focal adhesion kinase (FAK) reduction by small inhibitory RNAs</span></div><div class="casAuthors">Han, Edward Kyu-Ho; McGonigal, Thomas; Wang, Jieyi; Giranda, Vincent L.; Luo, Yan</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3899-3905</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">The focal adhesion kinase (FAK) is a non-receptor tyrosine kinase that localizes to the points of cell contact with the extracellular matrix, called focal adhesions.  Many factors induce tyrosine phosphorylation of FAK including growth factors, neuropeptides and integrin-dependent adhesion to the extracellular matrix.  FAK has been implicated in several cellular processes such as invasion, motility, proliferation and apoptosis.  In addn., FAK expression was shown to be elevated in a no. of different human cancers, suggesting a role in the development of malignancy.  We examd. the biol. functions of FAK using small inhibitory RNAs (siRNA) in cancer cells.  Although FAK siRNA reduced the FAK protein levels by ∼ 70% in several cancer cell lines, there was no clear evidence of apoptosis.  However, in clonogenic and soft-agar assays in H1299, a lung cancer cell line, FAK siRNA treatment led to a 43% to 55% decrease in colony formation.  Furthermore, FAK siRNA-treated cells displayed a decrease in migration when serum or EGF (epidermal growth factor) were used as chemo-attractants.  Our results demonstrated that inhibition of FAK protein leads to alterations in cell growth and migration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYeuT56eTYd7Vg90H21EOLACvtfcHk0lj_SL672StO0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitFylsbs%253D&md5=552629a5fbdc9c9547d38f1198354bc8</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DE.%2BK.%26aulast%3DMcGonigal%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DGiranda%26aufirst%3DV.%2BL.%26aulast%3DLuo%26aufirst%3DY.%26atitle%3DFunctional%2520analysis%2520of%2520focal%2520adhesion%2520kinase%2520%2528FAK%2529%2520reduction%2520by%2520small%2520inhibitory%2520RNAs%26jtitle%3DAnticancer%2520Res.%26date%3D2004%26volume%3D24%26spage%3D3899%26epage%3D3905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Sieg, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauck, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ilic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klingbeil, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damsky, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlaepfer, D. D.</span><span> </span><span class="NLM_article-title">FAK integrates growth-factor and integrin signals to promote cell migration</span> <span class="citation_source-journal">Nat. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">256</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1038%2F35010517" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=10806474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BD3cXktlOqs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2000&pages=249-256&author=D.+J.+Siegauthor=C.+R.+Hauckauthor=D.+Ilicauthor=C.+K.+Klingbeilauthor=E.+Schaeferauthor=C.+H.+Damskyauthor=D.+D.+Schlaepfer&title=FAK+integrates+growth-factor+and+integrin+signals+to+promote+cell+migration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">FAK integrates growth-factor and integrin signals to promote cell migration</span></div><div class="casAuthors">Sieg, David J.; Hauck, Christof R.; Ilic, Dusko; Kingbeil, Candice K.; Schaefer, Erik; Damsky, Caroline H.; Schlaepfer, David D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">249-256</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Here we show that cells lacking focal adhesion kinase (FAK) are refractory to motility signals from platelet-derived and epidermal growth factors (PDGF and EGF resp.), and that stable re-expression of FAK rescues these defects.  FAK assocs. with activated PDGF- and EGF-receptor (PDGFR and EGFR) signalling complexes, and expression of the band-4.1-like domain at the FAK amino terminus is sufficient to mediate an interaction with activated EGFR.  However, efficient EGF-stimulated cell migration also requires FAK to be targeted, by its carboxy-terminal domain, to sites of integrin-receptor clustering.  Although the kinase activity of FAK is not needed to promote PDGF- or EGF-stimulated cell motility, kinase-inactive FAK is transphosphorylated at the indispensable Src-kinase-binding site, FAK Y397, after EGF stimulation of cells.  Our results establish that FAK is an important receptor-proximal link between growth-factor-receptor and integrin signalling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8_jbj9KKEerVg90H21EOLACvtfcHk0lh1L3yEOeKhAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXktlOqs7o%253D&md5=8dd638fbecfd120065bedda6eb0a3ecd</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1038%2F35010517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35010517%26sid%3Dliteratum%253Aachs%26aulast%3DSieg%26aufirst%3DD.%2BJ.%26aulast%3DHauck%26aufirst%3DC.%2BR.%26aulast%3DIlic%26aufirst%3DD.%26aulast%3DKlingbeil%26aufirst%3DC.%2BK.%26aulast%3DSchaefer%26aufirst%3DE.%26aulast%3DDamsky%26aufirst%3DC.%2BH.%26aulast%3DSchlaepfer%26aufirst%3DD.%2BD.%26atitle%3DFAK%2520integrates%2520growth-factor%2520and%2520integrin%2520signals%2520to%2520promote%2520cell%2520migration%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2000%26volume%3D2%26spage%3D249%26epage%3D256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">George, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hannan, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, W. G.</span><span> </span><span class="NLM_article-title">Unravelling the molecular complexity of GPCR-mediated EGFR transactivation using functional genomics approaches</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">5258</span><span class="NLM_x">–</span> <span class="NLM_lpage">5268</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2013&pages=5258-5268&author=A.+J.+Georgeauthor=R.+D.+Hannanauthor=W.+G.+Thomas&title=Unravelling+the+molecular+complexity+of+GPCR-mediated+EGFR+transactivation+using+functional+genomics+approaches"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGeorge%26aufirst%3DA.%2BJ.%26aulast%3DHannan%26aufirst%3DR.%2BD.%26aulast%3DThomas%26aufirst%3DW.%2BG.%26atitle%3DUnravelling%2520the%2520molecular%2520complexity%2520of%2520GPCR-mediated%2520EGFR%2520transactivation%2520using%2520functional%2520genomics%2520approaches%26jtitle%3DFEBS%2520J.%26date%3D2013%26volume%3D280%26spage%3D5258%26epage%3D5268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Fischer, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gschwind, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullrich, A.</span><span> </span><span class="NLM_article-title">EGFR signal transactivation in cancer cells</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1203</span><span class="NLM_x">–</span> <span class="NLM_lpage">1208</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1042%2FBST0311203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=14641026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BD3sXps12jsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=1203-1208&author=O.+M.+Fischerauthor=S.+Hartauthor=A.+Gschwindauthor=A.+Ullrich&title=EGFR+signal+transactivation+in+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">EGFR signal transactivation in cancer cells</span></div><div class="casAuthors">Fischer, O. M.; Hart, S.; Gschwind, A.; Ullrich, A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1203-1208</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  The EGFR (epidermal growth factor receptor) plays a key role in the regulation of essential normal cellular processes and in the pathophysiol. of hyperproliferative diseases such as cancer.  Recent investigations have demonstrated that GPCRs (G-protein-coupled receptors) are able to utilize the EGFR as a downstream signaling partner in the generation of mitogenic signals.  This cross-talk mechanism combines the broad diversity of GPCRs with the signaling capacities of the EGFR and has emerged as a general concept in a multitude of cell types.  The mol. mechanisms of EGFR signal transactivation involve processing of transmembrane growth factor precursors by metalloproteases which have been recently identified as members of the ADAM (a disintegrin and metalloprotease) family of zinc-dependent proteases.  Subsequently, the EGFR transmits signals to prominent downstream pathways, such as mitogen-activated protein kinases, the phosphoinositide 3-kinase/Akt pathway and modulation of ion channels.  Anal. of GPCR-induced EGFR activation in more than 60 human carcinoma cell lines derived from different tissues has demonstrated the broad relevance of this signaling mechanism in cancer.  Moreover, EGFR signal transactivation was linked to diverse biol. processes in human cancer cells, such as cell proliferation, migration and anti-apoptosis.  Together with investigations revealing the importance of this GPCR-EGFR cross-talk mechanism in cardiac hypertrophy, Helicobacter pylori -induced pathophysiol. processes and cystic fibrosis, these findings support an important role for GPCR ligand-dependent EGFR signal transactivation in diverse pathophysiol. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp51i2zhIS7RrVg90H21EOLACvtfcHk0lh1L3yEOeKhAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXps12jsrY%253D&md5=279406d121ff9ba30a5005a8bea0b4a5</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1042%2FBST0311203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST0311203%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DO.%2BM.%26aulast%3DHart%26aufirst%3DS.%26aulast%3DGschwind%26aufirst%3DA.%26aulast%3DUllrich%26aufirst%3DA.%26atitle%3DEGFR%2520signal%2520transactivation%2520in%2520cancer%2520cells%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2003%26volume%3D31%26spage%3D1203%26epage%3D1208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Britten, C. D.</span><span> </span><span class="NLM_article-title">Targeting ErbB receptor signaling: a pan-ErbB approach to cancer</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1335</span><span class="NLM_x">–</span> <span class="NLM_lpage">1342</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=15486201" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BD2cXosVSrsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=1335-1342&author=C.+D.+Britten&title=Targeting+ErbB+receptor+signaling%3A+a+pan-ErbB+approach+to+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting ErbB receptor signaling: A pan-ErbB approach to cancer</span></div><div class="casAuthors">Britten, Carolyn D.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1335-1342</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  The ErbB receptors are localized to the cell membrane where they are activated by ligand to trigger a network of signaling pathways.  In some cancer cells, dysregulation of ErbB-mediated signaling confers a growth advantage, resulting in cellular transformation and increased metastatic potential.  Several agents that inhibit individual ErbB receptors have recently been approved for the treatment of human malignancies, validating ErbB receptors as therapeutic targets.  One strategy to improve the efficacy of ErbB-targeted therapies is to inhibit multiple ErbB receptors, thereby interfering with the cooperation that exists between receptors.  This minireview addresses the approaches being developed to concurrently inhibit multiple ErbB receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGor3VCGtjKxLrVg90H21EOLACvtfcHk0lg_Kwfen-qAUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXosVSrsLo%253D&md5=eeffcf170c80be9f2b6c472bef514c34</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBritten%26aufirst%3DC.%2BD.%26atitle%3DTargeting%2520ErbB%2520receptor%2520signaling%253A%2520a%2520pan-ErbB%2520approach%2520to%2520cancer%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2004%26volume%3D3%26spage%3D1335%26epage%3D1342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Gong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somwar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Politi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chmielecki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pao, W.</span><span> </span><span class="NLM_article-title">Induction of BIM is essential for apoptosis triggered by EGFR kinase inhibitors in mutant EGFR-dependent lung adenocarcinomas</span> <span class="citation_source-journal">PLoS Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">e294</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&pages=e294&author=Y.+Gongauthor=R.+Somwarauthor=K.+Politiauthor=M.+Balakauthor=J.+Chmieleckiauthor=X.+Jiangauthor=W.+Pao&title=Induction+of+BIM+is+essential+for+apoptosis+triggered+by+EGFR+kinase+inhibitors+in+mutant+EGFR-dependent+lung+adenocarcinomas"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DY.%26aulast%3DSomwar%26aufirst%3DR.%26aulast%3DPoliti%26aufirst%3DK.%26aulast%3DBalak%26aufirst%3DM.%26aulast%3DChmielecki%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DPao%26aufirst%3DW.%26atitle%3DInduction%2520of%2520BIM%2520is%2520essential%2520for%2520apoptosis%2520triggered%2520by%2520EGFR%2520kinase%2520inhibitors%2520in%2520mutant%2520EGFR-dependent%2520lung%2520adenocarcinomas%26jtitle%3DPLoS%2520Med.%26date%3D2007%26volume%3D4%26spage%3De294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">McKillop, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partridge, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemp, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spence, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendrew, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnett, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giles, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bichat, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guilbaud, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, T. C.</span><span> </span><span class="NLM_article-title">Tumor penetration of gefitinib (Iressa), an epidermal growth factor receptor tyrosine kinase inhibitor</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">641</span><span class="NLM_x">–</span> <span class="NLM_lpage">649</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1158%2F1535-7163.MCT-04-0329" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=15827338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtFegsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=641-649&author=D.+McKillopauthor=E.+A.+Partridgeauthor=J.+V.+Kempauthor=M.+P.+Spenceauthor=J.+Kendrewauthor=S.+Barnettauthor=P.+G.+Woodauthor=P.+B.+Gilesauthor=A.+B.+Pattersonauthor=F.+Bichatauthor=N.+Guilbaudauthor=T.+C.+Stephens&title=Tumor+penetration+of+gefitinib+%28Iressa%29%2C+an+epidermal+growth+factor+receptor+tyrosine+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor penetration of gefitinib (Iressa), an epidermal growth factor receptor tyrosine kinase inhibitor</span></div><div class="casAuthors">McKillop, David; Partridge, Elizabeth A.; Kemp, John V.; Spence, Mike P.; Kendrew, Jane; Barnett, Sharon; Wood, Phillippa G.; Giles, Petrina B.; Patterson, Andrew B.; Bichat, Francis; Guilbaud, Nicolas; Stephens, Trevor C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">641-649</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The relative distribution of gefitinib-related material in nude mice bearing s.c. human tumor xenografts and in an orthotopic rat lung tumor model was investigated following oral administration (50 mg/kg) of [14C]-gefitinib.  Selected tissue samples were monitored for radioactivity by liq. scintillation counting, whereas plasma and tumor exts. were assayed for gefitinib and its major metabolites (M523595 and M537194) by high-performance liq. chromatog. with tandem mass spectrometric detection.  Tissue distribution was also detd. by whole body autoradiog.  Gefitinib was extensively distributed into the tissues of tumor-bearing mice and unchanged gefitinib was shown to account for most of the tumor radioactivity.  Concns. of gefitinib in mouse s.c. tumor xenografts were similar to skin concns. and substantially greater (up to 12-fold based on area under the concn.-time curve) than plasma.  Concns. of gefitinib-related material in an orthotopic rat lung tumor were similar to those in healthy lung tissue and were much higher than corresponding blood levels.  Following treatment of breast cancer patients with oral gefitinib (Iressa) 250 mg/d for ≥ 14 days, gefitinib concns. (mean, 7.5 μg/g, 16.7 μmol/L) in breast tumor tissue were 42 times higher than plasma, confirming the preferential distribution of gefitinib from blood into tumor tissue in the clin. situation.  These gefitinib tumor concns. are considerably higher than those reportedly required in vitro to achieve complete inhibition of epidermal growth factor receptor autophosphorylation in both epidermal growth factor receptor mutant (0.2 μmol/L) and wild-type cells (2 μmol/L).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3SuCqMHy6nbVg90H21EOLACvtfcHk0lg_Kwfen-qAUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtFegsLs%253D&md5=5778e8d3f972cef6e40badacd5ce0d3f</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-04-0329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-04-0329%26sid%3Dliteratum%253Aachs%26aulast%3DMcKillop%26aufirst%3DD.%26aulast%3DPartridge%26aufirst%3DE.%2BA.%26aulast%3DKemp%26aufirst%3DJ.%2BV.%26aulast%3DSpence%26aufirst%3DM.%2BP.%26aulast%3DKendrew%26aufirst%3DJ.%26aulast%3DBarnett%26aufirst%3DS.%26aulast%3DWood%26aufirst%3DP.%2BG.%26aulast%3DGiles%26aufirst%3DP.%2BB.%26aulast%3DPatterson%26aufirst%3DA.%2BB.%26aulast%3DBichat%26aufirst%3DF.%26aulast%3DGuilbaud%26aufirst%3DN.%26aulast%3DStephens%26aufirst%3DT.%2BC.%26atitle%3DTumor%2520penetration%2520of%2520gefitinib%2520%2528Iressa%2529%252C%2520an%2520epidermal%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520inhibitor%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2005%26volume%3D4%26spage%3D641%26epage%3D649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Yan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vikis, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubet, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">You, M.</span><span> </span><span class="NLM_article-title">Effect of an epidermal growth factor receptor inhibitor in mouse models of lung cancer</span> <span class="citation_source-journal">Mol. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">971</span><span class="NLM_x">–</span> <span class="NLM_lpage">981</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1158%2F1541-7786.MCR-06-0086" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=17189387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlCrtr3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2006&pages=971-981&author=Y.+Yanauthor=Y.+Luauthor=M.+Wangauthor=H.+Vikisauthor=R.+Yaoauthor=Y.+Wangauthor=R.+A.+Lubetauthor=M.+You&title=Effect+of+an+epidermal+growth+factor+receptor+inhibitor+in+mouse+models+of+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of an Epidermal Growth Factor Receptor Inhibitor in Mouse Models of Lung Cancer</span></div><div class="casAuthors">Yan, Ying; Lu, Yan; Wang, Min; Vikis, Haris; Yao, Ruisheng; Wang, Yian; Lubet, Ronald A.; You, Ming</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">971-981</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Gefitinib (Iressa, ZD1839) is a potent high-affinity competitive tyrosine kinase inhibitor aimed primarily at epidermal growth factor receptor (EGFR).  Inhibitors in this class have recently been approved for clin. use in the treatment of advanced non-small cell lung cancer as monotherapy following failure of chemotherapy.  We examd. the efficacy of gefitinib on lung tumorigenesis in mouse models using both postinitiation and progression protocols.  Gefitinib was given at a dose of 200 mg/kg body wt. (i.g.) beginning either 2 or 12 wk following carcinogen initiation.  In the postinitiation protocol, gefitinib significantly inhibited both tumor multiplicity (∼70%) and tumor load (∼90%) in A/J or p53-mutant mice (P < 0.0001).  Interestingly, gefitinib was also highly effective against lung carcinogenesis in the progression protocol when individual animals already have multiple preinvasive lesions in the lung.  Gefitinib exhibited ∼60% inhibition of tumor multiplicity and ∼80% inhibition of tumor load when compared with control mice (both P < 0.0001).  These data show that gefitinib is a potent chemopreventive agent in both wild-type and p53-mutant mice and that a delayed administration was still highly effective.  Analyses of mutations in the EGFR and K-ras genes in lung tumors from either control or treatment groups showed no mutations in EGFR and consistent mutation in K-ras.  Using an oligonucleotide array on control and gefitinib-treated lesions showed that gefitinib treatment failed to alter the activity or the expression level of EGFR.  In contrast, gefitinib treatment significantly altered the expression of a series of genes involved in cell cycle, cell proliferation, cell transformation, angiogenesis, DNA synthesis, cell migration, immune responses, and apoptosis.  Thus, gefitinib showed highly promising chemopreventive and chemotherapeutic activity in this mouse model of lung carcinogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTbJ1XOG9cerVg90H21EOLACvtfcHk0lgxwQjzjsMOYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlCrtr3E&md5=9ba0c145b412d85029e8a6f74caac9a0</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-06-0086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-06-0086%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DVikis%26aufirst%3DH.%26aulast%3DYao%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLubet%26aufirst%3DR.%2BA.%26aulast%3DYou%26aufirst%3DM.%26atitle%3DEffect%2520of%2520an%2520epidermal%2520growth%2520factor%2520receptor%2520inhibitor%2520in%2520mouse%2520models%2520of%2520lung%2520cancer%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2006%26volume%3D4%26spage%3D971%26epage%3D981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Boehmerle, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muenzfeld, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huehnchen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endres, M.</span><span> </span><span class="NLM_article-title">Specific targeting of neurotoxic side effects and pharmacological profile of the novel cancer stem cell drug salinomycin in mice</span> <span class="citation_source-journal">J. Mol. Med. (Berlin)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">889</span><span class="NLM_x">–</span> <span class="NLM_lpage">900</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1007%2Fs00109-014-1155-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=24770997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A280%3ADC%252BC2cnntFaitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2014&pages=889-900&author=W.+Boehmerleauthor=H.+Muenzfeldauthor=A.+Springerauthor=P.+Huehnchenauthor=M.+Endres&title=Specific+targeting+of+neurotoxic+side+effects+and+pharmacological+profile+of+the+novel+cancer+stem+cell+drug+salinomycin+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Specific targeting of neurotoxic side effects and pharmacological profile of the novel cancer stem cell drug salinomycin in mice</span></div><div class="casAuthors">Boehmerle Wolfgang; Muenzfeld Hanna; Springer Andreas; Huehnchen Petra; Endres Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Journal of molecular medicine (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">889-900</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">UNLABELLED:  Salinomycin is a polyether antibiotic which effectively eliminates a variety of cancer stem cells and chemotherapy-resistant tumor cells in vitro and in vivo.  One important caveat for its clinical application is the paucity of preclinical pharmacological and safety data.  In the present study, we thus aimed to elucidate pharmacokinetic properties of salinomycin and to assess the side effect profile of chronic treatment with this compound in C57Bl/6 mice.  In addition, we tested whether neurotoxic side effects can be prevented by interference with the intracellular calcium homeostasis.  We observed that salinomycin has a narrow therapeutic index; however, a dose of 5 mg/kg body weight was well tolerated, and analysis of blood parameters as well as organ histology of liver, kidney, skeletal muscle, and heart showed no abnormalities after daily salinomycin injection for 4 weeks.  Pharmacokinetic evaluation revealed low micromolar peak concentrations and an almost complete systemic elimination within 5 h after injection.  In contrast to low systemic toxicity, typical signs of a sensory polyneuropathy with mechanical and cold allodynia, distinct gait alterations, decreased sensory nerve action potential amplitudes, and loss of myelinated fibers in the sciatic nerve were observed in salinomycin-treated animals.  Inhibition of the mitochondrial Na(+)/Ca(2+) exchanger partially prevented the development of salinomycin-induced neuropathy in vivo, an approach which did not reduce salinomycin's antineoplastic efficacy in vitro.  Taken together, this study establishes a framework of pharmacokinetic data for future preclinical trials and safety data for translational trials.  Furthermore, we established a strategy to reduce salinomycin's off-target neurotoxic effects.  KEY MESSAGE:  Salinomycin has a narrow therapeutic index; a dose of 5 mg/kg is tolerated in mice.  Mice treated with salinomycin develop a painful sensory polyneuropathy.  An optimized protocol was established to measure salinomycin in serum samples.  Inhibition of Na(+)/Ca(2+) exchangers prevents salinomycin-induced neuropathy.  Blocking mitochondrial Na(+)/Ca(2+) exchangers does not impair antineoplastic efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRKIfEmtOmUFkodMGTatQ7LfW6udTcc2eatlaty5DgvULntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cnntFaitA%253D%253D&md5=fe0454cdd367e9010523e22a20e40399</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1007%2Fs00109-014-1155-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00109-014-1155-0%26sid%3Dliteratum%253Aachs%26aulast%3DBoehmerle%26aufirst%3DW.%26aulast%3DMuenzfeld%26aufirst%3DH.%26aulast%3DSpringer%26aufirst%3DA.%26aulast%3DHuehnchen%26aufirst%3DP.%26aulast%3DEndres%26aufirst%3DM.%26atitle%3DSpecific%2520targeting%2520of%2520neurotoxic%2520side%2520effects%2520and%2520pharmacological%2520profile%2520of%2520the%2520novel%2520cancer%2520stem%2520cell%2520drug%2520salinomycin%2520in%2520mice%26jtitle%3DJ.%2520Mol.%2520Med.%2520%2528Berlin%2529%26date%3D2014%26volume%3D92%26spage%3D889%26epage%3D900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Ojo, O. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhadauria, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rath, S. K.</span><span> </span><span class="NLM_article-title">Dose-dependent adverse effects of salinomycin on male reproductive organs and fertility in mice</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e69086</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e69086&author=O.+O.+Ojoauthor=S.+Bhadauriaauthor=S.+K.+Rath&title=Dose-dependent+adverse+effects+of+salinomycin+on+male+reproductive+organs+and+fertility+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOjo%26aufirst%3DO.%2BO.%26aulast%3DBhadauria%26aufirst%3DS.%26aulast%3DRath%26aufirst%3DS.%2BK.%26atitle%3DDose-dependent%2520adverse%2520effects%2520of%2520salinomycin%2520on%2520male%2520reproductive%2520organs%2520and%2520fertility%2520in%2520mice%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De69086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Manna, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frazier, W. A.</span><span> </span><span class="NLM_article-title">CD47 mediates killing of breast tumor cells via Gi-dependent inhibition of protein kinase A</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">1026</span><span class="NLM_x">–</span> <span class="NLM_lpage">1036</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=1026-1036&author=P.+P.+Mannaauthor=W.+A.+Frazier&title=CD47+mediates+killing+of+breast+tumor+cells+via+Gi-dependent+inhibition+of+protein+kinase+A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManna%26aufirst%3DP.%2BP.%26aulast%3DFrazier%26aufirst%3DW.%2BA.%26atitle%3DCD47%2520mediates%2520killing%2520of%2520breast%2520tumor%2520cells%2520via%2520Gi-dependent%2520inhibition%2520of%2520protein%2520kinase%2520A%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D1026%26epage%3D1036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Chakravarti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddiqui, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dwivedi, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshpande, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samanta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatta, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panda, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prabhakar, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konwar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanyal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chattopadhyay, N.</span><span> </span><span class="NLM_article-title">Specific targeting of insulin-like growth factor 1 receptor signaling in human estrogen dependent breast cancer cell by a novel tyrosine-based benzoxazepine derivative</span> <span class="citation_source-journal">Mol. Cell. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">338</span><span class="NLM_x">, </span> <span class="NLM_fpage">68</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1016%2Fj.mce.2011.03.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=21457754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvVynsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=338&publication_year=2011&pages=68-78&author=B.+Chakravartiauthor=J.+A.+Siddiquiauthor=S.+K.+Dwivediauthor=S.+Deshpandeauthor=K.+Samantaauthor=R.+S.+Bhattaauthor=G.+Pandaauthor=Y.+S.+Prabhakarauthor=R.+Konwarauthor=S.+Sanyalauthor=N.+Chattopadhyay&title=Specific+targeting+of+insulin-like+growth+factor+1+receptor+signaling+in+human+estrogen+dependent+breast+cancer+cell+by+a+novel+tyrosine-based+benzoxazepine+derivative"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Specific targeting of insulin-like growth factor 1 receptor signaling in human estrogen dependent breast cancer cell by a novel tyrosine-based benzoxazepine derivative</span></div><div class="casAuthors">Chakravarti, Bandana; Siddiqui, Jawed A.; Dwivedi, Shailendra K. Dhar; Deshpande, Shreekant; Samanta, Krishnanda; Bhatta, Rabi S.; Panda, Gautam; Prabhakar, Yenamandra S.; Konwar, Rituraj; Sanyal, Sabaysachi; Chattopadhyay, Naibedya</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Endocrinology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">338</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">68-78</span>CODEN:
                <span class="NLM_cas:coden">MCEND6</span>;
        ISSN:<span class="NLM_cas:issn">0303-7207</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">The present study sought to investigate the in vitro and in vivo effects of a tyrosine-based benzoxazepine, 4-([4-(toluene-4-sulfonyl)-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-3-ylmethyl]-phenol) [THBP] in human breast cancer cells, with a focus on detg. its mol. target.  THBP had growth inhibitory effect on MCF-7 and MDA-MD-231 cells.  At IC50 value (∼ 20 μM), THBP resulted in G1 arrest, decrease in cyclin D1 levels and induction of apoptosis of MCF-7 cells.  Mechanistically, activation of caspase 8 contributes critically to the induction of apoptotic cell death as copresence of selective inhibition of caspase 8 effectively abrogates the cytotoxic effect of THBP in MCF-7 cells.  Further, THBP increased pro-apoptotic protein, Bax; decreased anti-apoptotic protein, Bcl-2; and decreased mitochondrial membrane potential in MCF-7 cells, indicating involvement of an intrinsic pathway of apoptosis following caspase 8 activation.  Out of the various growth factors/hormones, THBP selectively abrogated increased viability of MCF-7 cells by insulin-like growth factor 1 (IGF-1).  Mol. docking studies revealed that THBP occupied the ATP binding pocket of IGF-1 receptor (IGF-1R).  Accordingly THBP was found to inhibit IGF-1-induced phosphorylation of IGF-1R and insulin receptor substrate-1 (IRS-1) without inhibiting insulin signaling in MCF-7 cells.  In athymic nude mice, compared with vehicle, THBP treatment significantly reduced the growth of MCF-7 xenograft tumors through inhibition of cancer cell proliferation as well as promotion of cell death that correlated with reduced phospho-IGF-1R levels.  We suggest that interfering with the IGF-1R signaling by the benzoxazepine THBP offers a novel and selective therapeutic strategy for estrogen receptor-pos., postmenopausal breast cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHK6_l3F3BirVg90H21EOLACvtfcHk0liveXaSR6-XYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvVynsr8%253D&md5=628d2d9c1a83bc23619ebd3c8dcac68a</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.mce.2011.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mce.2011.03.012%26sid%3Dliteratum%253Aachs%26aulast%3DChakravarti%26aufirst%3DB.%26aulast%3DSiddiqui%26aufirst%3DJ.%2BA.%26aulast%3DDwivedi%26aufirst%3DS.%2BK.%26aulast%3DDeshpande%26aufirst%3DS.%26aulast%3DSamanta%26aufirst%3DK.%26aulast%3DBhatta%26aufirst%3DR.%2BS.%26aulast%3DPanda%26aufirst%3DG.%26aulast%3DPrabhakar%26aufirst%3DY.%2BS.%26aulast%3DKonwar%26aufirst%3DR.%26aulast%3DSanyal%26aufirst%3DS.%26aulast%3DChattopadhyay%26aufirst%3DN.%26atitle%3DSpecific%2520targeting%2520of%2520insulin-like%2520growth%2520factor%25201%2520receptor%2520signaling%2520in%2520human%2520estrogen%2520dependent%2520breast%2520cancer%2520cell%2520by%2520a%2520novel%2520tyrosine-based%2520benzoxazepine%2520derivative%26jtitle%3DMol.%2520Cell.%2520Endocrinol.%26date%3D2011%26volume%3D338%26spage%3D68%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Chakravarti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurya, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddiqui, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bid, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajendran, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yadav, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konwar, R.</span><span> </span><span class="NLM_article-title">In vitro anti-breast cancer activity of ethanolic extract of Wrightia tomentosa: role of pro-apoptotic effects of oleanolic acid and urosolic acid</span> <span class="citation_source-journal">J. Ethnopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x">, </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2012&pages=72-79&author=B.+Chakravartiauthor=R.+Mauryaauthor=J.+A.+Siddiquiauthor=H.+K.+Bidauthor=S.+M.+Rajendranauthor=P.+P.+Yadavauthor=R.+Konwar&title=In+vitro+anti-breast+cancer+activity+of+ethanolic+extract+of+Wrightia+tomentosa%3A+role+of+pro-apoptotic+effects+of+oleanolic+acid+and+urosolic+acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChakravarti%26aufirst%3DB.%26aulast%3DMaurya%26aufirst%3DR.%26aulast%3DSiddiqui%26aufirst%3DJ.%2BA.%26aulast%3DBid%26aufirst%3DH.%2BK.%26aulast%3DRajendran%26aufirst%3DS.%2BM.%26aulast%3DYadav%26aufirst%3DP.%2BP.%26aulast%3DKonwar%26aufirst%3DR.%26atitle%3DIn%2520vitro%2520anti-breast%2520cancer%2520activity%2520of%2520ethanolic%2520extract%2520of%2520Wrightia%2520tomentosa%253A%2520role%2520of%2520pro-apoptotic%2520effects%2520of%2520oleanolic%2520acid%2520and%2520urosolic%2520acid%26jtitle%3DJ.%2520Ethnopharmacol.%26date%3D2012%26volume%3D142%26spage%3D72%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Konecny, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatesan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dering, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginther, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahmeh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fejzo, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toft, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slamon, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podratz, K. C.</span><span> </span><span class="NLM_article-title">Activity of lapatinib a novel HER2 and EGFR dual kinase inhibitor in human endometrial cancer cells</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">1076</span><span class="NLM_x">–</span> <span class="NLM_lpage">1084</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1038%2Fsj.bjc.6604278" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=18334972" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtlGkurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2008&pages=1076-1084&author=G.+E.+Konecnyauthor=N.+Venkatesanauthor=G.+Yangauthor=J.+Deringauthor=C.+Gintherauthor=R.+Finnauthor=M.+Rahmehauthor=M.+S.+Fejzoauthor=D.+Toftauthor=S.+W.+Jiangauthor=D.+J.+Slamonauthor=K.+C.+Podratz&title=Activity+of+lapatinib+a+novel+HER2+and+EGFR+dual+kinase+inhibitor+in+human+endometrial+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Activity of lapatinib a novel HER2 and EGFR dual kinase inhibitor in human endometrial cancer cells</span></div><div class="casAuthors">Konecny, G. E.; Venkatesan, N.; Yang, G.; Dering, J.; Ginther, C.; Finn, R.; Rahmeh, M.; Schoenberg Fejzo, M.; Toft, D.; Jiang, S.-W.; Slamon, D. J.; Podratz, K. C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1076-1084</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">In this study, we explore the therapeutic potential of lapatinib a selective inhibitor of both the EGFR and HER2 tyrosine kinases for the treatment of endometrial cancer.  The effect of lapatinib on tumor cell growth and receptor activation was studied in a panel of human endometrial cancer cell lines.  Candidate mol. markers predicting sensitivity were assessed by baseline gene expression profiling, ELISA, and western blot analyses.  Multiple drug effect/combination index (CI) isobologram anal. was used to study the interactions between chemotherapeutic drugs and lapatinib.  Concn.-dependent anti-proliferative effects of lapatinib were seen in all endometrial cancer cell lines tested, but varied significantly between individual cell lines (IC50 range: 0.052-10.9 μmol).  HER2 overexpression or increased expression of EGFR was significantly assocd. with in vitro sensitivity (P=0.024 or 0.011, resp.).  Lapatinib exerts growth inhibition in a PTEN-independent manner.  Sensitive cell lines also exhibited increased expression of EGFR ligands or HER3.  In contrast, lapatinib-resistant cell lines exhibited high androgen receptor (AR) levels or epithelial-to-mesenchymal transition (post-EMT) features.  In endometrial cancer cells, at a wide range of clin. achievable drug concns., additive and synergistic interactions were obsd. for lapatinib plus carboplatin, paclitaxel, docetaxel, and doxorubicin.  These observations provide a clear biol. rational to test lapatinib as a single agent or in combination with chemotherapy in endometrial cancer with HER2 overexpression.  Expression of EGFR, its ligands, HER3, AR, and post-EMT markers warrant further evaluation to help define patients with HER2-nonoverexpressing endometrial cancer most likely to benefit from lapatinib.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreQmp51wKR8bVg90H21EOLACvtfcHk0liveXaSR6-XYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtlGkurY%253D&md5=c4fda5ffad2db3b936cc3da557c8c47f</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6604278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6604278%26sid%3Dliteratum%253Aachs%26aulast%3DKonecny%26aufirst%3DG.%2BE.%26aulast%3DVenkatesan%26aufirst%3DN.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DDering%26aufirst%3DJ.%26aulast%3DGinther%26aufirst%3DC.%26aulast%3DFinn%26aufirst%3DR.%26aulast%3DRahmeh%26aufirst%3DM.%26aulast%3DFejzo%26aufirst%3DM.%2BS.%26aulast%3DToft%26aufirst%3DD.%26aulast%3DJiang%26aufirst%3DS.%2BW.%26aulast%3DSlamon%26aufirst%3DD.%2BJ.%26aulast%3DPodratz%26aufirst%3DK.%2BC.%26atitle%3DActivity%2520of%2520lapatinib%2520a%2520novel%2520HER2%2520and%2520EGFR%2520dual%2520kinase%2520inhibitor%2520in%2520human%2520endometrial%2520cancer%2520cells%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2008%26volume%3D98%26spage%3D1076%26epage%3D1084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Byon, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardy, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponnazhagan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span> </span><span class="NLM_article-title">Free fatty acids enhance breast cancer cell migration through plasminogen activator inhibitor-1 and SMAD4</span> <span class="citation_source-journal">Lab. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">1221</span><span class="NLM_x">–</span> <span class="NLM_lpage">1228</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2009&pages=1221-1228&author=C.+H.+Byonauthor=R.+W.+Hardyauthor=C.+Renauthor=S.+Ponnazhaganauthor=D.+R.+Welchauthor=J.+M.+McDonaldauthor=Y.+Chen&title=Free+fatty+acids+enhance+breast+cancer+cell+migration+through+plasminogen+activator+inhibitor-1+and+SMAD4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DByon%26aufirst%3DC.%2BH.%26aulast%3DHardy%26aufirst%3DR.%2BW.%26aulast%3DRen%26aufirst%3DC.%26aulast%3DPonnazhagan%26aufirst%3DS.%26aulast%3DWelch%26aufirst%3DD.%2BR.%26aulast%3DMcDonald%26aufirst%3DJ.%2BM.%26aulast%3DChen%26aufirst%3DY.%26atitle%3DFree%2520fatty%2520acids%2520enhance%2520breast%2520cancer%2520cell%2520migration%2520through%2520plasminogen%2520activator%2520inhibitor-1%2520and%2520SMAD4%26jtitle%3DLab.%2520Invest.%26date%3D2009%26volume%3D89%26spage%3D1221%26epage%3D1228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Jiang, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiscox, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parr, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansel, R. E.</span><span> </span><span class="NLM_article-title">Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">3695</span><span class="NLM_x">–</span> <span class="NLM_lpage">3703</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=10589789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADyaK1MXotV2gt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1999&pages=3695-3703&author=W.+G.+Jiangauthor=S.+E.+Hiscoxauthor=C.+Parrauthor=T.+A.+Martinauthor=K.+Matsumotoauthor=T.+Nakamuraauthor=R.+E.+Mansel&title=Antagonistic+effect+of+NK4%2C+a+novel+hepatocyte+growth+factor+variant%2C+on+in+vitro+angiogenesis+of+human+vascular+endothelial+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells</span></div><div class="casAuthors">Jiang, Wen G.; Hiscox, Steve E.; Parr, Christian; Martin, Tracey A.; Matsumoto, Kunio; Nakamura, Toshikazu; Mansel, Robert E.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3695-3703</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Hepatocyte growth factor (HGF), also known as scatter factor (SF), is known to act on cancer cells as well as endothelial cells and stimulate angiogenesis, thus playing an unwanted role in the development and progression of cancer.  The current study examd. the effects of a newly discovered HGF variant, NK4, on angiogenesis in vitro.  Chem. generated NK4 (from recombinant human HGF/SF) was found to inhibit HGF-induced activation (tyrosine phosphorylation) of the HGF/SF receptor cMET but was itself unable to activate cMET.  Furthermore, NK4 was demonstrated to inhibit tubule formation from human umbilical vein endothelial cells that was induced by both HGF/SF and a HGF/SF-producing fibroblast (MRC5).  Under the same settings, NK4 failed to increase tubular formation.  NK4 had no effects on interleukin 8- and vascular endothelial growth factor-induced tubule formation.  Using computer-assisted motion anal., it was further shown that NK4 inhibited HGF-induced migration of human umbilical vein endothelial cells in a migration assay and in an endothelial wounding assay.  These data show that NK4 is a complete antagonist to HGF.  It inhibits HGF-induced endothelial movement and tubule formation.  Thus, NK4 may have an important bearing on the control of cancer progression through its role in angiogenesis.  Addnl. in vivo studies are warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbJbSJJXcJtbVg90H21EOLACvtfcHk0lj6-NKVScqbgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXotV2gt7k%253D&md5=de6a575d337dd65a9a92dadd02933067</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DW.%2BG.%26aulast%3DHiscox%26aufirst%3DS.%2BE.%26aulast%3DParr%26aufirst%3DC.%26aulast%3DMartin%26aufirst%3DT.%2BA.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DT.%26aulast%3DMansel%26aufirst%3DR.%2BE.%26atitle%3DAntagonistic%2520effect%2520of%2520NK4%252C%2520a%2520novel%2520hepatocyte%2520growth%2520factor%2520variant%252C%2520on%2520in%2520vitro%2520angiogenesis%2520of%2520human%2520vascular%2520endothelial%2520cells%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D1999%26volume%3D5%26spage%3D3695%26epage%3D3703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Parr, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansel, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, W. G.</span><span> </span><span class="NLM_article-title">Matriptase-2 inhibits breast tumor growth and invasion and correlates with favorable prognosis for breast cancer patients</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">3568</span><span class="NLM_x">–</span> <span class="NLM_lpage">3576</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1158%2F1078-0432.CCR-06-2357" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=17575220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFCqtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=3568-3576&author=C.+Parrauthor=A.+J.+Sandersauthor=G.+Daviesauthor=T.+Martinauthor=J.+Laneauthor=M.+D.+Masonauthor=R.+E.+Manselauthor=W.+G.+Jiang&title=Matriptase-2+inhibits+breast+tumor+growth+and+invasion+and+correlates+with+favorable+prognosis+for+breast+cancer+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Matriptase-2 Inhibits Breast Tumor Growth and Invasion and Correlates with Favorable Prognosis for Breast Cancer Patients</span></div><div class="casAuthors">Parr, Christian; Sanders, Andrew J.; Davies, Gaynor; Martin, Tracey; Lane, Jane; Mason, Malcolm D.; Mansel, Robert E.; Jiang, Wen G.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3568-3576</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The type II transmembrane serine proteases are cell surface proteolytic enzymes that mediate a diverse range of cellular functions, including tumor invasion and metastasis.  Matriptase (matriptase-1) and matriptase-2 belong to the type II transmembrane serine protease family.  Matriptase-1 is known to play a role in breast cancer progression, and elevated levels of matriptase-1 correlate with poor patient outcome.  The role of matriptase-2 and its cellular function in cancer is unknown.  This study aimed to provide new insights into the significance of matriptase-2 in cancer.  Matriptase-2 expression levels were assessed in a cohort of human breast cancer specimens (normal, n = 34; cancer, n = 95), in assocn. with patient clin. variables, using both quant. and qual. anal. of the matriptase-2 transcript along with immunohistochem. techniques.  Matriptase-2 was also exptl. overexpressed in the MDA-MB-231 human breast cancer cell line.  The effects of matriptase-2 overexpression were examd. through a series of in vitro and in vivo studies.  Here, we show that reduced matriptase-2 levels in breast cancer tissues correlate with an overall poor prognosis for the breast cancer patient.  This study also reveals that matriptase-2 overexpression in breast cancer cells significantly suppressed tumorigenesis in CD1 athymic mice (P = 0.000003).  Furthermore, we report that matriptase-2 overexpression dramatically reduced the invasive (P = 0.0001) and migratory properties (P = 0.01) of the breast cancer cells.  Matriptase-2 suppresses breast tumor development in vivo, displays prognostic value for breast cancer patients, inhibits both breast cancer cell invasion and motility in vitro, and may play a contrasting role to matriptase-1 in breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFR5QXQ23yk7Vg90H21EOLACvtfcHk0lj6-NKVScqbgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFCqtbg%253D&md5=6cd783acd4c46f92c6d94176f21b88c3</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-2357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-2357%26sid%3Dliteratum%253Aachs%26aulast%3DParr%26aufirst%3DC.%26aulast%3DSanders%26aufirst%3DA.%2BJ.%26aulast%3DDavies%26aufirst%3DG.%26aulast%3DMartin%26aufirst%3DT.%26aulast%3DLane%26aufirst%3DJ.%26aulast%3DMason%26aufirst%3DM.%2BD.%26aulast%3DMansel%26aufirst%3DR.%2BE.%26aulast%3DJiang%26aufirst%3DW.%2BG.%26atitle%3DMatriptase-2%2520inhibits%2520breast%2520tumor%2520growth%2520and%2520invasion%2520and%2520correlates%2520with%2520favorable%2520prognosis%2520for%2520breast%2520cancer%2520patients%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D3568%26epage%3D3576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Dontu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNicholas, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamura, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdallah, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wicha, M. S.</span><span> </span><span class="NLM_article-title">Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells</span> <span class="citation_source-journal">Breast Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">R605</span><span class="NLM_x">–</span> <span class="NLM_lpage">615</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1186%2Fbcr920" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=15535842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvVeiurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=R605-615&author=G.+Dontuauthor=K.+W.+Jacksonauthor=E.+McNicholasauthor=M.+J.+Kawamuraauthor=W.+M.+Abdallahauthor=M.+S.+Wicha&title=Role+of+Notch+signaling+in+cell-fate+determination+of+human+mammary+stem%2Fprogenitor+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells</span></div><div class="casAuthors">Dontu, Gabriela; Jackson, Kyle W.; McNicholas, Erin; Kawamura, Mari J.; Abdallah, Wissam M.; Wicha, Max S.</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">R605-R615</span>CODEN:
                <span class="NLM_cas:coden">BRCRFS</span>;
        ISSN:<span class="NLM_cas:issn">1465-542X</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Introduction Notch signaling has been implicated in the regulation of cell-fate decisions such as self-renewal of adult stem cells and differentiation of progenitor cells along a particular lineage.  Moreover, depending on the cellular and developmental context, the Notch pathway acts as a regulator of cell survival and cell proliferation.  Abnormal expression of Notch receptors has been found in different types of epithelial metaplastic lesions and neoplastic lesions, suggesting that Notch may act as a proto-oncogene.  The vertebrate Notch 1 and Notch4 homologs are involved in normal development of the mammary gland, and mutated forms of these genes are assocd. with development of mouse mammary tumors.  In order to det. the role of Notch signaling in mammary cell-fate detn., we have utilized a newly described in vitro system in which mammary stem/progenitor cells can be cultured in suspension as nonadherent 'mammospheres'.  Notch signaling was activated using exogenous ligands, or was inhibited using previously characterized Notch signaling antagonists.  Results Utilizing this system, we demonstrate that Notch signaling can act on mammary stem cells to promote self-renewal and on early progenitor cells to promote their proliferation, as demonstrated by a 10-fold increase in secondary mammosphere formation upon addn. of a Notch-activating DSL peptide.  In addn. to acting on stem cells, Notch signaling is also able to act on multipotent progenitor cells, facilitating myoepithelial lineage-specific commitment and proliferation.  Stimulation of this pathway also promotes branching morphogenesis in three-dimensional Matrigel cultures.  These effects are completely inhibited by a Notch4 blocking antibody or a gamma secretase inhibitor that blocks Notch processing.  In contrast to the effects of Notch signaling on mammary stem/progenitor cells, modulation of this pathway has no discernnable effect on fully committed, differentiated, mammary epithelial cells.  These studies suggest that Notch signaling plays a crit. role in normal human mammary development by acting on both stem cells and progenitor cells, affecting self-renewal and lineage-specific differentiation.  Based on these findings we propose that abnormal Notch signaling may contribute to mammary carcinogenesis by deregulating the self-renewal of normal mammary stem cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5GmDtqIH64bVg90H21EOLACvtfcHk0lhMJoUJ2WeVEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvVeiurk%253D&md5=2e81b1a4529e7a36ba92289beb6c2642</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1186%2Fbcr920&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fbcr920%26sid%3Dliteratum%253Aachs%26aulast%3DDontu%26aufirst%3DG.%26aulast%3DJackson%26aufirst%3DK.%2BW.%26aulast%3DMcNicholas%26aufirst%3DE.%26aulast%3DKawamura%26aufirst%3DM.%2BJ.%26aulast%3DAbdallah%26aufirst%3DW.%2BM.%26aulast%3DWicha%26aufirst%3DM.%2BS.%26atitle%3DRole%2520of%2520Notch%2520signaling%2520in%2520cell-fate%2520determination%2520of%2520human%2520mammary%2520stem%252Fprogenitor%2520cells%26jtitle%3DBreast%2520Cancer%2520Res.%26date%3D2004%26volume%3D6%26spage%3DR605%26epage%3D615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Singh, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yadav, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dwivedi, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishra, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurjar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manhas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yadav, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagavelu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddiqi, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trivedi, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chattopadhyay, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanyal, S.</span><span> </span><span class="NLM_article-title">Synthetic FXR agonist GW4064 is a modulator of multiple G protein-coupled receptors</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">659</span><span class="NLM_x">–</span> <span class="NLM_lpage">673</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1210%2Fme.2013-1353" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=24597548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVKjtbnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2014&pages=659-673&author=N.+Singhauthor=M.+Yadavauthor=A.+K.+Singhauthor=H.+Kumarauthor=S.+K.+Dwivediauthor=J.+S.+Mishraauthor=A.+Gurjarauthor=A.+Manhasauthor=S.+Chandraauthor=P.+N.+Yadavauthor=K.+Jagaveluauthor=M.+I.+Siddiqiauthor=A.+K.+Trivediauthor=N.+Chattopadhyayauthor=S.+Sanyal&title=Synthetic+FXR+agonist+GW4064+is+a+modulator+of+multiple+G+protein-coupled+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic FXR agonist GW4064 is a modulator of multiple G protein-coupled receptors</span></div><div class="casAuthors">Singh, Nidhi; Yadav, Manisha; Singh, Abhishek Kumar; Kumar, Harish; Dhar Dwivedi, Shailendra Kumar; Mishra, Jay Sharan; Gurjar, Anagha; Manhas, Amit; Chandra, Sharat; Yadav, Prem Narayan; Jagavelu, Kumaravelu; Siddiqi, Mohammad Imran; Trivedi, Arun Kumar; Chattopadhyay, Naibedya; Sanyal, Sabyasachi</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">659-673, 15 pp.</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">1944-9917</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">The synthetic nuclear bile acid receptor (farnesoid X receptor [FXR]) agonist GW4064 is extensively used as a specific pharmacol. tool to illustrate FXR functions.  We noticed that GW4064 activated empty luciferase reporters in FXR-deficient HEK-293T cells.  We postulated that this activity of GW4064 might be routed through as yet unknown cellular targets and undertook an unbiased exploratory approach to identify these targets.  Investigations revealed that GW4064 activated cAMP and nuclear factor for activated T-cell response elements (CRE and NFAT-RE, resp.) present on these empty reporters.  Whereas GW4064-induced NFAT-RE activation involved rapid intracellular Ca2+ accumulation and NFAT nuclear translocation, CRE activation involved sol. adenylyl cyclase-dependent cAMP accumulation and Ca2+-calcineurin-dependent nuclear translocation of transducers of regulated CRE-binding protein 2.  Use of dominant neg. heterotrimeric G-protein minigenes revealed that GW4064 caused activation of Gαi/o and Gq/11 G proteins.  Sequential pharmacol. inhibitor-based screening and radioligand-binding studies revealed that GW4064 interacted with multiple G protein-coupled receptors.  Functional studies demonstrated that GW4064 robustly activated H1 and H4 and inhibited H2 histamine receptor signaling events.  We also found that MCF-7 breast cancer cells, reported to undergo GW4064-induced apoptosis in an FXR-dependent manner, did not express FXR, and the GW4064-mediated apoptosis, also apparent in HEK-293T cells, could be blocked by selective histamine receptor regulators.  Taken together, our results demonstrate identification of histamine receptors as alternate targets for GW4064, which not only necessitates cautious interpretation of the biol. functions attributed to FXR using GW4064 as a pharmacol. tool but also provides a basis for the rational designing of new pharmacophores for histamine receptor modulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqv4YF4HG2QrVg90H21EOLACvtfcHk0lhMJoUJ2WeVEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVKjtbnM&md5=d4eb9b7e8acacbf1697c0febf505408b</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1210%2Fme.2013-1353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2013-1353%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DN.%26aulast%3DYadav%26aufirst%3DM.%26aulast%3DSingh%26aufirst%3DA.%2BK.%26aulast%3DKumar%26aufirst%3DH.%26aulast%3DDwivedi%26aufirst%3DS.%2BK.%26aulast%3DMishra%26aufirst%3DJ.%2BS.%26aulast%3DGurjar%26aufirst%3DA.%26aulast%3DManhas%26aufirst%3DA.%26aulast%3DChandra%26aufirst%3DS.%26aulast%3DYadav%26aufirst%3DP.%2BN.%26aulast%3DJagavelu%26aufirst%3DK.%26aulast%3DSiddiqi%26aufirst%3DM.%2BI.%26aulast%3DTrivedi%26aufirst%3DA.%2BK.%26aulast%3DChattopadhyay%26aufirst%3DN.%26aulast%3DSanyal%26aufirst%3DS.%26atitle%3DSynthetic%2520FXR%2520agonist%2520GW4064%2520is%2520a%2520modulator%2520of%2520multiple%2520G%2520protein-coupled%2520receptors%26jtitle%3DMol.%2520Endocrinol.%26date%3D2014%26volume%3D28%26spage%3D659%26epage%3D673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Spears, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sneyd, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loten, E. G.</span><span> </span><span class="NLM_article-title">A method for deriving kinetic constants for two enzymes acting on the same substrate</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">1149</span><span class="NLM_x">–</span> <span class="NLM_lpage">1151</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=1971&pages=1149-1151&author=G.+Spearsauthor=J.+G.+Sneydauthor=E.+G.+Loten&title=A+method+for+deriving+kinetic+constants+for+two+enzymes+acting+on+the+same+substrate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSpears%26aufirst%3DG.%26aulast%3DSneyd%26aufirst%3DJ.%2BG.%26aulast%3DLoten%26aufirst%3DE.%2BG.%26atitle%3DA%2520method%2520for%2520deriving%2520kinetic%2520constants%2520for%2520two%2520enzymes%2520acting%2520on%2520the%2520same%2520substrate%26jtitle%3DBiochem.%2520J.%26date%3D1971%26volume%3D125%26spage%3D1149%26epage%3D1151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Foltyn, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zehl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dikopoltsev, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, O. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolosker, H.</span><span> </span><span class="NLM_article-title">Phosphorylation of mouse serine racemase regulates D-serine synthesis</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">584</span><span class="NLM_x">, </span> <span class="NLM_fpage">2937</span><span class="NLM_x">–</span> <span class="NLM_lpage">2941</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=584&publication_year=2010&pages=2937-2941&author=V.+N.+Foltynauthor=M.+Zehlauthor=E.+Dikopoltsevauthor=O.+N.+Jensenauthor=H.+Wolosker&title=Phosphorylation+of+mouse+serine+racemase+regulates+D-serine+synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFoltyn%26aufirst%3DV.%2BN.%26aulast%3DZehl%26aufirst%3DM.%26aulast%3DDikopoltsev%26aufirst%3DE.%26aulast%3DJensen%26aufirst%3DO.%2BN.%26aulast%3DWolosker%26aufirst%3DH.%26atitle%3DPhosphorylation%2520of%2520mouse%2520serine%2520racemase%2520regulates%2520D-serine%2520synthesis%26jtitle%3DFEBS%2520Lett.%26date%3D2010%26volume%3D584%26spage%3D2937%26epage%3D2941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 28 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Linh Da Ho, Nansalmaa Otog, Ikuhide Fujisawa, <span class="NLM_string-name hlFld-ContribAuthor">Seiji Iwasa</span>. </span><span class="cited-content_cbyCitation_article-title">Catalytic Asymmetric Carbene Transfer Reactions of Diazo Oxime Ethers with Olefins and Their Synthetic Applications. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (18)
                                     , 7470-7474. <a href="https://doi.org/10.1021/acs.orglett.9b02771" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b02771</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b02771&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b02771%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DCatalytic%252BAsymmetric%252BCarbene%252BTransfer%252BReactions%252Bof%252BDiazo%252BOxime%252BEthers%252Bwith%252BOlefins%252Band%252BTheir%252BSynthetic%252BApplications%26aulast%3DDa%2BHo%26aufirst%3DLinh%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D06082019%26date%3D04092019%26volume%3D21%26issue%3D18%26spage%3D7470%26epage%3D7474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yashveer  Gautam</span>, <span class="hlFld-ContribAuthor ">Sharmistha  Das</span>, <span class="hlFld-ContribAuthor ">Hamidullah  Khan</span>, <span class="hlFld-ContribAuthor ">Nandini  Pathak</span>, <span class="hlFld-ContribAuthor ">Hina  Iqbal</span>, <span class="hlFld-ContribAuthor ">Pankaj  Yadav</span>, <span class="hlFld-ContribAuthor ">Vijay Kumar  Sirohi</span>, <span class="hlFld-ContribAuthor ">Sana  Khan</span>, <span class="hlFld-ContribAuthor ">Dushyant Singh  Raghuvanshi</span>, <span class="hlFld-ContribAuthor ">Anila  Dwivedi</span>, <span class="hlFld-ContribAuthor ">Debabrata  Chanda</span>, <span class="hlFld-ContribAuthor ">Karuna  Shanker</span>, <span class="hlFld-ContribAuthor ">Feroz  Khan</span>, <span class="hlFld-ContribAuthor ">Rituraj  Konwar</span>, <span class="hlFld-ContribAuthor ">Arvind S.  Negi</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and broad spectrum antibreast cancer activity of diarylindoles via induction of apoptosis in aggressive breast cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>42 </em>, 116252. <a href="https://doi.org/10.1016/j.bmc.2021.116252" title="DOI URL">https://doi.org/10.1016/j.bmc.2021.116252</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2021.116252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2021.116252%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbroad%252Bspectrum%252Bantibreast%252Bcancer%252Bactivity%252Bof%252Bdiarylindoles%252Bvia%252Binduction%252Bof%252Bapoptosis%252Bin%252Baggressive%252Bbreast%252Bcancer%252Bcells%26aulast%3DGautam%26aufirst%3DYashveer%26date%3D2021%26volume%3D42%26spage%3D116252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Igor B.  Krylov</span>, <span class="hlFld-ContribAuthor ">Oleg O.  Segida</span>, <span class="hlFld-ContribAuthor ">Alexander S.  Budnikov</span>, <span class="hlFld-ContribAuthor ">Alexander O.  Terent'ev</span>. </span><span class="cited-content_cbyCitation_article-title">Oxime‐Derived Iminyl Radicals in Selective Processes of Hydrogen Atom Transfer and Addition to Carbon‐Carbon π‐Bonds. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2021,</strong> <em>363 </em>
                                    (10)
                                     , 2502-2528. <a href="https://doi.org/10.1002/adsc.202100058" title="DOI URL">https://doi.org/10.1002/adsc.202100058</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.202100058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.202100058%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DOxime%2525E2%252580%252590Derived%252BIminyl%252BRadicals%252Bin%252BSelective%252BProcesses%252Bof%252BHydrogen%252BAtom%252BTransfer%252Band%252BAddition%252Bto%252BCarbon%2525E2%252580%252590Carbon%252B%2525CF%252580%2525E2%252580%252590Bonds%26aulast%3DKrylov%26aufirst%3DIgor%2BB.%26date%3D2021%26date%3D2021%26volume%3D363%26issue%3D10%26spage%3D2502%26epage%3D2528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaobo  Zhou</span>, <span class="hlFld-ContribAuthor ">Riping  Xiao</span>, <span class="hlFld-ContribAuthor ">Ming  Chen</span>, <span class="hlFld-ContribAuthor ">Li‐Ping  Bai</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Uscharin Oxime Analogues and Their Biological Evaluation as HIF‐1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2020,</strong> <em>5 </em>
                                    (42)
                                     , 12869-12872. <a href="https://doi.org/10.1002/slct.202003586" title="DOI URL">https://doi.org/10.1002/slct.202003586</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202003586&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202003586%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DSynthesis%252Bof%252BUscharin%252BOxime%252BAnalogues%252Band%252BTheir%252BBiological%252BEvaluation%252Bas%252BHIF%2525E2%252580%2525901%252BInhibitors%26aulast%3DZhou%26aufirst%3DXiaobo%26date%3D2020%26date%3D2020%26volume%3D5%26issue%3D42%26spage%3D12869%26epage%3D12872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Luo</span>, <span class="hlFld-ContribAuthor ">Chun-Hua  Chen</span>, <span class="hlFld-ContribAuthor ">Fan  Zhu</span>, <span class="hlFld-ContribAuthor ">Dong-Liang  Mo</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of α-aminooxy amides through [3 + 3] cycloaddition and Sc(OTf)
              3
              -catalyzed double C–N bond cleavage in a one-pot reaction. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (40)
                                     , 8209-8218. <a href="https://doi.org/10.1039/D0OB01788D" title="DOI URL">https://doi.org/10.1039/D0OB01788D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0OB01788D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0OB01788D%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DSynthesis%252Bof%252B%2525CE%2525B1-aminooxy%252Bamides%252Bthrough%252B%25255B3%252B%25252B%252B3%25255D%252Bcycloaddition%252Band%252BSc%252528OTf%252529%252B3%252B-catalyzed%252Bdouble%252BC%2525E2%252580%252593N%252Bbond%252Bcleavage%252Bin%252Ba%252Bone-pot%252Breaction%26aulast%3DLuo%26aufirst%3DYan%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D40%26spage%3D8209%26epage%3D8218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stanislav A.  Paveliev</span>, <span class="hlFld-ContribAuthor ">Artem I.  Churakov</span>, <span class="hlFld-ContribAuthor ">Liliya S.  Alimkhanova</span>, <span class="hlFld-ContribAuthor ">Oleg O.  Segida</span>, <span class="hlFld-ContribAuthor ">Gennady I.  Nikishin</span>, <span class="hlFld-ContribAuthor ">Alexander O.  Terent'ev</span>. </span><span class="cited-content_cbyCitation_article-title">Electrochemical Synthesis of
              O
              ‐Phthalimide Oximes from
              α
              ‐Azido Styrenes
              via
              Radical Sequence: Generation, Addition and Recombination of Imide‐
              N
              ‐Oxyl and Iminyl Radicals with C−O/N−O Bonds Formation. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2020,</strong> <em>362 </em>
                                    (18)
                                     , 3864-3871. <a href="https://doi.org/10.1002/adsc.202000618" title="DOI URL">https://doi.org/10.1002/adsc.202000618</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.202000618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.202000618%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DElectrochemical%252BSynthesis%252Bof%252BO%252B%2525E2%252580%252590Phthalimide%252BOximes%252Bfrom%252B%2525CE%2525B1%252B%2525E2%252580%252590Azido%252BStyrenes%252Bvia%252BRadical%252BSequence%25253A%252BGeneration%25252C%252BAddition%252Band%252BRecombination%252Bof%252BImide%2525E2%252580%252590%252BN%252B%2525E2%252580%252590Oxyl%252Band%252BIminyl%252BRadicals%252Bwith%252BC%2525E2%252588%252592O%25252FN%2525E2%252588%252592O%252BBonds%252BFormation%26aulast%3DPaveliev%26aufirst%3DStanislav%2BA.%26date%3D2020%26date%3D2020%26volume%3D362%26issue%3D18%26spage%3D3864%26epage%3D3871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinbo  Chen</span>, <span class="hlFld-ContribAuthor ">Zhongsen  Ma</span>, <span class="hlFld-ContribAuthor ">Changjiu  Xia</span>, <span class="hlFld-ContribAuthor ">Yajie  Zhang</span>, <span class="hlFld-ContribAuthor ">Xingtian  Shu</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient autocatalytic oximation of bio-based 2,5-diformylfuran with aqueous hydroxylamine under mild conditions. </span><span class="cited-content_cbyCitation_journal-name">Green Chemistry</span><span> <strong>2020,</strong> <em>22 </em>
                                    (13)
                                     , 4140-4146. <a href="https://doi.org/10.1039/D0GC01439G" title="DOI URL">https://doi.org/10.1039/D0GC01439G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0GC01439G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0GC01439G%26sid%3Dliteratum%253Aachs%26jtitle%3DGreen%2520Chemistry%26atitle%3DEfficient%252Bautocatalytic%252Boximation%252Bof%252Bbio-based%252B2%25252C5-diformylfuran%252Bwith%252Baqueous%252Bhydroxylamine%252Bunder%252Bmild%252Bconditions%26aulast%3DChen%26aufirst%3DJinbo%26date%3D2020%26date%3D2020%26volume%3D22%26issue%3D13%26spage%3D4140%26epage%3D4146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yang  Yang</span>, <span class="hlFld-ContribAuthor ">Christophe  Pannecouque</span>, <span class="hlFld-ContribAuthor ">Erik De  Clercq</span>, <span class="hlFld-ContribAuthor ">Chunlin  Zhuang</span>, <span class="hlFld-ContribAuthor ">Fen-Er  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Privileged scaffold inspired design of novel oxime-biphenyl-DAPYs in treatment of HIV-1. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>99 </em>, 103825. <a href="https://doi.org/10.1016/j.bioorg.2020.103825" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103825</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103825%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DPrivileged%252Bscaffold%252Binspired%252Bdesign%252Bof%252Bnovel%252Boxime-biphenyl-DAPYs%252Bin%252Btreatment%252Bof%252BHIV-1%26aulast%3DYang%26aufirst%3DYang%26date%3D2020%26volume%3D99%26spage%3D103825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaobao  Zeng</span>, <span class="hlFld-ContribAuthor ">Xin  Wang</span>, <span class="hlFld-ContribAuthor ">Yanan  Zhang</span>, <span class="hlFld-ContribAuthor ">Li  Zhu</span>, <span class="hlFld-ContribAuthor ">Yu  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">A silver-catalyzed radical ring-opening reaction of cyclopropanols with sulfonyl oxime ethers. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (19)
                                     , 3734-3739. <a href="https://doi.org/10.1039/D0OB00055H" title="DOI URL">https://doi.org/10.1039/D0OB00055H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0OB00055H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0OB00055H%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DA%252Bsilver-catalyzed%252Bradical%252Bring-opening%252Breaction%252Bof%252Bcyclopropanols%252Bwith%252Bsulfonyl%252Boxime%252Bethers%26aulast%3DZeng%26aufirst%3DXiaobao%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D19%26spage%3D3734%26epage%3D3739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ziwei  Han</span>, <span class="hlFld-ContribAuthor ">Subo  Shen</span>, <span class="hlFld-ContribAuthor ">Feng  Zheng</span>, <span class="hlFld-ContribAuthor ">Han  Hu</span>, <span class="hlFld-ContribAuthor ">Jianmin  Zhang</span>, <span class="hlFld-ContribAuthor ">Shizheng  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-catalyzed synthesis of oxime ethers from iminoxy radical (C N–O ) and maleimides via radical addition. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2019,</strong> <em>60 </em>
                                    (43)
                                     , 151188. <a href="https://doi.org/10.1016/j.tetlet.2019.151188" title="DOI URL">https://doi.org/10.1016/j.tetlet.2019.151188</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2019.151188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2019.151188%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DCopper-catalyzed%252Bsynthesis%252Bof%252Boxime%252Bethers%252Bfrom%252Biminoxy%252Bradical%252B%252528C%252BN%2525E2%252580%252593O%252B%252529%252Band%252Bmaleimides%252Bvia%252Bradical%252Baddition%26aulast%3DHan%26aufirst%3DZiwei%26date%3D2019%26volume%3D60%26issue%3D43%26spage%3D151188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai  Yang</span>, <span class="hlFld-ContribAuthor ">Feng  Zhang</span>, <span class="hlFld-ContribAuthor ">Tongchang  Fang</span>, <span class="hlFld-ContribAuthor ">Guan  Zhang</span>, <span class="hlFld-ContribAuthor ">Qiuling  Song</span>. </span><span class="cited-content_cbyCitation_article-title">Stereospecific 1,4‐Metallate Shift Enables Stereoconvergent Synthesis of Ketoximes. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2019,</strong> <em>131 </em>
                                    (38)
                                     , 13555-13560. <a href="https://doi.org/10.1002/ange.201906057" title="DOI URL">https://doi.org/10.1002/ange.201906057</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201906057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201906057%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DStereospecific%252B1%25252C4%2525E2%252580%252590Metallate%252BShift%252BEnables%252BStereoconvergent%252BSynthesis%252Bof%252BKetoximes%26aulast%3DYang%26aufirst%3DKai%26date%3D2019%26date%3D2019%26volume%3D131%26issue%3D38%26spage%3D13555%26epage%3D13560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai  Yang</span>, <span class="hlFld-ContribAuthor ">Feng  Zhang</span>, <span class="hlFld-ContribAuthor ">Tongchang  Fang</span>, <span class="hlFld-ContribAuthor ">Guan  Zhang</span>, <span class="hlFld-ContribAuthor ">Qiuling  Song</span>. </span><span class="cited-content_cbyCitation_article-title">Stereospecific 1,4‐Metallate Shift Enables Stereoconvergent Synthesis of Ketoximes. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2019,</strong> <em>58 </em>
                                    (38)
                                     , 13421-13426. <a href="https://doi.org/10.1002/anie.201906057" title="DOI URL">https://doi.org/10.1002/anie.201906057</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201906057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201906057%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DStereospecific%252B1%25252C4%2525E2%252580%252590Metallate%252BShift%252BEnables%252BStereoconvergent%252BSynthesis%252Bof%252BKetoximes%26aulast%3DYang%26aufirst%3DKai%26date%3D2019%26volume%3D58%26issue%3D38%26spage%3D13421%26epage%3D13426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yagnam  Swetha</span>, <span class="hlFld-ContribAuthor ">Eda Rami  Reddy</span>, <span class="hlFld-ContribAuthor ">Jakku Ranjith  Kumar</span>, <span class="hlFld-ContribAuthor ">Rajiv  Trivedi</span>, <span class="hlFld-ContribAuthor ">Lingamallu  Giribabu</span>, <span class="hlFld-ContribAuthor ">Balasubramanian  Sridhar</span>, <span class="hlFld-ContribAuthor ">Balaji  Rathod</span>, <span class="hlFld-ContribAuthor ">Reddy Shetty  Prakasham</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, characterization and antimicrobial evaluation of ferrocene–oxime ether benzyl 1
              H
              -1,2,3-triazole hybrids. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2019,</strong> <em>43 </em>
                                    (21)
                                     , 8341-8351. <a href="https://doi.org/10.1039/C9NJ00660E" title="DOI URL">https://doi.org/10.1039/C9NJ00660E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9NJ00660E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9NJ00660E%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DSynthesis%25252C%252Bcharacterization%252Band%252Bantimicrobial%252Bevaluation%252Bof%252Bferrocene%2525E2%252580%252593oxime%252Bether%252Bbenzyl%252B1%252BH%252B-1%25252C2%25252C3-triazole%252Bhybrids%26aulast%3DSwetha%26aufirst%3DYagnam%26date%3D2019%26date%3D2019%26volume%3D43%26issue%3D21%26spage%3D8341%26epage%3D8351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fatima  Arshad</span>, <span class="hlFld-ContribAuthor ">Mohemmed Faraz  Khan</span>, <span class="hlFld-ContribAuthor ">Wasim  Akhtar</span>, <span class="hlFld-ContribAuthor ">Mohammad Mumtaz  Alam</span>, <span class="hlFld-ContribAuthor ">Lalit Mohan  Nainwal</span>, <span class="hlFld-ContribAuthor ">Sumit Kumar  Kaushik</span>, <span class="hlFld-ContribAuthor ">Mymoona  Akhter</span>, <span class="hlFld-ContribAuthor ">Suhel  Parvez</span>, <span class="hlFld-ContribAuthor ">Syed Misbahul  Hasan</span>, <span class="hlFld-ContribAuthor ">Mohammad  Shaquiquzzaman</span>. </span><span class="cited-content_cbyCitation_article-title">Revealing quinquennial anticancer journey of morpholine: A SAR based review. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>167 </em>, 324-356. <a href="https://doi.org/10.1016/j.ejmech.2019.02.015" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.02.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.02.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.02.015%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRevealing%252Bquinquennial%252Banticancer%252Bjourney%252Bof%252Bmorpholine%25253A%252BA%252BSAR%252Bbased%252Breview%26aulast%3DArshad%26aufirst%3DFatima%26date%3D2019%26volume%3D167%26spage%3D324%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guofan  Jin</span>, <span class="hlFld-ContribAuthor ">Fuyan  Xiao</span>, <span class="hlFld-ContribAuthor ">Ruijiang  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of a new series of ortho-carboranyl biphenyloxime derivatives. </span><span class="cited-content_cbyCitation_journal-name">Chemistry Central Journal</span><span> <strong>2018,</strong> <em>12 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13065-018-0444-z" title="DOI URL">https://doi.org/10.1186/s13065-018-0444-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13065-018-0444-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13065-018-0444-z%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520Central%2520Journal%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Ba%252Bnew%252Bseries%252Bof%252Bortho-carboranyl%252Bbiphenyloxime%252Bderivatives%26aulast%3DJin%26aufirst%3DGuofan%26date%3D2018%26date%3D2018%26volume%3D12%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael S.  Malamas</span>, <span class="hlFld-ContribAuthor ">Jimit Girish  Raghav</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Ma</span>, <span class="hlFld-ContribAuthor ">Chandrashekhar  Honrao</span>, <span class="hlFld-ContribAuthor ">JodiAnne T.  Wood</span>, <span class="hlFld-ContribAuthor ">Othman  Benchama</span>, <span class="hlFld-ContribAuthor ">Han  Zhou</span>, <span class="hlFld-ContribAuthor ">Srikrishnan  Mallipeddi</span>, <span class="hlFld-ContribAuthor ">Alexandros  Makriyannis</span>. </span><span class="cited-content_cbyCitation_article-title">Oximes short-acting CB1 receptor agonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (18)
                                     , 4963-4970. <a href="https://doi.org/10.1016/j.bmc.2018.08.003" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.08.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.08.003%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DOximes%252Bshort-acting%252BCB1%252Breceptor%252Bagonists%26aulast%3DMalamas%26aufirst%3DMichael%2BS.%26date%3D2018%26volume%3D26%26issue%3D18%26spage%3D4963%26epage%3D4970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomasz  Kosmalski</span>, <span class="hlFld-ContribAuthor ">Renata  Studzińska</span>, <span class="hlFld-ContribAuthor ">Natalia  Daniszewska</span>, <span class="hlFld-ContribAuthor ">Małgorzata  Ullrich</span>, <span class="hlFld-ContribAuthor ">Adam  Sikora</span>, <span class="hlFld-ContribAuthor ">Michał  Marszałł</span>, <span class="hlFld-ContribAuthor ">Bożena  Modzelewska-Banachiewicz</span>. </span><span class="cited-content_cbyCitation_article-title">Study of the Room-Temperature Synthesis of Oxime Ethers by using a Super Base. </span><span class="cited-content_cbyCitation_journal-name">ChemistryOpen</span><span> <strong>2018,</strong> <em>7 </em>
                                    (7)
                                     , 551-557. <a href="https://doi.org/10.1002/open.201800098" title="DOI URL">https://doi.org/10.1002/open.201800098</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/open.201800098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fopen.201800098%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistryOpen%26atitle%3DStudy%252Bof%252Bthe%252BRoom-Temperature%252BSynthesis%252Bof%252BOxime%252BEthers%252Bby%252Busing%252Ba%252BSuper%252BBase%26aulast%3DKosmalski%26aufirst%3DTomasz%26date%3D2018%26date%3D2018%26volume%3D7%26issue%3D7%26spage%3D551%26epage%3D557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meng-Xue  Wei</span>, <span class="hlFld-ContribAuthor ">Jiao  Zhang</span>, <span class="hlFld-ContribAuthor ">Fu-Li  Ma</span>, <span class="hlFld-ContribAuthor ">Ming  Li</span>, <span class="hlFld-ContribAuthor ">Jia-Ying  Yu</span>, <span class="hlFld-ContribAuthor ">Wei  Luo</span>, <span class="hlFld-ContribAuthor ">Xue-Qiang  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological activities of dithiocarbamates containing 2(5H)-furanone-piperazine. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>155 </em>, 165-170. <a href="https://doi.org/10.1016/j.ejmech.2018.05.056" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.05.056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.05.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.05.056%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bactivities%252Bof%252Bdithiocarbamates%252Bcontaining%252B2%2525285H%252529-furanone-piperazine%26aulast%3DWei%26aufirst%3DMeng-Xue%26date%3D2018%26volume%3D155%26spage%3D165%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pinki  Yadav</span>, <span class="hlFld-ContribAuthor ">Kashmiri  Lal</span>, <span class="hlFld-ContribAuthor ">Poonam  Rani</span>, <span class="hlFld-ContribAuthor ">Satbir  Mor</span>, <span class="hlFld-ContribAuthor ">Ashwani  Kumar</span>, <span class="hlFld-ContribAuthor ">Anil  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient synthesis and antimicrobial evaluation of 2-((1-substituted-1H-1,2,3-triazol-4-yl)-1-naphthaldehydes and their oxime derivatives. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2017,</strong> <em>26 </em>
                                    (7)
                                     , 1469-1480. <a href="https://doi.org/10.1007/s00044-017-1845-6" title="DOI URL">https://doi.org/10.1007/s00044-017-1845-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-017-1845-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-017-1845-6%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DEfficient%252Bsynthesis%252Band%252Bantimicrobial%252Bevaluation%252Bof%252B2-%252528%2525281-substituted-1H-1%25252C2%25252C3-triazol-4-yl%252529-1-naphthaldehydes%252Band%252Btheir%252Boxime%252Bderivatives%26aulast%3DYadav%26aufirst%3DPinki%26date%3D2017%26date%3D2017%26volume%3D26%26issue%3D7%26spage%3D1469%26epage%3D1480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manisha  Yadav</span>, <span class="hlFld-ContribAuthor ">Abhishek Kumar  Singh</span>, <span class="hlFld-ContribAuthor ">Harish  Kumar</span>, <span class="hlFld-ContribAuthor ">Geeta  Rao</span>, <span class="hlFld-ContribAuthor ">Bandana  Chakravarti</span>, <span class="hlFld-ContribAuthor ">Anagha  Gurjar</span>, <span class="hlFld-ContribAuthor ">Shalini  Dogra</span>, <span class="hlFld-ContribAuthor ">Sapana  Kushwaha</span>, <span class="hlFld-ContribAuthor ">Achchhe Lal  Vishwakarma</span>, <span class="hlFld-ContribAuthor ">Prem Narayan  Yadav</span>, <span class="hlFld-ContribAuthor ">Dipak  Datta</span>, <span class="hlFld-ContribAuthor ">Anil Kumar  Tripathi</span>, <span class="hlFld-ContribAuthor ">Naibedya  Chattopadhyay</span>, <span class="hlFld-ContribAuthor ">Arun Kumar  Trivedi</span>, <span class="hlFld-ContribAuthor ">Sabyasachi  Sanyal</span>. </span><span class="cited-content_cbyCitation_article-title">Epidermal growth factor receptor inhibitor cancer drug gefitinib modulates cell growth and differentiation of acute myeloid leukemia cells via histamine receptors. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - General Subjects</span><span> <strong>2016,</strong> <em>1860 </em>
                                    (10)
                                     , 2178-2190. <a href="https://doi.org/10.1016/j.bbagen.2016.05.011" title="DOI URL">https://doi.org/10.1016/j.bbagen.2016.05.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbagen.2016.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbagen.2016.05.011%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520General%2520Subjects%26atitle%3DEpidermal%252Bgrowth%252Bfactor%252Breceptor%252Binhibitor%252Bcancer%252Bdrug%252Bgefitinib%252Bmodulates%252Bcell%252Bgrowth%252Band%252Bdifferentiation%252Bof%252Bacute%252Bmyeloid%252Bleukemia%252Bcells%252Bvia%252Bhistamine%252Breceptors%26aulast%3DYadav%26aufirst%3DManisha%26date%3D2016%26volume%3D1860%26issue%3D10%26spage%3D2178%26epage%3D2190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Krzysztof  Kuciński</span>, <span class="hlFld-ContribAuthor ">Grzegorz  Hreczycho</span>. </span><span class="cited-content_cbyCitation_article-title">Highly Efficient One-Step Synthesis of
              N
              -Trimethylsiloxy Alkyl Imidothioates. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>2016 </em>
                                    (26)
                                     , 4577-4585. <a href="https://doi.org/10.1002/ejoc.201600768" title="DOI URL">https://doi.org/10.1002/ejoc.201600768</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201600768&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201600768%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DHighly%252BEfficient%252BOne-Step%252BSynthesis%252Bof%252BN%252B-Trimethylsiloxy%252BAlkyl%252BImidothioates%26aulast%3DKuci%25C5%2584ski%26aufirst%3DKrzysztof%26date%3D2016%26date%3D2016%26volume%3D2016%26issue%3D26%26spage%3D4577%26epage%3D4585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wu  Zhang</span>, <span class="hlFld-ContribAuthor ">Aiqun  Wu</span>, <span class="hlFld-ContribAuthor ">Haitang  Xu</span>, <span class="hlFld-ContribAuthor ">Yuxing  Mo</span>, <span class="hlFld-ContribAuthor ">Jie  Chen</span>, <span class="hlFld-ContribAuthor ">Liqun  Shen</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Bioassay of Novel Compounds of Isolongifolenone Oxime Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Helvetica Chimica Acta</span><span> <strong>2016,</strong> <em>99 </em>
                                    (9)
                                     , 696-703. <a href="https://doi.org/10.1002/hlca.201600133" title="DOI URL">https://doi.org/10.1002/hlca.201600133</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/hlca.201600133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fhlca.201600133%26sid%3Dliteratum%253Aachs%26jtitle%3DHelvetica%2520Chimica%2520Acta%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBioassay%252Bof%252BNovel%252BCompounds%252Bof%252BIsolongifolenone%252BOxime%252BDerivatives%26aulast%3DZhang%26aufirst%3DWu%26date%3D2016%26date%3D2016%26volume%3D99%26issue%3D9%26spage%3D696%26epage%3D703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammad Imran  Ansari</span>, <span class="hlFld-ContribAuthor ">Ashutosh  Arun</span>, <span class="hlFld-ContribAuthor ">Mohammad Kamil  Hussain</span>, <span class="hlFld-ContribAuthor ">Rituraj  Konwar</span>, <span class="hlFld-ContribAuthor ">Kanchan  Hajela</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 3,4,6-Triaryl-2-pyridones as Potential Anticancer Agents that Promote ROS-Independent Mitochondrial-Mediated Apoptosis in Human Breast Carcinoma Cells. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2016,</strong> <em>1 </em>
                                    (14)
                                     , 4255-4264. <a href="https://doi.org/10.1002/slct.201600893" title="DOI URL">https://doi.org/10.1002/slct.201600893</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201600893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201600893%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DDiscovery%252Bof%252B3%25252C4%25252C6-Triaryl-2-pyridones%252Bas%252BPotential%252BAnticancer%252BAgents%252Bthat%252BPromote%252BROS-Independent%252BMitochondrial-Mediated%252BApoptosis%252Bin%252BHuman%252BBreast%252BCarcinoma%252BCells%26aulast%3DAnsari%26aufirst%3DMohammad%2BImran%26date%3D2016%26date%3D2016%26volume%3D1%26issue%3D14%26spage%3D4255%26epage%3D4264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Esmail  Vessally</span>, <span class="hlFld-ContribAuthor ">Morteza  Abdoli</span>. </span><span class="cited-content_cbyCitation_article-title">Oxime ethers as useful synthons in the synthesis of a number of key medicinal heteroaromatic compounds. </span><span class="cited-content_cbyCitation_journal-name">Journal of the Iranian Chemical Society</span><span> <strong>2016,</strong> <em>13 </em>
                                    (7)
                                     , 1235-1256. <a href="https://doi.org/10.1007/s13738-016-0838-6" title="DOI URL">https://doi.org/10.1007/s13738-016-0838-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13738-016-0838-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13738-016-0838-6%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520Iranian%2520Chemical%2520Society%26atitle%3DOxime%252Bethers%252Bas%252Buseful%252Bsynthons%252Bin%252Bthe%252Bsynthesis%252Bof%252Ba%252Bnumber%252Bof%252Bkey%252Bmedicinal%252Bheteroaromatic%252Bcompounds%26aulast%3DVessally%26aufirst%3DEsmail%26date%3D2016%26date%3D2016%26volume%3D13%26issue%3D7%26spage%3D1235%26epage%3D1256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Taelim  Kim</span>, <span class="hlFld-ContribAuthor ">Hye-In  Kim</span>, <span class="hlFld-ContribAuthor ">Ji-Young  An</span>, <span class="hlFld-ContribAuthor ">Jun  Lee</span>, <span class="hlFld-ContribAuthor ">Na-Rae  Lee</span>, <span class="hlFld-ContribAuthor ">Jinyuk  Heo</span>, <span class="hlFld-ContribAuthor ">Ji-Eun  Kim</span>, <span class="hlFld-ContribAuthor ">Jihyun  Yu</span>, <span class="hlFld-ContribAuthor ">Yong Sup  Lee</span>, <span class="hlFld-ContribAuthor ">Kyung-Soo  Inn</span>, <span class="hlFld-ContribAuthor ">Nam-Jung  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of novel estrogen receptor (ER) agonists that have additional and complementary anti-cancer activities via ER-independent mechanism. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (7)
                                     , 1844-1848. <a href="https://doi.org/10.1016/j.bmcl.2016.01.089" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.01.089</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.01.089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.01.089%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252Bnovel%252Bestrogen%252Breceptor%252B%252528ER%252529%252Bagonists%252Bthat%252Bhave%252Badditional%252Band%252Bcomplementary%252Banti-cancer%252Bactivities%252Bvia%252BER-independent%252Bmechanism%26aulast%3DKim%26aufirst%3DTaelim%26date%3D2016%26volume%3D26%26issue%3D7%26spage%3D1844%26epage%3D1848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kapil  Upadhyaya</span>, <span class="hlFld-ContribAuthor ">Hamidullah  Hamidullah</span>, <span class="hlFld-ContribAuthor ">Kartikey  Singh</span>, <span class="hlFld-ContribAuthor ">Ashutosh  Arun</span>, <span class="hlFld-ContribAuthor ">Mahendra  Shukla</span>, <span class="hlFld-ContribAuthor ">Neetika  Srivastava</span>, <span class="hlFld-ContribAuthor ">Raghib  Ashraf</span>, <span class="hlFld-ContribAuthor ">Abhisheak  Sharma</span>, <span class="hlFld-ContribAuthor ">Rohit  Mahar</span>, <span class="hlFld-ContribAuthor ">Sanjeev K.  Shukla</span>, <span class="hlFld-ContribAuthor ">Jayanta  Sarkar</span>, <span class="hlFld-ContribAuthor ">Ravishankar  Ramachandran</span>, <span class="hlFld-ContribAuthor ">Jawahar  Lal</span>, <span class="hlFld-ContribAuthor ">Rituraj  Konwar</span>, <span class="hlFld-ContribAuthor ">Rama Pati  Tripathi</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of gallic acid based glycoconjugates as a novel tubulin polymerization inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2016,</strong> <em>14 </em>
                                    (4)
                                     , 1338-1358. <a href="https://doi.org/10.1039/C5OB02113H" title="DOI URL">https://doi.org/10.1039/C5OB02113H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5OB02113H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5OB02113H%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DIdentification%252Bof%252Bgallic%252Bacid%252Bbased%252Bglycoconjugates%252Bas%252Ba%252Bnovel%252Btubulin%252Bpolymerization%252Binhibitors%26aulast%3DUpadhyaya%26aufirst%3DKapil%26date%3D2016%26date%3D2016%26volume%3D14%26issue%3D4%26spage%3D1338%26epage%3D1358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zohreh  Mirjafary</span>, <span class="hlFld-ContribAuthor ">Morteza  Abdoli</span>, <span class="hlFld-ContribAuthor ">Hamid  Saeidian</span>, <span class="hlFld-ContribAuthor ">Ali  Kakanejadifard</span>, <span class="hlFld-ContribAuthor ">S. Morteza F.  Farnia</span>. </span><span class="cited-content_cbyCitation_article-title">Review of the synthesis of acyclic and cyclic oxime ethers. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2016,</strong> <em>6 </em>
                                    (21)
                                     , 17740-17758. <a href="https://doi.org/10.1039/C5RA25591K" title="DOI URL">https://doi.org/10.1039/C5RA25591K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5RA25591K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5RA25591K%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DReview%252Bof%252Bthe%252Bsynthesis%252Bof%252Bacyclic%252Band%252Bcyclic%252Boxime%252Bethers%26aulast%3DMirjafary%26aufirst%3DZohreh%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D21%26spage%3D17740%26epage%3D17758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zohreh  Mirjafary</span>, <span class="hlFld-ContribAuthor ">Morteza  Abdoli</span>, <span class="hlFld-ContribAuthor ">Hamid  Saeidian</span>, <span class="hlFld-ContribAuthor ">Sadjad  Boroon</span>, <span class="hlFld-ContribAuthor ">Ali  Kakanejadifard</span>. </span><span class="cited-content_cbyCitation_article-title">Oxime ethers as versatile precursors in organic synthesis: a review. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2015,</strong> <em>5 </em>
                                    (97)
                                     , 79361-79384. <a href="https://doi.org/10.1039/C5RA15299B" title="DOI URL">https://doi.org/10.1039/C5RA15299B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5RA15299B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5RA15299B%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DOxime%252Bethers%252Bas%252Bversatile%252Bprecursors%252Bin%252Borganic%252Bsynthesis%25253A%252Ba%252Breview%26aulast%3DMirjafary%26aufirst%3DZohreh%26date%3D2015%26date%3D2015%26volume%3D5%26issue%3D97%26spage%3D79361%26epage%3D79384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/medium/jm-2014-00873e_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/large/jm-2014-00873e_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500873e&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/medium/jm-2014-00873e_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/large/jm-2014-00873e_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Designing strategy of thioaryl naphthylmethanone oxime ether analogs. Base (A) of the designed pharmacophore is taken from natural product resveratrol, whereas the crown (B) part is kept as aryl system as in most TKIs. The major portion is contributed by the hinge (C) which is based on novel oxime and their corresponding ether alkyl amine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/large/jm-2014-00873e_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500873e&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/medium/jm-2014-00873e_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/large/jm-2014-00873e_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Chemical Synthesis of Thioarylnaphthylmethanone Oxime Ether Analogs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/large/jm-2014-00873e_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500873e&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagent and conditions: (a) NH<sub>2</sub>OH·HCl, pyridine, ethanol, anhyd., reflux; (b) haloalkylamines, K<sub>2</sub>CO<sub>3</sub>, acetone/DMF, anhyd., reflux; (c) dihaloalkanes, K<sub>2</sub>CO<sub>3</sub>, Acetone/DMF, anhyd., reflux; (d) primary or secondary amines, MeOH/DMF, anhyd., reflux; (e) organic acid, dry methanol, dry ether; (f) ethylbromoacetate, K<sub>2</sub>CO<sub>3</sub>, acetone, anhyd., reflux; (g) <i>t</i>-BuOK, diethylamine, microwave assisted reaction, 120 °C.</p></p></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/medium/jm-2014-00873e_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/large/jm-2014-00873e_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. MND irreversibly inhibits cell growth, and induces apoptosis and cell cycle arrest of MCF-7 and MDA-MB-231 cells. (a) Cells were exposed to <b>MND</b> for 24 h (MCF-7–24 h, MDA-MB-231-24h) after which they were allowed to recover for 72 h in drug free medium (MCF-7-W, MDA-MB-231-W), and cell viability was determined by MTT assay. (b) Apoptosis was assessed at indicated concentration by flow cytometry using the FL1-H channel (Annexin-V) and FL2-H channel (PI) of a Becton Dickinson FACS Calibur. Shown are representative dot plots. (c) Caspase-8, caspase-9, and caspase-3 activity was determined by Caspase-Glo 8, 9, and 3 Assay kit. (d) Cell viability was determined by MTT assay in the presence of <b>MND</b> with or without caspase-inhibitors. (e) Membrane potential (<b>Δ</b><i><b>Ψ</b></i><b>m</b>) were assessed by JC-1 staining using flow cytometry analysis. (f) Immunoblotting of Bax and Bcl-2 protein. Protein loading was controlled with an anti-actin. (g) Cell cycle distribution was assessed by flow cytometry. Quantification of flow cytometry data has been shown as the percent of cells in different phases. (h) MCF-7 and (i) MDA-MB-231. Cells were treated with <b>MND</b> (1 μM). (j) MCF-7 and (k) MDA-MB-231 for the indicated length of time. Cell lysates were used for Western blot to detect the protein levels of cyclin D1 and p27. Protein loading was controlled with an anti-actin. Data presented as mean ± SEM from three independent experiments; *<i>P</i> < 0.05, **<i>P</i> < 0.01, and ***<i>P</i> < 0.001 compared to vehicle (<i>N</i> = 3). As indicated *<i>a</i> < 0.05, **<i>b</i> < 0.01, and ***<i>c</i> < 0.001 compared with <b>MND</b> alone.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/large/jm-2014-00873e_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500873e&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/medium/jm-2014-00873e_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/large/jm-2014-00873e_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. MND inhibits migration and invasion of breast cancer cells. (a) MDA-MB-231 cells were treated with <b>MND</b> (1 μM) for 24 h. Afterwards, the photograph was taken and cell migration was determined using image analysis software (Image-Pro Plus 6.1.0). (b) MCF-7 and MDA-MB-231 cells were placed in the upper Matrigel invasion chamber or <b>MND</b> (1 μM) in the bottom chamber for 24 h. Invaded cells were stained with crystal violet and quantified by measuring the absorbance of dissolved crystals in 0.1% SDS at 540 nm. (c) MDA-MB-231 cells were treated with <b>MND</b> (1 μM) for 24 h and qPCR was performed to measure PTEN, VEGF-A, VEGF-C, TGF-β1, TGF-β1R, MTA-1, and MMP-9. (d) CDC42 was analyzed in <b>MND</b> (1 μM) treated MDA-MB-231 cells for 24 h by ELISA. CDC42 control protein was used as a positive control (provided in kit). (e) MDA-MB-231 cells were treated with <b>MND</b> (1 μM) for 24 h and conditioned medium was collected and subjected for detection of secreted PAI-1 using ELISA. Data represent mean ± SEM *<i>P</i> < 0.05, **<i>P</i> < 0.01, and ***<i>P</i> < 0.001 compared to vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/large/jm-2014-00873e_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500873e&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/medium/jm-2014-00873e_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/large/jm-2014-00873e_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Regression of xenograft tumor by MND in athymic nude mice. (a) Effect of MND on body weight over time in various treatment groups indicated. <i>N</i> = 10 mice/group. (b) Increase in relative tumor volume over time in various treatment groups indicated. <i>N</i> = 10 mice/group; data represent mean ± SEM. *<i>P</i> < 0.05 and **<i>P</i> < 0.01 compared to control. (c) Effect of <b>MND</b> treatment on tumor morphology. Representative tumor sections from mice treated with vehicle or <b>MND</b> (16 mg.kg<sup>–1</sup>.day<sup>–1</sup>) for 25 days. (d) Effect of <b>MND</b> treatment on DNA fragmentation of tumors. Representative tumor sections from mice treated with vehicle or <b>MND</b> for 29 days were stained for TUNEL and quantified using image analysis software; *<i>P</i> < 0.05. (e) Effect of <b>MND</b> treatment on PCNA levels were analyzed by Western blotting in tumors of vehicle or <b>MND</b> treated mice, *<i>P</i> < 0.05. (f) mRNA levels of Bcl-2, Bax, and cyclin D1 were measured by qPCR from the tumors of vehicle or <b>MND</b> treated mice; *<i>P</i> < 0.05 compared to control. Error bars represent SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/large/jm-2014-00873e_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500873e&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/medium/jm-2014-00873e_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/large/jm-2014-00873e_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. MND inhibits mammosphere formation and cancer stem cell load. (a) MDA-MB-231 cells seeded at a density of 1000 cells per well in 12-well low-attachment plates were treated with various concentration (5 μM, 10 μM, and 20 μM) of <b>MND</b> and Salinomycin. After 8 days, mammospheres were counted and photographed. Shown are representative mammosphere pictures (magnification 40×) and quantitation of mammosphere-forming efficiency of MDA-MB-231 cells in presence or absence of <b>MND</b> and Salinomycin. (b) MDA-MB-231 cells derived mammospheres were treated with the indicated concentrations of <b>MND</b> and salinomycin for 24 h. Cells at 1 × 10<sup>6</sup> cells per mL were then incubated with activated ALDEFLUOR substrate. DEAB (ALDH1 inhibitor) was used to establish the baseline fluorescence of each sample and to define the ALDEFLUOR-positive region. FACS analysis using the SSC and FL1-H channel (ALDEFLOUR) was performed to examine ALDEFLOUR high-ALDH1 positive population in MDA-MB-231 cells. Shown are the representative dot plots. (c) Colon cancer stem cells were treated with the indicated concentrations of <b>MND</b>, 5-FU, and salinomycin for 24 h. Cells (1 × 10<sup>6</sup>) were then incubated with CD133 antibody and analyzed by flow cytometry using FL-1 and FL-2 channels.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/large/jm-2014-00873e_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500873e&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/medium/jm-2014-00873e_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/large/jm-2014-00873e_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. <b>MND</b> inhibits EGFR signaling in breast cancer cells. (a) Cell viability (MTT assay) of MCF-7 and MDA-MB-231 cells, treated with a panel of growth factors alone (Vehicle-V) or in the presence of <b>MND</b> (5 μM) as indicated. (b) p-EGFR at different tyrosine residues pTyr1068, pTyr845, and pTyr1173 were analyzed by ELISA. (c) p-EGFR was determined by immunoblotting of whole cell lysates with antibodies to the indicated proteins. (d) p-HER2 was measured using ELISA. (e) Total and phosphorylated levels of ERK, AKT, STAT1, and STAT3 were determined by Western blot. (f) Invasion of MDA-MB-231 cells was analyzed by Matrigel-coated invasion chamber assay. (g) Protein level of p-ELK-1, ELK-1, Mcl-1, and β-actin (loading control) were determined by Western blot method. (h) Secreted PAI-1 was determined using ELISA. (i) % migration was determined by scratch wound healing assay. (j) Protein levels of p-FAK-Tyr397, and total FAK were determined by Western blotting. (k) Tyrosine kinase profiling in cell free assay system with <b>MND</b> (10 μM). (l) cAMP level was measured using an HTRF-based kit and normalized with protein content. (m) Intracellular Ca<sup>2+</sup> was analyzed using flow cytometry. (n) Phosphodiesterase activity was determined in MDA-MB-231 cells. (o) Cell viability (MTT assay) of MDA-MB-231 cells, treated with <b>MND</b> (5 μM) in the presence of Pertussis toxin (PTX) 100 ng/mL and Cholera toxin (CTX) 100 ng/mL for 16 h. Data represent mean ± SEM. *<i>P</i> < 0.05, **<i>P</i> < 0.01, and ***<i>P</i> < 0.001 compared to control. As indicated, *<i>a</i> < 0.05, **<i>b</i> < 0.01, ***<i>c</i> < 0.001 compared with EGF.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-19/jm500873e/20141006/images/large/jm-2014-00873e_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500873e&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i47">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07278" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07278" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 80 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Levitzki, A.</span><span> </span><span class="NLM_article-title">Tyrosine kinase inhibitors: views of selectivity, sensitivity, and clinical performance</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2013&pages=161-185&author=A.+Levitzki&title=Tyrosine+kinase+inhibitors%3A+views+of+selectivity%2C+sensitivity%2C+and+clinical+performance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLevitzki%26aufirst%3DA.%26atitle%3DTyrosine%2520kinase%2520inhibitors%253A%2520views%2520of%2520selectivity%252C%2520sensitivity%252C%2520and%2520clinical%2520performance%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2013%26volume%3D53%26spage%3D161%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Huang, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. J.</span><span> </span><span class="NLM_article-title">Lapatinib induces autophagy, apoptosis and megakaryocytic differentiation in chronic myelogenous leukemia K562 cells</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e29014</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e29014&author=H.+L.+Huangauthor=Y.+C.+Chenauthor=Y.+C.+Huangauthor=K.+C.+Yangauthor=H.+Panauthor=S.+P.+Shihauthor=Y.+J.+Chen&title=Lapatinib+induces+autophagy%2C+apoptosis+and+megakaryocytic+differentiation+in+chronic+myelogenous+leukemia+K562+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%2BL.%26aulast%3DChen%26aufirst%3DY.%2BC.%26aulast%3DHuang%26aufirst%3DY.%2BC.%26aulast%3DYang%26aufirst%3DK.%2BC.%26aulast%3DPan%26aufirst%3DH.%26aulast%3DShih%26aufirst%3DS.%2BP.%26aulast%3DChen%26aufirst%3DY.%2BJ.%26atitle%3DLapatinib%2520induces%2520autophagy%252C%2520apoptosis%2520and%2520megakaryocytic%2520differentiation%2520in%2520chronic%2520myelogenous%2520leukemia%2520K562%2520cells%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De29014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Lainey, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfromm, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marie, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enot, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scoazec, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouteloup, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Micol, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Botton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galluzzi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenaux, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroemer, G.</span><span> </span><span class="NLM_article-title">Azacytidine and erlotinib exert synergistic effects against acute myeloid leukemia</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">4331</span><span class="NLM_x">–</span> <span class="NLM_lpage">4342</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=4331-4342&author=E.+Laineyauthor=A.+Wolfrommauthor=N.+Marieauthor=D.+Enotauthor=M.+Scoazecauthor=C.+Bouteloupauthor=C.+Leroyauthor=J.+B.+Micolauthor=S.+De+Bottonauthor=L.+Galluzziauthor=P.+Fenauxauthor=G.+Kroemer&title=Azacytidine+and+erlotinib+exert+synergistic+effects+against+acute+myeloid+leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLainey%26aufirst%3DE.%26aulast%3DWolfromm%26aufirst%3DA.%26aulast%3DMarie%26aufirst%3DN.%26aulast%3DEnot%26aufirst%3DD.%26aulast%3DScoazec%26aufirst%3DM.%26aulast%3DBouteloup%26aufirst%3DC.%26aulast%3DLeroy%26aufirst%3DC.%26aulast%3DMicol%26aufirst%3DJ.%2BB.%26aulast%3DDe%2BBotton%26aufirst%3DS.%26aulast%3DGalluzzi%26aufirst%3DL.%26aulast%3DFenaux%26aufirst%3DP.%26aulast%3DKroemer%26aufirst%3DG.%26atitle%3DAzacytidine%2520and%2520erlotinib%2520exert%2520synergistic%2520effects%2520against%2520acute%2520myeloid%2520leukemia%26jtitle%3DOncogene%26date%3D2013%26volume%3D32%26spage%3D4331%26epage%3D4342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Lainey, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfromm, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukkurwala, A. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Micol, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenaux, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galluzzi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kepp, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroemer, G.</span><span> </span><span class="NLM_article-title">EGFR inhibitors exacerbate differentiation and cell cycle arrest induced by retinoic acid and vitamin D3 in acute myeloid leukemia cells</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2978</span><span class="NLM_x">–</span> <span class="NLM_lpage">2991</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=2978-2991&author=E.+Laineyauthor=A.+Wolfrommauthor=A.+Q.+Sukkurwalaauthor=J.+B.+Micolauthor=P.+Fenauxauthor=L.+Galluzziauthor=O.+Keppauthor=G.+Kroemer&title=EGFR+inhibitors+exacerbate+differentiation+and+cell+cycle+arrest+induced+by+retinoic+acid+and+vitamin+D3+in+acute+myeloid+leukemia+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLainey%26aufirst%3DE.%26aulast%3DWolfromm%26aufirst%3DA.%26aulast%3DSukkurwala%26aufirst%3DA.%2BQ.%26aulast%3DMicol%26aufirst%3DJ.%2BB.%26aulast%3DFenaux%26aufirst%3DP.%26aulast%3DGalluzzi%26aufirst%3DL.%26aulast%3DKepp%26aufirst%3DO.%26aulast%3DKroemer%26aufirst%3DG.%26atitle%3DEGFR%2520inhibitors%2520exacerbate%2520differentiation%2520and%2520cell%2520cycle%2520arrest%2520induced%2520by%2520retinoic%2520acid%2520and%2520vitamin%2520D3%2520in%2520acute%2520myeloid%2520leukemia%2520cells%26jtitle%3DCell%2520Cycle%26date%3D2013%26volume%3D12%26spage%3D2978%26epage%3D2991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Stegmaier, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corsello, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deangelo, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golub, T. R.</span><span> </span><span class="NLM_article-title">Gefitinib induces myeloid differentiation of acute myeloid leukemia</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">2841</span><span class="NLM_x">–</span> <span class="NLM_lpage">2848</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2005&pages=2841-2848&author=K.+Stegmaierauthor=S.+M.+Corselloauthor=K.+N.+Rossauthor=J.+S.+Wongauthor=D.+J.+Deangeloauthor=T.+R.+Golub&title=Gefitinib+induces+myeloid+differentiation+of+acute+myeloid+leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStegmaier%26aufirst%3DK.%26aulast%3DCorsello%26aufirst%3DS.%2BM.%26aulast%3DRoss%26aufirst%3DK.%2BN.%26aulast%3DWong%26aufirst%3DJ.%2BS.%26aulast%3DDeangelo%26aufirst%3DD.%2BJ.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26atitle%3DGefitinib%2520induces%2520myeloid%2520differentiation%2520of%2520acute%2520myeloid%2520leukemia%26jtitle%3DBlood%26date%3D2005%26volume%3D106%26spage%3D2841%26epage%3D2848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Fabian, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biggs, W. H.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azimioara, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benedetti, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grotzfeld, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lelias, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velasco, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span> </span><span class="NLM_article-title">A small molecule-kinase interaction map for clinical kinase inhibitors</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1038%2Fnbt1068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=15711537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=329-336&author=M.+A.+Fabianauthor=W.+H.+Biggsauthor=D.+K.+Treiberauthor=C.+E.+Atteridgeauthor=M.+D.+Azimioaraauthor=M.+G.+Benedettiauthor=T.+A.+Carterauthor=P.+Ciceriauthor=P.+T.+Edeenauthor=M.+Floydauthor=J.+M.+Fordauthor=M.+Galvinauthor=J.+L.+Gerlachauthor=R.+M.+Grotzfeldauthor=S.+Herrgardauthor=D.+E.+Inskoauthor=M.+A.+Inskoauthor=A.+G.+Laiauthor=J.+M.+Leliasauthor=S.+A.+Mehtaauthor=Z.+V.+Milanovauthor=A.+M.+Velascoauthor=L.+M.+Wodickaauthor=H.+K.+Patelauthor=P.+P.+Zarrinkarauthor=D.+J.+Lockhart&title=A+small+molecule-kinase+interaction+map+for+clinical+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule-kinase interaction map for clinical kinase inhibitors</span></div><div class="casAuthors">Fabian, Miles A.; Biggs, William H.; Treiber, Daniel K.; Atteridge, Corey E.; Azimioara, Mihai D.; Benedetti, Michael G.; Carter, Todd A.; Ciceri, Pietro; Edeen, Philip T.; Floyd, Mark; Ford, Julia M.; Galvin, Margaret; Gerlach, Jay L.; Grotzfeld, Robert M.; Herrgard, Sanna; Insko, Darren E.; Insko, Michael A.; Lai, Andiliy G.; Lelias, Jean-Michel; Mehta, Shamal A.; Milanov, Zdravko V.; Velasco, Anne Marie; Wodicka, Lisa M.; Patel, Hitesh K.; Zarrinkar, Patrick P.; Lockhart, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">329-336</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors show great promise as a new class of therapeutics.  Here the authors describe an efficient way to det. kinase inhibitor specificity by measuring binding of small mols. to the ATP site of kinases.  The authors have profiled 20 kinase inhibitors, including 16 that are approved drugs or in clin. development, against a panel of 119 protein kinases.  The authors find that specificity varies widely and is not strongly correlated with chem. structure or the identity of the intended target.  Many novel interactions were identified, including tight binding of the p38 inhibitor BIRB-796 to an imatinib-resistant variant of the ABL kinase, and binding of imatinib to the SRC-family kinase LCK.  The authors also show that mutations in the epidermal growth factor receptor (EGFR) found in gefitinib-responsive patients do not affect the binding affinity of gefitinib or erlotinib.  Our results represent a systematic small mol.-protein interaction map for clin. compds. across a large no. of related proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA0vNmMOXrnrVg90H21EOLACvtfcHk0lhsj9PubNnauw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D&md5=6aedd5ceb8f77cd26ee50425dcec7bdf</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnbt1068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1068%26sid%3Dliteratum%253Aachs%26aulast%3DFabian%26aufirst%3DM.%2BA.%26aulast%3DBiggs%26aufirst%3DW.%2BH.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DAzimioara%26aufirst%3DM.%2BD.%26aulast%3DBenedetti%26aufirst%3DM.%2BG.%26aulast%3DCarter%26aufirst%3DT.%2BA.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DFord%26aufirst%3DJ.%2BM.%26aulast%3DGalvin%26aufirst%3DM.%26aulast%3DGerlach%26aufirst%3DJ.%2BL.%26aulast%3DGrotzfeld%26aufirst%3DR.%2BM.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DInsko%26aufirst%3DD.%2BE.%26aulast%3DInsko%26aufirst%3DM.%2BA.%26aulast%3DLai%26aufirst%3DA.%2BG.%26aulast%3DLelias%26aufirst%3DJ.%2BM.%26aulast%3DMehta%26aufirst%3DS.%2BA.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DVelasco%26aufirst%3DA.%2BM.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26atitle%3DA%2520small%2520molecule-kinase%2520interaction%2520map%2520for%2520clinical%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Biotechnol.%26date%3D2005%26volume%3D23%26spage%3D329%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Leggas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panetta, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuetz, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorrentino, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghton, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, C. F.</span><span> </span><span class="NLM_article-title">Gefitinib modulates the function of multiple ATP-binding cassette transporters in vivo</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">4802</span><span class="NLM_x">–</span> <span class="NLM_lpage">4807</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=4802-4807&author=M.+Leggasauthor=J.+C.+Panettaauthor=Y.+Zhuangauthor=J.+D.+Schuetzauthor=B.+Johnstonauthor=F.+Baiauthor=B.+Sorrentinoauthor=S.+Zhouauthor=P.+J.+Houghtonauthor=C.+F.+Stewart&title=Gefitinib+modulates+the+function+of+multiple+ATP-binding+cassette+transporters+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeggas%26aufirst%3DM.%26aulast%3DPanetta%26aufirst%3DJ.%2BC.%26aulast%3DZhuang%26aufirst%3DY.%26aulast%3DSchuetz%26aufirst%3DJ.%2BD.%26aulast%3DJohnston%26aufirst%3DB.%26aulast%3DBai%26aufirst%3DF.%26aulast%3DSorrentino%26aufirst%3DB.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DHoughton%26aufirst%3DP.%2BJ.%26aulast%3DStewart%26aufirst%3DC.%2BF.%26atitle%3DGefitinib%2520modulates%2520the%2520function%2520of%2520multiple%2520ATP-binding%2520cassette%2520transporters%2520in%2520vivo%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D4802%26epage%3D4807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Shi, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, X. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shukla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Si, Q. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robey, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashby, C. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambudkar, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z. S.</span><span> </span><span class="NLM_article-title">Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">11012</span><span class="NLM_x">–</span> <span class="NLM_lpage">11020</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=11012-11020&author=Z.+Shiauthor=X.+X.+Pengauthor=I.+W.+Kimauthor=S.+Shuklaauthor=Q.+S.+Siauthor=R.+W.+Robeyauthor=S.+E.+Batesauthor=T.+Shenauthor=C.+R.+Ashbyauthor=L.+W.+Fuauthor=S.+V.+Ambudkarauthor=Z.+S.+Chen&title=Erlotinib+%28Tarceva%2C+OSI-774%29+antagonizes+ATP-binding+cassette+subfamily+B+member+1+and+ATP-binding+cassette+subfamily+G+member+2-mediated+drug+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DZ.%26aulast%3DPeng%26aufirst%3DX.%2BX.%26aulast%3DKim%26aufirst%3DI.%2BW.%26aulast%3DShukla%26aufirst%3DS.%26aulast%3DSi%26aufirst%3DQ.%2BS.%26aulast%3DRobey%26aufirst%3DR.%2BW.%26aulast%3DBates%26aufirst%3DS.%2BE.%26aulast%3DShen%26aufirst%3DT.%26aulast%3DAshby%26aufirst%3DC.%2BR.%26aulast%3DFu%26aufirst%3DL.%2BW.%26aulast%3DAmbudkar%26aufirst%3DS.%2BV.%26aulast%3DChen%26aufirst%3DZ.%2BS.%26atitle%3DErlotinib%2520%2528Tarceva%252C%2520OSI-774%2529%2520antagonizes%2520ATP-binding%2520cassette%2520subfamily%2520B%2520member%25201%2520and%2520ATP-binding%2520cassette%2520subfamily%2520G%2520member%25202-mediated%2520drug%2520resistance%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D11012%26epage%3D11020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Aparicio-Gallego, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figueroa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Campelo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valladares-Ayerbes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grande-Pulido, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anton-Aparicio, L.</span><span> </span><span class="NLM_article-title">New insights into molecular mechanisms of sunitinib-associated side effects</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2215</span><span class="NLM_x">–</span> <span class="NLM_lpage">2223</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1158%2F1535-7163.MCT-10-1124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=22161785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFylurjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=2215-2223&author=G.+Aparicio-Gallegoauthor=M.+Blancoauthor=A.+Figueroaauthor=R.+Garcia-Campeloauthor=M.+Valladares-Ayerbesauthor=E.+Grande-Pulidoauthor=L.+Anton-Aparicio&title=New+insights+into+molecular+mechanisms+of+sunitinib-associated+side+effects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">New Insights into Molecular Mechanisms of Sunitinib-Associated Side Effects</span></div><div class="casAuthors">Aparicio-Gallego, Guadalupe; Blanco, Moises; Figueroa, Angelica; Garcia-Campelo, Rosario; Valladares-Ayerbes, Manuel; Grande-Pulido, Enrique; Anton-Aparicio, Luis</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2215-2223</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  The introduction of targeted therapy represents a major advance in the treatment of tumor progression.  Targeted agents are a novel therapeutic approach developed to disrupt different cellular signaling pathways.  The tyrosine kinase inhibitor sunitinib specifically blocks multiple tyrosine kinase receptors that are involved in the progression of many tumors.  Sunitinib is the current std. of care in first-line treatment of advanced renal cell carcinoma, and it is approved in imatinib-intolerant and imatinib-refractory gastrointestinal stromal tumors.  However, it is increasingly evident that sunitinib may display collateral effects on other proteins beyond its main target receptors, eliciting undesirable and unexpected adverse events.  A better understanding of the mol. mechanisms underlying these undesirable sunitinib-assocd. side effects will help physicians to maximize efficacy of sunitinib and minimize adverse events.  Here, we focus on new insights into mol. mechanisms that may mediate sunitinib-assocd. adverse events.  Mol Cancer Ther; 10(12); 2215-23.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpru_DT0hrZGbVg90H21EOLACvtfcHk0lgDzC_pt4UPRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFylurjN&md5=41d9f9d97b4c5910555bedef358c77f9</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-10-1124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-10-1124%26sid%3Dliteratum%253Aachs%26aulast%3DAparicio-Gallego%26aufirst%3DG.%26aulast%3DBlanco%26aufirst%3DM.%26aulast%3DFigueroa%26aufirst%3DA.%26aulast%3DGarcia-Campelo%26aufirst%3DR.%26aulast%3DValladares-Ayerbes%26aufirst%3DM.%26aulast%3DGrande-Pulido%26aufirst%3DE.%26aulast%3DAnton-Aparicio%26aufirst%3DL.%26atitle%3DNew%2520insights%2520into%2520molecular%2520mechanisms%2520of%2520sunitinib-associated%2520side%2520effects%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2011%26volume%3D10%26spage%3D2215%26epage%3D2223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Jacquel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrant, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Legros, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belhacene, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luciano, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pages, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auberger, P.</span><span> </span><span class="NLM_article-title">Imatinib induces mitochondria-dependent apoptosis of the Bcr-Abl-positive K562 cell line and its differentiation toward the erythroid lineage</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2160</span><span class="NLM_x">–</span> <span class="NLM_lpage">2162</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=2160-2162&author=A.+Jacquelauthor=M.+Herrantauthor=L.+Legrosauthor=N.+Belhaceneauthor=F.+Lucianoauthor=G.+Pagesauthor=P.+Hofmanauthor=P.+Auberger&title=Imatinib+induces+mitochondria-dependent+apoptosis+of+the+Bcr-Abl-positive+K562+cell+line+and+its+differentiation+toward+the+erythroid+lineage"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJacquel%26aufirst%3DA.%26aulast%3DHerrant%26aufirst%3DM.%26aulast%3DLegros%26aufirst%3DL.%26aulast%3DBelhacene%26aufirst%3DN.%26aulast%3DLuciano%26aufirst%3DF.%26aulast%3DPages%26aufirst%3DG.%26aulast%3DHofman%26aufirst%3DP.%26aulast%3DAuberger%26aufirst%3DP.%26atitle%3DImatinib%2520induces%2520mitochondria-dependent%2520apoptosis%2520of%2520the%2520Bcr-Abl-positive%2520K562%2520cell%2520line%2520and%2520its%2520differentiation%2520toward%2520the%2520erythroid%2520lineage%26jtitle%3DFASEB%2520J.%26date%3D2003%26volume%3D17%26spage%3D2160%26epage%3D2162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Ling, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Soler, R.</span><span> </span><span class="NLM_article-title">Erlotinib induces mitochondrial-mediated apoptosis in human H3255 non-small-cell lung cancer cells with epidermal growth factor receptorL858R mutation through mitochondrial oxidative phosphorylation-dependent activation of BAX and BAK</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">793</span><span class="NLM_x">–</span> <span class="NLM_lpage">806</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2008&pages=793-806&author=Y.+H.+Lingauthor=R.+Linauthor=R.+Perez-Soler&title=Erlotinib+induces+mitochondrial-mediated+apoptosis+in+human+H3255+non-small-cell+lung+cancer+cells+with+epidermal+growth+factor+receptorL858R+mutation+through+mitochondrial+oxidative+phosphorylation-dependent+activation+of+BAX+and+BAK"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLing%26aufirst%3DY.%2BH.%26aulast%3DLin%26aufirst%3DR.%26aulast%3DPerez-Soler%26aufirst%3DR.%26atitle%3DErlotinib%2520induces%2520mitochondrial-mediated%2520apoptosis%2520in%2520human%2520H3255%2520non-small-cell%2520lung%2520cancer%2520cells%2520with%2520epidermal%2520growth%2520factor%2520receptorL858R%2520mutation%2520through%2520mitochondrial%2520oxidative%2520phosphorylation-dependent%2520activation%2520of%2520BAX%2520and%2520BAK%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D74%26spage%3D793%26epage%3D806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Newcomb, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamasdan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Entzminger, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedlander, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crisan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zagzag, D.</span><span> </span><span class="NLM_article-title">Flavopiridol induces mitochondrial-mediated apoptosis in murine glioma GL261 cells via release of cytochrome c and apoptosis inducing factor</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">250</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=243-250&author=E.+W.+Newcombauthor=C.+Tamasdanauthor=Y.+Entzmingerauthor=J.+Alonsoauthor=D.+Friedlanderauthor=D.+Crisanauthor=D.+C.+Millerauthor=D.+Zagzag&title=Flavopiridol+induces+mitochondrial-mediated+apoptosis+in+murine+glioma+GL261+cells+via+release+of+cytochrome+c+and+apoptosis+inducing+factor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNewcomb%26aufirst%3DE.%2BW.%26aulast%3DTamasdan%26aufirst%3DC.%26aulast%3DEntzminger%26aufirst%3DY.%26aulast%3DAlonso%26aufirst%3DJ.%26aulast%3DFriedlander%26aufirst%3DD.%26aulast%3DCrisan%26aufirst%3DD.%26aulast%3DMiller%26aufirst%3DD.%2BC.%26aulast%3DZagzag%26aufirst%3DD.%26atitle%3DFlavopiridol%2520induces%2520mitochondrial-mediated%2520apoptosis%2520in%2520murine%2520glioma%2520GL261%2520cells%2520via%2520release%2520of%2520cytochrome%2520c%2520and%2520apoptosis%2520inducing%2520factor%26jtitle%3DCell%2520Cycle%26date%3D2003%26volume%3D2%26spage%3D243%26epage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Premkumar, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jane, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollack, I. F.</span><span> </span><span class="NLM_article-title">Co-administration of NVP-AEW541 and dasatinib induces mitochondrial-mediated apoptosis through Bax activation in malignant human glioma cell lines</span> <span class="citation_source-journal">Int. J. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">633</span><span class="NLM_x">–</span> <span class="NLM_lpage">643</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=20664932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFSkt73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2010&pages=633-643&author=D.+R.+Premkumarauthor=E.+P.+Janeauthor=I.+F.+Pollack&title=Co-administration+of+NVP-AEW541+and+dasatinib+induces+mitochondrial-mediated+apoptosis+through+Bax+activation+in+malignant+human+glioma+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Co-administration of NVP-AEW541 and dasatinib induces mitochondrial-mediated apoptosis through Bax activation in malignant human glioma cell lines</span></div><div class="casAuthors">Premkumar, Daniel R.; Jane, Esther P.; Pollack, Ian F.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">633-643</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">Glioblastoma multiforme represents a largely incurable tumor for which novel therapeutic strategies are required.  We report the effect of NVP-AEW541, an inhibitor of insulin-like growth factor-I receptor (IGF-IR) kinase activity on growth and signaling in a panel of glioma cell lines.  NVP-AEW541 blocked phosphorylation of IGF-IR in a dose- and time-dependent manner and inhibited proliferation and clonogenicity with median effective concns. of 2.5-10 μM.  NVP-AEW541 also induced loss of mitochondrial membrane potential and release of cytochrome c and apoptosis-inducing factor (AIF) from mitochondria.  Because concns. of NVP-AEW541 required to significantly inhibit glioma cell viability and downstream signaling also inhibited non-neoplastic astrocytes, we questioned whether differential efficacy could be enhanced by combination with inhibition of other tyrosine kinases dysregulated in gliomas.  Dasatinib was selected as a combination agent based on its distinct inhibitory profile for other relevant signaling targets.  Combined treatment with NVP-AEW541 and dasatinib induced significantly more apoptosis than either agent alone in glioma cells, but not non-neoplastic astrocytes, and synergistically inhibited clonogenic survival.  Mechanistic studies indicated that combination of NVP-AEW541 and dasatinib significantly reduced pERK and pAkt and markedly increased AIF release, Bax oligomerization and loss of mitochondrial potential compared to each agent alone.  Overexpression of Bcl-2 and Akt significantly attenuated NVP-AEW541 and dasatinib-induced Bax activation and cell death.  Our data indicate that activation of Bax plays a crit. role in mediating NVP-AEW541 and dasatinib-induced apoptosis, and suggest the potential value of combining IGFR inhibition with other classes of tyrosine kinase inhibitors to potentiate therapeutic efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFVHjUeZD8m7Vg90H21EOLACvtfcHk0li3FnfuPIqv2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFSkt73I&md5=7cf31004535ed63dddb02afc9c8afbf9</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPremkumar%26aufirst%3DD.%2BR.%26aulast%3DJane%26aufirst%3DE.%2BP.%26aulast%3DPollack%26aufirst%3DI.%2BF.%26atitle%3DCo-administration%2520of%2520NVP-AEW541%2520and%2520dasatinib%2520induces%2520mitochondrial-mediated%2520apoptosis%2520through%2520Bax%2520activation%2520in%2520malignant%2520human%2520glioma%2520cell%2520lines%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2010%26volume%3D37%26spage%3D633%26epage%3D643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Shaker, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiha, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibrahim, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehal, W. Z.</span><span> </span><span class="NLM_article-title">Nilotinib induces apoptosis and autophagic cell death of activated hepatic stellate cells via inhibition of histone deacetylases</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">1833</span><span class="NLM_x">, </span> <span class="NLM_fpage">1992</span><span class="NLM_x">–</span> <span class="NLM_lpage">2003</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1833&publication_year=2013&pages=1992-2003&author=M.+E.+Shakerauthor=A.+Ghaniauthor=G.+E.+Shihaauthor=T.+M.+Ibrahimauthor=W.+Z.+Mehal&title=Nilotinib+induces+apoptosis+and+autophagic+cell+death+of+activated+hepatic+stellate+cells+via+inhibition+of+histone+deacetylases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShaker%26aufirst%3DM.%2BE.%26aulast%3DGhani%26aufirst%3DA.%26aulast%3DShiha%26aufirst%3DG.%2BE.%26aulast%3DIbrahim%26aufirst%3DT.%2BM.%26aulast%3DMehal%26aufirst%3DW.%2BZ.%26atitle%3DNilotinib%2520induces%2520apoptosis%2520and%2520autophagic%2520cell%2520death%2520of%2520activated%2520hepatic%2520stellate%2520cells%2520via%2520inhibition%2520of%2520histone%2520deacetylases%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2013%26volume%3D1833%26spage%3D1992%26epage%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Wesierska-Gadek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gueorguieva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horky, M.</span><span> </span><span class="NLM_article-title">Roscovitine-induced up-regulation of p53AIP1 protein precedes the onset of apoptosis in human MCF-7 breast cancer cells</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">113</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.4161%2Fcbt.4.1.1446" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=15657359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXksFyqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=113-124&author=J.+Wesierska-Gadekauthor=M.+Gueorguievaauthor=M.+Horky&title=Roscovitine-induced+up-regulation+of+p53AIP1+protein+precedes+the+onset+of+apoptosis+in+human+MCF-7+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Roscovitine-induced up-regulation of p53AIP1 protein precedes the onset of apoptosis in human MCF-7 breast cancer cells</span></div><div class="casAuthors">Wesierska-Gadek, Jozefa; Gueorguieva, Marieta; Horky, Marcel</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">113-124</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">We reported recently that roscovitine arrested human MCF-7 cancer cells at G2-M phase of the cell cycle and concomitantly induced apoptosis.  After roscovitine treatment, the level of wild-type p53 protein strongly increased and p53 was accumulated in the nucleus.  Here, we raised the question of which pathway would be involved in roscovitine-induced apoptosis in MCF-7 cells, which are known to be caspase-3-deficient, and whether roscovitine-mediated activation of p53 protein might pos. affect the execution of cell death.  Roscovitine induced a depolarization of mitochondrial potential beginning at 6 h posttreatment as evidenced by changes in J-aggregate formation and release of the mitochondrial proteins cytochrome c and apoptosis-inducing factor.  Interestingly, roscovitine stimulated a site-specific phosphorylation of wild-type p53 protein in a time-dependent manner. p53 protein was specifically phosphorylated at Ser46.  P-Ser46-activated wild-type p53 tumor suppressor up-regulated p53AIP1 protein, its downstream target known to mediate the depolarization of mitochondria.  The onset of phosphorylation of p53 at Ser46 preceded the up-regulation of p53AIP1 protein and the depolarization of mitochondrial potential.  We compared the kinetics of roscovitine-mediated p53 activation between caspase-3-deficient parental MCF-7 cells and cells reconstituted with caspase-3.  The kinetics and the extent of p53 protein activation in caspase-3-proficient cells differed from those obsd. in caspase-3-deficient parental cells.  Remarkably, roscovitine failed to induce phosphorylation at Ser46 in caspase-3-reconstituted MCF-7 cells.  Our results indicate that, depending on the status of caspase-3 in MCF-7 cells, different apoptotic pathways were initialized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9w1R5p512sbVg90H21EOLACvtfcHk0lgOVjWad6RmhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXksFyqtg%253D%253D&md5=ecdb5babc47f5308ac2bdea69f47a52d</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.4161%2Fcbt.4.1.1446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.4.1.1446%26sid%3Dliteratum%253Aachs%26aulast%3DWesierska-Gadek%26aufirst%3DJ.%26aulast%3DGueorguieva%26aufirst%3DM.%26aulast%3DHorky%26aufirst%3DM.%26atitle%3DRoscovitine-induced%2520up-regulation%2520of%2520p53AIP1%2520protein%2520precedes%2520the%2520onset%2520of%2520apoptosis%2520in%2520human%2520MCF-7%2520breast%2520cancer%2520cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2005%26volume%3D4%26spage%3D113%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Min, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span> </span><span class="NLM_article-title">Gefitinib induces mitochondrial-dependent apoptosis in Saccharomyces cerevisiae</span> <span class="citation_source-journal">Mol. Med. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">362</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.3892%2Fmmr.2011.427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVOju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2011&pages=357-362&author=J.+Wuauthor=R.+Minauthor=M.+Wuauthor=W.+Chen&title=Gefitinib+induces+mitochondrial-dependent+apoptosis+in+Saccharomyces+cerevisiae"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Gefitinib induces mitochondrial-dependent apoptosis in Saccharomyces cerevisiae</span></div><div class="casAuthors">Wu, Jing; Min, Rou; Wu, Minchen; Chen, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine Reports</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">357-362</span>CODEN:
                <span class="NLM_cas:coden">MMROA5</span>;
        ISSN:<span class="NLM_cas:issn">1791-2997</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Gefitinib, a selective inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase, has been clin. demonstrated to be effective in certain cancer cell types.  In the present study, using the yeast Saccharomyces cerevisiae as a model, gefitinib-induced apoptotic cell death was demonstrated.  Gefitinib inhibited yeast cell proliferation and ultimately led to cell death in a time- and dose-dependent manner.  Furthermore, when cells were exposed to 15 μM gefitinib, typical apoptotic markers, including phosphatidylserine exposure, DNA fragmentation, reactive oxygen species prodn. and decrease in mitochondrial membrane potential, were obsd.  The Δcyc3 strain deleted in cyt c heme lyase and the rho0 mutant strain lacking mtDNA-delayed cell death, provided further evidence that the yeast cell death process involved the mitochondria.  Thus, these findings suggest that gefitinib induces apoptosis in yeast cells through a mitochondrial-dependent pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0VvQy-w4fVrVg90H21EOLACvtfcHk0lgO7gRduaNaxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVOju7s%253D&md5=254c63e9526e6084f114fdc5285a991a</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.3892%2Fmmr.2011.427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fmmr.2011.427%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DMin%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DW.%26atitle%3DGefitinib%2520induces%2520mitochondrial-dependent%2520apoptosis%2520in%2520Saccharomyces%2520cerevisiae%26jtitle%3DMol.%2520Med.%2520Rep.%26date%3D2011%26volume%3D4%26spage%3D357%26epage%3D362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konopleva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruvolo, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McQueen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bornmann, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCubrey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreeff, M.</span><span> </span><span class="NLM_article-title">Sorafenib induces apoptosis of AML cells via Bim-mediated activation of the intrinsic apoptotic pathway</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">808</span><span class="NLM_x">–</span> <span class="NLM_lpage">818</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=808-818&author=W.+Zhangauthor=M.+Konoplevaauthor=V.+R.+Ruvoloauthor=T.+McQueenauthor=R.+L.+Evansauthor=W.+G.+Bornmannauthor=J.+McCubreyauthor=J.+Cortesauthor=M.+Andreeff&title=Sorafenib+induces+apoptosis+of+AML+cells+via+Bim-mediated+activation+of+the+intrinsic+apoptotic+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DKonopleva%26aufirst%3DM.%26aulast%3DRuvolo%26aufirst%3DV.%2BR.%26aulast%3DMcQueen%26aufirst%3DT.%26aulast%3DEvans%26aufirst%3DR.%2BL.%26aulast%3DBornmann%26aufirst%3DW.%2BG.%26aulast%3DMcCubrey%26aufirst%3DJ.%26aulast%3DCortes%26aufirst%3DJ.%26aulast%3DAndreeff%26aufirst%3DM.%26atitle%3DSorafenib%2520induces%2520apoptosis%2520of%2520AML%2520cells%2520via%2520Bim-mediated%2520activation%2520of%2520the%2520intrinsic%2520apoptotic%2520pathway%26jtitle%3DLeukemia%26date%3D2008%26volume%3D22%26spage%3D808%26epage%3D818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Sordella, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haber, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Settleman, J.</span><span> </span><span class="NLM_article-title">Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">305</span><span class="NLM_x">, </span> <span class="NLM_fpage">1163</span><span class="NLM_x">–</span> <span class="NLM_lpage">1167</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2004&pages=1163-1167&author=R.+Sordellaauthor=D.+W.+Bellauthor=D.+A.+Haberauthor=J.+Settleman&title=Gefitinib-sensitizing+EGFR+mutations+in+lung+cancer+activate+anti-apoptotic+pathways"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSordella%26aufirst%3DR.%26aulast%3DBell%26aufirst%3DD.%2BW.%26aulast%3DHaber%26aufirst%3DD.%2BA.%26aulast%3DSettleman%26aufirst%3DJ.%26atitle%3DGefitinib-sensitizing%2520EGFR%2520mutations%2520in%2520lung%2520cancer%2520activate%2520anti-apoptotic%2520pathways%26jtitle%3DScience%26date%3D2004%26volume%3D305%26spage%3D1163%26epage%3D1167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Martin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliver, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partridge, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchison, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giles, P.</span><span> </span><span class="NLM_article-title">Pharmacokinetics of vandetanib: three phase I studies in healthy subjects</span> <span class="citation_source-journal">Clin. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span><span class="NLM_x">–</span> <span class="NLM_lpage">237</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1016%2Fj.clinthera.2011.11.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=22206795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVektb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2012&pages=221-237&author=P.+Martinauthor=S.+Oliverauthor=S.+J.+Kennedyauthor=E.+Partridgeauthor=M.+Hutchisonauthor=D.+Clarkeauthor=P.+Giles&title=Pharmacokinetics+of+vandetanib%3A+three+phase+I+studies+in+healthy+subjects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics of Vandetanib: Three Phase I Studies in Healthy Subjects</span></div><div class="casAuthors">Martin, Paul; Oliver, Stuart; Kennedy, Sarah-Jane; Partridge, Elizabeth; Hutchison, Michael; Clarke, David; Giles, Petrina</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">221-237</span>CODEN:
                <span class="NLM_cas:coden">CLTHDG</span>;
        ISSN:<span class="NLM_cas:issn">0149-2918</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Background: Vandetanib is an orally available inhibitor of vascular endothelial growth factor receptor 2 and epidermal growth factor receptor and is rearranged during transfection tyrosine kinase activity.  Development has included studies in non-small cell lung cancer and other tumor types.  Accurate elimination kinetics were not detd. in patient studies, and so the current human volunteer studies were performed to derive detailed kinetic data.  Objective: The aim of this study was to investigate pharmacokinetics, metab., excretion, and elimination kinetics after single oral doses of vandetanib in healthy subjects.  Methods: Three studies were conducted.  In Study A (n = 23), cohorts of 8 subjects were randomized to receive double-blind, ascending doses of vandetanib (300-1200 mg) or placebo (6:2).  Study B had a crossover design; subjects (n = 16) received vandetanib 300 mg under fed and fasted conditions.  In Study C, subjects (n = 4) received [14C] vandetanib 800 mg.  Blood samples were collected for pharmacokinetic anal. for up to 28 days after the dose (Studies A and B) and 42 days after the dose (Study C).  Plasma (all studies) and urine (Study A only) samples were collected for detn. of vandetanib concns.  In Study C radioactivity was measured in plasma, blood, urine, and feces, and metabolites were identified chromatog.  Tolerability was evaluated by recording of adverse events, clin. chem., hematol. and urinalysis parameters, vital signs, and ECGs (all studies).  Results: Study A: mean (SD) age 34.4 (6.9) years; 23/23 male; mean (SD; range) wt. 80.6 (8.1; 62-97) kg.  Study B: mean (SD) age 35.3 (8.4) years; 15/16 male; mean (SD; range) wt. 80.7 (11.2; 57-100) kg.  Study C: mean (SD) age 60.3 (7.4) years; 4/4 male; mean (SD; range) wt. 78.0 (7.7l; 72-87) kg.  Pharmacokinetic parameters were consistent across all studies (Studies A and C, vandetanib 800 mg: geometric mean CL/F, 13.1-13.3 L/h; geometric mean apparent vol. of distribution at steady state [VSS/F], 3592-4103 L; mean t1/2, 215.8-246.6 h).  Vandetanib was absorbed and eliminated slowly after single oral doses.  AUC0-∞ and Cmax were not significantly affected by ingestion of food.  Median (range) Tmax was 8 (3-18) hours after food and 6 (5-18) hours after fasting.  In plasma, concns. of total radioactivity were higher than vandetanib concns. at all time points, indicating the presence of circulating metabolites.  Unchanged vandetanib and 2 anticipated metabolites (N-desmethylvandetanib and vandetanib N-oxide) were detected in plasma, urine, and feces.  A further trace minor metabolite (glucuronide conjugate) was found in urine and feces.  Approx. two thirds of the dose was recovered in feces (44%) and urine (25%) over 21 days, underlining the importance of both routes of elimination.  Adverse events were reported by all subjects in Study A apart from 2 at a vandetanib dose of 300 mg; 12/15 (80%) and 14/16 (88%) subjects who took vandetanib under fed and fasted conditions, resp., in Study B; and 2/4 (50%) subjects in Study C. No serious adverse events were reported.  Increasing doses of vandetanib, in Study A, were assocd. with variable increases in systolic and diastolic blood pressures and variable increases from baseline in QTc interval.  Hematuria was reported by 3 subjects (vandetanib 300 mg) in Study A. Small but consistent increases from baseline in serum creatinine were noted in subjects who received vandetanib in these studies.  No other clin. important changes were obsd. in clin. chem., hematol. and urinalysis parameters, vital signs, and ECGs in any of the studies.  Conclusions: The pharmacokinetics of vandetanib after single oral doses to healthy subjects were defined and the metabolic pathway was proposed.  Vandetanib was absorbed and eliminated slowly with a t1/2 of ∼10 days after single oral doses.  The extent of absorption was not significantly affected by the presence of food.  Approx. two thirds of the dose was recovered in feces (44%) and urine (25%) over 21 days.  Unchanged vandetanib and N-desmethyl and N-oxide metabolites were detected in plasma, urine, and feces.  Vandetanib appeared to be was well tolerated in the populations studied.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJUcGqrKlcbLVg90H21EOLACvtfcHk0lg9GtUBFPH_aQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVektb4%253D&md5=cb3159f6708d6d95e4439e3e5c8242f5</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.clinthera.2011.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clinthera.2011.11.011%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DP.%26aulast%3DOliver%26aufirst%3DS.%26aulast%3DKennedy%26aufirst%3DS.%2BJ.%26aulast%3DPartridge%26aufirst%3DE.%26aulast%3DHutchison%26aufirst%3DM.%26aulast%3DClarke%26aufirst%3DD.%26aulast%3DGiles%26aufirst%3DP.%26atitle%3DPharmacokinetics%2520of%2520vandetanib%253A%2520three%2520phase%2520I%2520studies%2520in%2520healthy%2520subjects%26jtitle%3DClin.%2520Ther.%26date%3D2012%26volume%3D34%26spage%3D221%26epage%3D237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z. J.</span><span> </span><span class="NLM_article-title">Erlotinib effectively inhibits JAK2V617F activity and polycythemia vera cell growth</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">3428</span><span class="NLM_x">–</span> <span class="NLM_lpage">3432</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=3428-3432&author=Z.+Liauthor=M.+Xuauthor=S.+Xingauthor=W.+T.+Hoauthor=T.+Ishiiauthor=Q.+Liauthor=X.+Fuauthor=Z.+J.+Zhao&title=Erlotinib+effectively+inhibits+JAK2V617F+activity+and+polycythemia+vera+cell+growth"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DXing%26aufirst%3DS.%26aulast%3DHo%26aufirst%3DW.%2BT.%26aulast%3DIshii%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DFu%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DZ.%2BJ.%26atitle%3DErlotinib%2520effectively%2520inhibits%2520JAK2V617F%2520activity%2520and%2520polycythemia%2520vera%2520cell%2520growth%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D3428%26epage%3D3432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Higa, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, J.</span><span> </span><span class="NLM_article-title">Lapatinib in the treatment of breast cancer</span> <span class="citation_source-journal">Expert Rev. Anticancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1183</span><span class="NLM_x">–</span> <span class="NLM_lpage">1192</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1586%2F14737140.7.9.1183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=17892419" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVOgtLnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=1183-1192&author=G.+M.+Higaauthor=J.+Abraham&title=Lapatinib+in+the+treatment+of+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Lapatinib in the treatment of breast cancer</span></div><div class="casAuthors">Higa, Gerald M.; Abraham, Jame</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anticancer Therapy</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1183-1192</span>CODEN:
                <span class="NLM_cas:coden">ERATBJ</span>;
        ISSN:<span class="NLM_cas:issn">1473-7140</span>.
    
            (<span class="NLM_cas:orgname">Future Drugs Ltd.</span>)
        </div><div class="casAbstract">A review.  Within the past 2 years, four sep. groups have reported marked improvement in relapse-free survival when trastuzumab was added to adjuvant chemotherapy in patients with HER2-overexpressing breast cancer.  These results add further credence to the relevance of this receptor as a tumor target.  Despite the significant benefits obsd. in early and advanced HER2-pos. breast cancer, overexpression of the receptor is still assocd. with a poorer prognosis and an increased risk of disease relapse, even in patients with primary operable disease.  Besides cytotoxic chemotherapy, and possibly hormonal therapy, patients whose tumors exhibit resistance to trastuzumab have few mol.-targeted options available.  Recently, lapatinib, a small mol. dual inhibitor of both HER2 and EGF receptors, has been developed to expand the options for treating HER-pos. breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUgtgQa41YwbVg90H21EOLACvtfcHk0ljc2P0082e16g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVOgtLnK&md5=7d0a454789b2734587cfb9660ea94e97</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1586%2F14737140.7.9.1183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737140.7.9.1183%26sid%3Dliteratum%253Aachs%26aulast%3DHiga%26aufirst%3DG.%2BM.%26aulast%3DAbraham%26aufirst%3DJ.%26atitle%3DLapatinib%2520in%2520the%2520treatment%2520of%2520breast%2520cancer%26jtitle%3DExpert%2520Rev.%2520Anticancer%2520Ther.%26date%3D2007%26volume%3D7%26spage%3D1183%26epage%3D1192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Lin, N. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winer, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheatley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carey, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houston, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendelson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munster, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frakes, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleator, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uttenreuther-Fischer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wind, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinisko, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickish, T.</span><span> </span><span class="NLM_article-title">A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x">, </span> <span class="NLM_fpage">1057</span><span class="NLM_x">–</span> <span class="NLM_lpage">1065</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1007%2Fs10549-012-2003-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=22418700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvFeqsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2012&pages=1057-1065&author=N.+U.+Linauthor=E.+P.+Winerauthor=D.+Wheatleyauthor=L.+A.+Careyauthor=S.+Houstonauthor=D.+Mendelsonauthor=P.+Munsterauthor=L.+Frakesauthor=S.+Kellyauthor=A.+A.+Garciaauthor=S.+Cleatorauthor=M.+Uttenreuther-Fischerauthor=H.+Jonesauthor=S.+Windauthor=R.+Viniskoauthor=T.+Hickish&title=A+phase+II+study+of+afatinib+%28BIBW+2992%29%2C+an+irreversible+ErbB+family+blocker%2C+in+patients+with+HER2-positive+metastatic+breast+cancer+progressing+after+trastuzumab"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab</span></div><div class="casAuthors">Lin, Nancy U.; Winer, Eric P.; Wheatley, Duncan; Carey, Lisa A.; Houston, Stephen; Mendelson, David; Munster, Pamela; Frakes, Laurie; Kelly, Steve; Garcia, Agustin A.; Cleator, Susan; Uttenreuther-Fischer, Martina; Jones, Hilary; Wind, Sven; Vinisko, Richard; Hickish, Tamas</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1057-1065</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Afatinib is an oral, ErbB family blocker, which covalently binds and irreversibly blocks all kinase-competent ErbB family members.  This phase II, open-label, single-arm study explored afatinib activity in human epidermal growth factor receptor 2 (HER2)-pos. breast cancer patients progressing after trastuzumab treatment.  Patients had stage IIIB/IV HER2-pos. metastatic breast cancer, with progression following trastuzumab or trastuzumab intolerance and an Eastern Cooperative Oncol. Group (ECOG) performance status of 0-2.  Patients received 50 mg afatinib once-daily until disease progression.  Primary endpoint was objective response rate (Response Evaluation Criteria in Solid Tumors 1.0), with tumor assessments every 8 wk.  Forty-one patients were treated.  Patients had received a median of three prior chemotherapy lines (range, 0-15) and 68.3% had received trastuzumab for >1 yr.  Four patients (10% of 41 treated; 11% of evaluable patients) had partial response.  Fifteen patients (37% of 41) had stable disease as best response and 19 (46% of 41) achieved clin. benefit.  Median progression-free survival was 15.1 wk (95% confidence interval [CI]: 8.1-16.7); median overall survival was 61.0 wk (95% CI: 56.7-not evaluable).  Most frequent common terminol. criteria for adverse events grade 3 treatment-related adverse events were diarrhea (24.4%) and rash (9.8%).  Afatinib monotherapy was assocd. with promising clin. activity in extensively pretreated HER2-pos. breast cancer patients who had progressed following trastuzumab treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVxOybv2RnJrVg90H21EOLACvtfcHk0ljQEA-81uxHAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvFeqsLg%253D&md5=4922019e7aa039292a5b4df98786ac3b</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2Fs10549-012-2003-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-012-2003-y%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DN.%2BU.%26aulast%3DWiner%26aufirst%3DE.%2BP.%26aulast%3DWheatley%26aufirst%3DD.%26aulast%3DCarey%26aufirst%3DL.%2BA.%26aulast%3DHouston%26aufirst%3DS.%26aulast%3DMendelson%26aufirst%3DD.%26aulast%3DMunster%26aufirst%3DP.%26aulast%3DFrakes%26aufirst%3DL.%26aulast%3DKelly%26aufirst%3DS.%26aulast%3DGarcia%26aufirst%3DA.%2BA.%26aulast%3DCleator%26aufirst%3DS.%26aulast%3DUttenreuther-Fischer%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DH.%26aulast%3DWind%26aufirst%3DS.%26aulast%3DVinisko%26aufirst%3DR.%26aulast%3DHickish%26aufirst%3DT.%26atitle%3DA%2520phase%2520II%2520study%2520of%2520afatinib%2520%2528BIBW%25202992%2529%252C%2520an%2520irreversible%2520ErbB%2520family%2520blocker%252C%2520in%2520patients%2520with%2520HER2-positive%2520metastatic%2520breast%2520cancer%2520progressing%2520after%2520trastuzumab%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2012%26volume%3D133%26spage%3D1057%26epage%3D1065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Kantarjian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giles, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wunderle, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhalla, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wassmann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rae, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mietlowski, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bochinski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochhaus, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelzer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albitar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dugan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alland, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottmann, O. G.</span><span> </span><span class="NLM_article-title">Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">354</span><span class="NLM_x">, </span> <span class="NLM_fpage">2542</span><span class="NLM_x">–</span> <span class="NLM_lpage">2551</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1056%2FNEJMoa055104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=16775235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A280%3ADC%252BD28zmtFaitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=354&publication_year=2006&pages=2542-2551&author=H.+Kantarjianauthor=F.+Gilesauthor=L.+Wunderleauthor=K.+Bhallaauthor=S.+O%E2%80%99Brienauthor=B.+Wassmannauthor=C.+Tanakaauthor=P.+Manleyauthor=P.+Raeauthor=W.+Mietlowskiauthor=K.+Bochinskiauthor=A.+Hochhausauthor=J.+D.+Griffinauthor=D.+Hoelzerauthor=M.+Albitarauthor=M.+Duganauthor=J.+Cortesauthor=L.+Allandauthor=O.+G.+Ottmann&title=Nilotinib+in+imatinib-resistant+CML+and+Philadelphia+chromosome-positive+ALL"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL</span></div><div class="casAuthors">Kantarjian Hagop; Giles Francis; Wunderle Lydia; Bhalla Kapil; O'Brien Susan; Wassmann Barbara; Tanaka Chiaki; Manley Paul; Rae Patricia; Mietlowski William; Bochinski Kathy; Hochhaus Andreas; Griffin James D; Hoelzer Dieter; Albitar Maher; Dugan Margaret; Cortes Jorge; Alland Leila; Ottmann Oliver G</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">354</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2542-51</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Resistance to imatinib mesylate can occur in chronic myelogenous leukemia (CML).  Preclinical in vitro studies have shown that nilotinib (AMN107), a new BCR-ABL tyrosine kinase inhibitor, is more potent than imatinib against CML cells by a factor of 20 to 50.  METHODS:  In a phase 1 dose-escalation study, we assigned 119 patients with imatinib-resistant CML or acute lymphoblastic leukemia (ALL) to receive nilotinib orally at doses of 50 mg, 100 mg, 200 mg, 400 mg, 600 mg, 800 mg, and 1200 mg once daily and at 400 mg and 600 mg twice daily.  RESULTS:  Common adverse events were myelosuppression, transient indirect hyperbilirubinemia, and rashes.  Of 33 patients with the blastic phase of disease, 13 had a hematologic response and 9 had a cytogenetic response; of 46 patients with the accelerated phase, 33 had a hematologic response and 22 had a cytogenetic response; 11 of 12 patients with the chronic phase had a complete hematologic remission.  CONCLUSIONS:  Nilotinib has a relatively favorable safety profile and is active in imatinib-resistant CML. (ClinicalTrials.gov number, NCT00109707 [ClinicalTrials.gov].).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTSMguWnBLtEAaK-_ZudimnfW6udTcc2eYo6u6RXrBTF7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28zmtFaitQ%253D%253D&md5=929692a4d24d87a38ded7900953453f8</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa055104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa055104%26sid%3Dliteratum%253Aachs%26aulast%3DKantarjian%26aufirst%3DH.%26aulast%3DGiles%26aufirst%3DF.%26aulast%3DWunderle%26aufirst%3DL.%26aulast%3DBhalla%26aufirst%3DK.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DS.%26aulast%3DWassmann%26aufirst%3DB.%26aulast%3DTanaka%26aufirst%3DC.%26aulast%3DManley%26aufirst%3DP.%26aulast%3DRae%26aufirst%3DP.%26aulast%3DMietlowski%26aufirst%3DW.%26aulast%3DBochinski%26aufirst%3DK.%26aulast%3DHochhaus%26aufirst%3DA.%26aulast%3DGriffin%26aufirst%3DJ.%2BD.%26aulast%3DHoelzer%26aufirst%3DD.%26aulast%3DAlbitar%26aufirst%3DM.%26aulast%3DDugan%26aufirst%3DM.%26aulast%3DCortes%26aufirst%3DJ.%26aulast%3DAlland%26aufirst%3DL.%26aulast%3DOttmann%26aufirst%3DO.%2BG.%26atitle%3DNilotinib%2520in%2520imatinib-resistant%2520CML%2520and%2520Philadelphia%2520chromosome-positive%2520ALL%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2006%26volume%3D354%26spage%3D2542%26epage%3D2551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Goldman, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melo, J. V.</span><span> </span><span class="NLM_article-title">Chronic myeloid leukemia--advances in biology and new approaches to treatment</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">349</span><span class="NLM_x">, </span> <span class="NLM_fpage">1451</span><span class="NLM_x">–</span> <span class="NLM_lpage">1464</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1056%2FNEJMra020777" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=14534339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotVGgsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=2003&pages=1451-1464&author=J.+M.+Goldmanauthor=J.+V.+Melo&title=Chronic+myeloid+leukemia%2D%2Dadvances+in+biology+and+new+approaches+to+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic myeloid leukemia - Advances in biology and new approaches to treatment</span></div><div class="casAuthors">Goldman, John M.; Melo, Junia V.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">349</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1451-1464</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review presents recent advances in knowledge related to the pathogenesis of chronic myeloid leukemia (CML) and indicates where these may have important therapeutic implications.  It discusses the cytokinetics, cytogenetics, mol. events, graft-vs.-leukemia effect and treatment options of CML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXmKTzKKnN9bVg90H21EOLACvtfcHk0lh2yP87Q9tctw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotVGgsLc%253D&md5=88ae3d2434d003dca02f0e4af5bfff8d</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1056%2FNEJMra020777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra020777%26sid%3Dliteratum%253Aachs%26aulast%3DGoldman%26aufirst%3DJ.%2BM.%26aulast%3DMelo%26aufirst%3DJ.%2BV.%26atitle%3DChronic%2520myeloid%2520leukemia--advances%2520in%2520biology%2520and%2520new%2520approaches%2520to%2520treatment%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2003%26volume%3D349%26spage%3D1451%26epage%3D1464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Yokota, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashihara, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuroda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamitsuji, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawata, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urasaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruthardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatake, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inui, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maekawa, T.</span><span> </span><span class="NLM_article-title">INNO-406, a novel BCR-ABL/Lyn dual tyrosine kinase inhibitor, suppresses the growth of Ph+ leukemia cells in the central nervous system, and cyclosporine A augments its in vivo activity</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">306</span><span class="NLM_x">–</span> <span class="NLM_lpage">314</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2007&pages=306-314&author=A.+Yokotaauthor=S.+Kimuraauthor=S.+Masudaauthor=E.+Ashiharaauthor=J.+Kurodaauthor=K.+Satoauthor=Y.+Kamitsujiauthor=E.+Kawataauthor=Y.+Deguchiauthor=Y.+Urasakiauthor=Y.+Teruiauthor=M.+Ruthardtauthor=T.+Uedaauthor=K.+Hatakeauthor=K.+Inuiauthor=T.+Maekawa&title=INNO-406%2C+a+novel+BCR-ABL%2FLyn+dual+tyrosine+kinase+inhibitor%2C+suppresses+the+growth+of+Ph%2B+leukemia+cells+in+the+central+nervous+system%2C+and+cyclosporine+A+augments+its+in+vivo+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYokota%26aufirst%3DA.%26aulast%3DKimura%26aufirst%3DS.%26aulast%3DMasuda%26aufirst%3DS.%26aulast%3DAshihara%26aufirst%3DE.%26aulast%3DKuroda%26aufirst%3DJ.%26aulast%3DSato%26aufirst%3DK.%26aulast%3DKamitsuji%26aufirst%3DY.%26aulast%3DKawata%26aufirst%3DE.%26aulast%3DDeguchi%26aufirst%3DY.%26aulast%3DUrasaki%26aufirst%3DY.%26aulast%3DTerui%26aufirst%3DY.%26aulast%3DRuthardt%26aufirst%3DM.%26aulast%3DUeda%26aufirst%3DT.%26aulast%3DHatake%26aufirst%3DK.%26aulast%3DInui%26aufirst%3DK.%26aulast%3DMaekawa%26aufirst%3DT.%26atitle%3DINNO-406%252C%2520a%2520novel%2520BCR-ABL%252FLyn%2520dual%2520tyrosine%2520kinase%2520inhibitor%252C%2520suppresses%2520the%2520growth%2520of%2520Ph%252B%2520leukemia%2520cells%2520in%2520the%2520central%2520nervous%2520system%252C%2520and%2520cyclosporine%2520A%2520augments%2520its%2520in%2520vivo%2520activity%26jtitle%3DBlood%26date%3D2007%26volume%3D109%26spage%3D306%26epage%3D314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Gambacorti-Passerini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Assouline, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scapozza, L.</span><span> </span><span class="NLM_article-title">Abl inhibitor BMS354825 binding mode in Abelson kinase revealed by molecular docking studies</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1267</span><span class="NLM_x">–</span> <span class="NLM_lpage">1269</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2005&pages=1267-1269&author=C.+Gambacorti-Passeriniauthor=M.+Gasserauthor=S.+Ahmedauthor=S.+Assoulineauthor=L.+Scapozza&title=Abl+inhibitor+BMS354825+binding+mode+in+Abelson+kinase+revealed+by+molecular+docking+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGambacorti-Passerini%26aufirst%3DC.%26aulast%3DGasser%26aufirst%3DM.%26aulast%3DAhmed%26aufirst%3DS.%26aulast%3DAssouline%26aufirst%3DS.%26aulast%3DScapozza%26aufirst%3DL.%26atitle%3DAbl%2520inhibitor%2520BMS354825%2520binding%2520mode%2520in%2520Abelson%2520kinase%2520revealed%2520by%2520molecular%2520docking%2520studies%26jtitle%3DLeukemia%26date%3D2005%26volume%3D19%26spage%3D1267%26epage%3D1269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Clark, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cools, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curley, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lokker, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giese, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, D. G.</span><span> </span><span class="NLM_article-title">Variable sensitivity of FLT3 activation loop mutations to the small molecule tyrosine kinase inhibitor MLN518</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">2867</span><span class="NLM_x">–</span> <span class="NLM_lpage">2872</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2004&pages=2867-2872&author=J.+J.+Clarkauthor=J.+Coolsauthor=D.+P.+Curleyauthor=J.+C.+Yuauthor=N.+A.+Lokkerauthor=N.+A.+Gieseauthor=D.+G.+Gilliland&title=Variable+sensitivity+of+FLT3+activation+loop+mutations+to+the+small+molecule+tyrosine+kinase+inhibitor+MLN518"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DJ.%2BJ.%26aulast%3DCools%26aufirst%3DJ.%26aulast%3DCurley%26aufirst%3DD.%2BP.%26aulast%3DYu%26aufirst%3DJ.%2BC.%26aulast%3DLokker%26aufirst%3DN.%2BA.%26aulast%3DGiese%26aufirst%3DN.%2BA.%26aulast%3DGilliland%26aufirst%3DD.%2BG.%26atitle%3DVariable%2520sensitivity%2520of%2520FLT3%2520activation%2520loop%2520mutations%2520to%2520the%2520small%2520molecule%2520tyrosine%2520kinase%2520inhibitor%2520MLN518%26jtitle%3DBlood%26date%3D2004%26volume%3D104%26spage%3D2867%26epage%3D2872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Nam, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Im, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elvin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Min, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bang, Y. J.</span><span> </span><span class="NLM_article-title">Antitumor activity of saracatinib (AZD0530), a c-Src/Abl kinase inhibitor, alone or in combination with chemotherapeutic agents in gastric cancer</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1158%2F1535-7163.MCT-12-0109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=23144237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntValtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=16-26&author=H.+J.+Namauthor=S.+A.+Imauthor=D.+Y.+Ohauthor=P.+Elvinauthor=H.+P.+Kimauthor=Y.+K.+Yoonauthor=A.+Minauthor=S.+H.+Songauthor=S.+W.+Hanauthor=T.+Y.+Kimauthor=Y.+J.+Bang&title=Antitumor+activity+of+saracatinib+%28AZD0530%29%2C+a+c-Src%2FAbl+kinase+inhibitor%2C+alone+or+in+combination+with+chemotherapeutic+agents+in+gastric+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor Activity of Saracatinib (AZD0530), a c-Src/Abl Kinase Inhibitor, Alone or in Combination with Chemotherapeutic Agents in Gastric Cancer</span></div><div class="casAuthors">Nam, Hyun-Jin; Im, Seock-Ah; Oh, Do-Youn; Elvin, Paul; Kim, Hwang-Phill; Yoon, Young-Kwang; Min, Ahrum; Song, Sang-Hyun; Han, Sae-Won; Kim, Tae-You; Bang, Yung-Jue</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">16-26</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Src is a nonreceptor tyrosine kinase involved in the cross-talk and mediation of many signaling pathways that promote cell proliferation, adhesion, invasion, migration, and tumorigenesis.  Increased Src activity has been reported in many types of human cancer, including gastric cancer.  Therefore, this factor has been identified as a promising therapeutic target for cancer treatments, and targeting Src in gastric cancer is predicted to have potent effects.  We evaluated the antitumor effect of a c-Src/Abl kinase inhibitor, saracatinib (AZD0530), alone or combined with chemotherapeutic agents in gastric cancer cell lines and a NCI-N87 xenograft model.  Among 10 gastric cancer cell lines, saracatinib specifically inhibited the growth and migration/invasion of SNU216 and NCI-N87 cells.  Saracatinib blocked the Src/FAK, HER family, and oncogenic signaling pathways, and it induced G1 arrest and apoptosis in SNU216 and NCI-N87 cells.  Apoptosis required induction of the proapoptotic BCL2 family member Bim.  Knockdown of Bim using siRNA decreased apoptosis induced by treatment with saracatinib, suggesting that Bim has an important role in saracatinib-induced apoptosis.  Saracatinib enhanced the effects of lapatinib, an EGFR/HER2 dual inhibitor, in SNU216 and NCI-N87 cells.  Furthermore, combined treatment with saracatinib and 5-fluorouracil (5-FU) or cisplatin exerted synergistic effects in both saracatinib-sensitive and saracatinib-resistant cells.  Consistent with our in vitro findings, cotreatment with saracatinib and 5-FU resulted in enhanced antitumor activity in the NCI-N87 xenografts.  These data indicate that the inhibition of Src kinase activity by saracatinib alone or in combination with other agents can be a strategy to target gastric cancer.  Mol Cancer Ther; 12(1); 16-26. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpFSWq6HNftrVg90H21EOLACvtfcHk0lghomIBgg0WgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntValtw%253D%253D&md5=de92a9e602764f294ae9d231758ab283</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-12-0109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-12-0109%26sid%3Dliteratum%253Aachs%26aulast%3DNam%26aufirst%3DH.%2BJ.%26aulast%3DIm%26aufirst%3DS.%2BA.%26aulast%3DOh%26aufirst%3DD.%2BY.%26aulast%3DElvin%26aufirst%3DP.%26aulast%3DKim%26aufirst%3DH.%2BP.%26aulast%3DYoon%26aufirst%3DY.%2BK.%26aulast%3DMin%26aufirst%3DA.%26aulast%3DSong%26aufirst%3DS.%2BH.%26aulast%3DHan%26aufirst%3DS.%2BW.%26aulast%3DKim%26aufirst%3DT.%2BY.%26aulast%3DBang%26aufirst%3DY.%2BJ.%26atitle%3DAntitumor%2520activity%2520of%2520saracatinib%2520%2528AZD0530%2529%252C%2520a%2520c-Src%252FAbl%2520kinase%2520inhibitor%252C%2520alone%2520or%2520in%2520combination%2520with%2520chemotherapeutic%2520agents%2520in%2520gastric%2520cancer%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2013%26volume%3D12%26spage%3D16%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Boschelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arndt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gambacorti-Passerini, C.</span><span> </span><span class="NLM_article-title">Bosutinib: a review of preclinical studies in chronic myelogenous leukaemia</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1781</span><span class="NLM_x">–</span> <span class="NLM_lpage">1789</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2010&pages=1781-1789&author=F.+Boschelliauthor=K.+Arndtauthor=C.+Gambacorti-Passerini&title=Bosutinib%3A+a+review+of+preclinical+studies+in+chronic+myelogenous+leukaemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoschelli%26aufirst%3DF.%26aulast%3DArndt%26aufirst%3DK.%26aulast%3DGambacorti-Passerini%26aufirst%3DC.%26atitle%3DBosutinib%253A%2520a%2520review%2520of%2520preclinical%2520studies%2520in%2520chronic%2520myelogenous%2520leukaemia%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2010%26volume%3D46%26spage%3D1781%26epage%3D1789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Raje, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hideshima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roccaro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishitsuka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiraishi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauhan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. C.</span><span> </span><span class="NLM_article-title">Seliciclib (CYC202 or R-roscovitine), a small-molecule cyclin-dependent kinase inhibitor, mediates activity via down-regulation of Mcl-1 in multiple myeloma</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">1042</span><span class="NLM_x">–</span> <span class="NLM_lpage">1047</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2005&pages=1042-1047&author=N.+Rajeauthor=S.+Kumarauthor=T.+Hideshimaauthor=A.+Roccaroauthor=K.+Ishitsukaauthor=H.+Yasuiauthor=N.+Shiraishiauthor=D.+Chauhanauthor=N.+C.+Munshiauthor=S.+R.+Greenauthor=K.+C.+Anderson&title=Seliciclib+%28CYC202+or+R-roscovitine%29%2C+a+small-molecule+cyclin-dependent+kinase+inhibitor%2C+mediates+activity+via+down-regulation+of+Mcl-1+in+multiple+myeloma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRaje%26aufirst%3DN.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DHideshima%26aufirst%3DT.%26aulast%3DRoccaro%26aufirst%3DA.%26aulast%3DIshitsuka%26aufirst%3DK.%26aulast%3DYasui%26aufirst%3DH.%26aulast%3DShiraishi%26aufirst%3DN.%26aulast%3DChauhan%26aufirst%3DD.%26aulast%3DMunshi%26aufirst%3DN.%2BC.%26aulast%3DGreen%26aufirst%3DS.%2BR.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26atitle%3DSeliciclib%2520%2528CYC202%2520or%2520R-roscovitine%2529%252C%2520a%2520small-molecule%2520cyclin-dependent%2520kinase%2520inhibitor%252C%2520mediates%2520activity%2520via%2520down-regulation%2520of%2520Mcl-1%2520in%2520multiple%2520myeloma%26jtitle%3DBlood%26date%3D2005%26volume%3D106%26spage%3D1042%26epage%3D1047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Minutolo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sala, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagnacani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carboni, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Placanica, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prota, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rapposelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sacchi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macchia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghidoni, R.</span><span> </span><span class="NLM_article-title">Synthesis of a resveratrol analogue with high ceramide-mediated proapoptotic activity on human breast cancer cells</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6783</span><span class="NLM_x">–</span> <span class="NLM_lpage">6786</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050528k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6783-6786&author=F.+Minutoloauthor=G.+Salaauthor=A.+Bagnacaniauthor=S.+Bertiniauthor=I.+Carboniauthor=G.+Placanicaauthor=G.+Protaauthor=S.+Rapposelliauthor=N.+Sacchiauthor=M.+Macchiaauthor=R.+Ghidoni&title=Synthesis+of+a+resveratrol+analogue+with+high+ceramide-mediated+proapoptotic+activity+on+human+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm050528k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050528k%26sid%3Dliteratum%253Aachs%26aulast%3DMinutolo%26aufirst%3DF.%26aulast%3DSala%26aufirst%3DG.%26aulast%3DBagnacani%26aufirst%3DA.%26aulast%3DBertini%26aufirst%3DS.%26aulast%3DCarboni%26aufirst%3DI.%26aulast%3DPlacanica%26aufirst%3DG.%26aulast%3DProta%26aufirst%3DG.%26aulast%3DRapposelli%26aufirst%3DS.%26aulast%3DSacchi%26aufirst%3DN.%26aulast%3DMacchia%26aufirst%3DM.%26aulast%3DGhidoni%26aufirst%3DR.%26atitle%3DSynthesis%2520of%2520a%2520resveratrol%2520analogue%2520with%2520high%2520ceramide-mediated%2520proapoptotic%2520activity%2520on%2520human%2520breast%2520cancer%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6783%26epage%3D6786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Dawson, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobbs, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leid, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lange, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolluri, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontana, J. A.</span><span> </span><span class="NLM_article-title">Apoptosis induction in cancer cells by a novel analogue of 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalenecarboxylic acid lacking retinoid receptor transcriptional activation activity</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">4723</span><span class="NLM_x">–</span> <span class="NLM_lpage">4730</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=4723-4730&author=M.+I.+Dawsonauthor=P.+D.+Hobbsauthor=V.+J.+Petersonauthor=M.+Leidauthor=C.+W.+Langeauthor=K.+C.+Fengauthor=G.+Chenauthor=J.+Guauthor=H.+Liauthor=S.+K.+Kolluriauthor=X.+Zhangauthor=Y.+Zhangauthor=J.+A.+Fontana&title=Apoptosis+induction+in+cancer+cells+by+a+novel+analogue+of+6-%5B3-%281-adamantyl%29-4-hydroxyphenyl%5D-2-naphthalenecarboxylic+acid+lacking+retinoid+receptor+transcriptional+activation+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDawson%26aufirst%3DM.%2BI.%26aulast%3DHobbs%26aufirst%3DP.%2BD.%26aulast%3DPeterson%26aufirst%3DV.%2BJ.%26aulast%3DLeid%26aufirst%3DM.%26aulast%3DLange%26aufirst%3DC.%2BW.%26aulast%3DFeng%26aufirst%3DK.%2BC.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DGu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DKolluri%26aufirst%3DS.%2BK.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DFontana%26aufirst%3DJ.%2BA.%26atitle%3DApoptosis%2520induction%2520in%2520cancer%2520cells%2520by%2520a%2520novel%2520analogue%2520of%25206-%255B3-%25281-adamantyl%2529-4-hydroxyphenyl%255D-2-naphthalenecarboxylic%2520acid%2520lacking%2520retinoid%2520receptor%2520transcriptional%2520activation%2520activity%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D4723%26epage%3D4730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastow, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. H.</span><span> </span><span class="NLM_article-title">Antitumor agents. 266. Design, synthesis, and biological evaluation of novel 2-(furan-2-yl)naphthalen-1-ol derivatives as potent and selective antibreast cancer agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3586</span><span class="NLM_x">–</span> <span class="NLM_lpage">3590</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9001567" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3586-3590&author=Y.+Dongauthor=Q.+Shiauthor=Y.+N.+Liuauthor=X.+Wangauthor=K.+F.+Bastowauthor=K.+H.+Lee&title=Antitumor+agents.+266.+Design%2C+synthesis%2C+and+biological+evaluation+of+novel+2-%28furan-2-yl%29naphthalen-1-ol+derivatives+as+potent+and+selective+antibreast+cancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm9001567&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9001567%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DY.%26aulast%3DShi%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DY.%2BN.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DBastow%26aufirst%3DK.%2BF.%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DAntitumor%2520agents.%2520266.%2520Design%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520novel%25202-%2528furan-2-yl%2529naphthalen-1-ol%2520derivatives%2520as%2520potent%2520and%2520selective%2520antibreast%2520cancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3586%26epage%3D3590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Yasui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hideshima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ocio, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiziltepe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vallet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishitsuka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pargellis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raje, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. C.</span><span> </span><span class="NLM_article-title">BIRB 796 enhances cytotoxicity triggered by bortezomib, heat shock protein (Hsp) 90 inhibitor, and dexamethasone via inhibition of p38 mitogen-activated protein kinase/Hsp27 pathway in multiple myeloma cell lines and inhibits paracrine tumour growth</span> <span class="citation_source-journal">Br. J. Hamaetol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">414</span><span class="NLM_x">–</span> <span class="NLM_lpage">423</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1111%2Fj.1365-2141.2006.06443.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=17173546" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2007&pages=414-423&author=H.+Yasuiauthor=T.+Hideshimaauthor=H.+Ikedaauthor=J.+Jinauthor=E.+M.+Ocioauthor=T.+Kiziltepeauthor=Y.+Okawaauthor=S.+Valletauthor=K.+Podarauthor=K.+Ishitsukaauthor=P.+G.+Richardsonauthor=C.+Pargellisauthor=N.+Mossauthor=N.+Rajeauthor=K.+C.+Anderson&title=BIRB+796+enhances+cytotoxicity+triggered+by+bortezomib%2C+heat+shock+protein+%28Hsp%29+90+inhibitor%2C+and+dexamethasone+via+inhibition+of+p38+mitogen-activated+protein+kinase%2FHsp27+pathway+in+multiple+myeloma+cell+lines+and+inhibits+paracrine+tumour+growth"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2141.2006.06443.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2141.2006.06443.x%26sid%3Dliteratum%253Aachs%26aulast%3DYasui%26aufirst%3DH.%26aulast%3DHideshima%26aufirst%3DT.%26aulast%3DIkeda%26aufirst%3DH.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DOcio%26aufirst%3DE.%2BM.%26aulast%3DKiziltepe%26aufirst%3DT.%26aulast%3DOkawa%26aufirst%3DY.%26aulast%3DVallet%26aufirst%3DS.%26aulast%3DPodar%26aufirst%3DK.%26aulast%3DIshitsuka%26aufirst%3DK.%26aulast%3DRichardson%26aufirst%3DP.%2BG.%26aulast%3DPargellis%26aufirst%3DC.%26aulast%3DMoss%26aufirst%3DN.%26aulast%3DRaje%26aufirst%3DN.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26atitle%3DBIRB%2520796%2520enhances%2520cytotoxicity%2520triggered%2520by%2520bortezomib%252C%2520heat%2520shock%2520protein%2520%2528Hsp%2529%252090%2520inhibitor%252C%2520and%2520dexamethasone%2520via%2520inhibition%2520of%2520p38%2520mitogen-activated%2520protein%2520kinase%252FHsp27%2520pathway%2520in%2520multiple%2520myeloma%2520cell%2520lines%2520and%2520inhibits%2520paracrine%2520tumour%2520growth%26jtitle%3DBr.%2520J.%2520Hamaetol.%26date%3D2007%26volume%3D136%26spage%3D414%26epage%3D423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Targeting cancer with small molecule kinase inhibitors</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1038%2Fnrc2559" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=19104514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1yg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=28-39&author=J.+Zhangauthor=P.+L.+Yangauthor=N.+S.+Gray&title=Targeting+cancer+with+small+molecule+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cancer with small molecule kinase inhibitors</span></div><div class="casAuthors">Zhang, Jianming; Yang, Priscilla L.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-39</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Deregulation of kinase activity has emerged as a major mechanism by which cancer cells evade normal physiol. constraints on growth and survival.  To date, 11 kinase inhibitors have received US Food and Drug Administration approval as cancer treatments, and there are considerable efforts to develop selective small mol. inhibitors for a host of other kinases that are implicated in cancer and other diseases.  Herein we discuss the current challenges in the field, such as designing selective inhibitors and developing strategies to overcome resistance mutations.  This Review provides a broad overview of some of the approaches currently used to discover and characterize new kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriSM3BN_uEz7Vg90H21EOLACvtfcHk0lhtoE-kzNmPuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1yg&md5=35bc38f414cd21eef5e61ce181b580fb</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fnrc2559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2559%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DP.%2BL.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DTargeting%2520cancer%2520with%2520small%2520molecule%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2009%26volume%3D9%26spage%3D28%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Xing, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rai, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunney, E. A.</span><span> </span><span class="NLM_article-title">Scaffold mining of kinase hinge binders in crystal structure database</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">23</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1007%2Fs10822-013-9700-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=24375079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitVWhsLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2014&pages=13-23&author=L.+Xingauthor=B.+Raiauthor=E.+A.+Lunney&title=Scaffold+mining+of+kinase+hinge+binders+in+crystal+structure+database"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Scaffold mining of kinase hinge binders in crystal structure database</span></div><div class="casAuthors">Xing, Li; Rai, Brajesh; Lunney, Elizabeth A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-23</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Protein kinases are the second most prominent group of drug targets, after G-protein-coupled receptors.  Despite their distinct inhibition mechanisms, the majority of kinase inhibitors engage the conserved hydrogen bond interactions with the backbone of hinge residues.  The authors mined Pfizer internal crystal structure database (CSDb) comprising of several thousand of public as well as internal x-ray binary complexes to compile an inclusive list of hinge binding scaffolds.  The min. ring scaffolds with directly attached hetero-atoms and functional groups were extd. from the full compds. by applying a rule-based filtering procedure employing a comprehensive annotation of ATP-binding site of the human kinase complements.  The results indicated large no. of kinase inhibitors of diverse chem. structures are derived from a relatively small no. of common scaffolds, which serve as the crit. recognition elements for protein kinase interaction.  Out of the nearly 4,000 kinase-inhibitor complexes in the CSDb the authors identified approx. 600 unique scaffolds.  Hinge scaffolds are overwhelmingly flat with very little sp3 characteristics, and are less lipophilic than their corresponding parent compds.  Examples of the most common as well as the uncommon hinge scaffolds are presented.  Although the most common scaffolds are found in complex with multiple kinase targets, a large no. of them are uniquely bound to a specific kinase, suggesting certain scaffolds could be more promiscuous than the others.  The compiled collection of hinge scaffolds along with their three-dimensional binding coordinates could serve as basis set for hinge hopping, a practice frequently employed to generate novel invention as well as to optimize existing leads in medicinal chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_KvTBKTNyBbVg90H21EOLACvtfcHk0lj_8qE0BckT2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitVWhsLfO&md5=0dfcd290ca89041e699b610020e7109b</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1007%2Fs10822-013-9700-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-013-9700-4%26sid%3Dliteratum%253Aachs%26aulast%3DXing%26aufirst%3DL.%26aulast%3DRai%26aufirst%3DB.%26aulast%3DLunney%26aufirst%3DE.%2BA.%26atitle%3DScaffold%2520mining%2520of%2520kinase%2520hinge%2520binders%2520in%2520crystal%2520structure%2520database%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2014%26volume%3D28%26spage%3D13%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caflisch, A.</span><span> </span><span class="NLM_article-title">Discovery of tyrosine kinase inhibitors by docking into an inactive kinase conformation generated by molecular dynamics</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1983</span><span class="NLM_x">–</span> <span class="NLM_lpage">90</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1983-90&author=H.+Zhaoauthor=D.+Huangauthor=A.+Caflisch&title=Discovery+of+tyrosine+kinase+inhibitors+by+docking+into+an+inactive+kinase+conformation+generated+by+molecular+dynamics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DD.%26aulast%3DCaflisch%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520tyrosine%2520kinase%2520inhibitors%2520by%2520docking%2520into%2520an%2520inactive%2520kinase%2520conformation%2520generated%2520by%2520molecular%2520dynamics%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D1983%26epage%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Tseng, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tzeng, C. C.</span><span> </span><span class="NLM_article-title">Synthesis and antiproliferative evaluation of certain iminonaphtho[2,3-b]furan derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5172</span><span class="NLM_x">–</span> <span class="NLM_lpage">5182</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=5172-5182&author=C.+H.+Tsengauthor=Y.+L.+Chenauthor=S.+H.+Yangauthor=S.+I.+Pengauthor=C.+M.+Chengauthor=C.+H.+Hanauthor=S.+R.+Linauthor=C.+C.+Tzeng&title=Synthesis+and+antiproliferative+evaluation+of+certain+iminonaphtho%5B2%2C3-b%5Dfuran+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTseng%26aufirst%3DC.%2BH.%26aulast%3DChen%26aufirst%3DY.%2BL.%26aulast%3DYang%26aufirst%3DS.%2BH.%26aulast%3DPeng%26aufirst%3DS.%2BI.%26aulast%3DCheng%26aufirst%3DC.%2BM.%26aulast%3DHan%26aufirst%3DC.%2BH.%26aulast%3DLin%26aufirst%3DS.%2BR.%26aulast%3DTzeng%26aufirst%3DC.%2BC.%26atitle%3DSynthesis%2520and%2520antiproliferative%2520evaluation%2520of%2520certain%2520iminonaphtho%255B2%252C3-b%255Dfuran%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D5172%26epage%3D5182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Wang, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, I. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsiao, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tzeng, C. C.</span><span> </span><span class="NLM_article-title">Synthesis, antiproliferative, and antiplatelet activities of oxime- and methyloxime-containing flavone and isoflavone derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">6045</span><span class="NLM_x">–</span> <span class="NLM_lpage">6053</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=6045-6053&author=T.+C.+Wangauthor=I.+L.+Chenauthor=P.+J.+Luauthor=C.+H.+Wongauthor=C.+H.+Liaoauthor=K.+C.+Tsiaoauthor=K.+M.+Changauthor=Y.+L.+Chenauthor=C.+C.+Tzeng&title=Synthesis%2C+antiproliferative%2C+and+antiplatelet+activities+of+oxime-+and+methyloxime-containing+flavone+and+isoflavone+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%2BC.%26aulast%3DChen%26aufirst%3DI.%2BL.%26aulast%3DLu%26aufirst%3DP.%2BJ.%26aulast%3DWong%26aufirst%3DC.%2BH.%26aulast%3DLiao%26aufirst%3DC.%2BH.%26aulast%3DTsiao%26aufirst%3DK.%2BC.%26aulast%3DChang%26aufirst%3DK.%2BM.%26aulast%3DChen%26aufirst%3DY.%2BL.%26aulast%3DTzeng%26aufirst%3DC.%2BC.%26atitle%3DSynthesis%252C%2520antiproliferative%252C%2520and%2520antiplatelet%2520activities%2520of%2520oxime-%2520and%2520methyloxime-containing%2520flavone%2520and%2520isoflavone%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D6045%26epage%3D6053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Tseng, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tzeng, C. C.</span><span> </span><span class="NLM_article-title">Synthesis and antiproliferative evaluation of certain indeno[1,2-c]quinoline derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3153</span><span class="NLM_x">–</span> <span class="NLM_lpage">3162</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=3153-3162&author=C.+H.+Tsengauthor=Y.+L.+Chenauthor=P.+J.+Luauthor=C.+N.+Yangauthor=C.+C.+Tzeng&title=Synthesis+and+antiproliferative+evaluation+of+certain+indeno%5B1%2C2-c%5Dquinoline+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTseng%26aufirst%3DC.%2BH.%26aulast%3DChen%26aufirst%3DY.%2BL.%26aulast%3DLu%26aufirst%3DP.%2BJ.%26aulast%3DYang%26aufirst%3DC.%2BN.%26aulast%3DTzeng%26aufirst%3DC.%2BC.%26atitle%3DSynthesis%2520and%2520antiproliferative%2520evaluation%2520of%2520certain%2520indeno%255B1%252C2-c%255Dquinoline%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D3153%26epage%3D3162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Srivastava, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sangita, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dwivedi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, A.</span><span> </span><span class="NLM_article-title">Diaryl naphthyl methanes a novel class of anti-implantation agents</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1011</span><span class="NLM_x">–</span> <span class="NLM_lpage">1021</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=1011-1021&author=N.+Srivastavaauthor=R.+S.+Sangitaauthor=M.+M.+Singhauthor=A.+Dwivediauthor=A.+Kumar&title=Diaryl+naphthyl+methanes+a+novel+class+of+anti-implantation+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSrivastava%26aufirst%3DN.%26aulast%3DSangita%26aufirst%3DR.%2BS.%26aulast%3DSingh%26aufirst%3DM.%2BM.%26aulast%3DDwivedi%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DA.%26atitle%3DDiaryl%2520naphthyl%2520methanes%2520a%2520novel%2520class%2520of%2520anti-implantation%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D1011%26epage%3D1021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Chang, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capacio, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peter, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span> </span><span class="NLM_article-title">Interdimer processing mechanism of procaspase-8 activation</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">4132</span><span class="NLM_x">–</span> <span class="NLM_lpage">4142</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=4132-4142&author=D.+W.+Changauthor=Z.+Xingauthor=V.+L.+Capacioauthor=M.+E.+Peterauthor=X.+Yang&title=Interdimer+processing+mechanism+of+procaspase-8+activation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DD.%2BW.%26aulast%3DXing%26aufirst%3DZ.%26aulast%3DCapacio%26aufirst%3DV.%2BL.%26aulast%3DPeter%26aufirst%3DM.%2BE.%26aulast%3DYang%26aufirst%3DX.%26atitle%3DInterdimer%2520processing%2520mechanism%2520of%2520procaspase-8%2520activation%26jtitle%3DEMBO%2520J.%26date%3D2003%26volume%3D22%26spage%3D4132%26epage%3D4142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Song, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmena, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandolfi, P. P.</span><span> </span><span class="NLM_article-title">The functions and regulation of the PTEN tumour suppressor</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">296</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1038%2Fnrm3330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=22473468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvFSrurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=283-296&author=M.+S.+Songauthor=L.+Salmenaauthor=P.+P.+Pandolfi&title=The+functions+and+regulation+of+the+PTEN+tumour+suppressor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">The functions and regulation of the PTEN tumour suppressor</span></div><div class="casAuthors">Song, Min Sup; Salmena, Leonardo; Pandolfi, Pier Paolo</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">283-296</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The importance of the physiol. function of phosphatase and tensin homolog (PTEN) is illustrated by its frequent disruption in cancer.  By suppressing the phosphoinositide 3-kinase (PI3K)-AKT-mammalian target of rapamycin (mTOR) pathway through its lipid phosphatase activity, PTEN governs a plethora of cellular processes including survival, proliferation, energy metab. and cellular architecture.  Consequently, mechanisms regulating PTEN expression and function, including transcriptional regulation, post-transcriptional regulation by non-coding RNAs, post-translational modifications and protein-protein interactions, are all altered in cancer.  The repertoire of PTEN functions has recently been expanded to include phosphatase-independent activities and crucial functions within the nucleus.  Our increasing knowledge of PTEN and pathologies in which its function is altered will undoubtedly inform the rational design of novel therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_3dPgW7uhabVg90H21EOLACvtfcHk0lhjP4f97DZkrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvFSrurg%253D&md5=c0d6524414a050876046c647caacb9fa</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fnrm3330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3330%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DM.%2BS.%26aulast%3DSalmena%26aufirst%3DL.%26aulast%3DPandolfi%26aufirst%3DP.%2BP.%26atitle%3DThe%2520functions%2520and%2520regulation%2520of%2520the%2520PTEN%2520tumour%2520suppressor%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2012%26volume%3D13%26spage%3D283%26epage%3D296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Tamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aota, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, K. M.</span><span> </span><span class="NLM_article-title">Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">1614</span><span class="NLM_x">–</span> <span class="NLM_lpage">1617</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=1998&pages=1614-1617&author=M.+Tamuraauthor=J.+Guauthor=K.+Matsumotoauthor=S.+Aotaauthor=R.+Parsonsauthor=K.+M.+Yamada&title=Inhibition+of+cell+migration%2C+spreading%2C+and+focal+adhesions+by+tumor+suppressor+PTEN"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTamura%26aufirst%3DM.%26aulast%3DGu%26aufirst%3DJ.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DAota%26aufirst%3DS.%26aulast%3DParsons%26aufirst%3DR.%26aulast%3DYamada%26aufirst%3DK.%2BM.%26atitle%3DInhibition%2520of%2520cell%2520migration%252C%2520spreading%252C%2520and%2520focal%2520adhesions%2520by%2520tumor%2520suppressor%2520PTEN%26jtitle%3DScience%26date%3D1998%26volume%3D280%26spage%3D1614%26epage%3D1617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Bray, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillette, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loughran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sears, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargo-Gogola, T.</span><span> </span><span class="NLM_article-title">Cdc42 overexpression induces hyperbranching in the developing mammary gland by enhancing cell migration</span> <span class="citation_source-journal">Breast Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">R91</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=R91&author=K.+Brayauthor=M.+Gilletteauthor=J.+Youngauthor=E.+Loughranauthor=M.+Hwangauthor=J.+C.+Searsauthor=T.+Vargo-Gogola&title=Cdc42+overexpression+induces+hyperbranching+in+the+developing+mammary+gland+by+enhancing+cell+migration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBray%26aufirst%3DK.%26aulast%3DGillette%26aufirst%3DM.%26aulast%3DYoung%26aufirst%3DJ.%26aulast%3DLoughran%26aufirst%3DE.%26aulast%3DHwang%26aufirst%3DM.%26aulast%3DSears%26aufirst%3DJ.%2BC.%26aulast%3DVargo-Gogola%26aufirst%3DT.%26atitle%3DCdc42%2520overexpression%2520induces%2520hyperbranching%2520in%2520the%2520developing%2520mammary%2520gland%2520by%2520enhancing%2520cell%2520migration%26jtitle%3DBreast%2520Cancer%2520Res.%26date%3D2013%26volume%3D15%26spage%3DR91" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Fabre-Guillevin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cartier-Michaud, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peinado, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno-Bueno, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vallee, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palacios, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barlovatz-Meimon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charriere-Bertrand, C.</span><span> </span><span class="NLM_article-title">PAI-1 and functional blockade of SNAI1 in breast cancer cell migration</span> <span class="citation_source-journal">Breast Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">R100</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=R100&author=E.+Fabre-Guillevinauthor=M.+Maloauthor=A.+Cartier-Michaudauthor=H.+Peinadoauthor=G.+Moreno-Buenoauthor=B.+Valleeauthor=D.+A.+Lawrenceauthor=J.+Palaciosauthor=A.+Canoauthor=G.+Barlovatz-Meimonauthor=C.+Charriere-Bertrand&title=PAI-1+and+functional+blockade+of+SNAI1+in+breast+cancer+cell+migration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFabre-Guillevin%26aufirst%3DE.%26aulast%3DMalo%26aufirst%3DM.%26aulast%3DCartier-Michaud%26aufirst%3DA.%26aulast%3DPeinado%26aufirst%3DH.%26aulast%3DMoreno-Bueno%26aufirst%3DG.%26aulast%3DVallee%26aufirst%3DB.%26aulast%3DLawrence%26aufirst%3DD.%2BA.%26aulast%3DPalacios%26aufirst%3DJ.%26aulast%3DCano%26aufirst%3DA.%26aulast%3DBarlovatz-Meimon%26aufirst%3DG.%26aulast%3DCharriere-Bertrand%26aufirst%3DC.%26atitle%3DPAI-1%2520and%2520functional%2520blockade%2520of%2520SNAI1%2520in%2520breast%2520cancer%2520cell%2520migration%26jtitle%3DBreast%2520Cancer%2520Res.%26date%3D2008%26volume%3D10%26spage%3DR100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Beck, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanpain, C.</span><span> </span><span class="NLM_article-title">Unravelling cancer stem cell potential</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">727</span><span class="NLM_x">–</span> <span class="NLM_lpage">738</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1038%2Fnrc3597" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=24060864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsV2jsLvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=727-738&author=B.+Beckauthor=C.+Blanpain&title=Unravelling+cancer+stem+cell+potential"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Unravelling cancer stem cell potential</span></div><div class="casAuthors">Beck, Benjamin; Blanpain, Cedric</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">727-738</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The maintenance and repair of many adult tissues are ensured by stem cells (SCs), which reside at the top of the cellular hierarchy of these tissues.  Functional assays, such as in vitro clonogenic assays, transplantation and in vivo lineage tracing, have been used to assess the renewing and differentiation potential of normal SCs.  Similar strategies have suggested that solid tumors may also be hierarchically organized and contain cancer SCs (CSCs) that sustain tumor growth and relapse after therapy.  In this Opinion article, we discuss the different parallels that can be drawn between adult SCs and CSCs in solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJkbBvFMsWQrVg90H21EOLACvtfcHk0lj67phnatBebw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsV2jsLvI&md5=b48e1852cdee58e0106cb5592f1c4243</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1038%2Fnrc3597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3597%26sid%3Dliteratum%253Aachs%26aulast%3DBeck%26aufirst%3DB.%26aulast%3DBlanpain%26aufirst%3DC.%26atitle%3DUnravelling%2520cancer%2520stem%2520cell%2520potential%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2013%26volume%3D13%26spage%3D727%26epage%3D738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Welte, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adjaye, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehrach, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regenbrecht, C. R.</span><span> </span><span class="NLM_article-title">Cancer stem cells in solid tumors: elusive or illusive?</span> <span class="citation_source-journal">Cell Commun. Signal.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">6</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1186%2F1478-811X-8-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=20459772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A280%3ADC%252BC3cvhsVOnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=6&author=Y.+Welteauthor=J.+Adjayeauthor=H.+R.+Lehrachauthor=C.+R.+Regenbrecht&title=Cancer+stem+cells+in+solid+tumors%3A+elusive+or+illusive%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer stem cells in solid tumors: elusive or illusive?</span></div><div class="casAuthors">Welte Yvonne; Adjaye James; Lehrach Hans R; Regenbrecht Christian Ra</div><div class="citationInfo"><span class="NLM_cas:title">Cell communication and signaling : CCS</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">During the past years in vivo transplantation experiments and in vitro colony-forming assays indicated that tumors arise only from rare cells.  These cells were shown to bear self-renewal capacities and the ability to recapitulate all cell types within an individual tumor.  Due to their phenotypic resemblance to normal stem cells, the term "cancer stem cells" is used.  However, some pieces of the puzzle are missing: (a) a stringent definition of cancer stem cells in solid tumors (b) specific markers that only target cells that meet the criteria for a cancer stem cell in a certain type of tumor.  These missing parts started an ongoing debate about which is the best method to identify and characterize cancer stem cells, or even if their mere existence is just an artifact caused by the experimental procedures.  Recent findings query the cancer stem cell hypothesis for solid tumors itself since it was shown in xenograft transplantation experiments that under appropriate conditions tumor-initiating cells are not rare.In this review we critically discuss the challenges and prospects of the currently used major methods to identify cancer stem cells.  Further on, we reflect the present discussion about the existence of cancer stem cells in solid tumors as well as the amount and characteristics of tumor-initiating cells and finally provide new perspectives like the correlation of cancer stem cells and induced pluripotent cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRrWRy0-Q1KhRFwe7cAcrfPfW6udTcc2ebrn5uMBmuuW7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cvhsVOnsw%253D%253D&md5=c47d8d1793536e3e5ea4c420c026f7ed</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1186%2F1478-811X-8-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1478-811X-8-6%26sid%3Dliteratum%253Aachs%26aulast%3DWelte%26aufirst%3DY.%26aulast%3DAdjaye%26aufirst%3DJ.%26aulast%3DLehrach%26aufirst%3DH.%2BR.%26aulast%3DRegenbrecht%26aufirst%3DC.%2BR.%26atitle%3DCancer%2520stem%2520cells%2520in%2520solid%2520tumors%253A%2520elusive%2520or%2520illusive%253F%26jtitle%3DCell%2520Commun.%2520Signal.%26date%3D2010%26volume%3D8%26spage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Ginestier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hur, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charafe-Jauffret, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monville, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutcher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacquemier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viens, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleer, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schott, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birnbaum, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wicha, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dontu, G.</span><span> </span><span class="NLM_article-title">ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome</span> <span class="citation_source-journal">Cell Stem Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">555</span><span class="NLM_x">–</span> <span class="NLM_lpage">567</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1016%2Fj.stem.2007.08.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=18371393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVahtrvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2007&pages=555-567&author=C.+Ginestierauthor=M.+H.+Hurauthor=E.+Charafe-Jauffretauthor=F.+Monvilleauthor=J.+Dutcherauthor=M.+Brownauthor=J.+Jacquemierauthor=P.+Viensauthor=C.+G.+Kleerauthor=S.+Liuauthor=A.+Schottauthor=D.+Hayesauthor=D.+Birnbaumauthor=M.+S.+Wichaauthor=G.+Dontu&title=ALDH1+is+a+marker+of+normal+and+malignant+human+mammary+stem+cells+and+a+predictor+of+poor+clinical+outcome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome</span></div><div class="casAuthors">Ginestier, Christophe; Hur, Min Hee; Charafe-Jauffret, Emmanuelle; Monville, Florence; Dutcher, Julie; Brown, Marty; Jacquemier, Jocelyne; Viens, Patrice; Kleer, Celina G.; Liu, Suling; Schott, Anne; Hayes, Dan; Birnbaum, Daniel; Wicha, Max S.; Dontu, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Cell Stem Cell</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">555-567</span>CODEN:
                <span class="NLM_cas:coden">CSCEC4</span>;
        ISSN:<span class="NLM_cas:issn">1934-5909</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Application of stem cell biol. to breast cancer research has been limited by the lack of simple methods for identification and isolation of normal and malignant stem cells.  Utilizing in vitro and in vivo exptl. systems, we show that normal and cancer human mammary epithelial cells with increased aldehyde dehydrogenase activity (ALDH) have stem/progenitor properties.  These cells contain the subpopulation of normal breast epithelium with the broadest lineage differentiation potential and greatest growth capacity in a xenotransplant model.  In breast carcinomas, high ALDH activity identifies the tumorigenic cell fraction, capable of self-renewal and of generating tumors that recapitulate the heterogeneity of the parental tumor.  In a series of 577 breast carcinomas, expression of ALDH1 detected by immunostaining correlated with poor prognosis.  These findings offer an important new tool for the study of normal and malignant breast stem cells and facilitate the clin. application of stem cell concepts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9M3nlUhhfGLVg90H21EOLACvtfcHk0li7Z9jLT-3o6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVahtrvF&md5=a2f281c7f984404848e7195390a15012</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.stem.2007.08.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.stem.2007.08.014%26sid%3Dliteratum%253Aachs%26aulast%3DGinestier%26aufirst%3DC.%26aulast%3DHur%26aufirst%3DM.%2BH.%26aulast%3DCharafe-Jauffret%26aufirst%3DE.%26aulast%3DMonville%26aufirst%3DF.%26aulast%3DDutcher%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DM.%26aulast%3DJacquemier%26aufirst%3DJ.%26aulast%3DViens%26aufirst%3DP.%26aulast%3DKleer%26aufirst%3DC.%2BG.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DSchott%26aufirst%3DA.%26aulast%3DHayes%26aufirst%3DD.%26aulast%3DBirnbaum%26aufirst%3DD.%26aulast%3DWicha%26aufirst%3DM.%2BS.%26aulast%3DDontu%26aufirst%3DG.%26atitle%3DALDH1%2520is%2520a%2520marker%2520of%2520normal%2520and%2520malignant%2520human%2520mammary%2520stem%2520cells%2520and%2520a%2520predictor%2520of%2520poor%2520clinical%2520outcome%26jtitle%3DCell%2520Stem%2520Cell%26date%3D2007%26volume%3D1%26spage%3D555%26epage%3D567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Douville, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balicki, D.</span><span> </span><span class="NLM_article-title">ALDH1 as a functional marker of cancer stem and progenitor cells</span> <span class="citation_source-journal">Stem Cells Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2009&pages=17-25&author=J.+Douvilleauthor=R.+Beaulieuauthor=D.+Balicki&title=ALDH1+as+a+functional+marker+of+cancer+stem+and+progenitor+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDouville%26aufirst%3DJ.%26aulast%3DBeaulieu%26aufirst%3DR.%26aulast%3DBalicki%26aufirst%3DD.%26atitle%3DALDH1%2520as%2520a%2520functional%2520marker%2520of%2520cancer%2520stem%2520and%2520progenitor%2520cells%26jtitle%3DStem%2520Cells%2520Dev.%26date%3D2009%26volume%3D18%26spage%3D17%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Ren, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, W. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, X.</span><span> </span><span class="NLM_article-title">CD133: a cancer stem cells marker, is used in colorectal cancers</span> <span class="citation_source-journal">World J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2603</span><span class="NLM_x">–</span> <span class="NLM_lpage">2611</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.3748%2Fwjg.v19.i17.2603" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=23674867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptVGlu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=2603-2611&author=F.+Renauthor=W.+Q.+Shengauthor=X.+Du&title=CD133%3A+a+cancer+stem+cells+marker%2C+is+used+in+colorectal+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">CD133: a cancer stem cells marker, is used in colorectal cancers</span></div><div class="casAuthors">Ren, Fei; Sheng, Wei-Qi; Du, Xiang</div><div class="citationInfo"><span class="NLM_cas:title">World Journal of Gastroenterology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2603-2611</span>CODEN:
                <span class="NLM_cas:coden">WJGAF2</span>;
        ISSN:<span class="NLM_cas:issn">1007-9327</span>.
    
            (<span class="NLM_cas:orgname">Baishideng Publishing Group Co., Ltd.</span>)
        </div><div class="casAbstract">A review.  Colorectal cancer is one of the most common malignant tumors worldwide.  A model of cancer development involving cancer stem cells has been put forward because it provides a possible explanation of tumor hierarchy.  Cancer stem cells are characterized by their proliferation, tumorigenesis, differentiation and self-renewal capacities and chemoradiotherapy resistance.  Due to the role of cancer stem cells in tumor initiation and treatment failure, studies of cancer stem cell markers, such as CD133, have been of great interest.  CD133, a five-transmembrane glycoprotein, is widely used as a marker to identify and isolate colorectal cancer stem cells.  This marker has been investigated to better understand the characteristics and functions of cancer stem cells.  Moreover, it can also be used to predict tumor progression, patient survival, chemoradiotherapy resistance and other clin. parameters.  In this review, we discuss the use of CD133 in the identification of colorectal cancer stem cell, which is currently controversial.  Although the function of CD133 is as yet unclear, we have discussed several possible functions and assocd. mechanisms that may partially explain the role of CD133 in colorectal cancers.  In addn., we focus on the prognostic value of CD133 in colorectal cancers.  Finally, we predict that CD133 may be used as a possible target for colorectal cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzw7ya2O2nJrVg90H21EOLACvtfcHk0ljC5Epd6qANWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptVGlu78%253D&md5=6d534acbf5123eb513f7c5bdecca3c59</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.3748%2Fwjg.v19.i17.2603&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3748%252Fwjg.v19.i17.2603%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DF.%26aulast%3DSheng%26aufirst%3DW.%2BQ.%26aulast%3DDu%26aufirst%3DX.%26atitle%3DCD133%253A%2520a%2520cancer%2520stem%2520cells%2520marker%252C%2520is%2520used%2520in%2520colorectal%2520cancers%26jtitle%3DWorld%2520J.%2520Gastroenterol.%26date%3D2013%26volume%3D19%26spage%3D2603%26epage%3D2611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Gupta, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onder, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuperwasser, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lander, E. S.</span><span> </span><span class="NLM_article-title">Identification of selective inhibitors of cancer stem cells by high-throughput screening</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">138</span><span class="NLM_x">, </span> <span class="NLM_fpage">645</span><span class="NLM_x">–</span> <span class="NLM_lpage">659</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1016%2Fj.cell.2009.06.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=19682730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVCjs73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2009&pages=645-659&author=P.+B.+Guptaauthor=T.+T.+Onderauthor=G.+Jiangauthor=K.+Taoauthor=C.+Kuperwasserauthor=R.+A.+Weinbergauthor=E.+S.+Lander&title=Identification+of+selective+inhibitors+of+cancer+stem+cells+by+high-throughput+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of selective inhibitors of cancer stem cells by high-throughput screening</span></div><div class="casAuthors">Gupta, Piyush B.; Onder, Tamer T.; Jiang, Guozhi; Tao, Kai; Kuperwasser, Charlotte; Weinberg, Robert A.; Lander, Eric S.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">645-659</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Screens for agents that specifically kill epithelial cancer stem cells (CSCs) have not been possible due to the rarity of these cells within tumor cell populations and their relative instability in culture.  We describe here an approach to screening for agents with epithelial CSC-specific toxicity.  We implemented this method in a chem. screen and discovered compds. showing selective toxicity for breast CSCs.  One compd., salinomycin, reduces the proportion of CSCs by >100-fold relative to paclitaxel, a commonly used breast cancer chemotherapeutic drug.  Treatment of mice with salinomycin inhibits mammary tumor growth in vivo and induces increased epithelial differentiation of tumor cells.  In addn., global gene expression analyses show that salinomycin treatment results in the loss of expression of breast CSC genes previously identified by analyses of breast tissues isolated directly from patients.  This study demonstrates the ability to identify agents with specific toxicity for epithelial CSCs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2-8wgLz3XkbVg90H21EOLACvtfcHk0lhOe89so2f29Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVCjs73E&md5=d848e78a13fa2b5d78ce87bec07d1ed1</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2009.06.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2009.06.034%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DP.%2BB.%26aulast%3DOnder%26aufirst%3DT.%2BT.%26aulast%3DJiang%26aufirst%3DG.%26aulast%3DTao%26aufirst%3DK.%26aulast%3DKuperwasser%26aufirst%3DC.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26aulast%3DLander%26aufirst%3DE.%2BS.%26atitle%3DIdentification%2520of%2520selective%2520inhibitors%2520of%2520cancer%2520stem%2520cells%2520by%2520high-throughput%2520screening%26jtitle%3DCell%26date%3D2009%26volume%3D138%26spage%3D645%26epage%3D659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Wheeler, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harari, P. M.</span><span> </span><span class="NLM_article-title">Understanding resistance to EGFR inhibitors-impact on future treatment strategies</span> <span class="citation_source-journal">Nat. Rev. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">493</span><span class="NLM_x">–</span> <span class="NLM_lpage">507</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1038%2Fnrclinonc.2010.97" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=20551942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVyjsr7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2010&pages=493-507&author=D.+L.+Wheelerauthor=E.+F.+Dunnauthor=P.+M.+Harari&title=Understanding+resistance+to+EGFR+inhibitors-impact+on+future+treatment+strategies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding resistance to EGFR inhibitors-impact on future treatment strategies</span></div><div class="casAuthors">Wheeler, Deric L.; Dunn, Emily F.; Harari, Paul M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Clinical Oncology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">493-507</span>CODEN:
                <span class="NLM_cas:coden">NRCOAA</span>;
        ISSN:<span class="NLM_cas:issn">1759-4774</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  EGFR is one of the most studied targets in oncol., and several inhibitors have shown promising results in selected patient populations.  However, intrinsic and acquired resistance to these targeted therapies is increasingly recognized.  The authors of this Review describe the successful translation of EGFR inhibitors to the clinic, and highlight the mechanisms of resistance to these agents that limit their long-term efficacy.  Understanding these processes will allow researchers to develop therapies that overcome resistance and ultimately lead to more successful outcomes.  EGFR is a tyrosine kinase that participates in the regulation of cellular homeostasis.  Following ligand binding, EGFR stimulates downstream cell signaling cascades that influence cell proliferation, apoptosis, migration, survival and complex processes, including angiogenesis and tumorigenesis.  EGFR has been strongly implicated in the biol. of human epithelial malignancies, with therapeutic applications in cancers of the colon, head and neck, lung, and pancreas.  Accordingly, targeting EGFR has been intensely pursued, with the development of a series of promising mol. inhibitors for use in clin. oncol.  As is common in cancer therapy, challenges with respect to treatment resistance emerge over time.  This situation is certainly true of EGFR inhibitor therapies, where intrinsic and acquired resistance is now well recognized.  In this Review, we provide a brief overview regarding the biol. of EGFR, preclin. and clin. development of EGFR inhibitors, and mol. mechanisms that underlie the development of treatment resistance.  A greater understanding of the mechanisms that lead to EGFR resistance may provide valuable insights to help design new strategies that will enhance the impact of this promising class of inhibitors for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrw7LepfpXQa7Vg90H21EOLACvtfcHk0liJKt9v9LriVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVyjsr7L&md5=2f043ede90d7206e45ec80642302a766</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1038%2Fnrclinonc.2010.97&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrclinonc.2010.97%26sid%3Dliteratum%253Aachs%26aulast%3DWheeler%26aufirst%3DD.%2BL.%26aulast%3DDunn%26aufirst%3DE.%2BF.%26aulast%3DHarari%26aufirst%3DP.%2BM.%26atitle%3DUnderstanding%2520resistance%2520to%2520EGFR%2520inhibitors-impact%2520on%2520future%2520treatment%2520strategies%26jtitle%3DNat.%2520Rev.%2520Clin.%2520Oncol.%26date%3D2010%26volume%3D7%26spage%3D493%26epage%3D507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Habib, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neel, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vartanian, T.</span><span> </span><span class="NLM_article-title">Increased expression of epidermal growth factor receptor induces sequestration of extracellular signal-related kinases and selective attenuation of specific epidermal growth factor-mediated signal transduction pathways</span> <span class="citation_source-journal">Mol. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">233</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=12556561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnt1yltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2003&pages=219-233&author=A.+A.+Habibauthor=S.+J.+Chunauthor=B.+G.+Neelauthor=T.+Vartanian&title=Increased+expression+of+epidermal+growth+factor+receptor+induces+sequestration+of+extracellular+signal-related+kinases+and+selective+attenuation+of+specific+epidermal+growth+factor-mediated+signal+transduction+pathways"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Increased Expression of Epidermal Growth Factor Receptor Induces Sequestration of Extracellular Signal-Related Kinases and Selective Attenuation of Specific Epidermal Growth Factor-Mediated Signal Transduction Pathways</span></div><div class="casAuthors">Habib, Amyn A.; Chun, Soo Jin; Neel, Benjamin G.; Vartanian, Timothy</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">219-233</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Increased expression of the epidermal growth factor receptor (EGFR) is common in cancer and correlates with neoplastic progression.  Although the biol. of this receptor has been the subject of intense investigation, surprisingly little is known about how increased expression of the wild-type EGFR affects downstream signal transduction in cells.  We show that increasing the expression of the receptor results in dramatic shifts in signaling with attenuation of EGF-induced Ras, extracellular signal-related kinases (ERKs), and Akt activation, as well as amplification of STAT1 and STAT3 signaling.  In this study, we focus on the mechanism of attenuated ERK signaling and present evidence suggesting that the mechanism of attenuated ERK signaling in EGFR-overexpressing cells is a sequestration of ERKs at the cell membrane in EGFR-contg. complexes.  Increased expression of the EGFR results in an aberrant localization of ERKs to the cell membrane.  Furthermore, ERKs become assocd. with the EGFR in a phys. complex in EGFR-overexpressing cells but not in control cells.  The EGFR-ERK assocn. is detected in unstimulated cells or on exposure to a low concn. of EGF; under these conditions, ERK activation is minimal.  Exposure of these cells to satg. concns. of EGF results in a decreased membrane localization of ERKs, a concomitant dissocn. of ERKs from the EGFR, and restores ERK activation.  A similar assocn. can be detected between the EGFR and MEK1 in receptor-overexpressing cells, suggesting that multiple components of the ERK signaling pathway may become trapped in complexes with the EGFR.  These findings can be demonstrated in cells transfected to express high levels of the EGFR as well as in cancer cells which naturally overexpress the EGFR and, thus, may be representative of altered EGFR signaling in human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroMu6youqq3rVg90H21EOLACvtfcHk0lhibv794WXvAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnt1yltQ%253D%253D&md5=8f8fbbc1c2a2269fbc51db62ca5da9cc</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHabib%26aufirst%3DA.%2BA.%26aulast%3DChun%26aufirst%3DS.%2BJ.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26aulast%3DVartanian%26aufirst%3DT.%26atitle%3DIncreased%2520expression%2520of%2520epidermal%2520growth%2520factor%2520receptor%2520induces%2520sequestration%2520of%2520extracellular%2520signal-related%2520kinases%2520and%2520selective%2520attenuation%2520of%2520specific%2520epidermal%2520growth%2520factor-mediated%2520signal%2520transduction%2520pathways%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2003%26volume%3D1%26spage%3D219%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Price, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiganis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agarwal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Djakiew, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, E. W.</span><span> </span><span class="NLM_article-title">Epidermal growth factor promotes MDA-MB-231 breast cancer cell migration through a phosphatidylinositol 3′-kinase and phospholipase C-dependent mechanism</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">5475</span><span class="NLM_x">–</span> <span class="NLM_lpage">5478</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=5475-5478&author=J.+T.+Priceauthor=T.+Tiganisauthor=A.+Agarwalauthor=D.+Djakiewauthor=E.+W.+Thompson&title=Epidermal+growth+factor+promotes+MDA-MB-231+breast+cancer+cell+migration+through+a+phosphatidylinositol+3%E2%80%B2-kinase+and+phospholipase+C-dependent+mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrice%26aufirst%3DJ.%2BT.%26aulast%3DTiganis%26aufirst%3DT.%26aulast%3DAgarwal%26aufirst%3DA.%26aulast%3DDjakiew%26aufirst%3DD.%26aulast%3DThompson%26aufirst%3DE.%2BW.%26atitle%3DEpidermal%2520growth%2520factor%2520promotes%2520MDA-MB-231%2520breast%2520cancer%2520cell%2520migration%2520through%2520a%2520phosphatidylinositol%25203%25E2%2580%25B2-kinase%2520and%2520phospholipase%2520C-dependent%2520mechanism%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D5475%26epage%3D5478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Chazaud, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricoux, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christov, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plonquet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gherardi, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barlovatz-Meimon, G.</span><span> </span><span class="NLM_article-title">Promigratory effect of plasminogen activator inhibitor-1 on invasive breast cancer cell populations</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">160</span><span class="NLM_x">, </span> <span class="NLM_fpage">237</span><span class="NLM_x">–</span> <span class="NLM_lpage">246</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1016%2FS0002-9440%2810%2964367-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=11786417" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BD38XnvFegsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2002&pages=237-246&author=B.+Chazaudauthor=R.+Ricouxauthor=C.+Christovauthor=A.+Plonquetauthor=R.+K.+Gherardiauthor=G.+Barlovatz-Meimon&title=Promigratory+effect+of+plasminogen+activator+inhibitor-1+on+invasive+breast+cancer+cell+populations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Promigratory effect of plasminogen activator inhibitor-1 on invasive breast cancer cell populations</span></div><div class="casAuthors">Chazaud, Benedicte; Ricoux, Remy; Christov, Christo; Plonquet, Anne; Gherardi, Romain K.; Barlovatz-Meimon, Georgia</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">237-246</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">The urokinase-type plasminogen activator (uPA) system is a dynamic complex in which the membrane receptor uPAR binds uPA that binds the plasminogen activator inhibitor (PAI)-1 localized in the extracellular matrix, resulting in endocytosis of the whole complex by the low-d. lipoprotein receptor-related protein (LRP).  High expression of PAI-1 is paradoxically assocd. with marked tumor spreading and poor prognosis.  We previously reported a nonproteolytic role of the [uPAR:uPA:PAI-1:LRP] complex operative in cell migration.  Here the authors explored whether matrix PAI-1 could be used as a migration support by human breast cancer cells.  We showed that the uPA system and LRP are localized at filopodia of invasive cells, and that formation/internalization of the [uPAR:uPA:PAI-LRP] complex is required for attachment and migration of cancer cells on plastic and on a PAI-1 coat.  PAI-1 increased both filopodia formation and migration of cancer cells suggesting a chemokine-like activity.  Migration velocity, expression of the uPA system, use of the [uPAR:uPA:PAI-1:LRP] complex to migrate, and promigratory effects of PAI-1 paralleled cancer cell invasiveness.  Phenotyping and functional anal. of invasive cancer cel subclones indicated that different cell subpopulations may use different strategies to migrate depending on both the environment and their expression of the uPA system, some of them taking advantage of abundant available PAI-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofmUpT5GvSQLVg90H21EOLACvtfcHk0lgxfm4re9DWSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnvFegsQ%253D%253D&md5=77e495407e0ab2db6a6202f38d3863ff</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2FS0002-9440%2810%2964367-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-9440%252810%252964367-2%26sid%3Dliteratum%253Aachs%26aulast%3DChazaud%26aufirst%3DB.%26aulast%3DRicoux%26aufirst%3DR.%26aulast%3DChristov%26aufirst%3DC.%26aulast%3DPlonquet%26aufirst%3DA.%26aulast%3DGherardi%26aufirst%3DR.%2BK.%26aulast%3DBarlovatz-Meimon%26aufirst%3DG.%26atitle%3DPromigratory%2520effect%2520of%2520plasminogen%2520activator%2520inhibitor-1%2520on%2520invasive%2520breast%2520cancer%2520cell%2520populations%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2002%26volume%3D160%26spage%3D237%26epage%3D246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Booy, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henson, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, S. B.</span><span> </span><span class="NLM_article-title">Epidermal growth factor regulates Mcl-1 expression through the MAPK-Elk-1 signalling pathway contributing to cell survival in breast cancer</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">2367</span><span class="NLM_x">–</span> <span class="NLM_lpage">2378</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=2367-2378&author=E.+P.+Booyauthor=E.+S.+Hensonauthor=S.+B.+Gibson&title=Epidermal+growth+factor+regulates+Mcl-1+expression+through+the+MAPK-Elk-1+signalling+pathway+contributing+to+cell+survival+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBooy%26aufirst%3DE.%2BP.%26aulast%3DHenson%26aufirst%3DE.%2BS.%26aulast%3DGibson%26aufirst%3DS.%2BB.%26atitle%3DEpidermal%2520growth%2520factor%2520regulates%2520Mcl-1%2520expression%2520through%2520the%2520MAPK-Elk-1%2520signalling%2520pathway%2520contributing%2520to%2520cell%2520survival%2520in%2520breast%2520cancer%26jtitle%3DOncogene%26date%3D2011%26volume%3D30%26spage%3D2367%26epage%3D2378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Gao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, X.</span><span> </span><span class="NLM_article-title">MiR-26a inhibits proliferation and migration of breast cancer through repression of MCL-1</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e65138</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e65138&author=J.+Gaoauthor=L.+Liauthor=M.+Wuauthor=M.+Liuauthor=X.+Xieauthor=J.+Guoauthor=H.+Tangauthor=X.+Xie&title=MiR-26a+inhibits+proliferation+and+migration+of+breast+cancer+through+repression+of+MCL-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DH.%26aulast%3DXie%26aufirst%3DX.%26atitle%3DMiR-26a%2520inhibits%2520proliferation%2520and%2520migration%2520of%2520breast%2520cancer%2520through%2520repression%2520of%2520MCL-1%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De65138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Koehler, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherr, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorenz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urbanik, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kautz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elssner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welte, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bermejo, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jager, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulze-Bergkamen, H.</span><span> </span><span class="NLM_article-title">Beyond cell death - antiapoptotic Bcl-2 proteins regulate migration and invasion of colorectal cancer cells in vitro</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e76446</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e76446&author=B.+C.+Koehlerauthor=A.+L.+Scherrauthor=S.+Lorenzauthor=T.+Urbanikauthor=N.+Kautzauthor=C.+Elssnerauthor=S.+Welteauthor=J.+L.+Bermejoauthor=D.+Jagerauthor=H.+Schulze-Bergkamen&title=Beyond+cell+death+-+antiapoptotic+Bcl-2+proteins+regulate+migration+and+invasion+of+colorectal+cancer+cells+in+vitro"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoehler%26aufirst%3DB.%2BC.%26aulast%3DScherr%26aufirst%3DA.%2BL.%26aulast%3DLorenz%26aufirst%3DS.%26aulast%3DUrbanik%26aufirst%3DT.%26aulast%3DKautz%26aufirst%3DN.%26aulast%3DElssner%26aufirst%3DC.%26aulast%3DWelte%26aufirst%3DS.%26aulast%3DBermejo%26aufirst%3DJ.%2BL.%26aulast%3DJager%26aufirst%3DD.%26aulast%3DSchulze-Bergkamen%26aufirst%3DH.%26atitle%3DBeyond%2520cell%2520death%2520-%2520antiapoptotic%2520Bcl-2%2520proteins%2520regulate%2520migration%2520and%2520invasion%2520of%2520colorectal%2520cancer%2520cells%2520in%2520vitro%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De76446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Han, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGonigal, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giranda, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span> </span><span class="NLM_article-title">Functional analysis of focal adhesion kinase (FAK) reduction by small inhibitory RNAs</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">3899</span><span class="NLM_x">–</span> <span class="NLM_lpage">3905</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=15736429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitFylsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=3899-3905&author=E.+K.+Hanauthor=T.+McGonigalauthor=J.+Wangauthor=V.+L.+Girandaauthor=Y.+Luo&title=Functional+analysis+of+focal+adhesion+kinase+%28FAK%29+reduction+by+small+inhibitory+RNAs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Functional analysis of focal adhesion kinase (FAK) reduction by small inhibitory RNAs</span></div><div class="casAuthors">Han, Edward Kyu-Ho; McGonigal, Thomas; Wang, Jieyi; Giranda, Vincent L.; Luo, Yan</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3899-3905</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">The focal adhesion kinase (FAK) is a non-receptor tyrosine kinase that localizes to the points of cell contact with the extracellular matrix, called focal adhesions.  Many factors induce tyrosine phosphorylation of FAK including growth factors, neuropeptides and integrin-dependent adhesion to the extracellular matrix.  FAK has been implicated in several cellular processes such as invasion, motility, proliferation and apoptosis.  In addn., FAK expression was shown to be elevated in a no. of different human cancers, suggesting a role in the development of malignancy.  We examd. the biol. functions of FAK using small inhibitory RNAs (siRNA) in cancer cells.  Although FAK siRNA reduced the FAK protein levels by ∼ 70% in several cancer cell lines, there was no clear evidence of apoptosis.  However, in clonogenic and soft-agar assays in H1299, a lung cancer cell line, FAK siRNA treatment led to a 43% to 55% decrease in colony formation.  Furthermore, FAK siRNA-treated cells displayed a decrease in migration when serum or EGF (epidermal growth factor) were used as chemo-attractants.  Our results demonstrated that inhibition of FAK protein leads to alterations in cell growth and migration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYeuT56eTYd7Vg90H21EOLACvtfcHk0lhNGzSp55UFeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitFylsbs%253D&md5=552629a5fbdc9c9547d38f1198354bc8</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DE.%2BK.%26aulast%3DMcGonigal%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DGiranda%26aufirst%3DV.%2BL.%26aulast%3DLuo%26aufirst%3DY.%26atitle%3DFunctional%2520analysis%2520of%2520focal%2520adhesion%2520kinase%2520%2528FAK%2529%2520reduction%2520by%2520small%2520inhibitory%2520RNAs%26jtitle%3DAnticancer%2520Res.%26date%3D2004%26volume%3D24%26spage%3D3899%26epage%3D3905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Sieg, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauck, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ilic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klingbeil, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damsky, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlaepfer, D. D.</span><span> </span><span class="NLM_article-title">FAK integrates growth-factor and integrin signals to promote cell migration</span> <span class="citation_source-journal">Nat. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">256</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1038%2F35010517" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=10806474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BD3cXktlOqs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2000&pages=249-256&author=D.+J.+Siegauthor=C.+R.+Hauckauthor=D.+Ilicauthor=C.+K.+Klingbeilauthor=E.+Schaeferauthor=C.+H.+Damskyauthor=D.+D.+Schlaepfer&title=FAK+integrates+growth-factor+and+integrin+signals+to+promote+cell+migration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">FAK integrates growth-factor and integrin signals to promote cell migration</span></div><div class="casAuthors">Sieg, David J.; Hauck, Christof R.; Ilic, Dusko; Kingbeil, Candice K.; Schaefer, Erik; Damsky, Caroline H.; Schlaepfer, David D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">249-256</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Here we show that cells lacking focal adhesion kinase (FAK) are refractory to motility signals from platelet-derived and epidermal growth factors (PDGF and EGF resp.), and that stable re-expression of FAK rescues these defects.  FAK assocs. with activated PDGF- and EGF-receptor (PDGFR and EGFR) signalling complexes, and expression of the band-4.1-like domain at the FAK amino terminus is sufficient to mediate an interaction with activated EGFR.  However, efficient EGF-stimulated cell migration also requires FAK to be targeted, by its carboxy-terminal domain, to sites of integrin-receptor clustering.  Although the kinase activity of FAK is not needed to promote PDGF- or EGF-stimulated cell motility, kinase-inactive FAK is transphosphorylated at the indispensable Src-kinase-binding site, FAK Y397, after EGF stimulation of cells.  Our results establish that FAK is an important receptor-proximal link between growth-factor-receptor and integrin signalling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8_jbj9KKEerVg90H21EOLACvtfcHk0ljGTJlTqPmHAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXktlOqs7o%253D&md5=8dd638fbecfd120065bedda6eb0a3ecd</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1038%2F35010517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35010517%26sid%3Dliteratum%253Aachs%26aulast%3DSieg%26aufirst%3DD.%2BJ.%26aulast%3DHauck%26aufirst%3DC.%2BR.%26aulast%3DIlic%26aufirst%3DD.%26aulast%3DKlingbeil%26aufirst%3DC.%2BK.%26aulast%3DSchaefer%26aufirst%3DE.%26aulast%3DDamsky%26aufirst%3DC.%2BH.%26aulast%3DSchlaepfer%26aufirst%3DD.%2BD.%26atitle%3DFAK%2520integrates%2520growth-factor%2520and%2520integrin%2520signals%2520to%2520promote%2520cell%2520migration%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2000%26volume%3D2%26spage%3D249%26epage%3D256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">George, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hannan, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, W. G.</span><span> </span><span class="NLM_article-title">Unravelling the molecular complexity of GPCR-mediated EGFR transactivation using functional genomics approaches</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">5258</span><span class="NLM_x">–</span> <span class="NLM_lpage">5268</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2013&pages=5258-5268&author=A.+J.+Georgeauthor=R.+D.+Hannanauthor=W.+G.+Thomas&title=Unravelling+the+molecular+complexity+of+GPCR-mediated+EGFR+transactivation+using+functional+genomics+approaches"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGeorge%26aufirst%3DA.%2BJ.%26aulast%3DHannan%26aufirst%3DR.%2BD.%26aulast%3DThomas%26aufirst%3DW.%2BG.%26atitle%3DUnravelling%2520the%2520molecular%2520complexity%2520of%2520GPCR-mediated%2520EGFR%2520transactivation%2520using%2520functional%2520genomics%2520approaches%26jtitle%3DFEBS%2520J.%26date%3D2013%26volume%3D280%26spage%3D5258%26epage%3D5268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Fischer, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gschwind, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullrich, A.</span><span> </span><span class="NLM_article-title">EGFR signal transactivation in cancer cells</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1203</span><span class="NLM_x">–</span> <span class="NLM_lpage">1208</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1042%2FBST0311203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=14641026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BD3sXps12jsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=1203-1208&author=O.+M.+Fischerauthor=S.+Hartauthor=A.+Gschwindauthor=A.+Ullrich&title=EGFR+signal+transactivation+in+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">EGFR signal transactivation in cancer cells</span></div><div class="casAuthors">Fischer, O. M.; Hart, S.; Gschwind, A.; Ullrich, A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1203-1208</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  The EGFR (epidermal growth factor receptor) plays a key role in the regulation of essential normal cellular processes and in the pathophysiol. of hyperproliferative diseases such as cancer.  Recent investigations have demonstrated that GPCRs (G-protein-coupled receptors) are able to utilize the EGFR as a downstream signaling partner in the generation of mitogenic signals.  This cross-talk mechanism combines the broad diversity of GPCRs with the signaling capacities of the EGFR and has emerged as a general concept in a multitude of cell types.  The mol. mechanisms of EGFR signal transactivation involve processing of transmembrane growth factor precursors by metalloproteases which have been recently identified as members of the ADAM (a disintegrin and metalloprotease) family of zinc-dependent proteases.  Subsequently, the EGFR transmits signals to prominent downstream pathways, such as mitogen-activated protein kinases, the phosphoinositide 3-kinase/Akt pathway and modulation of ion channels.  Anal. of GPCR-induced EGFR activation in more than 60 human carcinoma cell lines derived from different tissues has demonstrated the broad relevance of this signaling mechanism in cancer.  Moreover, EGFR signal transactivation was linked to diverse biol. processes in human cancer cells, such as cell proliferation, migration and anti-apoptosis.  Together with investigations revealing the importance of this GPCR-EGFR cross-talk mechanism in cardiac hypertrophy, Helicobacter pylori -induced pathophysiol. processes and cystic fibrosis, these findings support an important role for GPCR ligand-dependent EGFR signal transactivation in diverse pathophysiol. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp51i2zhIS7RrVg90H21EOLACvtfcHk0liNU37cZmP7nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXps12jsrY%253D&md5=279406d121ff9ba30a5005a8bea0b4a5</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1042%2FBST0311203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST0311203%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DO.%2BM.%26aulast%3DHart%26aufirst%3DS.%26aulast%3DGschwind%26aufirst%3DA.%26aulast%3DUllrich%26aufirst%3DA.%26atitle%3DEGFR%2520signal%2520transactivation%2520in%2520cancer%2520cells%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2003%26volume%3D31%26spage%3D1203%26epage%3D1208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Britten, C. D.</span><span> </span><span class="NLM_article-title">Targeting ErbB receptor signaling: a pan-ErbB approach to cancer</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1335</span><span class="NLM_x">–</span> <span class="NLM_lpage">1342</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=15486201" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BD2cXosVSrsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=1335-1342&author=C.+D.+Britten&title=Targeting+ErbB+receptor+signaling%3A+a+pan-ErbB+approach+to+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting ErbB receptor signaling: A pan-ErbB approach to cancer</span></div><div class="casAuthors">Britten, Carolyn D.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1335-1342</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  The ErbB receptors are localized to the cell membrane where they are activated by ligand to trigger a network of signaling pathways.  In some cancer cells, dysregulation of ErbB-mediated signaling confers a growth advantage, resulting in cellular transformation and increased metastatic potential.  Several agents that inhibit individual ErbB receptors have recently been approved for the treatment of human malignancies, validating ErbB receptors as therapeutic targets.  One strategy to improve the efficacy of ErbB-targeted therapies is to inhibit multiple ErbB receptors, thereby interfering with the cooperation that exists between receptors.  This minireview addresses the approaches being developed to concurrently inhibit multiple ErbB receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGor3VCGtjKxLrVg90H21EOLACvtfcHk0ljcuFCxWsJOVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXosVSrsLo%253D&md5=eeffcf170c80be9f2b6c472bef514c34</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBritten%26aufirst%3DC.%2BD.%26atitle%3DTargeting%2520ErbB%2520receptor%2520signaling%253A%2520a%2520pan-ErbB%2520approach%2520to%2520cancer%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2004%26volume%3D3%26spage%3D1335%26epage%3D1342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Gong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somwar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Politi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chmielecki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pao, W.</span><span> </span><span class="NLM_article-title">Induction of BIM is essential for apoptosis triggered by EGFR kinase inhibitors in mutant EGFR-dependent lung adenocarcinomas</span> <span class="citation_source-journal">PLoS Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">e294</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&pages=e294&author=Y.+Gongauthor=R.+Somwarauthor=K.+Politiauthor=M.+Balakauthor=J.+Chmieleckiauthor=X.+Jiangauthor=W.+Pao&title=Induction+of+BIM+is+essential+for+apoptosis+triggered+by+EGFR+kinase+inhibitors+in+mutant+EGFR-dependent+lung+adenocarcinomas"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DY.%26aulast%3DSomwar%26aufirst%3DR.%26aulast%3DPoliti%26aufirst%3DK.%26aulast%3DBalak%26aufirst%3DM.%26aulast%3DChmielecki%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DPao%26aufirst%3DW.%26atitle%3DInduction%2520of%2520BIM%2520is%2520essential%2520for%2520apoptosis%2520triggered%2520by%2520EGFR%2520kinase%2520inhibitors%2520in%2520mutant%2520EGFR-dependent%2520lung%2520adenocarcinomas%26jtitle%3DPLoS%2520Med.%26date%3D2007%26volume%3D4%26spage%3De294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">McKillop, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partridge, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemp, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spence, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendrew, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnett, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giles, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bichat, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guilbaud, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, T. C.</span><span> </span><span class="NLM_article-title">Tumor penetration of gefitinib (Iressa), an epidermal growth factor receptor tyrosine kinase inhibitor</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">641</span><span class="NLM_x">–</span> <span class="NLM_lpage">649</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1158%2F1535-7163.MCT-04-0329" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=15827338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtFegsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=641-649&author=D.+McKillopauthor=E.+A.+Partridgeauthor=J.+V.+Kempauthor=M.+P.+Spenceauthor=J.+Kendrewauthor=S.+Barnettauthor=P.+G.+Woodauthor=P.+B.+Gilesauthor=A.+B.+Pattersonauthor=F.+Bichatauthor=N.+Guilbaudauthor=T.+C.+Stephens&title=Tumor+penetration+of+gefitinib+%28Iressa%29%2C+an+epidermal+growth+factor+receptor+tyrosine+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor penetration of gefitinib (Iressa), an epidermal growth factor receptor tyrosine kinase inhibitor</span></div><div class="casAuthors">McKillop, David; Partridge, Elizabeth A.; Kemp, John V.; Spence, Mike P.; Kendrew, Jane; Barnett, Sharon; Wood, Phillippa G.; Giles, Petrina B.; Patterson, Andrew B.; Bichat, Francis; Guilbaud, Nicolas; Stephens, Trevor C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">641-649</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The relative distribution of gefitinib-related material in nude mice bearing s.c. human tumor xenografts and in an orthotopic rat lung tumor model was investigated following oral administration (50 mg/kg) of [14C]-gefitinib.  Selected tissue samples were monitored for radioactivity by liq. scintillation counting, whereas plasma and tumor exts. were assayed for gefitinib and its major metabolites (M523595 and M537194) by high-performance liq. chromatog. with tandem mass spectrometric detection.  Tissue distribution was also detd. by whole body autoradiog.  Gefitinib was extensively distributed into the tissues of tumor-bearing mice and unchanged gefitinib was shown to account for most of the tumor radioactivity.  Concns. of gefitinib in mouse s.c. tumor xenografts were similar to skin concns. and substantially greater (up to 12-fold based on area under the concn.-time curve) than plasma.  Concns. of gefitinib-related material in an orthotopic rat lung tumor were similar to those in healthy lung tissue and were much higher than corresponding blood levels.  Following treatment of breast cancer patients with oral gefitinib (Iressa) 250 mg/d for ≥ 14 days, gefitinib concns. (mean, 7.5 μg/g, 16.7 μmol/L) in breast tumor tissue were 42 times higher than plasma, confirming the preferential distribution of gefitinib from blood into tumor tissue in the clin. situation.  These gefitinib tumor concns. are considerably higher than those reportedly required in vitro to achieve complete inhibition of epidermal growth factor receptor autophosphorylation in both epidermal growth factor receptor mutant (0.2 μmol/L) and wild-type cells (2 μmol/L).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3SuCqMHy6nbVg90H21EOLACvtfcHk0ljBLW7h5wVpVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtFegsLs%253D&md5=5778e8d3f972cef6e40badacd5ce0d3f</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-04-0329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-04-0329%26sid%3Dliteratum%253Aachs%26aulast%3DMcKillop%26aufirst%3DD.%26aulast%3DPartridge%26aufirst%3DE.%2BA.%26aulast%3DKemp%26aufirst%3DJ.%2BV.%26aulast%3DSpence%26aufirst%3DM.%2BP.%26aulast%3DKendrew%26aufirst%3DJ.%26aulast%3DBarnett%26aufirst%3DS.%26aulast%3DWood%26aufirst%3DP.%2BG.%26aulast%3DGiles%26aufirst%3DP.%2BB.%26aulast%3DPatterson%26aufirst%3DA.%2BB.%26aulast%3DBichat%26aufirst%3DF.%26aulast%3DGuilbaud%26aufirst%3DN.%26aulast%3DStephens%26aufirst%3DT.%2BC.%26atitle%3DTumor%2520penetration%2520of%2520gefitinib%2520%2528Iressa%2529%252C%2520an%2520epidermal%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520inhibitor%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2005%26volume%3D4%26spage%3D641%26epage%3D649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Yan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vikis, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubet, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">You, M.</span><span> </span><span class="NLM_article-title">Effect of an epidermal growth factor receptor inhibitor in mouse models of lung cancer</span> <span class="citation_source-journal">Mol. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">971</span><span class="NLM_x">–</span> <span class="NLM_lpage">981</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1158%2F1541-7786.MCR-06-0086" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=17189387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlCrtr3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2006&pages=971-981&author=Y.+Yanauthor=Y.+Luauthor=M.+Wangauthor=H.+Vikisauthor=R.+Yaoauthor=Y.+Wangauthor=R.+A.+Lubetauthor=M.+You&title=Effect+of+an+epidermal+growth+factor+receptor+inhibitor+in+mouse+models+of+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of an Epidermal Growth Factor Receptor Inhibitor in Mouse Models of Lung Cancer</span></div><div class="casAuthors">Yan, Ying; Lu, Yan; Wang, Min; Vikis, Haris; Yao, Ruisheng; Wang, Yian; Lubet, Ronald A.; You, Ming</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">971-981</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Gefitinib (Iressa, ZD1839) is a potent high-affinity competitive tyrosine kinase inhibitor aimed primarily at epidermal growth factor receptor (EGFR).  Inhibitors in this class have recently been approved for clin. use in the treatment of advanced non-small cell lung cancer as monotherapy following failure of chemotherapy.  We examd. the efficacy of gefitinib on lung tumorigenesis in mouse models using both postinitiation and progression protocols.  Gefitinib was given at a dose of 200 mg/kg body wt. (i.g.) beginning either 2 or 12 wk following carcinogen initiation.  In the postinitiation protocol, gefitinib significantly inhibited both tumor multiplicity (∼70%) and tumor load (∼90%) in A/J or p53-mutant mice (P < 0.0001).  Interestingly, gefitinib was also highly effective against lung carcinogenesis in the progression protocol when individual animals already have multiple preinvasive lesions in the lung.  Gefitinib exhibited ∼60% inhibition of tumor multiplicity and ∼80% inhibition of tumor load when compared with control mice (both P < 0.0001).  These data show that gefitinib is a potent chemopreventive agent in both wild-type and p53-mutant mice and that a delayed administration was still highly effective.  Analyses of mutations in the EGFR and K-ras genes in lung tumors from either control or treatment groups showed no mutations in EGFR and consistent mutation in K-ras.  Using an oligonucleotide array on control and gefitinib-treated lesions showed that gefitinib treatment failed to alter the activity or the expression level of EGFR.  In contrast, gefitinib treatment significantly altered the expression of a series of genes involved in cell cycle, cell proliferation, cell transformation, angiogenesis, DNA synthesis, cell migration, immune responses, and apoptosis.  Thus, gefitinib showed highly promising chemopreventive and chemotherapeutic activity in this mouse model of lung carcinogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTbJ1XOG9cerVg90H21EOLACvtfcHk0ljBLW7h5wVpVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlCrtr3E&md5=9ba0c145b412d85029e8a6f74caac9a0</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-06-0086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-06-0086%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DVikis%26aufirst%3DH.%26aulast%3DYao%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLubet%26aufirst%3DR.%2BA.%26aulast%3DYou%26aufirst%3DM.%26atitle%3DEffect%2520of%2520an%2520epidermal%2520growth%2520factor%2520receptor%2520inhibitor%2520in%2520mouse%2520models%2520of%2520lung%2520cancer%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2006%26volume%3D4%26spage%3D971%26epage%3D981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Boehmerle, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muenzfeld, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huehnchen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endres, M.</span><span> </span><span class="NLM_article-title">Specific targeting of neurotoxic side effects and pharmacological profile of the novel cancer stem cell drug salinomycin in mice</span> <span class="citation_source-journal">J. Mol. Med. (Berlin)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">889</span><span class="NLM_x">–</span> <span class="NLM_lpage">900</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1007%2Fs00109-014-1155-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=24770997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A280%3ADC%252BC2cnntFaitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2014&pages=889-900&author=W.+Boehmerleauthor=H.+Muenzfeldauthor=A.+Springerauthor=P.+Huehnchenauthor=M.+Endres&title=Specific+targeting+of+neurotoxic+side+effects+and+pharmacological+profile+of+the+novel+cancer+stem+cell+drug+salinomycin+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Specific targeting of neurotoxic side effects and pharmacological profile of the novel cancer stem cell drug salinomycin in mice</span></div><div class="casAuthors">Boehmerle Wolfgang; Muenzfeld Hanna; Springer Andreas; Huehnchen Petra; Endres Matthias</div><div class="citationInfo"><span class="NLM_cas:title">Journal of molecular medicine (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">889-900</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">UNLABELLED:  Salinomycin is a polyether antibiotic which effectively eliminates a variety of cancer stem cells and chemotherapy-resistant tumor cells in vitro and in vivo.  One important caveat for its clinical application is the paucity of preclinical pharmacological and safety data.  In the present study, we thus aimed to elucidate pharmacokinetic properties of salinomycin and to assess the side effect profile of chronic treatment with this compound in C57Bl/6 mice.  In addition, we tested whether neurotoxic side effects can be prevented by interference with the intracellular calcium homeostasis.  We observed that salinomycin has a narrow therapeutic index; however, a dose of 5 mg/kg body weight was well tolerated, and analysis of blood parameters as well as organ histology of liver, kidney, skeletal muscle, and heart showed no abnormalities after daily salinomycin injection for 4 weeks.  Pharmacokinetic evaluation revealed low micromolar peak concentrations and an almost complete systemic elimination within 5 h after injection.  In contrast to low systemic toxicity, typical signs of a sensory polyneuropathy with mechanical and cold allodynia, distinct gait alterations, decreased sensory nerve action potential amplitudes, and loss of myelinated fibers in the sciatic nerve were observed in salinomycin-treated animals.  Inhibition of the mitochondrial Na(+)/Ca(2+) exchanger partially prevented the development of salinomycin-induced neuropathy in vivo, an approach which did not reduce salinomycin's antineoplastic efficacy in vitro.  Taken together, this study establishes a framework of pharmacokinetic data for future preclinical trials and safety data for translational trials.  Furthermore, we established a strategy to reduce salinomycin's off-target neurotoxic effects.  KEY MESSAGE:  Salinomycin has a narrow therapeutic index; a dose of 5 mg/kg is tolerated in mice.  Mice treated with salinomycin develop a painful sensory polyneuropathy.  An optimized protocol was established to measure salinomycin in serum samples.  Inhibition of Na(+)/Ca(2+) exchangers prevents salinomycin-induced neuropathy.  Blocking mitochondrial Na(+)/Ca(2+) exchangers does not impair antineoplastic efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRKIfEmtOmUFkodMGTatQ7LfW6udTcc2eZX9k503629L7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cnntFaitA%253D%253D&md5=fe0454cdd367e9010523e22a20e40399</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1007%2Fs00109-014-1155-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00109-014-1155-0%26sid%3Dliteratum%253Aachs%26aulast%3DBoehmerle%26aufirst%3DW.%26aulast%3DMuenzfeld%26aufirst%3DH.%26aulast%3DSpringer%26aufirst%3DA.%26aulast%3DHuehnchen%26aufirst%3DP.%26aulast%3DEndres%26aufirst%3DM.%26atitle%3DSpecific%2520targeting%2520of%2520neurotoxic%2520side%2520effects%2520and%2520pharmacological%2520profile%2520of%2520the%2520novel%2520cancer%2520stem%2520cell%2520drug%2520salinomycin%2520in%2520mice%26jtitle%3DJ.%2520Mol.%2520Med.%2520%2528Berlin%2529%26date%3D2014%26volume%3D92%26spage%3D889%26epage%3D900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Ojo, O. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhadauria, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rath, S. K.</span><span> </span><span class="NLM_article-title">Dose-dependent adverse effects of salinomycin on male reproductive organs and fertility in mice</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e69086</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e69086&author=O.+O.+Ojoauthor=S.+Bhadauriaauthor=S.+K.+Rath&title=Dose-dependent+adverse+effects+of+salinomycin+on+male+reproductive+organs+and+fertility+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOjo%26aufirst%3DO.%2BO.%26aulast%3DBhadauria%26aufirst%3DS.%26aulast%3DRath%26aufirst%3DS.%2BK.%26atitle%3DDose-dependent%2520adverse%2520effects%2520of%2520salinomycin%2520on%2520male%2520reproductive%2520organs%2520and%2520fertility%2520in%2520mice%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De69086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Manna, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frazier, W. A.</span><span> </span><span class="NLM_article-title">CD47 mediates killing of breast tumor cells via Gi-dependent inhibition of protein kinase A</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">1026</span><span class="NLM_x">–</span> <span class="NLM_lpage">1036</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=1026-1036&author=P.+P.+Mannaauthor=W.+A.+Frazier&title=CD47+mediates+killing+of+breast+tumor+cells+via+Gi-dependent+inhibition+of+protein+kinase+A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManna%26aufirst%3DP.%2BP.%26aulast%3DFrazier%26aufirst%3DW.%2BA.%26atitle%3DCD47%2520mediates%2520killing%2520of%2520breast%2520tumor%2520cells%2520via%2520Gi-dependent%2520inhibition%2520of%2520protein%2520kinase%2520A%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D1026%26epage%3D1036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Chakravarti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddiqui, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dwivedi, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshpande, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samanta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatta, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panda, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prabhakar, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konwar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanyal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chattopadhyay, N.</span><span> </span><span class="NLM_article-title">Specific targeting of insulin-like growth factor 1 receptor signaling in human estrogen dependent breast cancer cell by a novel tyrosine-based benzoxazepine derivative</span> <span class="citation_source-journal">Mol. Cell. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">338</span><span class="NLM_x">, </span> <span class="NLM_fpage">68</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1016%2Fj.mce.2011.03.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=21457754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvVynsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=338&publication_year=2011&pages=68-78&author=B.+Chakravartiauthor=J.+A.+Siddiquiauthor=S.+K.+Dwivediauthor=S.+Deshpandeauthor=K.+Samantaauthor=R.+S.+Bhattaauthor=G.+Pandaauthor=Y.+S.+Prabhakarauthor=R.+Konwarauthor=S.+Sanyalauthor=N.+Chattopadhyay&title=Specific+targeting+of+insulin-like+growth+factor+1+receptor+signaling+in+human+estrogen+dependent+breast+cancer+cell+by+a+novel+tyrosine-based+benzoxazepine+derivative"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Specific targeting of insulin-like growth factor 1 receptor signaling in human estrogen dependent breast cancer cell by a novel tyrosine-based benzoxazepine derivative</span></div><div class="casAuthors">Chakravarti, Bandana; Siddiqui, Jawed A.; Dwivedi, Shailendra K. Dhar; Deshpande, Shreekant; Samanta, Krishnanda; Bhatta, Rabi S.; Panda, Gautam; Prabhakar, Yenamandra S.; Konwar, Rituraj; Sanyal, Sabaysachi; Chattopadhyay, Naibedya</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Endocrinology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">338</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">68-78</span>CODEN:
                <span class="NLM_cas:coden">MCEND6</span>;
        ISSN:<span class="NLM_cas:issn">0303-7207</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">The present study sought to investigate the in vitro and in vivo effects of a tyrosine-based benzoxazepine, 4-([4-(toluene-4-sulfonyl)-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-3-ylmethyl]-phenol) [THBP] in human breast cancer cells, with a focus on detg. its mol. target.  THBP had growth inhibitory effect on MCF-7 and MDA-MD-231 cells.  At IC50 value (∼ 20 μM), THBP resulted in G1 arrest, decrease in cyclin D1 levels and induction of apoptosis of MCF-7 cells.  Mechanistically, activation of caspase 8 contributes critically to the induction of apoptotic cell death as copresence of selective inhibition of caspase 8 effectively abrogates the cytotoxic effect of THBP in MCF-7 cells.  Further, THBP increased pro-apoptotic protein, Bax; decreased anti-apoptotic protein, Bcl-2; and decreased mitochondrial membrane potential in MCF-7 cells, indicating involvement of an intrinsic pathway of apoptosis following caspase 8 activation.  Out of the various growth factors/hormones, THBP selectively abrogated increased viability of MCF-7 cells by insulin-like growth factor 1 (IGF-1).  Mol. docking studies revealed that THBP occupied the ATP binding pocket of IGF-1 receptor (IGF-1R).  Accordingly THBP was found to inhibit IGF-1-induced phosphorylation of IGF-1R and insulin receptor substrate-1 (IRS-1) without inhibiting insulin signaling in MCF-7 cells.  In athymic nude mice, compared with vehicle, THBP treatment significantly reduced the growth of MCF-7 xenograft tumors through inhibition of cancer cell proliferation as well as promotion of cell death that correlated with reduced phospho-IGF-1R levels.  We suggest that interfering with the IGF-1R signaling by the benzoxazepine THBP offers a novel and selective therapeutic strategy for estrogen receptor-pos., postmenopausal breast cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHK6_l3F3BirVg90H21EOLACvtfcHk0lg0EZ1_DuCNuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvVynsr8%253D&md5=628d2d9c1a83bc23619ebd3c8dcac68a</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.mce.2011.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mce.2011.03.012%26sid%3Dliteratum%253Aachs%26aulast%3DChakravarti%26aufirst%3DB.%26aulast%3DSiddiqui%26aufirst%3DJ.%2BA.%26aulast%3DDwivedi%26aufirst%3DS.%2BK.%26aulast%3DDeshpande%26aufirst%3DS.%26aulast%3DSamanta%26aufirst%3DK.%26aulast%3DBhatta%26aufirst%3DR.%2BS.%26aulast%3DPanda%26aufirst%3DG.%26aulast%3DPrabhakar%26aufirst%3DY.%2BS.%26aulast%3DKonwar%26aufirst%3DR.%26aulast%3DSanyal%26aufirst%3DS.%26aulast%3DChattopadhyay%26aufirst%3DN.%26atitle%3DSpecific%2520targeting%2520of%2520insulin-like%2520growth%2520factor%25201%2520receptor%2520signaling%2520in%2520human%2520estrogen%2520dependent%2520breast%2520cancer%2520cell%2520by%2520a%2520novel%2520tyrosine-based%2520benzoxazepine%2520derivative%26jtitle%3DMol.%2520Cell.%2520Endocrinol.%26date%3D2011%26volume%3D338%26spage%3D68%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Chakravarti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurya, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddiqui, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bid, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajendran, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yadav, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konwar, R.</span><span> </span><span class="NLM_article-title">In vitro anti-breast cancer activity of ethanolic extract of Wrightia tomentosa: role of pro-apoptotic effects of oleanolic acid and urosolic acid</span> <span class="citation_source-journal">J. Ethnopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x">, </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2012&pages=72-79&author=B.+Chakravartiauthor=R.+Mauryaauthor=J.+A.+Siddiquiauthor=H.+K.+Bidauthor=S.+M.+Rajendranauthor=P.+P.+Yadavauthor=R.+Konwar&title=In+vitro+anti-breast+cancer+activity+of+ethanolic+extract+of+Wrightia+tomentosa%3A+role+of+pro-apoptotic+effects+of+oleanolic+acid+and+urosolic+acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChakravarti%26aufirst%3DB.%26aulast%3DMaurya%26aufirst%3DR.%26aulast%3DSiddiqui%26aufirst%3DJ.%2BA.%26aulast%3DBid%26aufirst%3DH.%2BK.%26aulast%3DRajendran%26aufirst%3DS.%2BM.%26aulast%3DYadav%26aufirst%3DP.%2BP.%26aulast%3DKonwar%26aufirst%3DR.%26atitle%3DIn%2520vitro%2520anti-breast%2520cancer%2520activity%2520of%2520ethanolic%2520extract%2520of%2520Wrightia%2520tomentosa%253A%2520role%2520of%2520pro-apoptotic%2520effects%2520of%2520oleanolic%2520acid%2520and%2520urosolic%2520acid%26jtitle%3DJ.%2520Ethnopharmacol.%26date%3D2012%26volume%3D142%26spage%3D72%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Konecny, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatesan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dering, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginther, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahmeh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fejzo, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toft, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slamon, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podratz, K. C.</span><span> </span><span class="NLM_article-title">Activity of lapatinib a novel HER2 and EGFR dual kinase inhibitor in human endometrial cancer cells</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">1076</span><span class="NLM_x">–</span> <span class="NLM_lpage">1084</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1038%2Fsj.bjc.6604278" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=18334972" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtlGkurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2008&pages=1076-1084&author=G.+E.+Konecnyauthor=N.+Venkatesanauthor=G.+Yangauthor=J.+Deringauthor=C.+Gintherauthor=R.+Finnauthor=M.+Rahmehauthor=M.+S.+Fejzoauthor=D.+Toftauthor=S.+W.+Jiangauthor=D.+J.+Slamonauthor=K.+C.+Podratz&title=Activity+of+lapatinib+a+novel+HER2+and+EGFR+dual+kinase+inhibitor+in+human+endometrial+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Activity of lapatinib a novel HER2 and EGFR dual kinase inhibitor in human endometrial cancer cells</span></div><div class="casAuthors">Konecny, G. E.; Venkatesan, N.; Yang, G.; Dering, J.; Ginther, C.; Finn, R.; Rahmeh, M.; Schoenberg Fejzo, M.; Toft, D.; Jiang, S.-W.; Slamon, D. J.; Podratz, K. C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1076-1084</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">In this study, we explore the therapeutic potential of lapatinib a selective inhibitor of both the EGFR and HER2 tyrosine kinases for the treatment of endometrial cancer.  The effect of lapatinib on tumor cell growth and receptor activation was studied in a panel of human endometrial cancer cell lines.  Candidate mol. markers predicting sensitivity were assessed by baseline gene expression profiling, ELISA, and western blot analyses.  Multiple drug effect/combination index (CI) isobologram anal. was used to study the interactions between chemotherapeutic drugs and lapatinib.  Concn.-dependent anti-proliferative effects of lapatinib were seen in all endometrial cancer cell lines tested, but varied significantly between individual cell lines (IC50 range: 0.052-10.9 μmol).  HER2 overexpression or increased expression of EGFR was significantly assocd. with in vitro sensitivity (P=0.024 or 0.011, resp.).  Lapatinib exerts growth inhibition in a PTEN-independent manner.  Sensitive cell lines also exhibited increased expression of EGFR ligands or HER3.  In contrast, lapatinib-resistant cell lines exhibited high androgen receptor (AR) levels or epithelial-to-mesenchymal transition (post-EMT) features.  In endometrial cancer cells, at a wide range of clin. achievable drug concns., additive and synergistic interactions were obsd. for lapatinib plus carboplatin, paclitaxel, docetaxel, and doxorubicin.  These observations provide a clear biol. rational to test lapatinib as a single agent or in combination with chemotherapy in endometrial cancer with HER2 overexpression.  Expression of EGFR, its ligands, HER3, AR, and post-EMT markers warrant further evaluation to help define patients with HER2-nonoverexpressing endometrial cancer most likely to benefit from lapatinib.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreQmp51wKR8bVg90H21EOLACvtfcHk0li6ZcLuLGyYBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtlGkurY%253D&md5=c4fda5ffad2db3b936cc3da557c8c47f</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6604278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6604278%26sid%3Dliteratum%253Aachs%26aulast%3DKonecny%26aufirst%3DG.%2BE.%26aulast%3DVenkatesan%26aufirst%3DN.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DDering%26aufirst%3DJ.%26aulast%3DGinther%26aufirst%3DC.%26aulast%3DFinn%26aufirst%3DR.%26aulast%3DRahmeh%26aufirst%3DM.%26aulast%3DFejzo%26aufirst%3DM.%2BS.%26aulast%3DToft%26aufirst%3DD.%26aulast%3DJiang%26aufirst%3DS.%2BW.%26aulast%3DSlamon%26aufirst%3DD.%2BJ.%26aulast%3DPodratz%26aufirst%3DK.%2BC.%26atitle%3DActivity%2520of%2520lapatinib%2520a%2520novel%2520HER2%2520and%2520EGFR%2520dual%2520kinase%2520inhibitor%2520in%2520human%2520endometrial%2520cancer%2520cells%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2008%26volume%3D98%26spage%3D1076%26epage%3D1084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Byon, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardy, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponnazhagan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span> </span><span class="NLM_article-title">Free fatty acids enhance breast cancer cell migration through plasminogen activator inhibitor-1 and SMAD4</span> <span class="citation_source-journal">Lab. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">1221</span><span class="NLM_x">–</span> <span class="NLM_lpage">1228</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2009&pages=1221-1228&author=C.+H.+Byonauthor=R.+W.+Hardyauthor=C.+Renauthor=S.+Ponnazhaganauthor=D.+R.+Welchauthor=J.+M.+McDonaldauthor=Y.+Chen&title=Free+fatty+acids+enhance+breast+cancer+cell+migration+through+plasminogen+activator+inhibitor-1+and+SMAD4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DByon%26aufirst%3DC.%2BH.%26aulast%3DHardy%26aufirst%3DR.%2BW.%26aulast%3DRen%26aufirst%3DC.%26aulast%3DPonnazhagan%26aufirst%3DS.%26aulast%3DWelch%26aufirst%3DD.%2BR.%26aulast%3DMcDonald%26aufirst%3DJ.%2BM.%26aulast%3DChen%26aufirst%3DY.%26atitle%3DFree%2520fatty%2520acids%2520enhance%2520breast%2520cancer%2520cell%2520migration%2520through%2520plasminogen%2520activator%2520inhibitor-1%2520and%2520SMAD4%26jtitle%3DLab.%2520Invest.%26date%3D2009%26volume%3D89%26spage%3D1221%26epage%3D1228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Jiang, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiscox, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parr, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansel, R. E.</span><span> </span><span class="NLM_article-title">Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">3695</span><span class="NLM_x">–</span> <span class="NLM_lpage">3703</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=10589789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADyaK1MXotV2gt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1999&pages=3695-3703&author=W.+G.+Jiangauthor=S.+E.+Hiscoxauthor=C.+Parrauthor=T.+A.+Martinauthor=K.+Matsumotoauthor=T.+Nakamuraauthor=R.+E.+Mansel&title=Antagonistic+effect+of+NK4%2C+a+novel+hepatocyte+growth+factor+variant%2C+on+in+vitro+angiogenesis+of+human+vascular+endothelial+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells</span></div><div class="casAuthors">Jiang, Wen G.; Hiscox, Steve E.; Parr, Christian; Martin, Tracey A.; Matsumoto, Kunio; Nakamura, Toshikazu; Mansel, Robert E.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3695-3703</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Hepatocyte growth factor (HGF), also known as scatter factor (SF), is known to act on cancer cells as well as endothelial cells and stimulate angiogenesis, thus playing an unwanted role in the development and progression of cancer.  The current study examd. the effects of a newly discovered HGF variant, NK4, on angiogenesis in vitro.  Chem. generated NK4 (from recombinant human HGF/SF) was found to inhibit HGF-induced activation (tyrosine phosphorylation) of the HGF/SF receptor cMET but was itself unable to activate cMET.  Furthermore, NK4 was demonstrated to inhibit tubule formation from human umbilical vein endothelial cells that was induced by both HGF/SF and a HGF/SF-producing fibroblast (MRC5).  Under the same settings, NK4 failed to increase tubular formation.  NK4 had no effects on interleukin 8- and vascular endothelial growth factor-induced tubule formation.  Using computer-assisted motion anal., it was further shown that NK4 inhibited HGF-induced migration of human umbilical vein endothelial cells in a migration assay and in an endothelial wounding assay.  These data show that NK4 is a complete antagonist to HGF.  It inhibits HGF-induced endothelial movement and tubule formation.  Thus, NK4 may have an important bearing on the control of cancer progression through its role in angiogenesis.  Addnl. in vivo studies are warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbJbSJJXcJtbVg90H21EOLACvtfcHk0ljltfbR-DHXdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXotV2gt7k%253D&md5=de6a575d337dd65a9a92dadd02933067</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DW.%2BG.%26aulast%3DHiscox%26aufirst%3DS.%2BE.%26aulast%3DParr%26aufirst%3DC.%26aulast%3DMartin%26aufirst%3DT.%2BA.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DT.%26aulast%3DMansel%26aufirst%3DR.%2BE.%26atitle%3DAntagonistic%2520effect%2520of%2520NK4%252C%2520a%2520novel%2520hepatocyte%2520growth%2520factor%2520variant%252C%2520on%2520in%2520vitro%2520angiogenesis%2520of%2520human%2520vascular%2520endothelial%2520cells%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D1999%26volume%3D5%26spage%3D3695%26epage%3D3703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Parr, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansel, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, W. G.</span><span> </span><span class="NLM_article-title">Matriptase-2 inhibits breast tumor growth and invasion and correlates with favorable prognosis for breast cancer patients</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">3568</span><span class="NLM_x">–</span> <span class="NLM_lpage">3576</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1158%2F1078-0432.CCR-06-2357" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=17575220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFCqtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=3568-3576&author=C.+Parrauthor=A.+J.+Sandersauthor=G.+Daviesauthor=T.+Martinauthor=J.+Laneauthor=M.+D.+Masonauthor=R.+E.+Manselauthor=W.+G.+Jiang&title=Matriptase-2+inhibits+breast+tumor+growth+and+invasion+and+correlates+with+favorable+prognosis+for+breast+cancer+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Matriptase-2 Inhibits Breast Tumor Growth and Invasion and Correlates with Favorable Prognosis for Breast Cancer Patients</span></div><div class="casAuthors">Parr, Christian; Sanders, Andrew J.; Davies, Gaynor; Martin, Tracey; Lane, Jane; Mason, Malcolm D.; Mansel, Robert E.; Jiang, Wen G.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3568-3576</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The type II transmembrane serine proteases are cell surface proteolytic enzymes that mediate a diverse range of cellular functions, including tumor invasion and metastasis.  Matriptase (matriptase-1) and matriptase-2 belong to the type II transmembrane serine protease family.  Matriptase-1 is known to play a role in breast cancer progression, and elevated levels of matriptase-1 correlate with poor patient outcome.  The role of matriptase-2 and its cellular function in cancer is unknown.  This study aimed to provide new insights into the significance of matriptase-2 in cancer.  Matriptase-2 expression levels were assessed in a cohort of human breast cancer specimens (normal, n = 34; cancer, n = 95), in assocn. with patient clin. variables, using both quant. and qual. anal. of the matriptase-2 transcript along with immunohistochem. techniques.  Matriptase-2 was also exptl. overexpressed in the MDA-MB-231 human breast cancer cell line.  The effects of matriptase-2 overexpression were examd. through a series of in vitro and in vivo studies.  Here, we show that reduced matriptase-2 levels in breast cancer tissues correlate with an overall poor prognosis for the breast cancer patient.  This study also reveals that matriptase-2 overexpression in breast cancer cells significantly suppressed tumorigenesis in CD1 athymic mice (P = 0.000003).  Furthermore, we report that matriptase-2 overexpression dramatically reduced the invasive (P = 0.0001) and migratory properties (P = 0.01) of the breast cancer cells.  Matriptase-2 suppresses breast tumor development in vivo, displays prognostic value for breast cancer patients, inhibits both breast cancer cell invasion and motility in vitro, and may play a contrasting role to matriptase-1 in breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFR5QXQ23yk7Vg90H21EOLACvtfcHk0lhPp3BCIRKLUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFCqtbg%253D&md5=6cd783acd4c46f92c6d94176f21b88c3</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-2357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-2357%26sid%3Dliteratum%253Aachs%26aulast%3DParr%26aufirst%3DC.%26aulast%3DSanders%26aufirst%3DA.%2BJ.%26aulast%3DDavies%26aufirst%3DG.%26aulast%3DMartin%26aufirst%3DT.%26aulast%3DLane%26aufirst%3DJ.%26aulast%3DMason%26aufirst%3DM.%2BD.%26aulast%3DMansel%26aufirst%3DR.%2BE.%26aulast%3DJiang%26aufirst%3DW.%2BG.%26atitle%3DMatriptase-2%2520inhibits%2520breast%2520tumor%2520growth%2520and%2520invasion%2520and%2520correlates%2520with%2520favorable%2520prognosis%2520for%2520breast%2520cancer%2520patients%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D3568%26epage%3D3576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Dontu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNicholas, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamura, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdallah, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wicha, M. S.</span><span> </span><span class="NLM_article-title">Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells</span> <span class="citation_source-journal">Breast Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">R605</span><span class="NLM_x">–</span> <span class="NLM_lpage">615</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1186%2Fbcr920" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=15535842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvVeiurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=R605-615&author=G.+Dontuauthor=K.+W.+Jacksonauthor=E.+McNicholasauthor=M.+J.+Kawamuraauthor=W.+M.+Abdallahauthor=M.+S.+Wicha&title=Role+of+Notch+signaling+in+cell-fate+determination+of+human+mammary+stem%2Fprogenitor+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells</span></div><div class="casAuthors">Dontu, Gabriela; Jackson, Kyle W.; McNicholas, Erin; Kawamura, Mari J.; Abdallah, Wissam M.; Wicha, Max S.</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">R605-R615</span>CODEN:
                <span class="NLM_cas:coden">BRCRFS</span>;
        ISSN:<span class="NLM_cas:issn">1465-542X</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Introduction Notch signaling has been implicated in the regulation of cell-fate decisions such as self-renewal of adult stem cells and differentiation of progenitor cells along a particular lineage.  Moreover, depending on the cellular and developmental context, the Notch pathway acts as a regulator of cell survival and cell proliferation.  Abnormal expression of Notch receptors has been found in different types of epithelial metaplastic lesions and neoplastic lesions, suggesting that Notch may act as a proto-oncogene.  The vertebrate Notch 1 and Notch4 homologs are involved in normal development of the mammary gland, and mutated forms of these genes are assocd. with development of mouse mammary tumors.  In order to det. the role of Notch signaling in mammary cell-fate detn., we have utilized a newly described in vitro system in which mammary stem/progenitor cells can be cultured in suspension as nonadherent 'mammospheres'.  Notch signaling was activated using exogenous ligands, or was inhibited using previously characterized Notch signaling antagonists.  Results Utilizing this system, we demonstrate that Notch signaling can act on mammary stem cells to promote self-renewal and on early progenitor cells to promote their proliferation, as demonstrated by a 10-fold increase in secondary mammosphere formation upon addn. of a Notch-activating DSL peptide.  In addn. to acting on stem cells, Notch signaling is also able to act on multipotent progenitor cells, facilitating myoepithelial lineage-specific commitment and proliferation.  Stimulation of this pathway also promotes branching morphogenesis in three-dimensional Matrigel cultures.  These effects are completely inhibited by a Notch4 blocking antibody or a gamma secretase inhibitor that blocks Notch processing.  In contrast to the effects of Notch signaling on mammary stem/progenitor cells, modulation of this pathway has no discernnable effect on fully committed, differentiated, mammary epithelial cells.  These studies suggest that Notch signaling plays a crit. role in normal human mammary development by acting on both stem cells and progenitor cells, affecting self-renewal and lineage-specific differentiation.  Based on these findings we propose that abnormal Notch signaling may contribute to mammary carcinogenesis by deregulating the self-renewal of normal mammary stem cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5GmDtqIH64bVg90H21EOLACvtfcHk0ljnRpqjjMAPcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvVeiurk%253D&md5=2e81b1a4529e7a36ba92289beb6c2642</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1186%2Fbcr920&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fbcr920%26sid%3Dliteratum%253Aachs%26aulast%3DDontu%26aufirst%3DG.%26aulast%3DJackson%26aufirst%3DK.%2BW.%26aulast%3DMcNicholas%26aufirst%3DE.%26aulast%3DKawamura%26aufirst%3DM.%2BJ.%26aulast%3DAbdallah%26aufirst%3DW.%2BM.%26aulast%3DWicha%26aufirst%3DM.%2BS.%26atitle%3DRole%2520of%2520Notch%2520signaling%2520in%2520cell-fate%2520determination%2520of%2520human%2520mammary%2520stem%252Fprogenitor%2520cells%26jtitle%3DBreast%2520Cancer%2520Res.%26date%3D2004%26volume%3D6%26spage%3DR605%26epage%3D615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Singh, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yadav, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dwivedi, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishra, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurjar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manhas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yadav, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagavelu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddiqi, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trivedi, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chattopadhyay, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanyal, S.</span><span> </span><span class="NLM_article-title">Synthetic FXR agonist GW4064 is a modulator of multiple G protein-coupled receptors</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">659</span><span class="NLM_x">–</span> <span class="NLM_lpage">673</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Fjm500873e&amp;key=10.1210%2Fme.2013-1353" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Fjm500873e&amp;key=24597548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Fjm500873e&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVKjtbnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2014&pages=659-673&author=N.+Singhauthor=M.+Yadavauthor=A.+K.+Singhauthor=H.+Kumarauthor=S.+K.+Dwivediauthor=J.+S.+Mishraauthor=A.+Gurjarauthor=A.+Manhasauthor=S.+Chandraauthor=P.+N.+Yadavauthor=K.+Jagaveluauthor=M.+I.+Siddiqiauthor=A.+K.+Trivediauthor=N.+Chattopadhyayauthor=S.+Sanyal&title=Synthetic+FXR+agonist+GW4064+is+a+modulator+of+multiple+G+protein-coupled+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic FXR agonist GW4064 is a modulator of multiple G protein-coupled receptors</span></div><div class="casAuthors">Singh, Nidhi; Yadav, Manisha; Singh, Abhishek Kumar; Kumar, Harish; Dhar Dwivedi, Shailendra Kumar; Mishra, Jay Sharan; Gurjar, Anagha; Manhas, Amit; Chandra, Sharat; Yadav, Prem Narayan; Jagavelu, Kumaravelu; Siddiqi, Mohammad Imran; Trivedi, Arun Kumar; Chattopadhyay, Naibedya; Sanyal, Sabyasachi</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">659-673, 15 pp.</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">1944-9917</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">The synthetic nuclear bile acid receptor (farnesoid X receptor [FXR]) agonist GW4064 is extensively used as a specific pharmacol. tool to illustrate FXR functions.  We noticed that GW4064 activated empty luciferase reporters in FXR-deficient HEK-293T cells.  We postulated that this activity of GW4064 might be routed through as yet unknown cellular targets and undertook an unbiased exploratory approach to identify these targets.  Investigations revealed that GW4064 activated cAMP and nuclear factor for activated T-cell response elements (CRE and NFAT-RE, resp.) present on these empty reporters.  Whereas GW4064-induced NFAT-RE activation involved rapid intracellular Ca2+ accumulation and NFAT nuclear translocation, CRE activation involved sol. adenylyl cyclase-dependent cAMP accumulation and Ca2+-calcineurin-dependent nuclear translocation of transducers of regulated CRE-binding protein 2.  Use of dominant neg. heterotrimeric G-protein minigenes revealed that GW4064 caused activation of Gαi/o and Gq/11 G proteins.  Sequential pharmacol. inhibitor-based screening and radioligand-binding studies revealed that GW4064 interacted with multiple G protein-coupled receptors.  Functional studies demonstrated that GW4064 robustly activated H1 and H4 and inhibited H2 histamine receptor signaling events.  We also found that MCF-7 breast cancer cells, reported to undergo GW4064-induced apoptosis in an FXR-dependent manner, did not express FXR, and the GW4064-mediated apoptosis, also apparent in HEK-293T cells, could be blocked by selective histamine receptor regulators.  Taken together, our results demonstrate identification of histamine receptors as alternate targets for GW4064, which not only necessitates cautious interpretation of the biol. functions attributed to FXR using GW4064 as a pharmacol. tool but also provides a basis for the rational designing of new pharmacophores for histamine receptor modulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqv4YF4HG2QrVg90H21EOLACvtfcHk0liiYSG0pYUY6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVKjtbnM&md5=d4eb9b7e8acacbf1697c0febf505408b</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1210%2Fme.2013-1353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2013-1353%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DN.%26aulast%3DYadav%26aufirst%3DM.%26aulast%3DSingh%26aufirst%3DA.%2BK.%26aulast%3DKumar%26aufirst%3DH.%26aulast%3DDwivedi%26aufirst%3DS.%2BK.%26aulast%3DMishra%26aufirst%3DJ.%2BS.%26aulast%3DGurjar%26aufirst%3DA.%26aulast%3DManhas%26aufirst%3DA.%26aulast%3DChandra%26aufirst%3DS.%26aulast%3DYadav%26aufirst%3DP.%2BN.%26aulast%3DJagavelu%26aufirst%3DK.%26aulast%3DSiddiqi%26aufirst%3DM.%2BI.%26aulast%3DTrivedi%26aufirst%3DA.%2BK.%26aulast%3DChattopadhyay%26aufirst%3DN.%26aulast%3DSanyal%26aufirst%3DS.%26atitle%3DSynthetic%2520FXR%2520agonist%2520GW4064%2520is%2520a%2520modulator%2520of%2520multiple%2520G%2520protein-coupled%2520receptors%26jtitle%3DMol.%2520Endocrinol.%26date%3D2014%26volume%3D28%26spage%3D659%26epage%3D673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Spears, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sneyd, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loten, E. G.</span><span> </span><span class="NLM_article-title">A method for deriving kinetic constants for two enzymes acting on the same substrate</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">1149</span><span class="NLM_x">–</span> <span class="NLM_lpage">1151</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=1971&pages=1149-1151&author=G.+Spearsauthor=J.+G.+Sneydauthor=E.+G.+Loten&title=A+method+for+deriving+kinetic+constants+for+two+enzymes+acting+on+the+same+substrate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSpears%26aufirst%3DG.%26aulast%3DSneyd%26aufirst%3DJ.%2BG.%26aulast%3DLoten%26aufirst%3DE.%2BG.%26atitle%3DA%2520method%2520for%2520deriving%2520kinetic%2520constants%2520for%2520two%2520enzymes%2520acting%2520on%2520the%2520same%2520substrate%26jtitle%3DBiochem.%2520J.%26date%3D1971%26volume%3D125%26spage%3D1149%26epage%3D1151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Foltyn, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zehl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dikopoltsev, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, O. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolosker, H.</span><span> </span><span class="NLM_article-title">Phosphorylation of mouse serine racemase regulates D-serine synthesis</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">584</span><span class="NLM_x">, </span> <span class="NLM_fpage">2937</span><span class="NLM_x">–</span> <span class="NLM_lpage">2941</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=584&publication_year=2010&pages=2937-2941&author=V.+N.+Foltynauthor=M.+Zehlauthor=E.+Dikopoltsevauthor=O.+N.+Jensenauthor=H.+Wolosker&title=Phosphorylation+of+mouse+serine+racemase+regulates+D-serine+synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFoltyn%26aufirst%3DV.%2BN.%26aulast%3DZehl%26aufirst%3DM.%26aulast%3DDikopoltsev%26aufirst%3DE.%26aulast%3DJensen%26aufirst%3DO.%2BN.%26aulast%3DWolosker%26aufirst%3DH.%26atitle%3DPhosphorylation%2520of%2520mouse%2520serine%2520racemase%2520regulates%2520D-serine%2520synthesis%26jtitle%3DFEBS%2520Lett.%26date%3D2010%26volume%3D584%26spage%3D2937%26epage%3D2941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i42"><a href="/doi/suppl/10.1021/jm500873e">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_30168"></div></div></div></div></div><hr /></hr><p class="last">Synthetic scheme, spectral data (<sup>1</sup>H NMR and <sup>13</sup>C NMR) for characterization of compounds, and biological results.This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm500873e/suppl_file/jm500873e_si_001.pdf">jm500873e_si_001.pdf (538.14 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm500873e&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-19%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Fjm500873e%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm500873e" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                9MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67990d0328d63d94","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
